Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003785	s-cea	ug/l (ug/l)	21031	75196	0.00%
3003785	p-cea	ug/l (ug/l)	10935	42488	3.58%
3003785	s-cea	— (—)	9432	22549	100.00%	Distribution not available
3003785	p-cea	— (—)	4940	10504	100.00%	Distribution not available
3003785	s-ceakym	ug/l (—)	118	141	100.00%	Distribution not available
3003785	s-karsinoembryonaalinenantigeeni	ug/l (—)	101	124	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Benign neoplasm of other and ill-defined parts of digestive system

1765

6966

3.03

320.41

3.3

4.0

4.84

25.19

ug/l

6.04

1400

5670

General symptoms and signs

7569

23374

1.69

319.70

4.1

4.0

29.23

23.47

ug/l

0.48

6117

18454

Complications of medical and surgical care

5365

29789

1.82

319.39

4.6

3.8

22.03

25.38

ug/l

0.20

4392

23821

Tramadol

5542

20574

1.82

317.13

3.8

24.04

18.41

ug/l

0.63

4560

16081

Benign neoplasm: Rectum

1766

7037

3.02

315.58

4.9

4.0

12.24

25.64

ug/l

2.19

1495

5794

Constipation

6453

28195

1.73

311.97

4.0

18.80

26.82

ug/l

0.78

5217

22693

Nausea and vomiting

2032

8354

2.64

310.84

4.8

3.9

23.54

19.99

ug/l

0.26

1698

6721

Iron deficiency anaemia

3271

16479

2.15

310.41

4.1

3.8

16.08

22.91

ug/l

0.89

2720

13322

Family history of malignant neoplasm

1050

3125

4.08

310.26

5.3

3.9

6.91

35.92

ug/l

1.56

800

2426

Pleural effusion

1548

5807

3.21

310.23

3.4

4.1

16.84

19.57

ug/l

0.29

1297

4824

Diseases of liver

2759

13244

2.32

309.34

3.6

4.1

9.46

27.64

ug/l

5.02

2248

10753

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

284

237

22.88

308.19

4.6

1.4

127.94

3.98

ug/l

2.96

252

188

GASTRO-related operations

7040

7544

5.17

307.65

4.5

1.7

28.51

21.80

ug/l

0.49

5621

5363

Complications of surgical and medical care, not elsewhere classified

7545

29968

1.93

307.65

4.5

3.8

21.37

25.87

ug/l

0.38

6163

23806

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

535

722

10.05

307.65

3.6

1.4

64.30

3.73

ug/l

4.22

445

543

First line medication for Crohn's disease

8380

24633

1.96

307.65

4.8

3.6

32.15

21.14

ug/l

1.27

6864

19257

Carcinoma in situ of other and unspecified digestive organs

442

358

25.24

307.65

5.5

1.5

18.82

3.71

ug/l

1.37

375

274

Any gastric operation

7040

7544

5.17

307.65

4.5

1.7

28.51

21.80

ug/l

0.49

5621

5363

Symptoms and signs involving the digestive system and abdomen

7674

20197

2.01

307.65

4.0

29.17

25.59

ug/l

0.25

6223

16112

Colon adenocarcinoma

3380

4225

27.13

307.65

9.4

3.4

31.22

21.39

ug/l

1.01

3131

3458

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2697

7370

2.72

307.65

3.7

1.5

13.45

8.71

ug/l

0.83

2201

5570

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2724

7456

2.71

307.65

3.7

1.5

13.35

8.71

ug/l

0.82

2219

5635

Benign neoplasm of colon, rectum, anus and anal canal

6532

24138

2.84

307.65

4.5

3.9

17.26

28.13

ug/l

1.29

5456

19685

Complications of procedures, not elsewhere classified

6130

29398

1.93

307.65

4.6

3.8

24.22

25.81

ug/l

0.09

5020

23397

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

1284

989

27.10

307.65

5.5

1.4

31.12

4.05

ug/l

3.70

1158

750

Colitis, primary sclerosing, strict definition

320

214

79.66

307.65

8.4

4.5

2.46

27.08

ug/l

0.65

259

174

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1944

4569

4.83

307.65

3.2

1.5

13.80

8.28

ug/l

0.79

1428

3395

Other diseases of pancreas

1160

2404

7.50

307.65

3.5

4.0

6.38

23.54

ug/l

2.87

969

1957

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

2288

3475

6.92

307.65

3.4

1.4

58.29

7.59

ug/l

5.79

2089

2620

Primary_lymphoid and hematopoietic malignant neoplasms

1492

4324

3.86

307.65

2.8

1.5

9.60

6.69

ug/l

0.39

1121

3260

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

735

1035

9.96

307.65

4.4

1.4

98.07

3.40

ug/l

3.35

679

782

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

3189

8324

2.82

307.65

3.7

1.5

13.26

9.71

ug/l

0.59

2555

6241

Benign neoplasm: Sigmoid colon

1655

3216

6.37

307.65

4.4

1.5

29.30

7.48

ug/l

0.60

1402

2439

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

5615

3541

51.34

307.65

8.6

1.4

32.70

7.11

ug/l

5.32

5132

2675

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

448

438

17.03

307.65

4.9

1.4

10.49

3.55

ug/l

1.27

370

333

Benign neoplasm of other and ill-defined parts of digestive system

1765

3055

7.33

307.65

3.3

1.4

4.84

8.21

ug/l

0.39

1400

2270

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2795

7568

2.73

307.65

3.7

1.5

13.52

9.99

ug/l

0.54

2267

5708

Chronic pancreatitis

1574

3908

5.44

307.65

5.8

4.3

17.59

28.28

ug/l

0.81

1436

3233

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

5436

6168

7.29

307.65

3.8

1.5

13.26

9.53

ug/l

0.60

4101

4487

Benign neoplasm: Ascending colon

1168

2233

6.56

307.65

4.5

1.4

7.92

9.01

ug/l

0.07

1000

1663

Other and unspecified anaemias

3561

16662

2.30

307.65

3.9

32.04

24.56

ug/l

0.37

2982

13730

Opioids

6764

21043

1.76

307.65

4.3

3.8

35.46

18.17

ug/l

2.14

5521

16337

Anaemias

1913

1820

7.91

307.65

4.5

2.0

25.63

8.07

ug/l

2.48

1551

1214

Abnormal findings on diagnostic imaging of lung

4326

19984

2.37

307.65

3.6

4.1

20.09

25.42

ug/l

0.74

3714

16362

Benign neoplasm: Caecum

982

1709

7.46

307.65

4.4

1.5

5.34

10.84

ug/l

0.36

832

1271

Benign neoplasms

7029

20628

2.01

307.65

3.9

4.0

20.60

31.09

ug/l

1.09

5630

16345

Benign neoplasm of colon, rectum, anus and anal canal

6114

7573

7.08

307.65

4.6

1.5

16.73

10.09

ug/l

0.57

5104

5602

Benign neoplasms

5090

6519

4.79

307.65

4.0

1.6

22.93

10.59

ug/l

0.94

4036

4610

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

433

387

18.21

307.65

6.5

1.4

27.92

3.70

ug/l

2.65

406

300

Diseases of oesophagus, stomach and duodenum

7701

28075

1.75

307.65

3.5

4.1

15.63

26.93

ug/l

3.21

6137

22400

Adenocarcinoma and papilloma adenocarcinoma of rectum

2748

3287

32.96

307.65

10.2

3.5

35.21

21.46

ug/l

0.62

2523

2704

Malignant neoplasm, wide definition for exclusion

12202

11207

8.02

307.65

5.3

1.6

29.97

9.36

ug/l

5.58

9886

8141

Nutritional anaemias

3888

19635

2.10

307.65

4.2

3.8

16.04

23.17

ug/l

1.16

3249

15910

Abdominal and pelvic pain

7352

20196

1.93

307.65

3.9

4.0

21.31

25.59

ug/l

0.50

5904

16111

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

5862

25579

2.37

307.65

3.6

4.1

20.09

26.74

ug/l

1.02

4946

20677

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

1005

953

17.50

307.65

5.8

1.4

27.76

4.06

ug/l

4.39

905

721

Any event in cancer register

11484

13961

5.86

307.65

5.4

2.0

29.03

14.79

ug/l

2.77

9376

10347

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

3380

2060

58.50

307.65

9.4

1.4

31.22

9.26

ug/l

2.50

3131

1552

Benign neoplasm: Pancreas

433

380

22.01

307.65

3.6

1.5

2.83

3.63

ug/l

0.51

363

287

Lung cancer and mesothelioma

2352

6794

3.67

307.65

3.3

4.3

54.39

24.23

ug/l

2.50

2135

5606

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

12201

11200

8.03

307.65

5.3

1.6

29.80

9.37

ug/l

5.51

9885

8135

Any reimbursement code in KELA

3450

6176

2.95

307.65

4.5

2.4

31.52

13.28

ug/l

0.96

2693

4379

Other bacterial diseases

8054

27285

2.22

307.65

4.6

3.9

32.65

23.23

ug/l

1.08

6732

21643

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

1734

1365

26.24

307.65

6.0

1.4

62.41

3.69

ug/l

2.70

1618

1023

Aplastic and other anaemias

3847

17891

2.26

307.65

3.8

3.9

31.86

23.88

ug/l

0.44

3223

14723

Disorders of gallbladder, biliary tract and pancreas

8625

27381

2.21

307.65

4.2

3.9

19.28

27.31

ug/l

1.36

7091

21736

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

665

496

30.11

307.65

7.9

1.4

107.87

3.60

ug/l

1.59

640

376

Cholangitis (primary sclerosing, PSC), with reimbursement 202

490

441

39.26

307.65

8.0

4.3

2.95

16.75

ug/l

0.82

391

365

Follow-up examination after treatment for malignant neoplasms

1345

4027

4.32

307.65

6.1

4.2

12.20

22.96

ug/l

1.03

1157

3293

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

1058

1120

15.93

307.65

2.4

1.4

6.95

13.96

ug/l

0.29

773

832

Right hemicolectomy

1139

2036

10.57

307.65

7.6

3.8

13.96

22.81

ug/l

0.71

1029

1695

Ascites

1144

2231

8.00

307.65

4.2

4.0

64.40

28.47

ug/l

0.64

948

1820

Benign neoplasm: Rectum

1766

3099

7.28

307.65

4.9

1.5

12.24

7.70

ug/l

0.48

1495

2330

Leiomyoma of uterus

2513

5102

2.97

307.65

3.3

1.6

20.69

9.16

ug/l

1.12

1890

3655

Neoplasms

6285

5442

6.87

307.65

4.7

1.6

31.77

9.82

ug/l

2.58

4921

3837

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

665

530

24.38

307.65

4.9

1.4

40.24

4.62

ug/l

2.44

608

397

Benign neoplasm: Transverse colon

872

1655

6.60

307.65

4.6

1.4

8.80

11.15

ug/l

0.12

748

1229

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

489

389

25.12

307.65

7.3

1.4

142.63

3.84

ug/l

1.52

468

292

Cholangitis (primary sclerosing, PSC)

1097

1754

10.74

307.65

6.6

4.1

10.26

26.92

ug/l

1.37

931

1434

Malignant neoplasm of breast, HER2-negative

5614

14153

3.52

307.65

3.9

3.6

14.00

24.74

ug/l

2.14

4313

11174

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

3726

2179

64.39

307.65

9.2

1.4

30.79

9.09

ug/l

1.53

3386

1639

Benign neoplasm: Rectum, anus and anal canal

1914

3564

6.72

307.65

4.8

1.5

11.67

7.43

ug/l

0.51

1611

2683

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

629

1067

7.49

307.65

3.1

1.4

5.89

14.63

ug/l

0.35

460

795

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

4105

5513

7.95

307.65

4.1

1.5

14.28

9.77

ug/l

0.66

3174

4058

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6690

27492

1.74

307.65

4.5

3.9

19.75

27.42

ug/l

1.26

5438

21760

Other diseases of biliary tract

1405

2812

7.90

307.65

5.9

3.9

24.49

25.63

ug/l

0.05

1255

2291

Other benign neoplasms of skin

1879

7028

2.82

307.65

3.6

1.5

15.04

9.03

ug/l

0.68

1530

5228

Benign neoplasm: Colon, unspecified

2076

4450

5.57

307.65

4.1

1.5

17.37

9.88

ug/l

0.71

1733

3354

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

505

474

22.63

307.65

2.0

1.4

6.95

3.24

ug/l

0.84

304

355

L02BG Aromatase inhibitors

3355

11748

3.57

307.65

4.4

3.7

14.38

21.67

ug/l

1.42

2670

9394

Oxycodone

4931

13748

4.45

307.65

5.7

3.9

59.74

20.06

ug/l

5.82

4389

11137

Medicines for HER+ breast cancer

4229

13845

3.69

307.65

4.1

3.7

14.13

25.42

ug/l

2.14

3264

10993

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

841

1533

9.97

307.65

5.5

3.9

34.97

23.60

ug/l

0.44

763

1299

Malignant neoplasm of breast, HER-positive

4054

13442

3.72

307.65

4.1

3.7

13.90

24.27

ug/l

1.91

3135

10671

Benign neoplasm: Colon

5307

22627

2.66

307.65

4.4

3.9

18.30

25.53

ug/l

0.58

4454

18568

Colorectal adenocarcinoma

6073

6886

31.98

307.65

9.7

2.8

33.15

20.74

ug/l

1.30

5602

5555

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

5431

6168

7.28

307.65

3.8

1.5

13.27

9.53

ug/l

0.60

4097

4487

Hernia of abdominal wall, postoperative

1683

2892

7.03

307.65

5.8

1.7

12.45

22.64

ug/l

0.92

1442

2139

Artificial opening status

943

1698

9.85

307.65

9.2

4.1

13.42

23.48

ug/l

0.92

829

1419

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

6073

3613

63.62

307.65

9.7

1.4

33.15

7.32

ug/l

4.19

5602

2720

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1707

2653

7.80

307.65

3.7

1.4

58.22

8.60

ug/l

3.84

1561

1998

Other medical care

5962

15163

5.06

307.65

5.2

3.8

68.52

14.29

ug/l

10.62

5272

12197

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8399

28701

2.28

307.65

4.1

3.9

24.54

25.26

ug/l

0.05

6876

22742

Adenocarcinoma and ductal carcinoma of pancreas

665

1139

12.35

307.65

7.9

4.0

107.87

23.37

ug/l

1.13

640

952

Malignant neoplasm of colon

4144

5233

23.89

307.65

9.2

3.2

31.79

21.76

ug/l

1.03

3828

4249

IBD (strict) with PSC

317

183

134.92

307.65

9.0

4.5

2.43

32.96

ug/l

0.68

252

145

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

2993

1710

72.79

307.65

10.1

1.4

33.30

3.64

ug/l

2.51

2743

1279

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

420

276

38.27

307.65

7.3

1.3

35.11

3.94

ug/l

1.69

393

206

Malignant neoplasm of pancreas

1136

2124

9.48

307.65

6.3

3.8

76.94

21.94

ug/l

1.26

1068

1775

Laparoscopic right hemicolectomy

1608

1955

51.58

307.65

7.9

3.8

5.48

22.63

ug/l

2.70

1460

1606

Malignant neoplasm of breast

5864

14094

3.64

307.65

3.9

3.7

14.10

24.66

ug/l

2.08

4477

11139

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

733

422

57.91

307.65

9.5

1.4

22.59

3.60

ug/l

2.23

643

315

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

13132

7242

35.92

307.65

7.5

1.5

37.18

8.88

ug/l

8.15

11908

5478

Malignant neoplasm

12289

13039

6.96

307.65

5.5

1.8

33.31

11.61

ug/l

5.39

10019

9633

Malignant neoplasm of digestive organs

10497

12129

19.95

307.65

8.2

2.2

39.04

16.84

ug/l

4.56

9614

9587

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

8087

7529

15.37

307.65

7.3

1.5

70.34

8.74

ug/l

15.60

7249

5669

Ulcerative colitis (strict) with PSC

259

147

140.60

307.65

9.2

4.5

2.47

9.59

ug/l

1.37

204

117

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1915

3600

6.68

307.65

2.7

1.5

6.78

9.12

ug/l

0.27

1402

2699

Other diseases of intestines

8219

23596

2.16

307.65

4.2

3.9

16.07

29.84

ug/l

3.94

6606

18593

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

1570

2517

8.08

307.65

5.1

1.5

24.79

8.59

ug/l

1.72

1343

1886

Malignant neoplasm of stomach

798

1708

7.19

307.65

6.0

3.9

28.18

19.27

ug/l

0.53

726

1435

Diverticular disease of intestine

5815

20478

2.04

307.65

3.4

3.9

13.69

31.95

ug/l

5.27

4714

16583

Colorectal cancer

7070

8046

28.45

307.65

9.5

2.6

32.71

23.32

ug/l

0.87

6510

6464

Bacterial infection, other or unspecified

5127

19551

2.69

307.65

5.0

3.9

40.34

23.71

ug/l

1.51

4376

15870

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

524

584

15.24

307.65

1.9

1.4

3.94

3.73

ug/l

0.07

380

438

Colectomy operation

3930

5976

14.02

307.65

7.8

3.5

9.74

25.62

ug/l

4.10

3516

4848

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

2895

1648

72.80

307.65

10.0

1.4

33.90

3.69

ug/l

2.45

2652

1233

Colorectal cancer, excluding all cancers (controls excluding all cancers)

8772

5248

55.14

307.65

8.7

1.5

33.05

10.19

ug/l

4.16

7990

3984

Other or unspecified ileus, impaction or obstruction

2102

6397

4.06

307.65

6.4

3.9

17.50

27.99

ug/l

1.41

1801

5280

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

2521

3959

6.66

307.65

3.3

1.5

51.49

10.32

ug/l

4.49

2272

3007

L02BA Anti-estrogens

1958

6260

3.98

307.65

5.1

3.6

15.78

22.12

ug/l

0.62

1502

4924

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

4168

3222

29.89

307.65

8.7

1.5

87.43

7.51

ug/l

9.42

3820

2430

Persons encountering health services for specific procedures and health care

9293

25925

2.41

307.65

4.4

3.8

42.13

16.31

ug/l

5.46

7741

20162

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

2869

3419

33.34

307.65

10.2

3.5

34.33

20.88

ug/l

0.64

2635

2803

Paralytic ileus and intestinal obstruction

2759

9421

3.50

307.65

6.1

3.9

14.80

25.23

ug/l

2.24

2346

7733

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

12208

11200

8.04

307.65

5.3

1.6

29.79

9.37

ug/l

5.50

9892

8135

Malignant neoplasm of rectum

2671

3301

28.54

307.65

10.0

3.5

36.78

21.33

ug/l

0.71

2459

2703

Colitis, primary sclerosing

410

297

68.49

307.65

8.3

4.4

2.53

21.08

ug/l

0.69

329

239

Intestinal stricture

3421

12164

3.41

307.65

6.2

3.8

14.55

26.12

ug/l

2.25

2900

9961

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

4326

4316

17.67

307.65

7.8

1.5

79.27

9.94

ug/l

8.48

3953

3263

Laparoscopic left hemicolectomy

450

582

32.98

307.65

8.9

4.4

13.96

32.56

ug/l

0.62

412

488

Other symptoms and signs involving the digestive system and abdomen

1540

5460

3.28

307.65

3.3

3.8

30.99

19.82

ug/l

0.22

1254

4300

Non-small cell lung cancer

1707

6074

3.43

307.65

3.7

4.0

58.22

21.33

ug/l

2.42

1561

5013

Benign neoplasm: Colon

5215

7295

6.72

307.65

4.4

1.5

17.87

10.36

ug/l

0.57

4378

5434

Other anaemias

3598

16808

2.30

307.65

3.8

3.9

31.77

24.47

ug/l

0.36

3012

13838

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

905

2287

4.55

307.65

2.5

1.5

10.88

9.21

ug/l

0.10

658

1708

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

517

382

27.47

307.65

4.2

1.4

4.47

3.75

ug/l

0.25

451

290

In situ neoplasms

2445

6522

4.02

307.65

3.9

1.5

17.98

7.34

ug/l

1.93

1971

4816

Fever of other and unknown origin

4511

19317

2.36

307.65

5.1

4.0

30.32

23.22

ug/l

0.78

3717

15444

Benign neoplasm of ovary

1119

3231

3.91

307.65

3.1

1.5

15.54

10.06

ug/l

0.27

869

2401

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1665

3605

3.04

306.58

4.0

1.6

22.86

8.73

ug/l

1.54

1370

2736

Malignant neoplasm of rectosigmoid junction

386

541

22.41

306.31

10.2

4.2

24.16

34.19

ug/l

0.25

347

458

Benign neoplasm: Descending colon

573

1074

6.72

306.05

5.3

1.4

5.83

3.91

ug/l

0.86

483

811

Benign neoplasm: Rectum, anus and anal canal

1914

8027

2.81

304.84

4.8

4.0

11.67

25.16

ug/l

2.61

1611

6612

Malignant neoplasm of liver and intrahepatic bile ducts

543

1035

8.96

304.08

4.4

4.1

30.21

24.88

ug/l

0.14

481

888

Renal tubulo-interstitial diseases

6119

28526

1.74

302.05

4.1

3.9

18.26

26.48

ug/l

1.82

5122

22659

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

244

167

33.48

299.84

5.4

1.5

26.72

4.38

ug/l

0.51

206

130

Adenocarcinoma of pancreas

489

902

10.22

287.74

7.3

4.1

142.63

22.43

ug/l

1.20

468

767

Diseases of the digestive system

3484

18559

2.03

285.41

4.2

3.9

16.58

26.30

ug/l

1.81

2932

15127

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1612

3509

2.97

283.54

3.9

1.5

23.44

8.90

ug/l

1.54

1332

2666

Gastrointestinal diseases

3594

9150

2.05

281.17

4.1

3.7

19.80

39.92

ug/l

1.91

2849

6978

Unspecified jaundice

621

1382

6.04

278.74

5.5

4.1

46.23

18.30

ug/l

1.00

570

1155

Other and unspecified iron deficiency

2532

12287

2.27

274.29

4.1

3.8

12.26

24.21

ug/l

1.89

2096

9910

Examination and observation for other reasons

4254

14395

1.89

271.59

3.7

4.3

16.49

31.30

ug/l

2.13

3384

11472

Benign neoplasm: Liver/bile ducts

281

272

14.69

268.71

2.5

1.5

2.64

2.79

ug/l

0.25

195

207

Septicaemia

3083

15516

2.08

266.91

4.2

3.9

25.52

22.25

ug/l

0.30

2630

12687

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7556

27954

1.61

266.46

4.1

4.0

21.13

26.76

ug/l

0.55

5959

22298

Acute pancreatitis

1633

6720

2.76

264.38

4.1

9.37

22.21

ug/l

3.18

1353

5491

Pneumonias (Asthma/COPD co-morbidities)

6645

29424

1.63

260.39

3.9

4.0

21.59

25.68

ug/l

0.52

5492

23211

Metabolic disorders

6643

26300

1.64

259.60

3.7

4.1

29.39

23.55

ug/l

0.42

5424

20949

Non-follicular lymphoma, hilmo, excluding all cancers

647

1528

4.94

259.05

2.3

1.4

10.52

3.66

ug/l

1.04

452

1134

All pneumoniae

6665

29452

1.63

258.96

3.9

4.0

21.55

25.66

ug/l

0.52

5502

23237

Fentanyl

1031

3395

3.64

258.69

5.7

3.6

32.58

14.37

ug/l

1.72

910

2757

Malignant neoplasm of bronchus and lung

1728

6905

2.69

257.47

3.4

3.9

64.21

20.53

ug/l

3.07

1580

5715

Malignant neoplasm of respiratory system and intrathoracic organs

1932

7958

2.54

257.23

3.3

3.9

58.60

21.12

ug/l

2.79

1740

6582

Influenza and pneumonia

6875

29212

1.61

253.71

3.9

4.0

20.42

25.90

ug/l

0.80

5669

22996

Other septicaemia

2785

14104

2.11

252.65

4.3

3.8

23.52

21.50

ug/l

0.18

2392

11553

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6518

29448

1.62

249.78

3.9

4.1

22.12

25.58

ug/l

0.41

5403

23262

Persons encountering health services in other circumstances, wide

8140

28124

1.56

249.44

4.1

4.0

20.37

26.67

ug/l

0.73

6523

22424

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

748

2014

4.23

249.25

3.1

1.4

16.78

10.07

ug/l

0.41

601

1505

Depression medications

1219

1948

3.27

245.51

3.8

2.1

16.78

7.77

ug/l

1.00

950

1284

Carcinoma in situ of colon

235

214

22.54

243.70

5.4

1.5

14.53

4.26

ug/l

0.95

199

163

Carcinoma in situ of other and unspecified digestive organs

442

873

9.68

243.53

5.5

4.3

18.82

28.49

ug/l

0.35

375

733

Pneumonia, organism unspecified

6061

27963

1.64

242.17

3.9

4.1

20.08

26.52

ug/l

1.06

5039

22170

Other diseases of the digestive system

2487

12591

2.17

240.41

4.1

3.9

19.36

25.42

ug/l

0.70

2091

10390

Benign neoplasm: Liver

251

243

14.71

240.05

2.5

1.5

2.61

2.80

ug/l

0.31

170

184

Malignant neoplasm of ovary

629

1631

5.66

239.80

2.0

3.8

6.56

12.12

ug/l

1.27

459

1312

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

251

252

16.78

239.37

3.1

1.4

3.61

3.96

ug/l

0.10

172

193

Benign neoplasm: Sigmoid colon

1655

7285

2.65

236.05

4.4

4.1

29.30

26.19

ug/l

0.06

1402

6008

6149

24659

1.63

235.40

3.9

4.0

21.45

25.85

ug/l

0.52

5067

19484

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6149

24659

1.63

235.40

3.9

4.0

21.45

25.85

ug/l

0.52

5067

19484

Other functional intestinal disorders

3078

15918

1.97

234.29

3.8

13.91

28.87

ug/l

3.97

2466

12831

Benign lipomatous neoplasm

1370

5391

2.72

233.69

3.5

1.6

16.79

6.82

ug/l

1.12

1099

4003

Non-invasive ventilation

1774

7445

2.47

232.56

5.4

4.5

12.75

27.76

ug/l

1.62

1467

5899

Certain infectious and parasitic diseases

6652

21543

1.60

229.73

4.2

3.9

28.44

25.38

ug/l

0.20

5345

16973

Other diseases of intestine

1108

4064

3.21

229.11

4.9

3.9

18.68

28.52

ug/l

0.72

913

3338

Explicit Sepsis

3148

16695

1.95

228.90

4.3

4.0

27.21

25.36

ug/l

0.14

2678

13656

Abnormal findings on diagnostic imaging of other body structures

1177

4495

3.10

226.68

3.6

4.0

21.52

23.34

ug/l

0.07

943

3588

Hypothyroidism (congenital or acquired)

1051

1896

3.32

226.57

3.7

2.0

24.39

7.94

ug/l

0.79

798

1244

Serous carcinoma of ovary

524

1250

6.70

226.38

1.9

4.0

3.94

13.90

ug/l

2.67

380

1004

Benign neoplasm: Pancreas

433

892

8.79

226.27

3.6

4.2

2.83

25.91

ug/l

1.79

363

741

Other diseases of pleura

3420

17245

1.90

225.56

3.4

4.1

25.13

25.47

ug/l

0.03

2868

14280

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4300

26032

1.75

223.79

4.6

3.8

22.31

23.90

ug/l

0.07

3502

20918

GI-bleeding

2439

12589

2.12

222.55

4.1

3.9

17.99

24.77

ug/l

0.89

2056

10395

Pulmonary embolism

2336

11948

2.16

220.89

5.3

3.9

34.10

22.24

ug/l

1.32

1971

9815

Pulmonary heart disease

2336

11953

2.16

220.63

5.3

3.9

34.10

22.07

ug/l

1.34

1971

9814

Malaise and fatigue

3476

16529

1.86

220.16

3.4

3.9

33.80

22.33

ug/l

1.06

2851

13365

Cholelithiasis, broad definition with cholecystitis

5893

26137

1.62

219.83

3.6

3.9

19.03

27.29

ug/l

1.05

4754

20784

Benign neoplasm: Colon, unspecified

2076

10289

2.28

217.79

4.1

4.0

17.37

25.27

ug/l

0.88

1733

8514

Hypothyroidism and >3 levothyroxin purchases

1031

1891

3.26

217.06

3.7

2.0

24.81

7.95

ug/l

0.79

782

1243

Hypothyroidism, levothyroxine purchases

1031

1891

3.26

217.06

3.7

2.0

24.81

7.95

ug/l

0.79

782

1243

Malignant neoplasm of oesophagus

411

834

8.61

216.85

4.8

4.3

37.13

20.86

ug/l

0.46

375

711

Adenocarcinoma and papillary adenocarcinoma of stomach

433

903

7.41

216.47

6.5

4.1

27.92

28.47

ug/l

0.02

406

768

Venous thromboembolism

3980

23288

1.77

214.60

4.8

3.8

33.83

22.49

ug/l

1.36

3302

19020

Acute pancreatitis (for exclusion)

1633

7390

2.49

213.69

4.1

4.2

9.37

23.34

ug/l

3.55

1353

6091

Benign neoplasm: Stomach

615

1611

4.38

213.68

3.3

1.4

4.27

11.15

ug/l

0.45

490

1205

Intestinal adhesions without obstruction

821

2665

3.76

212.86

6.3

3.8

9.80

26.10

ug/l

2.27

692

2159

DVT of lower extremities and pulmonary embolism

3132

17782

1.90

209.40

5.0

3.8

39.26

22.90

ug/l

1.73

2624

14591

Carcinoma in situ of breast, intraductal

577

1473

4.58

209.01

3.5

1.5

19.97

12.56

ug/l

0.28

446

1087

Benign neoplasm: Small intestine

361

632

7.38

208.31

3.6

1.4

7.92

3.67

ug/l

0.71

297

481

Benign neoplasm: Rectosigmoid junction

357

617

7.41

208.26

4.7

1.4

10.05

3.41

ug/l

1.41

281

469

malignant neoplasm of female genital organs

1395

6047

2.72

207.42

2.5

3.8

5.85

22.00

ug/l

3.68

1028

4879

Non-small cell lung cancer, adenocarcinoma

735

2325

4.17

204.94

4.4

4.0

98.07

23.43

ug/l

2.19

679

1933

Non-small cell lung cancer, adenocarcinoma, helper endpoint

735

2325

4.17

204.94

4.4

4.0

98.07

23.43

ug/l

2.19

679

1933

Pulmonary heart disease, diseases of pulmonary circulation

2464

13147

2.05

204.94

5.2

3.8

32.85

21.60

ug/l

1.32

2069

10815

Secondary uncertain malignant neoplasm

1156

4615

2.94

203.41

3.6

4.0

61.78

22.70

ug/l

2.92

972

3815

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

633

1758

4.08

201.64

3.0

1.4

14.42

10.54

ug/l

0.19

510

1314

Melanocytic naevi

1196

4727

2.68

200.90

3.6

1.6

9.88

7.10

ug/l

0.24

915

3413

Cholelithiasis

5626

25821

1.60

200.43

3.6

3.9

19.70

26.79

ug/l

0.79

4517

20534

L01XE Protein kinase inhibitors

676

2071

4.42

199.69

8.7

4.1

27.39

20.99

ug/l

0.30

607

1703

Total colectomy

476

1136

5.57

196.02

7.1

4.3

8.67

24.50

ug/l

1.21

382

933

Total colectomy operation

476

1136

5.57

196.02

7.1

4.3

8.67

24.50

ug/l

1.21

382

933

Hypothyroidism, drug reimbursement

717

1456

3.74

195.19

3.8

1.9

18.47

9.18

ug/l

0.35

546

990

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

684

2084

3.63

187.06

3.6

1.4

40.53

4.49

ug/l

1.23

571

1581

Fibrosis and cirrhosis of liver

751

2519

3.73

186.73

3.6

4.2

4.76

25.11

ug/l

4.16

636

2074

Malignant melanoma, excluding all cancers (controls excluding all cancers)

871

3080

3.08

184.70

3.7

1.5

11.42

8.26

ug/l

0.24

680

2316

Carcinoma in situ of rectum

157

118

31.70

184.21

6.1

1.3

12.87

5.18

ug/l

0.54

130

Procreative management

1837

7568

2.18

184.13

5.2

3.9

12.48

20.27

ug/l

0.99

1355

5829

Left hemicolectomy

376

812

7.67

183.66

8.4

4.1

11.22

30.04

ug/l

1.02

341

683

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3944

24642

1.69

183.59

4.6

3.9

22.52

23.17

ug/l

0.03

3209

19848

Malignant neoplasm of other and unspecified parts of biliary tract

269

440

13.89

181.92

7.2

4.2

48.42

35.10

ug/l

0.20

252

374

Benign neoplasm of other and unspecified endocrine glands

662

2014

3.63

181.90

3.6

1.5

31.60

10.24

ug/l

0.79

542

1486

Agranulocytosis

978

3810

3.02

180.73

5.8

4.0

27.23

23.06

ug/l

0.24

812

3044

Hepatocellular carcinoma

323

628

8.74

177.36

3.9

4.4

3.78

33.58

ug/l

1.58

280

529

Benign neoplasm: Caecum

982

3921

3.05

176.43

4.4

4.1

5.34

22.88

ug/l

4.55

832

3228

Medical observation and evaluation for suspected diseases and conditions

4504

14521

1.65

175.48

3.5

4.3

18.84

31.40

ug/l

1.71

3578

11574

Benign neoplasm: Adrenal gland

459

1129

4.70

174.19

3.6

1.4

31.85

14.78

ug/l

0.39

385

839

Benign neoplasm: Ascending colon

1168

5084

2.71

172.27

4.5

4.1

7.92

24.64

ug/l

3.96

1000

4181

Drug-induced neutropenia

709

2412

3.66

171.88

5.9

4.1

28.45

22.85

ug/l

0.27

592

1950

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

121

93.24

171.44

11.9

1.4

14.47

7.12

ug/l

0.60

112

Other diseases of anus and rectum

2067

10996

2.02

170.34

4.0

3.9

17.59

27.98

ug/l

1.23

1655

8969

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1182

5174

2.62

169.22

3.5

4.4

10.64

25.36

ug/l

2.72

1042

4320

Inflammatory bowel disease treatment related agents

7248

29039

1.46

168.55

3.6

4.1

23.20

25.48

ug/l

0.23

5819

23029

Parasetamol

4815

15896

1.59

165.57

4.1

4.0

24.73

27.45

ug/l

0.18

3865

12400

ILD medications: prednisolone, methylprednisolone, prednisone

7009

27872

1.47

164.91

3.5

4.2

22.20

25.30

ug/l

0.37

5645

22100

Malignant neoplasm of breast, HER-negative

1562

7690

2.26

164.51

3.4

3.7

14.29

20.33

ug/l

0.71

1179

6178

Oral corticosteroids

6793

28909

1.47

162.83

3.5

4.1

21.44

25.54

ug/l

0.57

5507

22960

Other pleural conditions

904

3635

2.91

156.70

3.4

4.1

29.45

21.92

ug/l

0.31

741

3030

Codeine

5604

20953

1.52

155.39

3.5

3.8

16.59

18.23

ug/l

0.20

4496

16274

Cirrhosis of liver, NAS

537

1661

4.22

154.49

3.3

4.2

5.03

20.43

ug/l

2.25

473

1377

Exclusions for E4_PCOS_CONSORTIUM

4270

17445

1.59

150.37

3.2

3.9

18.21

23.76

ug/l

0.62

3228

13570

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

173

196

13.71

150.08

3.2

1.4

3.44

4.26

ug/l

0.23

135

153

Benign neoplasm: Duodenum

236

378

8.25

149.36

3.5

1.5

8.68

3.66

ug/l

0.52

191

289

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2912

10982

1.76

149.32

4.2

18.98

24.41

ug/l

0.43

2348

8398

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

706

2503

3.07

149.00

3.6

1.4

12.82

8.63

ug/l

0.27

547

1865

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

320

667

5.54

148.82

2.6

1.4

8.33

3.54

ug/l

1.78

293

505

Bleeding

5438

27398

1.50

148.40

3.8

4.1

17.38

27.40

ug/l

2.22

4508

22186

Hydronephrosis

924

3871

2.73

145.17

6.3

3.9

29.52

25.66

ug/l

0.16

780

3170

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2131

5700

1.94

145.01

4.2

4.4

21.85

25.68

ug/l

0.20

1708

4448

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

317

693

5.50

141.17

2.0

1.4

7.36

3.60

ug/l

0.60

219

522

Diffuse large B-cell lymphoma, helper endpoint

317

693

5.50

141.17

2.0

1.4

7.36

3.60

ug/l

0.60

219

522

Any operation in hilmo

200

14.40

141.10

4.9

1.6

62.96

6.54

ug/l

0.81

167

Oesophageal varices

438

1256

4.56

140.91

3.7

4.2

5.51

25.65

ug/l

2.11

383

1043

Other diseases of liver

1286

6236

2.28

140.58

3.5

4.1

9.04

31.95

ug/l

2.52

1003

4998

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

154

165

15.47

140.26

3.2

1.4

3.83

4.52

ug/l

0.13

118

130

Ventral hernia

1775

9636

2.01

140.03

5.5

4.0

26.69

26.42

ug/l

0.01

1505

7862

Attention to artificial openings

395

1057

4.78

138.88

6.0

3.9

37.39

20.89

ug/l

0.41

333

874

Cholecystectomy

4690

28512

1.52

137.49

4.1

3.9

13.29

25.78

ug/l

3.24

3742

22895

Other diseases of blood and blood-forming organs, wide

1574

8270

2.08

137.27

4.8

4.1

25.73

28.27

ug/l

0.13

1290

6705

Noninfective enteritis and colitis

2804

17254

1.70

136.70

4.4

3.9

22.50

24.76

ug/l

0.15

2241

13759

Dyspnoea

5628

30520

1.46

136.48

3.4

4.1

20.97

26.04

ug/l

0.62

4565

24426

Abnormalities of breathing

5461

22614

1.48

136.30

3.5

4.2

22.07

27.47

ug/l

0.62

4351

17933

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

123

101

25.15

135.80

7.0

1.4

14.86

5.42

ug/l

0.94

117

ILD medications

6995

27931

1.41

134.86

3.5

4.2

21.69

25.27

ug/l

0.44

5631

22127

Implicit Sepsis

4689

25052

1.51

134.48

3.4

4.1

17.50

26.88

ug/l

1.82

3860

20232

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

555

1842

3.38

133.67

3.1

1.4

5.37

12.87

ug/l

0.52

438

1393

Hypertension, essential

4866

19083

1.51

130.74

3.9

4.2

18.88

23.20

ug/l

0.46

3951

15027

Other disorders of fluid, electrolyte and acid-base balance

2129

11973

1.84

130.50

3.8

4.0

31.50

21.82

ug/l

0.29

1814

9856

Malignant neoplasm of other and unspecified female genital organs

238

477

9.76

129.94

1.8

3.8

2.73

10.01

ug/l

3.63

149

388

Benign neoplasm: Transverse colon

872

3788

2.71

129.31

4.6

4.1

8.80

23.84

ug/l

2.92

748

3126

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

458

1379

3.73

129.18

2.7

1.4

4.76

3.63

ug/l

0.80

367

1040

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

280

591

5.58

129.16

3.5

1.4

8.96

3.64

ug/l

0.86

213

440

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

433

1263

3.79

127.31

4.4

1.5

25.19

14.35

ug/l

0.32

338

940

Carcinoma in situ of colon

235

478

9.45

126.01

5.4

4.5

14.53

36.28

ug/l

0.64

199

408

Disorders of lipoprotein metabolism and other lipidaemias

5453

24366

1.46

125.95

3.6

4.1

25.46

24.34

ug/l

0.08

4448

19670

Benign leiomyoma with endometriosis

750

3002

2.69

124.73

3.3

1.5

23.89

7.59

ug/l

0.96

580

2241

Hernia

5839

28616

1.43

123.00

4.1

3.9

20.03

25.84

ug/l

0.83

4783

22828

Pure hypercholesterolaemia

4896

23071

1.48

122.89

3.7

4.1

26.72

24.63

ug/l

0.14

4047

18716

Benign neoplasm: Liver/bile ducts

281

646

5.92

122.14

2.5

4.0

2.64

25.54

ug/l

1.15

195

523

Gastro-oesophageal reflux disease

4263

26055

1.51

121.95

3.2

4.2

17.47

27.29

ug/l

1.69

3339

20985

Type 2 diabetes, wide definition

5216

24166

1.46

121.27

3.7

4.1

24.10

26.35

ug/l

0.19

4338

19412

In situ neoplasms

2445

15129

1.72

120.13

3.9

3.8

17.98

23.38

ug/l

0.59

1971

12205

Haemangioma and lymphangioma, any site

420

1245

3.69

119.92

3.6

1.5

25.55

13.52

ug/l

0.33

329

904

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

588

2137

2.99

118.68

3.6

1.4

19.13

3.88

ug/l

1.71

482

1620

Appendectomy

3715

24183

1.53

118.32

3.9

4.0

14.36

24.45

ug/l

2.21

2841

19095

Factors influencing health status and contact with health services

1956

5458

1.87

117.80

4.2

4.0

19.15

25.42

ug/l

0.45

1604

4321

Secondary malignant neoplasm of respiratory and digestive organs

215

425

8.99

117.19

5.5

4.3

117.41

42.73

ug/l

1.03

203

359

Benign neoplasm: Skin of eyelid, including canthus

686

2719

2.71

116.23

3.6

1.5

14.93

8.46

ug/l

0.46

555

2043

Bacterial Sepsis

2940

16981

1.62

114.71

3.6

4.1

21.59

27.33

ug/l

0.54

2483

13972

Ovarian cyst

2314

8010

1.75

114.41

3.0

4.0

13.87

30.41

ug/l

1.76

1706

6221

Pain in throat and chest

5139

22398

1.44

113.93

3.5

4.2

16.74

27.61

ug/l

1.54

4040

17831

Benign neoplasm of mouth and pharynx

503

1727

3.16

112.42

3.5

1.5

11.01

11.46

ug/l

0.02

403

1270

Haemangioma, any site

393

1166

3.69

112.17

3.5

1.5

27.06

13.86

ug/l

0.34

305

848

Pain (limb, back, neck, head abdominally)

4596

16020

1.48

111.46

4.0

4.3

19.34

28.46

ug/l

1.08

3695

12946

Mucosal proctocolitis

793

3450

2.51

111.33

5.4

4.1

5.77

34.47

ug/l

2.09

613

2732

Benign neoplasm: Liver

251

569

6.01

111.05

2.5

4.0

2.61

14.58

ug/l

0.92

170

458

Other postsurgical states

533

1951

3.21

111.00

5.6

4.1

5.15

19.74

ug/l

2.57

482

1604

Malignant neoplasm of small intestine

290

755

5.74

110.96

4.5

4.2

8.15

32.10

ug/l

1.28

236

638

Pain, not elsewhere classified

1639

9261

1.87

110.42

3.9

19.97

20.07

ug/l

0.01

1304

7332

Asthma, unspecified (mode), excluding more controls

3120

16121

1.58

109.82

3.4

4.3

15.69

26.18

ug/l

1.16

2564

12612

Cardiovascular diseases (excluding rheumatic etc)

3202

12066

1.57

108.50

4.0

4.1

20.32

23.57

ug/l

0.22

2479

9050

Mucinous and mucinous cystic tumor of rectum

121

150

38.60

108.20

11.9

4.9

14.47

33.81

ug/l

0.31

112

126

Gastroduodenal ulcer

1819

10688

1.82

107.74

3.8

4.1

21.60

25.80

ug/l

0.28

1522

8913

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

155

225

9.07

107.31

4.3

1.4

21.60

4.10

ug/l

1.62

123

175

Heart failure, not strict

4954

24669

1.44

106.86

3.4

4.3

19.82

27.58

ug/l

1.34

4160

19974

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

100

22.36

106.75

3.6

1.4

5.15

2.64

ug/l

1.10

Excluding asthma or asthma-COPD overlap

5034

18008

1.44

106.08

4.0

4.3

20.32

25.11

ug/l

0.49

4068

14107

Symptoms and signs involving the urinary system

4821

26883

1.44

105.72

3.8

4.1

21.48

26.53

ug/l

0.45

3954

21790

Dental caries

1581

8878

1.87

105.39

4.6

4.2

17.88

26.31

ug/l

0.60

1324

7128

Benign neoplasm: Skin of other and unspecified parts of face

499

1771

3.05

105.05

3.7

1.4

23.95

11.08

ug/l

0.44

412

1307

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6038

29288

1.38

104.60

4.1

4.0

20.52

25.92

ug/l

0.73

4902

23437

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

375

1141

3.62

103.26

4.5

1.5

28.52

14.61

ug/l

0.38

289

850

Enlarged lymph nodes

1038

5190

2.16

102.84

3.3

4.0

18.64

25.18

ug/l

0.46

833

4148

Condition for Implicit Sepsis (Organ dysfunction codes)

5125

27187

1.41

102.60

3.5

4.1

17.53

26.78

ug/l

1.97

4201

21776

Acute tubulo-interstitial nephritis

3762

23260

1.49

101.96

4.1

3.9

16.40

25.70

ug/l

1.85

3099

18612

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

472

1655

3.09

101.68

3.5

1.5

11.88

3.79

ug/l

1.69

402

1232

Iron deficiency anaemia secondary to blood loss (chronic)

1126

5854

2.10

101.37

3.9

3.8

27.26

24.68

ug/l

0.10

941

4757

Mesothelioma, excluding all cancers (controls excluding all cancers)

136

184

10.15

100.81

2.3

1.3

2.19

4.72

ug/l

0.94

107

140

Benign neoplasm of breast

545

2070

2.84

100.76

4.0

1.5

9.35

9.80

ug/l

0.03

429

1532

Asthma, unspecified (mode)

3191

17039

1.54

100.69

3.4

4.2

15.42

25.19

ug/l

1.10

2627

13378

COPD differential diagnosis

4987

17976

1.43

100.55

4.0

4.3

19.94

25.11

ug/l

0.54

4031

14091

ILD differential diagnosis

4986

17974

1.43

100.45

4.0

4.3

19.94

25.11

ug/l

0.54

4030

14089

Renal failure

2830

17201

1.58

99.73

3.5

4.0

21.95

26.04

ug/l

0.39

2418

14245

Melanocytic naevi of trunk

469

1650

3.04

99.66

3.8

1.6

5.02

11.89

ug/l

0.43

361

1191

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

178

317

6.69

99.29

2.2

1.4

35.59

3.97

ug/l

1.67

162

248

Dentinal caries

1412

7859

1.90

98.87

4.6

4.2

19.05

25.74

ug/l

0.40

1190

6335

Carcinoma in situ of rectum

157

279

12.55

98.40

6.1

4.4

12.87

51.29

ug/l

0.73

130

237

Benign neoplasm: Appendix

122

152

11.60

97.50

3.7

1.4

3.94

4.42

ug/l

0.09

100

116

Ulcerative colitis

1435

8117

1.87

96.46

4.6

4.1

13.28

27.36

ug/l

1.31

1129

6502

Hernia of abdominal wall

2817

18896

1.56

95.86

5.0

4.0

26.67

24.45

ug/l

0.14

2358

15384

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

249

607

4.72

95.75

2.7

1.4

10.73

3.29

ug/l

0.81

197

463

Other pulmonary diagnosis

4958

18008

1.42

95.58

3.9

4.3

20.00

25.11

ug/l

0.53

3991

14107

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

270

702

4.45

95.48

3.2

1.4

9.79

4.32

ug/l

0.42

218

532

Use of hypnotics and sedatives

6521

28687

1.35

95.36

4.0

20.51

26.39

ug/l

0.89

5328

22796

Inflammatory bowel disease

1792

10836

1.74

94.29

4.3

4.1

16.80

24.44

ug/l

0.51

1413

8661

Implicit bacterial Sepsis

2535

15280

1.60

94.16

3.4

4.0

19.68

25.40

ug/l

0.60

2156

12623

COPD (mode)

2126

10630

1.68

93.39

3.0

4.4

31.54

27.05

ug/l

0.25

1890

8707

Benign lipomatous neoplasm of other sites/unspecified

416

1436

3.15

92.41

3.3

1.4

8.18

12.20

ug/l

0.19

339

1069

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

116

147

11.93

92.13

3.3

1.5

4.06

2.62

ug/l

0.70

113

Benign neoplasm: Descending colon

573

2418

2.81

91.07

5.3

4.1

5.83

24.66

ug/l

3.38

483

2001

Misadventures to patients during surgical and medical care

953

4857

2.15

90.90

4.8

3.8

20.27

25.66

ug/l

0.16

793

3897

Oedema, not elsewhere classified

1927

11959

1.69

90.40

3.6

3.9

29.77

20.77

ug/l

0.52

1573

9702

Hypertensive diseases (excluding secondary)

2916

11313

1.55

90.19

3.8

4.2

15.83

24.47

ug/l

0.79

2323

8628

Benzodiazepine use

5894

31903

1.35

89.26

3.6

4.0

23.37

25.13

ug/l

0.17

4755

25405

Symptoms and signs concerning food and fluid intake

696

3160

2.42

89.21

2.6

3.9

12.35

20.89

ug/l

0.71

572

2548

Hypertensive diseases

4664

19267

1.41

89.05

3.9

4.2

24.00

23.12

ug/l

0.06

3785

15133

Hypertension

4663

19261

1.41

88.97

3.9

4.2

24.01

23.12

ug/l

0.06

3784

15130

Malignant neoplasm of other and ill-defined digestive organs

135

227

11.85

87.73

3.7

4.3

203.08

72.44

ug/l

0.95

121

193

Postprocedural disorders of digestive system, not elsewhere classified

312

972

4.02

87.63

6.2

4.1

16.01

25.88

ug/l

0.39

268

804

Other heart diseases

2552

11061

1.57

87.55

3.6

4.2

23.98

24.86

ug/l

0.04

2024

8455

Chronic periapical parodontitis

1369

7928

1.85

86.32

4.6

4.2

18.21

25.49

ug/l

0.62

1122

6416

Diseases of pulp and periapical tissues

2133

13810

1.62

85.02

4.3

4.2

16.72

28.34

ug/l

1.72

1753

11060

Other soft tissue disorders, not elsewhere classified

5306

24688

1.36

83.84

3.5

4.2

13.07

28.00

ug/l

5.39

4189

19682

Carcinoma in situ of skin

386

1358

3.13

83.61

3.7

1.4

28.28

3.68

ug/l

1.09

303

1024

Gastric ulcer

1226

6962

1.90

83.21

3.8

4.1

23.13

24.35

ug/l

0.05

1022

5774

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

138

230

7.37

82.93

2.2

1.3

16.77

4.23

ug/l

0.50

108

172

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

119

171

8.88

82.69

4.6

1.5

9.77

4.42

ug/l

0.53

100

135

Acute renal failure

1353

7930

1.84

82.52

3.9

4.0

23.33

22.76

ug/l

0.03

1169

6599

COPD/asthma/ILD related infections

6393

24668

1.33

82.51

3.9

4.0

17.37

25.85

ug/l

1.67

5144

19489

COPD/asthma related infections

6393

24668

1.33

82.51

3.9

4.0

17.37

25.85

ug/l

1.67

5144

19489

Ulcerative colitis, NAS

825

4117

2.16

82.01

4.8

4.0

7.28

32.99

ug/l

2.11

653

3268

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

517

2114

2.60

81.70

3.6

1.6

12.24

10.01

ug/l

0.13

409

1545

Cardiovascular diseases

2787

10190

1.52

81.56

3.9

4.1

21.21

25.87

ug/l

0.28

2115

7593

IBD patients in KELA-register

1223

6928

1.86

81.36

4.8

4.1

16.47

30.39

ug/l

0.77

956

5479

Diabetes, varying definitions

5991

27542

1.33

81.01

3.7

4.1

24.07

24.63

ug/l

0.05

4970

21656

Carcinoma in situ of skin of other and unspecified parts of face

380

1349

3.10

80.96

3.3

1.3

35.21

3.34

ug/l

1.23

293

1022

Pain in limb

4526

24370

1.38

79.72

3.6

4.2

13.79

27.95

ug/l

3.77

3572

19457

Benign neoplasm: Other and unspecified parts of small intestine

138

242

7.25

79.52

3.9

1.4

6.10

4.75

ug/l

0.22

118

186

Malignant neoplasm, without specification of site

303

983

3.80

79.50

2.8

3.9

51.56

23.77

ug/l

1.04

257

827

Diabetes mellitus

5990

27582

1.33

79.24

3.7

4.1

24.13

24.60

ug/l

0.04

4973

21672

General examination and investigation of persons without complaint and reported diagnosis

3793

14492

1.43

78.59

3.6

4.3

22.68

31.41

ug/l

0.84

3057

11553

Benign neoplasm: Anus and anal canal

178

391

5.31

78.37

4.4

1.5

3.78

3.64

ug/l

0.05

152

293

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

889

4626

2.05

77.94

5.1

4.1

9.05

31.84

ug/l

2.01

687

3663

Benign neoplasm of eye and adnexa

415

1567

2.85

77.73

4.4

1.5

12.47

12.13

ug/l

0.01

347

1167

Inflammatory bowel disease, strict (require KELA)

1223

7022

1.83

77.72

4.8

4.1

16.47

30.01

ug/l

0.74

956

5561

Benign neoplasm of major salivary glands

416

1575

2.84

77.52

3.8

1.5

28.08

11.22

ug/l

0.44

359

1178

Diaphragmatic hernia

2339

15853

1.55

76.56

3.3

3.9

20.19

24.97

ug/l

0.27

1889

12926

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5723

26965

1.33

76.41

3.7

4.1

23.36

24.94

ug/l

0.15

4763

21319

Diabetes, insulin treatment (Kela reimbursement)

6042

28743

1.32

75.97

3.7

4.1

23.06

24.73

ug/l

0.17

5037

22784

Dysphagia

1427

8645

1.74

75.47

3.2

4.0

14.14

21.15

ug/l

0.93

1158

7048

Glucagon-like peptide-1 (GLP-1) analogues

3594

21596

1.43

75.30

3.5

4.1

24.91

24.11

ug/l

0.06

3036

17665

Need for other prophylactic measures

410

1602

2.94

74.84

4.7

4.3

15.10

22.66

ug/l

0.32

333

1316

Diabetes medication

5997

28366

1.31

74.66

3.7

4.0

24.83

24.34

ug/l

0.04

4956

22337

Hypokalaemia

800

4118

2.13

74.56

4.2

3.9

19.82

25.05

ug/l

0.25

684

3320

5-aminosalicylic acid

1175

6764

1.83

74.12

4.7

4.3

15.03

26.87

ug/l

0.61

913

5345

Diarrhoea and gastroenteritis of presumed infectious origin

3771

25197

1.40

74.06

4.0

3.9

19.03

24.41

ug/l

0.64

2987

20067

Insulin medication

3483

21677

1.42

73.27

3.9

4.1

21.24

25.19

ug/l

0.41

3012

17464

Other gastritis (incl. Duodenitis)

1458

8995

1.72

72.50

3.5

4.2

24.85

27.45

ug/l

0.10

1206

7418

Ulcerative colitis (strict definition, require KELA)

906

4861

1.98

72.38

5.1

4.2

8.90

31.31

ug/l

2.11

702

3860

Codeine or tramadol medication

6751

29587

1.29

72.27

3.6

4.1

21.74

25.04

ug/l

0.26

5419

23538

Persons encountering health services for examination and investigation

3957

14525

1.40

71.81

3.9

4.3

25.85

31.39

ug/l

0.40

3206

11576

Type 2 diabetes

5865

27170

1.31

71.56

3.7

4.1

25.49

24.82

ug/l

0.05

4856

21436

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

254

768

3.72

71.52

2.4

1.4

3.76

3.58

ug/l

0.11

204

580

Hypo-osmolality and hyponatraemia

1141

6629

1.85

71.11

3.4

4.0

14.05

23.35

ug/l

1.69

967

5456

Crohn's disease (strict) with PSC

102.18

71.03

7.4

3.6

2.09

2.62

ug/l

0.49

Care involving use of rehabilitation procedures

3407

23624

1.41

70.60

3.5

3.8

16.64

16.58

ug/l

0.01

2750

18585

Speech therapy

1701

10971

1.64

70.33

3.4

4.1

14.91

25.55

ug/l

1.31

1409

8895

Other inflammatory liver diseases

465

2005

2.61

68.48

4.2

7.51

24.24

ug/l

2.33

374

1625

Benign neoplasm: Endocrine pancreas

13.63

68.36

3.1

1.5

2.88

5.80

ug/l

0.41

Malignant neoplasm of mesothelium and soft tissue

368

1441

3.03

68.27

2.6

4.0

5.94

24.98

ug/l

1.86

274

1194

Insulin, intermediate and long-acting

3191

22827

1.42

67.96

3.9

4.0

19.34

26.87

ug/l

1.00

2752

18500

Personal history of malignant neoplasm

310

1111

3.31

67.69

4.2

4.0

6.37

20.04

ug/l

1.60

254

902

Prophylactic surgery

102

161

9.59

67.35

3.1

4.2

5.24

7.35

ug/l

0.25

124

Benign neoplasm: Small intestine

361

1420

3.09

67.24

3.6

4.2

7.92

21.62

ug/l

1.25

297

1176

Chronic gastritis

1818

12017

1.60

67.23

3.2

4.1

14.53

22.16

ug/l

1.09

1451

9967

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

958

5359

1.89

66.89

5.0

4.2

18.10

30.79

ug/l

0.52

748

4261

Other noninfective gastroenteritis and colitis

1369

8455

1.70

66.60

4.5

3.9

26.81

30.17

ug/l

0.14

1104

6811

Erysipelas

3154

20981

1.42

66.50

3.7

3.9

19.00

23.67

ug/l

0.46

2610

17036

Chronic periodontitis

993

5673

1.89

66.45

4.7

4.3

16.02

18.61

ug/l

0.25

841

4677

Benign neoplasm of meninges

418

1719

2.61

65.87

3.6

1.4

14.99

11.19

ug/l

0.14

333

1275

Functional dyspepsia

1565

10043

1.64

65.38

3.1

4.1

15.65

24.93

ug/l

0.89

1223

8051

Follow-up examination after treatment for conditions other than malignant neoplasms

2618

12019

1.47

65.15

3.3

4.2

18.11

27.30

ug/l

0.92

2038

9491

Benign neoplasm of urinary organs

230

691

3.70

65.13

3.4

1.4

4.22

3.68

ug/l

0.32

168

520

Benign neoplasm: Parotid gland

326

1196

2.94

64.70

3.9

1.4

31.83

3.96

ug/l

0.72

284

892

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

11.94

64.46

2.8

1.4

13.13

2.71

ug/l

1.35

Follicular lymphoma

222

660

3.78

64.21

2.9

1.4

25.60

3.39

ug/l

1.27

174

493

Multiple myeloma, excluding all cancers (controls excluding all cancers)

238

739

3.59

64.14

2.8

1.4

5.60

3.64

ug/l

0.88

190

555

Neuroendocrine tumor and carcinoma of small intestine

173

461

5.47

64.04

3.2

4.3

3.44

37.28

ug/l

1.24

135

390

Carcinoma in situ of other and unspecified sites

189

507

4.25

63.90

3.7

1.4

24.88

3.67

ug/l

0.92

157

383

Infections, IBD-co-morbidities

1120

4776

1.81

63.84

3.7

5.0

24.67

39.64

ug/l

0.65

920

3834

Portal vein thrombosis

173

456

5.14

63.58

5.0

4.3

4.75

40.35

ug/l

1.29

145

387

Autoimmune diseases excluding thyroid diseases

5991

26333

1.29

63.52

3.8

4.1

23.56

25.15

ug/l

0.13

4834

20959

Other heart diseases, wide

5093

24587

1.31

63.50

3.6

4.2

18.80

27.05

ug/l

1.22

4044

19415

Benign neoplasm: Rectosigmoid junction

357

1435

2.99

63.46

4.7

4.1

10.05

22.28

ug/l

1.07

281

1189

Autoimmune diseases excluding thyroid diseases, strict definition

5827

25673

1.29

62.62

3.8

4.1

22.39

25.42

ug/l

0.27

4700

20452

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

280

964

3.15

62.59

3.8

1.5

9.28

16.11

ug/l

0.22

206

721

Other disorders of urethra and urinary system

4069

23207

1.35

62.36

3.6

3.9

14.94

25.72

ug/l

2.47

3218

18523

Asthma, excluding more controls

4180

16848

1.35

62.35

3.4

4.3

14.02

26.01

ug/l

1.89

3382

13145

Type 2 diabetes, definitions combined

5662

26725

1.29

62.13

3.7

4.1

25.08

25.05

ug/l

0.00

4665

21170

Benign neoplasm: Cerebral meninges

378

1530

2.65

61.69

3.6

1.4

15.14

12.04

ug/l

0.10

303

1140

Other special examinations and investigations of persons without complaint or reported diagnosis

3842

14524

1.37

61.50

3.7

4.3

24.61

31.40

ug/l

0.51

3144

11575

Multiple myeloma and malignant plasma cell neoplasms

233

733

3.54

61.47

2.8

1.4

5.63

3.64

ug/l

0.88

186

552

Carcinoma in situ, bladder

178

472

4.32

61.31

3.7

1.4

24.73

3.73

ug/l

0.84

148

358

Primary_lymphoid and hematopoietic malignant neoplasms

1492

9656

1.64

61.03

2.8

4.1

9.60

25.91

ug/l

4.42

1121

8005

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

321

1204

2.86

60.99

3.4

1.5

34.08

15.06

ug/l

0.40

264

889

Type 2 diabetes, definitions combined, including avohilmo

5679

26655

1.29

60.96

3.7

4.1

24.68

24.85

ug/l

0.01

4689

21097

Neuroendocrine tumor and carcinoma of pancreas

100

181

10.10

59.99

3.6

4.6

5.15

30.47

ug/l

0.56

151

Other complications of surgical and medical care, not elsewhere classified

598

2990

2.17

59.99

5.6

3.8

63.98

21.21

ug/l

0.36

478

2393

Type 2 diabetes, strict (exclude DM1)

5680

26965

1.29

59.64

3.7

4.1

24.99

24.89

ug/l

0.01

4684

21383

Asthma

4346

17856

1.33

59.30

3.4

4.3

14.98

25.25

ug/l

1.49

3518

13983

Gastrointestinal stromal tumor and sarcoma

154

407

5.83

58.56

3.2

4.4

3.84

38.54

ug/l

1.08

118

347

Alcoholic liver disease

640

3325

2.11

58.23

3.1

4.4

14.19

25.70

ug/l

1.10

569

2782

Persons encountering health services for specific procedures, not carried out

420

1843

2.47

58.04

4.3

4.0

10.07

18.37

ug/l

0.60

347

1470

Abnormal findings on examination of blood, without diagnosis

2695

18400

1.42

57.45

3.5

4.2

34.76

27.05

ug/l

0.26

2203

15213

Abnormal weight loss

581

2950

2.17

56.73

2.4

4.1

11.16

21.57

ug/l

0.76

469

2416

Transplanted organ and tissue status

566

2833

2.17

56.55

3.5

4.3

6.38

21.77

ug/l

2.39

476

2323

Intestinal infectious diseases

5076

31356

1.28

55.95

3.9

4.0

19.02

25.86

ug/l

1.10

4013

25002

Malignant neoplasm of anus and anal canal

181

11.76

55.89

4.8

4.4

5.00

69.03

ug/l

0.85

152

Other ulcerative colitis

355

1477

2.65

55.85

5.9

4.2

6.32

23.98

ug/l

1.80

285

1195

Insulin, combination of fast acting with intermediate-acting or long-acting

3487

24440

1.35

55.74

3.9

4.0

21.23

26.92

ug/l

0.68

3014

19770

Crohn disease

681

3632

1.99

55.63

4.2

4.1

8.10

33.69

ug/l

1.79

524

2869

Other benign neoplasms of connective and other soft tissue

359

1484

2.56

55.52

3.9

1.5

38.78

12.82

ug/l

0.49

290

1092

Malignant neoplasm of retroperitoneum and peritoneum

111

237

7.88

55.42

2.6

4.1

3.01

34.13

ug/l

0.60

207

Benign neoplasm of bone and articular cartilage

295

1111

2.81

55.24

3.7

1.6

35.16

15.99

ug/l

0.43

232

817

Secondary malignant neoplasm of other and unspecified sites

165

473

4.97

55.04

4.9

4.5

114.70

29.17

ug/l

1.26

153

405

Benign neoplasm of middle ear and respiratory system

311

1212

2.74

54.72

3.7

1.5

44.27

3.85

ug/l

0.85

257

897

Weight loss

612

3199

2.09

54.67

2.5

4.0

12.61

22.12

ug/l

0.69

493

2603

Non-follicular lymphoma

647

3474

2.05

53.88

2.3

4.0

10.52

21.48

ug/l

1.29

452

2890

Fitting and adjustment of other devices

2002

13053

1.48

53.86

3.3

3.8

21.48

14.38

ug/l

0.51

1655

10631

Infections of the skin and subcutaneous tissue

2881

21325

1.38

53.73

3.8

4.1

19.98

25.07

ug/l

0.54

2337

17027

Other (not insulin) diabetes medications

5691

27627

1.27

53.67

3.6

4.1

24.96

24.70

ug/l

0.02

4692

21917

Endocrine, nutritional and metabolic diseases

4303

16944

1.31

53.50

3.8

4.3

35.95

22.66

ug/l

0.73

3440

13171

Vitamin B12 deficiency anaemia

712

3936

1.96

53.28

4.8

3.8

14.12

23.52

ug/l

0.99

613

3235

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

275

1021

2.87

53.16

3.3

1.5

24.38

3.47

ug/l

0.63

211

751

Diseases of arteries, arterioles and capillaries (FINNGEN)

1489

6830

1.59

53.11

3.2

4.5

30.37

23.26

ug/l

0.32

1240

5512

Symptoms and signs involving the circulatory and respiratory systems

5636

22632

1.27

53.00

3.6

4.2

20.48

27.45

ug/l

0.93

4462

17946

Benign neoplasm: Kidney

173

497

3.91

52.77

3.5

1.4

4.08

3.38

ug/l

0.39

124

382

Provisional assignment of new diseases of uncertain etiology

2192

15656

1.44

52.50

4.0

3.9

14.66

23.64

ug/l

0.99

1775

12396

Phlebitis and thrombophlebitis (not including DVT)

1352

8845

1.61

52.43

4.4

4.0

16.47

28.13

ug/l

1.06

1096

7132

Codes for special purposes

2195

15690

1.44

52.33

4.0

3.9

14.65

23.60

ug/l

0.98

1778

12418

Chronic kidney disease

1718

11755

1.52

52.16

3.0

3.9

18.88

23.53

ug/l

0.37

1473

9793

Other disorders of teeth and supporting structures

1267

8176

1.63

52.02

3.9

4.1

9.17

22.84

ug/l

2.20

1062

6619

Other diseases of urinary system

5902

26894

1.26

51.89

3.7

4.0

16.34

27.26

ug/l

2.52

4640

21531

Chronic hepatitis, not elsewhere classified

258

964

3.11

51.85

4.3

4.2

3.01

19.22

ug/l

2.09

213

786

Acute peritonitis

427

2000

2.37

51.68

5.0

4.0

49.50

16.47

ug/l

0.99

370

1650

Asthma (mode)

4207

17974

1.31

51.42

3.4

4.3

18.72

25.11

ug/l

0.60

3390

14089

Unspecified haematuria

2447

15327

1.42

50.97

3.7

4.1

24.37

28.92

ug/l

0.22

2005

12680

Noninfectious colitis NAS

759

4319

1.87

50.74

4.6

3.9

20.45

32.01

ug/l

0.54

616

3446

Fall on same level

6397

29239

1.24

50.73

3.7

4.1

21.26

25.92

ug/l

0.55

5137

23192

Haemorrhage from respiratory passages

2101

13955

1.45

50.24

3.5

4.3

17.85

29.16

ug/l

1.05

1732

11579

Melanocytic naevi, other sites/unspecified

272

1034

2.79

50.09

3.6

1.6

5.11

5.20

ug/l

0.02

206

755

Paralytic ileus

276

1084

2.91

49.96

5.3

3.9

15.44

26.00

ug/l

0.41

234

898

Hodgkin lymphoma

131

321

4.51

49.60

3.0

1.6

41.28

3.70

ug/l

1.31

109

244

Ulcerative ileocolitis

266

1023

2.91

49.57

6.3

4.3

13.34

27.20

ug/l

0.54

201

832

Benign neoplasm: Duodenum

236

880

3.33

49.29

3.5

4.3

8.68

24.92

ug/l

0.89

191

744

Cardiac arrhythmias

3212

16094

1.35

49.20

3.6

4.2

15.40

25.72

ug/l

1.51

2516

12399

Autoimmune diseases related-to ILD

4607

32370

1.28

49.08

3.6

4.0

29.47

23.86

ug/l

0.39

3649

25788

Biguanides

5588

27963

1.26

49.07

3.6

4.1

25.04

24.59

ug/l

0.04

4602

22276

Atrial fibrillation and flutter

1853

8403

1.49

48.95

3.6

4.4

15.75

23.94

ug/l

0.74

1496

6679

Benign neoplasm of ovary

1119

7182

1.66

48.04

3.1

3.7

15.54

18.87

ug/l

0.16

869

5676

Disorders of mineral metabolism

516

2662

2.12

47.92

3.6

4.0

36.00

25.86

ug/l

0.36

435

2146

Alcohol use disorder, Swedish definition

2900

20402

1.35

47.30

3.3

4.3

24.07

26.86

ug/l

0.18

2515

16488

Disorders of breast

2633

18261

1.38

47.27

3.6

3.7

13.83

22.12

ug/l

1.40

1999

14123

Diseases of peritoneum

640

3565

1.94

46.81

4.4

3.9

44.91

19.46

ug/l

0.89

532

2881

Volume depletion

557

2963

2.03

46.79

4.3

3.9

15.99

24.16

ug/l

0.79

472

2448

Nonalcoholic fatty liver disease

540

2846

2.05

46.75

3.1

4.1

4.55

20.58

ug/l

4.04

417

2287

Hepatic failure, not elsewhere classified

271

1097

2.86

46.62

3.1

4.1

6.62

25.15

ug/l

1.55

231

903

L04AD Calcineurin inhibitors

575

3093

1.99

46.40

3.2

4.3

14.05

26.74

ug/l

0.67

470

2484

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

254

979

2.78

45.89

3.8

1.5

11.42

3.89

ug/l

1.22

203

725

Other diseases of stomach and duodenum

429

2119

2.24

45.32

4.3

4.2

8.45

17.00

ug/l

1.12

359

1737

Intestinal malabsorption

294

1242

2.65

45.30

4.3

4.2

14.88

18.50

ug/l

0.14

260

1005

Early onset COPD, excluding more controls

1193

7834

1.59

45.05

3.1

4.5

21.97

23.42

ug/l

0.08

1058

6396

Pain in joint

3005

15139

1.34

44.81

3.3

4.3

15.24

27.77

ug/l

1.58

2312

12208

Genitourinary diseases

3096

11772

1.34

44.57

4.2

4.4

21.86

40.58

ug/l

2.25

2488

9527

Covid-19 confirmed case

1464

10045

1.51

44.38

4.2

4.0

8.47

28.13

ug/l

4.53

1202

8099

Lymphoid leukaemia

220

804

2.95

44.20

3.2

1.4

6.53

3.42

ug/l

0.61

161

607

Ulcerative colitis (strict definition, all Crohn cases excluded)

706

4090

1.81

43.88

4.9

4.1

9.27

33.97

ug/l

1.87

559

3231

Asthma (only as main-diagnosis), excluding more controls

3619

16848

1.30

43.36

3.3

4.3

22.56

26.01

ug/l

0.22

2936

13145

Deposits [accretions] on teeth

396

1853

2.23

42.86

4.6

4.3

24.50

22.25

ug/l

0.06

321

1500

Sequelae with surgical and medical care as external cause

1167

7745

1.59

42.73

4.3

4.0

23.41

23.54

ug/l

0.00

935

6311

Later onset COPD, excluding more controls

1332

7043

1.56

42.55

3.1

4.3

38.62

23.59

ug/l

0.78

1180

5834

Unspecified misadventure during surgical and medical care

354

1668

2.37

42.53

5.3

4.2

40.88

19.96

ug/l

0.27

299

1372

Sequelae of external causes of morbidity and mortality

1414

9749

1.52

42.45

4.2

4.1

20.62

27.26

ug/l

0.31

1132

7974

Paracetamol of NSAID medication

900

2712

1.71

42.33

4.2

4.0

24.65

38.17

ug/l

0.58

739

2136

Hyperlipidaemia, other/unspecified

2329

16521

1.38

42.30

3.5

4.1

34.68

24.35

ug/l

0.33

1909

13668

Budesonide

723

4270

1.79

42.26

3.7

4.1

4.07

30.77

ug/l

2.32

550

3357

Dialysis, with operation codes

719

4261

1.80

42.12

3.0

4.3

11.02

23.96

ug/l

1.57

605

3542

Symptoms and signs involving cognition, perception, emotional state and behaviour

5373

30996

1.24

42.11

3.3

4.1

16.42

26.61

ug/l

2.25

4286

24794

Benign neoplasm of brain and other parts of central nervous system

234

904

2.75

41.98

3.7

1.5

9.09

3.34

ug/l

0.79

190

672

Streptococcal septicaemia

486

2564

2.05

41.95

3.8

3.9

30.99

15.90

ug/l

0.47

398

2107

Polyarthropathies

3872

20499

1.29

41.86

3.3

4.3

21.53

29.40

ug/l

0.88

3113

16421

Carcinoma in situ of breast, intraductal

577

3248

1.95

41.68

3.5

3.8

19.97

23.58

ug/l

0.13

446

2574

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

195

691

3.06

41.66

3.4

1.5

6.20

4.42

ug/l

0.51

176

521

Alcohol-induced chronic pancreatitis

399

1978

2.21

41.55

3.3

4.6

29.06

22.93

ug/l

0.13

361

1648

2977

21167

1.32

41.39

3.4

4.2

24.65

26.59

ug/l

0.12

2584

17056

Parodontitis or operation codes

5116

30974

1.24

41.26

4.0

18.59

26.25

ug/l

1.37

4192

24788

Endometroid carcinoma of ovary

116

319

5.18

41.10

3.3

3.7

4.06

7.90

ug/l

1.09

264

Retention of urine

1936

11938

1.42

41.04

3.9

4.1

21.38

29.02

ug/l

0.60

1607

9968

Parodontitis

5109

30975

1.24

40.97

4.0

18.61

26.25

ug/l

1.37

4186

24791

Benign neoplasm: Choroid

236

932

2.73

40.86

4.7

1.4

19.14

3.45

ug/l

1.16

199

689

Nephropathy related operations

693

4106

1.80

40.73

3.1

4.3

11.18

25.23

ug/l

1.66

582

3413

Diseases of the respiratory system

3923

15590

1.28

40.61

4.0

4.2

22.28

23.58

ug/l

0.09

3161

12273

Benign neoplasm: Skin of trunk

168

555

3.27

40.51

3.7

1.5

5.20

3.26

ug/l

0.71

136

421

Other CVD (FINNGEN)

700

3242

1.81

40.49

3.4

4.4

21.03

27.42

ug/l

0.19

584

2651

3107

21735

1.31

40.23

3.4

4.2

24.14

27.25

ug/l

0.22

2693

17473

Colorectal squamous cell carcinoma, excluding all cancers (controls excluding all cancers)

73.20

40.23

3.4

1.6

2.14

3.57

ug/l

—

Heart failure and antihypertensive medication

1509

6938

1.49

40.15

3.1

4.6

14.17

29.30

ug/l

2.38

1259

5611

Disorders of calcium metabolism

406

2056

2.18

40.14

3.0

4.1

41.95

20.80

ug/l

0.73

343

1660

COPD

2754

17516

1.34

40.12

3.0

4.2

29.66

25.82

ug/l

0.26

2430

14418

Other embolism and thrombosis

775

4749

1.74

40.06

4.7

3.9

16.90

24.67

ug/l

0.79

654

3842

Chronic periodontitis, complicated

575

3258

1.91

40.02

4.5

4.3

15.95

26.55

ug/l

0.87

483

2681

Dorsalgia

5526

24706

1.23

40.01

3.4

4.3

16.97

26.07

ug/l

1.77

4351

19656

Benign neoplasm: Skin, unspecified

163

534

3.31

39.92

2.9

1.5

4.00

3.33

ug/l

0.40

129

403

Cerebrovascular diseases (FINNGEN)

1728

8829

1.44

39.86

3.7

4.4

20.36

27.00

ug/l

0.39

1438

6958

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

160

523

3.36

39.61

2.6

1.4

7.33

3.54

ug/l

0.76

130

397

Secondary and unspecified malignant neoplasm of lymph nodes

520

2869

1.97

39.57

2.8

4.1

16.00

22.73

ug/l

0.54

401

2371

Chronic periodontitis, including avohilmo

5076

30982

1.24

39.56

4.0

18.72

26.24

ug/l

1.33

4157

24801

Atrial fibrillation and flutter with reimbursement

1592

7184

1.47

39.56

3.5

4.5

11.57

23.79

ug/l

2.11

1277

5788

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

105

7.77

39.52

2.6

1.4

26.09

5.38

ug/l

0.42

Persons encountering health services in other circumstances

1839

13379

1.41

39.42

3.6

3.9

15.15

25.51

ug/l

1.43

1536

10644

Other bacterial intestinal infections

1003

6546

1.61

39.29

3.8

3.9

18.63

31.50

ug/l

0.96

822

5331

Asthma (only as main-diagnosis)

3724

17856

1.28

39.05

3.3

4.3

21.95

25.25

ug/l

0.22

3034

13983

Melanocytic naevi of lower limb, including hip

160

525

3.27

38.93

3.8

1.5

3.27

3.33

ug/l

0.03

128

394

Headache

3155

20673

1.30

38.89

3.2

3.9

23.76

21.39

ug/l

0.15

2435

16232

Other Crohn's disease

347

1662

2.23

38.68

4.7

4.2

5.48

17.24

ug/l

1.80

264

1311

Unspecified lump in breast

926

5981

1.64

38.43

3.9

3.7

7.87

27.09

ug/l

2.14

711

4693

Other reaction to severe stress, and adjustment disorders

1611

11531

1.43

38.01

4.1

4.0

25.99

24.17

ug/l

0.08

1277

8814

Viral Sepsis

1032

6823

1.58

38.00

3.2

4.0

9.28

25.05

ug/l

4.24

845

5580

Benign neoplasm: Ill-defined sites within the digestive system

8.37

37.81

4.4

1.3

13.93

2.75

ug/l

1.16

Benign neoplasm: Appendix

122

366

4.52

37.72

3.7

4.1

3.94

40.96

ug/l

1.07

100

312

Implicit viral Sepsis

1029

6811

1.58

37.69

3.2

4.0

9.30

25.04

ug/l

4.20

842

5569

Melanocytic naevi of other and unspecified parts of face

207

794

2.76

37.65

3.3

1.5

28.91

3.28

ug/l

0.57

156

580

Abscess of anal and rectal regions

417

2155

2.05

37.62

5.4

4.1

29.44

27.78

ug/l

0.04

333

1741

Other chronic obstructive pulmonary disease

2640

16987

1.33

37.53

3.0

4.2

30.51

26.26

ug/l

0.29

2335

13994

Explicit bacterial Sepsis

569

3258

1.86

37.50

3.9

4.1

32.13

25.37

ug/l

0.19

467

2694

Carcinoma in situ of skin of lower limb, including hip

112

306

4.24

37.35

2.8

1.4

11.51

4.57

ug/l

0.51

235

Other benign neoplasms of uterus

236

976

2.61

37.31

3.2

1.4

4.67

3.09

ug/l

1.37

185

736

Low back pain

3918

24387

1.26

37.08

3.4

4.3

19.68

26.12

ug/l

0.80

3062

19413

Anaemia in chronic diseases classified elsewhere

190

728

3.08

36.96

2.7

4.1

182.47

27.37

ug/l

0.53

163

602

Azathioprine

735

4510

1.70

36.90

3.9

4.2

13.25

27.10

ug/l

0.85

580

3526

Cystitis

4756

23917

1.24

36.77

3.6

3.9

17.47

26.74

ug/l

1.41

3703

19071

Used for control exclusion in common control thyroid runs

5833

24713

1.21

36.64

3.8

4.1

18.68

25.99

ug/l

1.10

4666

19693

Other chronic obstructive pulmonary disease, including avohilmo

3159

20852

1.30

36.61

3.0

4.1

34.66

25.70

ug/l

0.75

2780

17174

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

113

311

4.00

36.57

3.5

1.4

5.20

2.62

ug/l

1.41

228

656

3923

1.75

36.49

4.1

3.9

6.93

36.71

ug/l

2.21

505

3078

Diseases of the skin and subcutaneous tissue

5847

24521

1.21

36.46

3.6

4.1

24.01

26.09

ug/l

0.15

4646

19542

Other antidepressants

5873

25667

1.21

36.35

3.5

4.2

22.71

26.44

ug/l

0.26

4735

20490

Syncope and collapse

2371

16062

1.34

36.32

3.3

4.0

18.45

22.62

ug/l

0.40

1913

13084

Chronic lymphocytic leukaemia, helper endpoint

132

408

3.59

36.01

3.4

1.4

8.55

3.70

ug/l

0.58

100

305

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

132

408

3.59

36.01

3.4

1.4

8.55

3.70

ug/l

0.58

100

305

ILD medications: azathioprine

735

4541

1.69

35.93

3.9

4.2

13.25

26.93

ug/l

0.85

580

3566

Diffuse large B-cell lymphoma

317

1542

2.33

35.75

2.0

4.1

7.36

20.46

ug/l

1.31

219

1291

Bacterial intestinal infections, IBD co-morbidities

1005

6705

1.57

35.62

3.8

3.9

18.69

21.78

ug/l

0.23

820

5457

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

250

4.42

35.57

4.7

1.6

36.66

4.04

ug/l

0.68

188

Melanoma in situ

174

635

3.00

35.51

3.8

1.4

4.09

3.65

ug/l

0.23

140

481

Insulin, fast-acting

1825

13517

1.39

35.35

3.8

4.1

18.97

25.95

ug/l

0.55

1559

10910

Carcinoma in situ of cervix uteri

229

945

2.51

35.33

3.6

1.6

11.27

18.29

ug/l

0.19

181

641

Other CVD

1102

7519

1.54

35.29

3.3

3.8

16.78

25.20

ug/l

0.54

906

6217

Vascular disorders of the intestines

398

2088

2.07

35.18

3.1

3.7

7.74

24.71

ug/l

2.28

328

1736

Pneumothorax

410

2171

2.04

35.17

4.2

42.22

26.82

ug/l

0.33

344

1796

Cutaneous abscess, furuncle and carbuncle

1199

8276

1.50

35.15

3.9

4.1

20.42

27.63

ug/l

0.49

988

6633

Haemorrhoids and perianal venous thrombosis

1564

11325

1.43

35.13

3.6

3.9

22.20

28.59

ug/l

0.34

1275

9287

Anosmia

113

315

3.87

35.06

3.7

1.8

8.95

9.90

ug/l

0.06

234

Cholecystitis

772

4877

1.67

34.99

4.0

3.9

16.18

24.11

ug/l

0.77

662

3969

Carcinoma in situ of skin of scalp and neck

116

338

3.88

34.97

3.8

1.3

9.21

3.87

ug/l

1.14

253

Other and unspecified abdominal hernia

282

1318

2.40

34.87

6.8

4.0

11.60

15.21

ug/l

0.28

242

1090

Asthma (diagnoses ohter than nonallergic)

4543

32132

1.23

34.84

3.3

4.0

14.60

25.69

ug/l

2.31

3717

25511

Crohn's disease NAS

335

1653

2.17

34.70

4.7

4.2

11.39

24.82

ug/l

0.99

267

1318

Mesothelioma

136

458

3.82

34.57

2.3

4.7

2.19

40.13

ug/l

1.44

107

390

DVT of lower extremities

1103

7560

1.53

34.41

4.4

4.0

45.60

24.89

ug/l

0.78

903

6183

Benign neoplasm of other and unspecified sites

137

445

3.35

34.20

3.7

1.5

61.20

3.45

ug/l

0.50

113

335

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

459

2549

1.95

34.12

4.3

4.0

8.43

19.20

ug/l

1.66

378

2076

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

153

532

3.12

33.97

2.8

1.4

11.61

3.96

ug/l

0.47

119

403

Carcinoma in situ of skin of trunk

135

439

3.40

33.94

2.8

1.3

12.16

4.25

ug/l

0.65

109

328

Senile cataract

3873

19579

1.26

33.67

3.8

4.2

20.37

28.45

ug/l

1.08

3204

15998

Disorders of lens

4071

21037

1.25

33.64

3.8

4.2

19.26

28.37

ug/l

1.39

3346

17097

Exposure to unspecified factor

5048

32787

1.21

33.58

3.8

4.0

16.54

25.75

ug/l

1.76

4001

26123

Benign neoplasm: Stomach

615

3739

1.77

33.50

3.3

4.0

4.27

25.30

ug/l

4.29

490

3029

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

476

2682

1.89

33.29

5.4

3.8

74.84

21.27

ug/l

0.39

404

2142

Disorders of eyelid, lacrimal system and orbit

4697

30704

1.22

33.22

3.5

4.0

15.53

26.19

ug/l

2.24

3754

24642

Chronic lower respiratory diseases

6523

30088

1.19

32.96

3.3

4.1

20.23

25.13

ug/l

0.66

5366

23695

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

110

321

3.80

32.81

3.6

1.5

23.36

3.76

ug/l

0.81

246

Benign neoplasm: Endocrine pancreas

199

6.02

32.77

3.1

4.8

2.88

27.20

ug/l

0.63

170

COPD, hospital admissions

2652

17693

1.31

32.73

3.0

4.1

29.82

25.70

ug/l

0.29

2341

14670

Lower back pain or/and sciatica

5507

32271

1.20

32.58

3.3

4.1

18.68

25.78

ug/l

1.17

4327

25780

Autoimmune diseases

6095

26408

1.19

32.40

3.8

4.1

20.51

25.10

ug/l

0.58

4878

21015

Heart failure,strict

3120

18064

1.28

32.33

3.1

4.3

18.79

27.25

ug/l

0.96

2634

14932

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

545

3229

1.80

32.27

4.4

4.0

14.82

22.84

ug/l

0.33

444

2625

Non-small cell lung cancer, squamous

320

1611

2.18

32.16

2.6

3.8

8.33

27.21

ug/l

2.21

293

1363

Non-small cell lung cancer, squamous, helper endpoint

320

1611

2.18

32.16

2.7

3.8

8.33

27.21

ug/l

2.21

293

1363

COPD, early/later onset

2664

17793

1.30

31.90

3.0

4.1

30.47

25.50

ug/l

0.36

2353

14748

Symptoms and signs involving the skin and subcutaneous tissue

3619

29489

1.25

31.64

3.5

4.0

11.94

24.76

ug/l

4.92

2887

23546

Spondylopathies

4665

23632

1.22

31.52

3.2

4.3

28.14

26.72

ug/l

0.06

3812

19029

Primary biliary cholangitis (PBC)

185

761

2.87

31.41

3.9

4.1

3.43

25.74

ug/l

1.38

139

616

Osteopathies and chondropathies

2956

22501

1.27

31.22

3.6

4.0

18.66

23.70

ug/l

0.62

2436

18116

Leiomyoma of uterus

3463

15961

1.26

31.16

3.4

3.7

19.77

22.29

ug/l

0.19

2634

12442

Irritable bowel syndrome

1286

9187

1.44

31.14

2.7

3.8

10.81

28.51

ug/l

2.34

965

7230

Benign neoplasm of other and unspecified female genital organs

172

668

2.76

30.90

3.4

1.4

6.43

21.82

ug/l

0.39

132

490

Benign neoplasm: Adrenal gland

459

2640

1.89

30.80

3.6

4.1

31.85

20.43

ug/l

0.27

385

2159

Mental and behavioural disorders due to tobacco

461

2641

1.87

30.67

2.9

4.3

8.97

29.80

ug/l

2.61

413

2138

Smoking dependency

461

2646

1.86

30.48

2.9

4.2

8.97

29.75

ug/l

2.60

413

2139

Diseases of oral cavity, salivary glands and jaws

5276

22834

1.20

30.20

3.9

4.0

28.84

28.13

ug/l

0.04

4250

18250

Benign neoplasm: Long bones of lower limb

116

367

3.38

30.06

3.6

1.6

38.22

3.42

ug/l

0.50

276

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

127

5.84

30.05

2.3

1.5

2.44

2.80

ug/l

0.44

102

Alcohol-induced acute pancreatitis

229

1046

2.44

29.82

3.2

4.6

5.41

26.97

ug/l

1.85

196

872

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

124

416

3.26

29.46

2.6

1.4

13.67

3.76

ug/l

0.49

309

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

165

5.01

29.44

3.5

1.4

34.31

4.58

ug/l

0.50

130

Carcinoid syndrome

104

331

4.20

29.41

3.6

4.3

12.94

40.50

ug/l

0.61

283

Other and unspecified drugs and medicaments

455

2637

1.84

29.12

5.6

4.0

78.20

21.54

ug/l

0.40

386

2123

Unspecific neurodegenerative disorder

1465

13550

0.72

29.03

2.7

3.8

15.04

22.81

ug/l

0.83

1201

11327

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

171

4.88

29.02

4.8

1.6

48.64

4.54

ug/l

0.68

131

Polyp of the female genital tract

1775

7769

1.37

29.00

3.5

4.1

17.88

30.87

ug/l

0.93

1353

6109

Parodontitis and operation codes

4700

30838

1.21

28.96

4.0

4.1

18.16

26.38

ug/l

1.43

3841

24723

Ulcerative enterocolitis

190

808

2.59

28.85

5.3

4.3

4.05

27.61

ug/l

1.54

143

663

Dizziness and giddiness

4140

28068

1.22

28.84

3.3

4.1

18.13

26.62

ug/l

1.26

3307

22640

Endometriosis

1779

7965

1.36

28.71

3.3

4.0

15.20

30.47

ug/l

1.44

1330

6206

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

114

371

3.36

28.54

3.6

1.5

5.30

3.67

ug/l

0.70

105

280

Other other unspecified disorders of the circulatory system

249

1203

2.31

28.40

3.5

4.1

12.31

24.27

ug/l

0.81

193

996

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

8.09

28.36

3.0

1.6

5.73

2.65

ug/l

1.11

Duodenal ulcer

631

4007

1.66

28.26

3.7

4.2

17.60

24.44

ug/l

0.35

536

3353

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

118

5.80

28.24

2.6

1.5

45.66

5.32

ug/l

0.83

Benign neoplasm: Oesophagus

175

4.77

28.20

2.8

1.5

7.37

4.57

ug/l

0.40

132

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

116

383

3.27

28.15

3.1

1.5

16.57

3.65

ug/l

0.48

288

Insulin, fast-acting or short human

1832

14040

1.34

28.13

3.8

4.0

19.11

26.22

ug/l

0.58

1565

11361

Follow-up care involving plastic surgery

237

1123

2.32

27.99

3.7

24.81

12.65

ug/l

0.35

175

889

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

239

4.10

27.95

2.3

1.4

3.01

4.03

ug/l

0.34

186

Enterocolitis due to Clostridium difficile

595

3743

1.68

27.79

3.4

3.8

23.30

23.00

ug/l

0.01

489

3060

Benign neoplasm: Tongue

120

410

3.19

27.66

3.9

1.4

8.17

3.51

ug/l

0.60

102

309

Other metabolic disorders

664

4283

1.62

27.49

3.6

4.0

78.19

20.24

ug/l

0.57

515

3341

Dementia

1582

14378

0.74

27.49

2.7

3.9

18.01

25.13

ug/l

0.68

1299

12017

Asthma-related pneumonia

1885

14552

1.33

27.46

3.3

3.9

11.21

23.78

ug/l

3.13

1599

11811

Other disorders of skin and subcutaneous tissue

3744

28571

1.22

27.45

3.4

4.0

15.56

25.83

ug/l

2.19

3034

23091

Gingivitis and periodontal diseases

5175

22698

1.19

27.43

3.9

4.0

23.87

28.24

ug/l

0.36

4134

18140

Parodontitis or/and operation codes

3185

15417

1.25

27.42

4.0

3.9

19.99

21.39

ug/l

0.10

2594

12081

Asthma-related pneumonia or sepsis

1887

14572

1.33

27.41

3.3

3.9

11.20

23.76

ug/l

3.12

1600

11826

Asthma, hospital admissions 3, pneumonia

1887

14572

1.33

27.41

3.3

3.9

11.20

23.76

ug/l

3.12

1600

11826

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

162

645

2.65

27.41

2.8

1.6

37.32

3.65

ug/l

0.57

122

479

Benign neoplasm: Other and unspecified parts of mouth

133

483

2.96

27.28

3.8

1.5

22.94

3.37

ug/l

0.91

103

365

External causes of morbidity and mortality

3811

15782

1.23

27.04

3.9

4.0

27.70

29.23

ug/l

0.06

3014

12471

Crohn's disease of large intestine

261

1293

2.16

26.89

4.7

4.3

3.11

23.20

ug/l

2.07

211

1035

Other dorsopathies, not elsewhere classified

5479

24724

1.18

26.66

3.4

4.3

16.85

26.05

ug/l

1.71

4319

19667

N06DA Anticholinesterases

1059

11897

0.70

26.59

2.6

3.7

15.93

22.59

ug/l

0.50

856

9950

Use of anticholinesterases

1059

11897

0.70

26.59

2.6

3.7

15.93

22.59

ug/l

0.50

856

9950

Other symptoms and signs involving the urinary system

559

3502

1.69

26.57

3.6

4.3

21.94

25.05

ug/l

0.09

491

2903

Colorectal neuroendocrine tumor and carcinoma

119

427

3.36

26.54

4.6

4.3

9.77

13.78

ug/l

0.22

100

360

Direct fill therapy

627

4020

1.63

26.52

4.7

4.2

21.38

25.38

ug/l

0.12

527

3216

Barrett oesophagus

301

1594

2.08

26.45

3.4

4.4

9.51

15.35

ug/l

0.57

242

1317

Other arrhythmias

3450

21858

1.23

26.31

3.5

4.2

13.36

27.98

ug/l

3.77

2729

17492

Benign neoplasm: Conjunctiva

119

415

3.08

26.26

4.3

1.5

3.52

3.94

ug/l

0.17

320

Other diseases of pericardium

281

1458

2.12

26.15

3.6

4.5

16.68

28.44

ug/l

0.54

226

1211

Any event in hilmo or specialist outpatient

33.58

26.14

4.4

1.4

17.37

1.53

ug/l

—

Asthma-related infections

2882

23133

1.25

26.01

3.2

4.0

12.26

24.94

ug/l

3.12

2384

18435

Asthma, hospital admission 2, infections

2882

23133

1.25

26.01

3.2

4.0

12.26

24.94

ug/l

3.12

2384

18435

Dementia, including avohilmo

1707

15231

0.75

26.00

2.7

4.0

17.18

25.69

ug/l

0.96

1405

12733

Other disorders of kidney and ureter

695

4604

1.59

25.96

3.2

4.1

35.56

21.16

ug/l

0.37

559

3774

Coagulation defects, purpura and other haemorrhagic conditions

925

6461

1.49

25.89

3.7

4.0

13.28

27.81

ug/l

1.32

738

5184

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

237

3.93

25.82

3.4

1.4

7.53

4.14

ug/l

0.51

186

Congenital malformations of gallbladder, bile ducts and liver

270

4.09

25.75

3.0

4.2

3.91

25.16

ug/l

0.76

225

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

185

4.21

25.61

5.5

2.0

4.24

ug/l

0.00

147

Other benign neoplasm of uterus: Other parts/unspecified

183

805

2.45

25.46

3.0

1.4

4.90

3.18

ug/l

1.19

142

614

Disorders of choroid and retina

4497

27860

1.20

25.16

3.6

4.1

22.76

26.52

ug/l

0.37

3674

22658

Liposarcoma, excluding all cancers (controls excluding all cancers)

143

4.97

25.09

3.3

1.6

3.23

4.84

ug/l

0.36

112

Suppurative and necrotic conditions of lower respiratory tract

314

1710

1.99

25.08

3.0

4.2

8.76

27.34

ug/l

1.87

269

1438

Benign neoplasm: Extrahepatic bile ducts

11.47

25.00

2.3

1.1

2.85

2.97

ug/l

0.08

Benign neoplasm: Bronchus and lung

191

4.28

24.98

4.5

1.4

51.95

4.28

ug/l

0.54

153

All-cause Heart Failure

3334

19959

1.23

24.85

3.1

4.2

17.96

25.73

ug/l

1.00

2818

16573

Benign neoplasm: other/unspecified salivary gland

113

397

3.08

24.76

3.2

1.5

11.71

3.55

ug/l

1.00

310

Small cell lung cancer, helper endpoint

178

796

2.52

24.68

2.2

4.0

35.59

31.49

ug/l

0.09

162

683

Small cell lung cancer

178

796

2.52

24.68

2.2

4.0

35.59

31.49

ug/l

0.09

162

683

Postprocedural endocrine and metabolic disorders, not elsewhere classified

608

3944

1.61

24.63

3.7

4.0

84.93

20.19

ug/l

0.59

472

3077

Benign neoplasm: Other and unspecified parts of small intestine

138

559

2.95

24.50

3.9

4.0

6.10

34.18

ug/l

1.22

118

474

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

11.03

24.45

1.3

1.8

7.36

2.38

ug/l

0.46

Other congenital malformations of the digestive system

204

948

2.29

24.39

3.5

4.1

3.90

27.01

ug/l

1.79

153

768

Substance abuse, excluding more controls

2765

19764

1.25

24.34

3.2

4.3

25.36

26.29

ug/l

0.05

2389

15874

Benign neoplasm: Skin of ear and external auricular canal

141

559

2.68

24.30

3.1

1.4

4.68

3.47

ug/l

0.46

119

421

Heart failure, strict

3373

20237

1.23

24.26

3.1

4.2

18.10

27.12

ug/l

1.19

2851

16800

Alzheimer disease, including avohilmo

1184

11499

0.72

24.05

2.6

3.7

20.27

22.21

ug/l

0.11

956

9609

ILD medications: immunosuppressive drugs

3090

24545

1.23

23.96

3.3

4.2

29.15

24.15

ug/l

0.27

2444

19432

Any dementia

1362

12648

0.74

23.91

2.6

3.8

20.26

21.92

ug/l

0.10

1115

10560

Missing teeth due to accident, extraction or parodontitis

658

4387

1.58

23.90

3.4

4.1

6.50

19.63

ug/l

4.04

567

3586

Thrombocytopenia, unspecified

379

2220

1.82

23.55

3.9

4.1

21.38

24.20

ug/l

0.10

314

1827

Benign neoplasm: Lip

291

3.41

23.51

2.6

1.5

4.37

3.81

ug/l

0.15

220

Hyperkalaemia

309

1712

1.95

23.32

4.4

4.0

103.22

28.10

ug/l

0.36

272

1423

Heartburn

480

2982

1.68

23.26

3.6

3.9

7.02

24.60

ug/l

2.20

369

2372

Degenerative diseases of the nervous system

1129

11449

0.72

23.22

2.6

3.7

21.36

21.91

ug/l

0.03

914

9568

Abnormal serum enzyme levels

1600

12248

1.33

23.15

3.7

4.3

21.48

29.23

ug/l

0.61

1319

10308

Carcinoma in situ of breast, lobular

103

5.70

23.15

4.4

1.3

5.02

2.76

ug/l

1.52

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

279

3.44

23.05

3.6

1.4

9.17

3.97

ug/l

1.14

216

Purpura and other haemorrhagic conditions

659

4417

1.56

23.03

3.8

4.0

16.45

22.95

ug/l

0.48

546

3580

Secondary hypertension

393

2304

1.78

23.00

2.9

4.4

5.28

19.70

ug/l

2.60

310

1856

Vocal cord dysfunction

744

4727

1.52

23.00

4.1

4.6

8.91

36.61

ug/l

2.64

623

3735

Substance use, excluding alcohol

807

5604

1.48

22.99

2.8

4.4

9.10

28.36

ug/l

2.14

695

4412

Substance abuse

2765

21746

1.24

22.89

3.2

4.2

25.36

26.51

ug/l

0.06

2389

17463

Malignant neoplasm of urinary organs

558

3631

1.63

22.88

3.0

4.0

11.82

21.32

ug/l

0.90

447

3014

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

8.47

22.83

3.3

1.8

2.09

8.16

ug/l

0.53

Mental and behavioural disorders due to psychoactive substance use

2848

22184

1.23

22.81

3.3

4.2

25.13

26.15

ug/l

0.06

2461

17801

Malignant neoplasm of heart, mediastinum and pleura

106

393

3.26

22.40

2.1

4.6

3.74

39.83

ug/l

1.12

331

Fracture of rib(s), sternum and thoracic spine

1506

11642

1.33

22.21

3.4

4.1

22.79

23.48

ug/l

0.03

1250

9595

Other infectious diseases

418

2551

1.74

22.19

4.3

4.0

24.01

22.23

ug/l

0.07

337

2103

Benign neoplasm of thyroid gland

126

496

2.72

22.16

4.4

1.5

14.01

3.34

ug/l

1.15

377

Alzheimer disease

973

10027

0.71

22.10

2.6

3.6

21.11

22.98

ug/l

0.09

777

8407

Gout

1541

10896

1.33

22.05

3.3

4.4

23.80

31.29

ug/l

0.40

1275

9192

Injuries to the thorax

2244

18182

1.26

22.03

3.4

4.1

23.20

25.10

ug/l

0.12

1861

14842

Carcinoma in situ of skin of upper limb, including shoulder

100

354

3.12

21.91

3.2

1.3

3.54

4.35

ug/l

0.33

264

Early onset COPD

1193

8962

1.38

21.81

3.1

4.4

21.97

25.08

ug/l

0.18

1058

7396

All influenza

1166

8704

1.38

21.76

3.8

4.0

21.01

29.37

ug/l

0.43

964

7069

Other disorders of ear

5066

29282

1.17

21.67

3.6

4.1

14.42

28.08

ug/l

3.71

4092

23546

Melanoma of uvea

152

4.48

21.48

3.7

1.3

9.11

2.78

ug/l

0.89

117

Continuous positive airway pressure

1013

6387

1.41

21.41

3.2

4.6

22.71

25.57

ug/l

0.10

832

5178

Benign neoplasm: Larynx

111

417

2.83

21.35

3.4

1.5

10.54

3.58

ug/l

0.58

315

Adjustment and management of implanted device

911

6582

1.43

21.27

2.8

3.8

20.02

12.30

ug/l

0.59

710

5411

malignant neoplasm of male genital organs

2201

11291

1.27

21.18

3.8

4.3

20.03

32.01

ug/l

1.55

1824

9610

Diseases of spleen

122

496

2.83

21.08

2.9

4.6

26.06

33.09

ug/l

0.10

103

414

Diseases of arteries, arterioles and capillaries

3752

23847

1.20

21.06

3.4

4.1

24.95

25.29

ug/l

0.02

3166

19589

Other noninflammatory disorders of uterus, except cervix

1306

6774

1.36

20.96

3.5

4.1

14.17

32.71

ug/l

1.63

1019

5427

Dementia in Alzheimer disease

483

6332

0.63

20.94

2.5

3.6

33.09

26.59

ug/l

0.18

371

5311

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

206

3.80

20.87

2.9

1.5

23.85

4.20

ug/l

0.47

163

Excessive, frequent and irregular menstruation

1846

8095

1.29

20.85

3.3

4.0

20.64

30.22

ug/l

0.63

1407

6276

Drug-induced polyneuropathy

271

3.77

20.84

6.2

4.0

4.76

24.43

ug/l

0.68

226

Colorectal squamous cell carcinoma

21.94

20.83

3.4

5.5

2.14

12.02

ug/l

1.17

Valvular heart disease excluding rheumatic fever

2662

16081

1.23

20.81

3.5

4.4

27.36

27.07

ug/l

0.01

2175

13275

Polyneuropathies and other disorders of the peripheral nervous system

1134

8529

1.38

20.67

3.2

4.2

62.01

22.92

ug/l

0.78

935

7072

Diseases of pulp and periapical tissues, including avohilmo

5922

26980

1.15

20.62

3.8

4.0

17.68

27.72

ug/l

2.14

4757

21491

Non-rheumatic valve diseases

2654

16037

1.23

20.49

3.5

4.4

27.42

26.78

ug/l

0.03

2169

13246

Benign neoplasm: Pituitary gland, craniopharyngeal duct

147

641

2.40

20.48

3.8

1.5

100.21

3.20

ug/l

0.85

111

482

Soft tissue disorders

5474

24809

1.16

20.47

3.5

4.2

18.34

27.92

ug/l

1.54

4353

19771

6269

29167

1.15

20.46

3.8

4.0

21.88

25.52

ug/l

0.34

4978

23252

Benign neoplasm: Other/unspecified site

213

3.67

20.43

3.2

1.5

106.84

4.17

ug/l

0.50

159

Non-ischemic cardiomyopathy

1754

11453

1.30

20.41

3.3

4.3

24.78

26.58

ug/l

0.09

1502

9520

Fissure and fistula of anal and rectal regions

1124

8427

1.37

20.41

3.7

4.0

19.21

29.70

ug/l

0.73

865

6777

Congenital malformation of biliary tract

9.58

20.40

3.8

4.1

3.75

12.53

ug/l

0.85

Shoulder lesions

4448

23496

1.18

20.38

3.4

4.3

19.37

28.77

ug/l

1.30

3591

18965

Localized swelling, mass and lump of skin and subcutaneous tissue

1579

12417

1.30

20.33

3.7

4.1

14.65

25.14

ug/l

1.23

1265

10007

Dental pulpitis 4

5924

27014

1.15

20.33

3.8

4.0

17.24

27.80

ug/l

2.35

4759

21521

Antihypertensive medication - note that there are other indications

2548

11405

1.24

20.25

3.8

4.3

19.39

27.90

ug/l

0.67

1969

8598

Cough

2132

16630

1.25

20.21

3.5

4.2

13.84

26.50

ug/l

1.75

1668

13435

Polycythaemia vera

126

519

2.59

20.19

2.8

1.4

20.84

3.81

ug/l

0.49

100

391

Malignant immunoproliferative diseases

141

4.51

20.18

2.8

1.4

9.31

4.98

ug/l

0.27

109

Dental pulpitis 1

5921

27024

1.15

20.12

3.8

4.0

17.24

27.79

ug/l

2.34

4758

21528

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

298

3.17

20.06

3.6

1.5

5.89

3.86

ug/l

0.67

229

Polyuria

1157

8766

1.36

19.97

3.5

4.1

13.26

26.72

ug/l

1.67

926

7217

Benign neoplasm of other and unspecified endocrine glands

662

4583

1.51

19.92

3.6

4.0

31.60

22.93

ug/l

0.26

542

3686

Malignant neoplasm of kidney, except renal pelvis

505

3318

1.61

19.91

3.0

4.1

8.06

22.59

ug/l

2.19

405

2753

Other diseases of gallbladder

257

1415

1.96

19.90

3.6

4.1

10.98

22.44

ug/l

0.79

201

1167

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

117

4.90

19.79

4.0

1.4

58.90

5.41

ug/l

0.75

Abnormal results of function studies

402

2497

1.69

19.75

3.8

4.1

12.15

21.23

ug/l

0.78

330

2010

Polycystic ovarian syndrome, consortium definition

3475

17762

1.20

19.75

3.3

3.7

19.40

21.32

ug/l

0.13

2666

13576

Inflammatory diseases of female pelvic organs

2907

18340

1.21

19.67

3.4

3.7

13.70

21.94

ug/l

1.17

2206

14057

Paroxysmal tachycardia

1093

6917

1.37

19.60

3.6

4.3

10.40

26.54

ug/l

1.75

873

5472

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

297

3.15

19.59

3.4

1.5

29.92

3.75

ug/l

0.79

232

Carcinoma in situ of skin of ear and external auricular canal

171

3.97

19.52

3.7

1.4

5.10

4.61

ug/l

0.07

133

Fistulae involving female genital tract

122

516

2.71

19.46

5.6

4.2

4.76

30.05

ug/l

0.63

425

Any dementia, excluding more controls

1307

11687

0.76

19.45

2.7

3.9

20.76

23.66

ug/l

0.18

1074

9747

COPD related to multimorbidity

2168

14940

1.25

19.40

2.9

4.1

24.08

25.26

ug/l

0.08

1901

12408

Presence of other functional implants

3238

19423

1.20

19.36

3.7

3.9

25.53

28.75

ug/l

0.22

2646

15967

Postmenopausal bleeding

1642

7113

1.31

19.28

3.6

4.1

16.12

28.15

ug/l

0.98

1272

5704

Chronic hepatitis NAS

100

387

3.01

19.22

4.1

4.6

3.23

26.85

ug/l

1.20

325

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

132

567

2.46

19.20

3.6

1.5

67.23

3.40

ug/l

0.53

106

422

Faecal incontinence

460

2976

1.63

19.19

3.5

3.8

7.13

22.01

ug/l

1.94

354

2400

Bacterial pneumoniae

2086

15050

1.25

19.18

3.7

4.0

31.15

27.01

ug/l

0.21

1752

12234

Familial hypercholesterolemia

880

6450

1.42

19.14

3.4

4.1

12.32

24.59

ug/l

1.86

757

5349

Other noninfective disorders of lymphatic vessels and lymph nodes

203

1049

2.11

19.13

4.2

4.1

7.34

23.49

ug/l

1.23

162

859

Carcinoma in situ of breast, other/unspecified

224

3.55

19.08

5.0

1.4

4.30

2.61

ug/l

1.42

176

Injury, poisoning and certain other consequences of external causes

3066

12876

1.21

19.01

3.9

4.0

33.79

30.43

ug/l

0.10

2439

10121

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

138

4.36

18.94

3.5

1.5

3.22

5.05

ug/l

0.39

106

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

139

615

2.37

18.83

3.5

1.5

63.13

3.30

ug/l

0.50

118

462

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

5.28

18.77

3.8

1.5

9.69

5.99

ug/l

0.37

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

139

4.29

18.71

3.4

1.6

4.26

4.68

ug/l

0.05

107

119

2621

0.43

18.63

2.7

4.1

15.07

27.06

ug/l

0.83

102

2208

Osteoporosis

1417

10626

1.31

18.59

3.4

3.8

12.79

21.26

ug/l

1.49

1189

8692

Oesophageal obstruction

213

1132

2.05

18.59

3.7

4.3

93.04

14.30

ug/l

0.67

186

938

Collagenous colitis

457

2984

1.61

18.39

4.2

4.0

12.70

25.17

ug/l

0.96

353

2398

Gout, FINNGEN

1541

12255

1.29

18.37

3.3

4.2

23.80

25.72

ug/l

0.09

1275

10309

6-mercaptopurine

127

550

2.46

18.29

3.7

4.4

2.76

31.86

ug/l

1.20

444

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

5.33

18.23

3.4

1.5

4.22

5.78

ug/l

0.17

Cyst of kidney

387

2449

1.69

18.19

3.1

4.2

38.10

25.94

ug/l

0.20

309

2025

Benign neoplasm: Skin of lower limb, including hip

383

2.76

18.09

4.3

1.5

14.01

3.48

ug/l

0.65

298

Benign neoplasm: Skin of upper limb, including shoulder

261

3.19

18.07

3.1

1.5

18.45

3.96

ug/l

0.56

193

Seminoma of testis, excluding all cancers (controls excluding all cancers)

4.84

18.07

6.4

1.9

4.14

5.44

ug/l

0.18

Cellulitis

988

7411

1.37

18.07

3.7

4.1

20.67

24.88

ug/l

0.19

803

5987

Fungal Sepsis

210

1121

2.04

18.05

4.0

4.1

25.87

18.56

ug/l

0.20

174

929

Hypotension

862

6356

1.41

18.04

3.2

3.8

18.22

23.69

ug/l

0.24

722

5276

Special screening examination for neoplasms

257

1457

1.89

18.03

4.3

16.56

14.68

ug/l

0.06

210

1195

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

252

3.27

18.02

3.3

1.5

33.25

4.00

ug/l

0.77

198

Alzheimer’s disease, wide definition

741

8544

0.70

18.02

2.5

3.6

25.86

24.42

ug/l

0.05

585

7156

Convulsions, not elsewhere classified

942

6908

1.37

18.00

3.7

4.0

13.17

23.51

ug/l

1.36

776

5510

Unspecified kidney failure

524

3544

1.55

17.90

3.3

3.9

42.71

23.43

ug/l

0.48

450

2965

Injuries to the head

5606

32288

1.14

17.90

3.6

4.0

9.61

27.36

ug/l

11.94

4530

25643

Bacterial pneumonia, not elsewhere classified

1980

14313

1.25

17.88

3.7

4.0

27.90

26.01

ug/l

0.09

1665

11668

Abnormalities of heart beat

1768

14168

1.26

17.77

3.4

4.2

17.91

24.26

ug/l

0.58

1392

11468

Morphin

114

486

2.64

17.71

4.1

3.8

18.57

12.77

ug/l

0.33

101

411

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

681

3538

1.48

17.70

3.1

5.0

25.86

34.87

ug/l

0.28

559

2933

Gout, unspecified

1054

8035

1.36

17.67

3.3

4.2

25.42

21.46

ug/l

0.14

873

6774

Menorrhagia

1787

7931

1.27

17.63

3.4

4.0

17.46

30.53

ug/l

0.99

1352

6207

Myeloid leukaemia

354

2.81

17.58

3.5

1.4

15.43

3.69

ug/l

0.51

268

Melanoma in situ of trunk

205

3.55

17.51

4.2

1.5

4.64

4.25

ug/l

0.09

161

Gout, idiopatic and unspecified

1272

9950

1.32

17.50

3.4

4.2

21.88

23.05

ug/l

0.05

1055

8395

UC patients in KELA-register (code 208), prior to 1994

257

1477

1.87

17.39

5.4

4.3

6.67

21.12

ug/l

1.55

205

1220

Status post-ami

164

2597

0.50

17.27

2.8

3.8

28.98

30.57

ug/l

0.03

137

2228

Other and unspecified types of non-Hodgkin lymphoma, hilmo

249

1425

1.90

17.25

2.7

4.1

10.73

22.30

ug/l

0.80

197

1187

Benign neoplasm of other and unspecified intrathoracic organs

157

3.93

17.24

3.1

1.4

4.20

4.61

ug/l

0.06

124

Hyperplasia of prostate

1930

8948

1.26

17.22

4.2

4.5

22.68

36.99

ug/l

1.15

1614

7615

Haemorrhage, not elsewhere classified

210

1140

1.99

17.12

4.1

4.0

8.84

17.99

ug/l

0.94

170

948

Pyothorax

232

1300

1.93

17.10

3.0

4.3

10.46

23.20

ug/l

0.95

199

1089

Clear cell adenocarcinoma of kidney

270

1590

1.85

17.02

3.2

4.2

9.79

20.22

ug/l

0.67

218

1327

Dental pulpitis 2

4163

18507

1.17

17.00

3.9

4.0

26.74

28.64

ug/l

0.11

3373

14897

Other external causes of accidental injury

4705

20617

1.16

17.00

3.8

4.1

15.77

30.00

ug/l

3.04

3770

16366

Brain meningioma, excluding all cancers (controls excluding all cancers)

167

830

2.11

16.97

3.8

1.4

26.09

3.48

ug/l

0.58

137

623

Crohn's disease of small intestine

288

1706

1.77

16.92

3.8

4.2

5.42

21.97

ug/l

2.11

205

1360

Care involving dialysis

355

2225

1.67

16.90

2.5

4.1

11.61

14.61

ug/l

0.15

302

1821

Essential (haemorrhagic) thrombocythaemia

127

569

2.36

16.88

2.8

1.4

4.40

3.75

ug/l

0.23

436

Accidents

4702

20617

1.15

16.84

3.8

4.1

15.77

30.00

ug/l

3.04

3771

16366

Congenital malformations of ovaries, fallopian tubes and broad ligaments

231

1286

1.88

16.82

3.2

3.7

5.46

39.03

ug/l

0.65

173

953

Gout, strict definition

925

6979

1.38

16.77

3.3

4.2

16.58

22.39

ug/l

0.30

767

5900

Other intervertebral disc disorders

4524

24264

1.15

16.67

3.2

4.3

18.77

26.19

ug/l

0.96

3621

19392

Acute posthaemorrhagic anaemia

199

1072

2.01

16.60

3.1

3.8

7.60

22.62

ug/l

1.17

163

886

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

116

4.53

16.52

2.8

1.4

2.80

5.36

ug/l

0.52

Invasive ventilation

359

2277

1.66

16.44

3.8

4.2

16.61

24.39

ug/l

0.37

294

1874

Oesophagitis

286

1716

1.77

16.41

3.5

4.3

5.65

13.72

ug/l

2.17

231

1419

Scar conditions and fibrosis of skin

205

1116

1.96

16.39

3.7

4.2

3.38

23.44

ug/l

1.93

153

896

Malignant neoplasm of prostate

2140

11187

1.23

16.39

3.8

4.3

20.45

32.06

ug/l

1.44

1776

9531

Benign neoplasm: Cranial nerves

104

434

2.56

16.32

3.9

1.5

15.04

3.63

ug/l

0.66

333

Dental caries 1

4581

20535

1.15

16.21

3.9

4.0

25.37

27.94

ug/l

0.17

3712

16530

Dental caries 3

4774

21469

1.15

16.09

3.9

4.0

25.13

27.23

ug/l

0.14

3881

17221

Candidiasis

620

4408

1.46

16.03

3.7

3.9

17.53

29.01

ug/l

0.59

502

3490

Dental caries, including avohilmo

4575

20529

1.15

16.00

3.9

4.0

25.39

27.95

ug/l

0.17

3707

16525

COPD, hospital admission 2, with asthma infections

1702

11832

1.26

15.97

2.8

4.1

31.71

24.15

ug/l

0.44

1488

9845

Benign neoplasm: Anus and anal canal

178

942

2.08

15.95

4.4

4.1

3.78

24.89

ug/l

1.71

152

788

Malignant neoplasm of skin

3555

23238

1.17

15.84

3.6

4.0

14.02

25.12

ug/l

4.35

2891

19198

Other and unspecified polyneuropathies, also in other diseases

972

7440

1.35

15.84

3.0

4.2

69.87

22.05

ug/l

0.83

802

6169

Other abnormal uterine and vaginal bleeding

1218

6798

1.31

15.77

3.2

4.1

21.50

30.24

ug/l

0.35

959

5404

Toxic colitis

5.74

15.60

6.4

4.3

29.50

8.24

ug/l

0.77

Diagnoses used for exclusion with ILD

1284

10192

1.29

15.51

3.3

4.0

15.28

24.54

ug/l

0.71

1021

8374

Pericarditis

200

1103

1.95

15.48

2.8

4.5

6.47

24.32

ug/l

1.41

156

911

Dental caries 2, only avohilmo

2539

23592

0.84

15.40

3.6

4.0

17.50

24.03

ug/l

0.36

1870

18517

Implicit fungal Sepsis

189

1030

1.99

15.32

3.8

4.1

23.48

19.93

ug/l

0.08

153

852

Dental caries 2 and operation codes, only avohilmo

2402

17665

0.83

15.30

3.6

4.0

17.92

20.26

ug/l

0.10

1778

13957

Other diseases of oesophagus

483

3313

1.52

15.29

3.4

4.1

13.80

24.85

ug/l

0.87

410

2726

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2069

17240

1.22

15.28

3.3

4.3

29.48

27.95

ug/l

0.07

1793

14005

Alzheimer’s disease, wide definition, excluding more controls

585

5539

0.69

15.18

2.7

4.3

25.91

28.10

ug/l

0.06

468

4669

Viral pneumonia

557

3921

1.47

15.17

3.5

4.1

9.17

24.01

ug/l

2.54

453

3205

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

322

2.75

15.15

3.7

1.4

35.73

3.63

ug/l

0.62

244

Melanocytic naevi of upper limb, including shoulder

288

2.84

15.08

2.9

1.5

26.49

3.73

ug/l

0.71

219

Persons encountering health services in circumstances related to reproduction

2369

13506

1.20

14.92

4.6

4.1

18.06

23.06

ug/l

0.42

1839

10574

Pneumonia due to other infectious organisms, not elsewhere classified

172

916

2.03

14.89

4.4

4.0

15.20

23.40

ug/l

0.25

137

753

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

6.95

14.88

2.6

1.7

4.91

2.34

ug/l

1.09

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

5.22

14.79

4.5

1.7

22.28

2.38

ug/l

0.59

Complications following infusion, transfusion and therapeutic injection

425

2.60

14.76

5.6

4.0

6.19

20.27

ug/l

0.78

355

Other cataract

2408

15807

1.20

14.64

3.6

4.2

17.61

25.82

ug/l

1.04

1965

12972

Heart failure and bmi 25plus

1837

10468

1.24

14.61

3.1

4.2

17.26

24.34

ug/l

0.93

1539

8636

Falls/tendency to fall

5836

26163

1.13

14.59

3.7

4.1

18.47

27.03

ug/l

1.66

4673

20700

Other specific joint derangements/joint disorders

3529

20587

1.16

14.56

3.3

4.3

17.80

29.33

ug/l

1.46

2726

16326

Viral hepatitis, IBD co-morbidity

233

1357

1.79

14.52

3.2

5.2

9.79

45.34

ug/l

0.81

203

1070

Haemangioma and lymphangioma, any site

420

2834

1.55

14.46

3.6

4.0

25.55

18.96

ug/l

0.20

329

2262

Asthma/COPD (KELA code 203)

4799

30053

1.14

14.45

3.3

4.1

19.96

25.14

ug/l

0.56

3976

23670

Dental operations

3886

17443

1.16

14.42

4.0

4.1

24.76

29.84

ug/l

0.39

3130

14136

Other/unspecified dorsalgia

1868

15451

1.22

14.38

3.1

4.2

15.12

25.62

ug/l

1.51

1453

12365

Any mental disorder

6176

27806

1.12

14.37

3.5

4.2

23.48

25.31

ug/l

0.18

5001

22110

Conductive and sensorineural hearing loss

4404

27002

1.14

14.33

3.6

4.1

15.26

28.78

ug/l

3.09

3605

21938

STROKE

3233

19458

1.17

14.33

3.5

4.4

33.41

25.59

ug/l

0.33

2649

15677

Inguinal hernia

2879

16667

1.18

14.32

4.0

4.1

17.15

29.88

ug/l

2.31

2402

13640

Use of donepezil

591

7795

0.71

14.27

2.6

3.6

13.05

23.57

ug/l

1.32

470

6514

Organic, including symptomatic, mental disorders

2031

17423

0.83

14.15

2.9

4.0

15.11

25.36

ug/l

1.60

1677

14536

Dental pulpitis 2, only avohilmo

4209

18972

1.15

14.06

3.8

4.0

26.18

28.67

ug/l

0.15

3415

15279

Benign neoplasm: Skin of scalp and neck

328

2.65

14.06

3.2

1.5

7.65

3.66

ug/l

0.63

254

Zoster [herpes zoster]

886

6808

1.34

14.04

3.8

3.9

11.16

22.53

ug/l

2.00

727

5550

Other endocrine disorders

193

1033

1.88

14.02

3.6

4.2

9.89

22.84

ug/l

0.82

145

826

Alzheimer’s disease (Late onset)

689

7907

0.73

14.01

2.5

3.6

26.84

25.46

ug/l

0.05

547

6640

Other retinal disorders

3376

23685

1.16

13.91

3.4

4.0

23.22

26.04

ug/l

0.21

2792

19443

Certain disorders involving the immune mechanism

892

6861

1.34

13.90

3.5

4.2

14.66

29.44

ug/l

1.22

675

5533

Malignant neoplasm of endocrine gland

357

2354

1.59

13.88

4.2

4.1

21.21

23.86

ug/l

0.07

273

1895

Presence of cardiac and vascular implants and grafts

2412

15547

1.20

13.85

3.1

4.0

19.24

30.15

ug/l

1.10

1975

12937

Diseases of male genital organs

2356

10048

1.20

13.83

4.3

4.6

21.01

36.02

ug/l

1.64

1955

8438

Myocardial infarction, unclassifiable

728

8612

0.74

13.79

3.2

3.7

11.05

24.44

ug/l

3.35

611

7211

Dental caries 1 and operation codes

4953

22635

1.13

13.75

3.9

4.0

23.61

27.64

ug/l

0.32

3998

18232

Dorsopathies

5417

24739

1.13

13.74

3.4

4.3

18.17

26.04

ug/l

1.23

4312

19673

Other viral hepatitis

222

1298

1.78

13.66

3.4

4.5

8.79

22.75

ug/l

0.99

194

1021

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

5.16

13.60

2.9

1.3

13.77

6.51

ug/l

0.38

Benign neoplasm: Peripheral nerves and autonomic nervous system

220

3.05

13.56

4.1

1.5

3.59

4.13

ug/l

0.14

171

Disorders of magnesium metabolism

211

3.41

13.54

7.8

5.2

48.55

58.55

ug/l

0.08

177

Undetermined asthma, excluding more controls

587

4251

1.42

13.54

3.4

4.2

27.73

31.36

ug/l

0.06

476

3384

Covid-19 suspected case

786

5944

1.35

13.53

3.6

4.0

20.45

26.20

ug/l

0.18

626

4579

Crohn disease (strict definition, require KELA, min 2 HDR)

245

1478

1.73

13.52

3.7

4.3

11.34

22.91

ug/l

0.65

190

1171

Alcohol use disorder, ICD-based

1886

15795

1.21

13.43

3.2

4.3

30.64

28.32

ug/l

0.10

1637

12852

Bacterial pneumonia (organism specified)

2229

17241

1.20

13.42

3.7

3.9

30.33

24.45

ug/l

0.35

1865

14082

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

265

1635

1.69

13.39

3.8

4.3

10.74

22.18

ug/l

0.72

205

1297

Benign neoplasm: Ill-defined sites within the digestive system

214

3.45

13.38

4.4

4.3

13.93

8.32

ug/l

0.42

185

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

219

3.05

13.17

4.1

1.4

14.24

2.70

ug/l

0.65

171

Haemangioma, any site

393

2670

1.54

13.16

3.5

4.0

27.06

19.29

ug/l

0.22

305

2146

Melanocytic naevi of scalp and neck

273

2.74

13.16

4.1

1.5

2.93

3.82

ug/l

0.35

204

Viral infections characterized by skin and mucous membrane lesions

1858

15566

1.21

13.08

3.8

4.0

31.18

22.41

ug/l

0.21

1490

12457

Elevated blood glucose level

374

2518

1.55

13.06

3.7

4.1

39.13

24.68

ug/l

0.31

308

2065

Disorders of skin appendages

2027

17112

1.20

13.01

3.6

4.0

16.51

23.79

ug/l

0.74

1588

13517

Alzheimer’s disease (Late onset), excluding more controls

559

5096

0.71

12.99

2.7

4.3

26.07

25.98

ug/l

0.00

450

4312

Benign neoplasm: Spinal meninges

146

3.56

12.99

3.4

1.4

2.46

4.61

ug/l

0.58

118

Finngen Rheumatological endpoints

5007

25547

1.13

12.97

3.5

4.2

23.55

25.79

ug/l

0.18

3966

20246

Volvulus

140

731

2.07

12.90

3.8

3.9

13.50

33.43

ug/l

0.83

118

600

Autoimmune hepatitis

245

3.10

12.84

3.9

4.2

3.53

12.25

ug/l

2.33

202

Benign neoplasm: Skin of lip

183

3.20

12.82

3.3

1.5

3.62

4.33

ug/l

0.15

140

Mucinous and mucinous cystic tumor

143

4.06

12.81

1.8

4.2

17.58

10.00

ug/l

0.38

115

Persons with potential health hazards related to communicable diseases

1263

10106

1.26

12.80

4.3

3.9

16.62

24.91

ug/l

0.56

971

7626

Other acute lower respiratory infections

2432

19922

1.18

12.76

3.6

3.9

17.56

24.90

ug/l

0.72

1990

16022

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

415

2877

1.51

12.70

2.8

3.9

9.27

20.37

ug/l

1.47

337

2353

Salpingitis and oophoritis

905

7070

1.32

12.68

3.8

3.9

20.11

24.63

ug/l

0.17

693

5500

L02BX Other hormone antagonists and related agents

291

1886

1.65

12.64

2.9

4.3

21.45

29.70

ug/l

0.34

240

1606

Benign neoplasm: Other parts of oropharynx

109

3.93

12.59

2.5

1.5

4.07

2.87

ug/l

0.41

Neuroendocrine tumor and carcinoma of lung

249

3.09

12.55

2.6

4.2

26.09

24.33

ug/l

0.02

211

Pruritus

505

3624

1.44

12.53

3.4

3.8

6.02

32.29

ug/l

1.94

405

2870

Viral hepatitis

271

1709

1.64

12.52

3.4

4.3

8.91

22.15

ug/l

1.24

233

1356

Undetermined asthma

587

4310

1.40

12.49

3.4

4.1

27.73

31.15

ug/l

0.06

476

3437

Crohn disease (strict definition, require KELA)

245

1510

1.69

12.47

3.7

4.3

11.34

22.48

ug/l

0.63

190

1197

Ulcerative proctitis

252

1567

1.68

12.44

3.1

4.2

18.43

24.13

ug/l

0.18

177

1251

Coronary artery bypass grafting

1099

10398

0.79

12.41

3.1

4.3

11.59

28.72

ug/l

4.44

911

8811

Other and unspecified local infections of skin and subcutaneous tissue

420

2926

1.49

12.31

3.8

4.0

21.58

23.13

ug/l

0.04

340

2372

Problems related to lifestyle

381

2595

1.51

12.29

2.7

4.2

26.24

35.99

ug/l

0.23

336

2073

Disorders of thyroid, IBD co-morbidities

920

5226

1.31

12.28

3.3

4.8

9.26

35.71

ug/l

2.51

705

4082

Pneumocystosis

108

531

2.30

12.25

5.2

4.3

20.90

36.95

ug/l

0.32

453

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

183

3.14

12.22

2.1

1.3

3.75

4.36

ug/l

0.14

143

Coxibs

1399

6055

1.25

12.21

3.5

4.3

20.08

24.53

ug/l

0.27

1114

4968

Sensorineural hearing loss

4202

26238

1.13

12.20

3.6

4.1

14.95

28.27

ug/l

2.94

3452

21381

Mental and behavioural disorders due to alcohol

2333

19507

1.18

12.19

3.3

4.3

28.67

27.07

ug/l

0.08

2021

15719

Degeneration of macula and posterior pole

2618

18728

1.17

12.19

3.5

4.0

20.67

23.80

ug/l

0.27

2166

15587

Acetic acid derivatives and related substances

1425

6046

1.25

12.18

3.5

4.3

21.36

24.55

ug/l

0.17

1107

4964

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

6.40

12.17

3.9

1.4

4.98

2.97

ug/l

0.66

Ulcerative rectosigmoiditis

343

2303

1.54

12.05

4.0

4.2

5.58

19.57

ug/l

2.19

262

1844

Other degenerative diseases of the nervous system

1053

9950

0.79

11.99

2.9

4.4

21.16

31.66

ug/l

0.66

850

8216

Use of memantine

840

9324

0.77

11.97

2.6

3.6

13.98

24.51

ug/l

1.37

678

7839

Use of other anti-dementia drugs

840

9324

0.77

11.97

2.6

3.6

13.98

24.51

ug/l

1.37

678

7839

Emphysema

359

2448

1.54

11.95

3.1

4.1

14.57

26.21

ug/l

0.64

316

2045

Disorders of the thyroid gland

4906

28851

1.12

11.90

3.5

4.0

19.01

25.49

ug/l

0.84

3838

23096

Dental caries 1, only avohilmo

4616

21132

1.13

11.88

3.9

4.0

25.30

27.47

ug/l

0.14

3743

17047

Urolithiasis

1580

13195

1.22

11.86

4.2

4.1

18.53

29.31

ug/l

1.10

1291

10929

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

124

3.63

11.79

3.4

1.4

22.35

4.94

ug/l

0.76

Protozoal diseases

150

829

1.96

11.79

5.0

4.6

16.90

31.04

ug/l

0.42

122

696

Benign neoplasm: Vulva

327

2.51

11.77

3.7

1.5

3.00

3.24

ug/l

0.15

247

Vitamin deficiency

231

1432

1.70

11.77

3.3

4.1

7.32

20.92

ug/l

1.44

189

1160

Vitamin deficiency, wide

231

1432

1.70

11.77

3.3

4.1

7.32

20.92

ug/l

1.44

189

1160

Alzheimer disease, excluding more controls

700

6093

0.75

11.71

2.8

4.4

24.34

28.88

ug/l

0.16

562

5135

Ulcer of oesophagus

355

2426

1.53

11.71

3.4

4.3

5.20

21.29

ug/l

3.35

302

2017

Dental caries 3 and operation codes

5070

23423

1.12

11.71

3.9

4.0

24.05

27.10

ug/l

0.23

4102

18812

Oxicams

1278

5897

1.25

11.67

3.2

4.3

20.56

24.92

ug/l

0.35

1034

4879

Other diseases of lip and oral mucosa

804

6258

1.32

11.62

3.7

4.1

22.35

22.71

ug/l

0.01

667

5072

Other local infections of skin and subcutaneous tissue

446

3175

1.45

11.62

3.8

4.0

20.48

22.25

ug/l

0.05

361

2574

Intracranial trauma

2869

18718

1.16

11.58

3.5

4.4

11.33

28.98

ug/l

4.26

2296

14829

Carcinoma in situ of skin, other sites/unspecified

173

3.17

11.56

2.5

1.3

3.09

4.58

ug/l

0.42

136

Disorders of other endocrine glands

1957

16392

1.19

11.55

3.2

3.9

17.98

21.86

ug/l

0.29

1542

13083

Other misadventures during surgical and medical care

124

650

2.09

11.54

4.6

4.3

4.47

31.50

ug/l

1.42

543

Colonic or urogenital fistula

1283

10531

1.24

11.53

3.9

4.1

19.36

25.85

ug/l

0.46

992

8572

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

121

3.60

11.48

4.3

1.5

66.59

5.28

ug/l

0.52

Follicular cysts of skin and subcutaneous tissue

823

6434

1.31

11.40

3.8

4.2

26.66

30.49

ug/l

0.12

665

5205

Abscess of lung

428

2.36

11.37

2.8

4.7

4.91

36.98

ug/l

1.08

364

Benign mammary dysplasia

742

5742

1.33

11.37

3.4

3.7

15.34

21.63

ug/l

0.47

579

4589

Congenital malformations of genital organs

302

1981

1.56

11.33

3.1

3.7

4.94

43.94

ug/l

1.33

218

1464

Extracorporeal dialysis

283

1859

1.60

11.32

2.4

4.2

12.90

22.18

ug/l

0.44

240

1542

Other maternal disorders predominantly related to pregnancy

1895

14024

0.84

11.32

3.4

3.8

19.08

22.09

ug/l

0.16

1388

10556

Osteonecrosis due to drugs

400

2.46

11.31

7.7

4.6

36.45

40.59

ug/l

0.05

345

Acute bronchitis

1904

15881

1.19

11.28

3.4

3.9

17.92

23.37

ug/l

0.37

1551

12829

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1295

10651

1.24

11.27

3.2

4.1

9.76

27.19

ug/l

3.47

1039

8584

Psychiatric diseases

5981

27241

1.11

11.26

3.5

4.2

22.14

25.82

ug/l

0.41

4840

21635

Unspecified privation

472

3416

1.43

11.17

4.1

18.12

21.82

ug/l

0.18

387

2774

1893

15987

1.19

11.14

3.2

4.0

12.10

23.70

ug/l

1.67

1543

12638

Use of rivastigmine

389

5452

0.69

11.07

2.6

3.6

8.65

23.89

ug/l

3.37

310

4550

Acute gastritis

367

2549

1.50

11.05

2.9

4.1

6.95

20.01

ug/l

2.70

304

2067

Nerve, nerve root and plexus disorders

5564

31772

1.11

11.05

3.4

4.1

17.61

26.04

ug/l

1.49

4497

25342

Dental caries 3, only avohilmo

4782

22026

1.12

11.04

3.9

4.0

25.54

26.86

ug/l

0.09

3877

17704

Secondary thrombocytopenia

377

2.46

11.00

3.6

4.5

17.62

18.67

ug/l

0.03

316

Other obstructive and reflux uropathy

189

1130

1.75

10.98

5.6

3.9

6.27

21.50

ug/l

1.29

161

911

Benign neoplasm: Nasopharynx

115

3.62

10.94

3.5

1.6

3.23

2.79

ug/l

0.24

Other diseases of appendix

372

2.46

10.88

4.0

3.84

20.71

ug/l

0.82

300

Presence of other devices

1158

9467

1.25

10.87

3.3

3.8

10.46

22.54

ug/l

2.32

968

7794

1587

11848

1.21

10.86

3.2

3.8

21.66

22.67

ug/l

0.06

1317

9858

Dermatitis

2978

26275

1.15

10.82

3.6

4.0

15.69

23.76

ug/l

1.72

2397

21082

Basal cell carcinoma

3123

22025

1.15

10.75

3.6

4.0

14.01

24.33

ug/l

3.61

2564

18215

Oter anti-inflammatory and antirheumatic agents, non-steroids

1264

5737

1.24

10.74

3.7

4.3

36.45

25.26

ug/l

0.42

1011

4787

Benign neoplasm: Tonsil

169

3.08

10.74

3.5

1.5

12.95

4.50

ug/l

0.95

133

Other specified/unspecified bacterial intestinal infections

311

2108

1.54

10.71

4.2

4.1

13.93

18.29

ug/l

0.25

260

1730

Migraine, single triptan purchase ok & required. ICD-code if available is included

2732

21096

0.87

10.70

3.4

4.1

16.79

24.36

ug/l

0.76

2024

16477

Triptan medication for migraine, single purchase ok

2732

21096

0.87

10.70

3.4

4.1

16.79

24.36

ug/l

0.76

2024

16477

Other and unspecified dermatitis

2458

21437

1.16

10.68

3.7

4.0

15.92

24.32

ug/l

1.47

1976

17143

Coeliac disease

513

3792

1.39

10.61

3.6

3.9

6.49

21.90

ug/l

2.88

421

2991

Conduction disorders

1524

10638

1.21

10.60

3.3

4.3

20.00

27.76

ug/l

0.53

1228

8847

Malignant neoplasm of thyroid gland

324

2220

1.53

10.58

4.3

4.1

23.38

24.81

ug/l

0.03

245

1790

Other benign neoplasms of skin

1879

16094

1.19

10.57

3.6

4.0

15.04

23.44

ug/l

1.06

1530

13072

Sarcoidosis

629

4806

1.35

10.52

3.5

4.1

10.74

25.75

ug/l

1.66

469

3876

Osteosarcoma, excluding all cancers (controls excluding all cancers)

6.00

10.47

3.6

1.7

28.71

2.87

ug/l

0.48

Dental caries 2 and operation codes

2619

23729

0.87

10.44

3.6

4.0

16.79

24.46

ug/l

0.47

1949

18624

Dental caries 2

2690

24060

0.87

10.41

3.7

4.1

16.73

24.31

ug/l

0.48

1999

18899

Chronic diseases of tonsils and adenoids

3102

22180

0.88

10.39

3.6

4.2

32.49

23.82

ug/l

0.34

2360

17568

Benign neoplasm: Vagina

178

2.96

10.34

2.6

1.5

14.56

2.75

ug/l

0.68

133

Carcinoma in situ of other and unspecified genital organs

249

2.61

10.21

3.3

1.4

3.23

2.62

ug/l

0.69

185

COPD, hospital admissions 3, with asthma pneumonia sepsis

1387

9867

1.22

10.20

2.8

4.0

31.72

24.34

ug/l

0.40

1222

8240

Hypertensive heart and/or renal disease

1332

8590

1.23

10.20

2.9

4.3

14.47

22.53

ug/l

0.99

1121

7137

Carcinoma in situ of middle ear and respiratory system

4.64

10.13

6.9

1.5

5.37

7.32

ug/l

0.16

ILD, hospital admission 2, with pulmonary infections

464

3414

1.41

10.13

3.1

4.0

13.58

22.90

ug/l

0.88

380

2846

Hypertensive Heart Disease

1194

8053

1.24

10.11

3.0

4.3

15.61

22.15

ug/l

0.65

1004

6707

Mycoses

1191

9838

1.23

10.11

3.6

4.1

17.52

26.35

ug/l

0.86

963

7983

Other disorders of lacrimal gland

1651

14048

1.20

10.11

3.2

4.0

16.54

23.25

ug/l

0.40

1297

11291

Basal cell carcinoma, including avohilmo

3188

22336

1.14

10.09

3.6

4.0

13.78

24.36

ug/l

3.87

2615

18460

Pain associated with micturition

528

3959

1.37

10.06

2.9

3.9

4.36

23.97

ug/l

5.13

405

3170

Reimbursement for rheumatic diseases

2870

25332

1.14

10.06

3.9

4.0

29.15

23.17

ug/l

0.30

2266

20281

Open wound of head

2436

21004

1.16

9.98

3.6

4.1

12.56

28.69

ug/l

3.64

2002

17089

Melanoma in situ of other and unspecified parts of face

172

2.99

9.90

3.7

1.4

4.67

4.63

ug/l

0.01

136

Granulosa cell carcinoma of ovary

4.42

9.88

1.3

4.8

7.36

6.68

ug/l

0.04

Depression or dysthymia

3849

19309

1.13

9.88

3.4

4.4

21.09

27.38

ug/l

0.63

3082

15494

Wilms' tumor, excluding all cancers (controls excluding all cancers)

4.20

9.86

1.6

1.4

3.26

6.70

ug/l

0.41

Calculus of kidney and ureter

1440

12141

1.21

9.84

4.2

4.1

19.81

27.97

ug/l

0.67

1171

10047

Colitis due to radiation

337

2.47

9.81

4.2

4.5

3.22

44.13

ug/l

1.10

288

Spinal stenosis

2876

19965

1.14

9.77

3.1

4.3

24.41

26.15

ug/l

0.06

2374

16413

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

4.50

9.76

3.2

1.4

5.04

2.52

ug/l

0.56

Tonsillectomy and adenotomy

1437

11907

0.83

9.74

3.6

4.0

23.46

22.15

ug/l

0.05

1019

8999

Myalgia

1027

8386

1.25

9.73

3.1

4.2

16.66

25.94

ug/l

0.58

787

6608

Benign neoplasm: Parathyroid gland

163

3.01

9.63

3.7

1.3

6.37

4.43

ug/l

0.35

128

Malignant melanoma

726

5729

1.31

9.62

3.8

4.1

8.48

24.26

ug/l

4.22

566

4724

Chronic viral hepatitis

173

1044

1.71

9.62

3.0

4.7

10.13

26.71

ug/l

0.92

156

821

Malignant neoplasm of corpus uteri

452

3354

1.41

9.61

3.3

3.7

5.91

23.79

ug/l

2.96

362

2696

Torsion of ovary, ovarian pedicle and fallopian tube

102

529

2.04

9.56

3.2

3.8

54.27

82.38

ug/l

0.14

401

Gestational diabetes (for exclusion)

726

6537

0.78

9.55

3.4

3.5

13.39

19.94

ug/l

0.31

508

4542

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

4.80

9.49

3.8

1.4

27.52

7.99

ug/l

0.35

Type of accident

1190

9883

1.22

9.49

3.2

4.1

10.08

27.99

ug/l

3.22

955

7973

Asthma, including avohilmo

5951

31736

1.10

9.48

3.3

4.1

18.93

25.97

ug/l

0.97

4820

25173

Other viral diseases

1016

8275

1.24

9.43

3.8

4.1

20.42

27.42

ug/l

0.30

792

6405

Combinations of oral blood glucose lowering drugs

1435

12154

1.20

9.43

3.9

4.3

35.81

24.52

ug/l

0.53

1209

10052

Other disorders of bladder

575

4416

1.34

9.37

3.6

4.2

11.16

26.40

ug/l

1.99

464

3670

Endometriosis of ovary

755

5974

1.29

9.31

3.3

4.2

19.59

30.08

ug/l

0.47

552

4665

Dental pulpitis 4, only avohilmo

5842

27979

1.10

9.30

3.7

4.0

16.50

27.60

ug/l

2.59

4688

22323

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3034

21363

1.14

9.27

3.6

4.0

14.72

24.68

ug/l

3.30

2490

17710

Benign neoplasm: Bladder

117

3.33

9.24

3.1

1.4

3.87

5.12

ug/l

0.20

Benign neoplasm of male genital organs

261

2.46

9.19

4.2

1.5

4.47

4.05

ug/l

0.11

196

Spondylopathies in diseases classified elsewhere

407

2.27

9.17

4.3

22.00

37.62

ug/l

0.30

332

Osteopathy in diseases classified elsewhere

233

2.78

9.14

6.3

4.3

6.45

27.72

ug/l

0.63

196

1101

8644

1.23

9.13

3.0

3.7

20.02

21.68

ug/l

0.11

922

7177

Diabetes mellitus in pregnancy

609

5110

0.76

9.10

3.1

3.5

32.09

20.86

ug/l

0.23

433

3496

Toxic liver disease

411

2.20

9.09

3.4

4.2

27.66

18.49

ug/l

0.14

333

Spondylosis

2879

21983

1.14

9.07

3.2

4.4

26.77

26.98

ug/l

0.01

2353

17845

Benign neoplasm: Extrahepatic bile ducts

4.16

9.05

2.3

4.7

2.85

11.66

ug/l

1.19

Malignant neoplasm of other connective and soft tissue

129

743

1.87

8.98

3.1

4.2

11.59

33.36

ug/l

0.95

101

632

All influenza (not pneumonia)

591

4567

1.32

8.95

3.8

4.1

26.29

23.46

ug/l

0.07

484

3711

Nosocomial condition (hospital)

156

3.13

8.93

3.8

4.3

4.54

51.87

ug/l

0.59

135

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

120

3.27

8.93

4.2

1.5

4.50

2.80

ug/l

0.39

Small fibre neuropathy

148

889

1.79

8.88

3.4

4.4

195.91

27.34

ug/l

0.43

124

743

Other/unspecified cytomegaloviral diseases

498

2.06

8.85

3.3

4.3

30.07

34.41

ug/l

0.06

414

Melanocytic naevi of lip

110

3.34

8.82

3.4

1.6

2.21

5.24

ug/l

0.58

Melanocytic naevi of ear and external auricular canal

4.44

8.80

3.4

1.7

3.11

7.62

ug/l

0.40

Alzheimer’s disease (Early onset)

1517

0.49

8.78

2.1

3.5

7.45

20.99

ug/l

1.17

1271

Injuries to the abdomen, lower back, lumbar spine and pelvis

1748

14995

1.17

8.78

3.5

3.9

19.01

23.82

ug/l

0.30

1417

12156

Hodgkin lymphoma, hilmo

131

759

1.83

8.74

3.0

4.5

41.28

26.28

ug/l

0.31

109

635

Umbilical hernia

1161

9705

1.22

8.73

3.8

4.2

40.15

29.22

ug/l

0.41

942

7930

Fenamates

765

4109

1.28

8.67

3.4

4.2

8.00

21.30

ug/l

3.82

595

3351

Impotence

245

1657

1.55

8.64

4.1

4.7

33.21

26.54

ug/l

0.14

202

1419

Adrenocortical insufficiency

164

1014

1.71

8.62

3.3

4.2

24.54

25.24

ug/l

0.01

138

824

Other disorders of adrenal gland

190

1216

1.63

8.58

3.2

4.3

21.69

23.03

ug/l

0.03

160

985

Use of levodopa decarboxylase inhibitor

403

5393

0.73

8.58

2.6

4.0

12.38

23.47

ug/l

0.75

314

4503

Other disorders of breast

549

4240

1.33

8.54

3.7

3.8

12.14

28.43

ug/l

0.89

402

3289

Leisure time condition

724

5780

1.28

8.53

3.2

4.0

6.03

28.66

ug/l

3.07

569

4647

Other diseases of jaws

306

2161

1.47

8.50

4.1

19.70

37.48

ug/l

0.52

247

1730

Dental pulpitis 1, only avohilmo

5834

28063

1.09

8.47

3.7

4.0

16.53

27.51

ug/l

2.54

4675

22389

Fracture of shoulder and upper arm

1650

14234

1.18

8.43

3.6

4.0

19.55

24.52

ug/l

0.35

1369

11550

Pyoderma gangrenosum

191

2.80

8.35

3.8

4.4

4.62

10.31

ug/l

1.12

153

Alzheimer’s disease (Early onset), excluding more controls

1406

0.50

8.30

2.1

4.2

7.45

23.98

ug/l

1.46

1179

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

176

2.98

8.29

3.0

4.2

5.73

8.88

ug/l

0.47

141

Vascular diseases of the intestine

194

1264

1.62

8.26

3.3

4.0

8.29

23.62

ug/l

1.16

163

1065

Fracture of lumbar spine and pelvis

1008

8363

1.23

8.23

3.6

3.9

10.92

23.90

ug/l

2.70

827

6863

Carcinoma in situ of breast

4.03

8.22

3.0

1.4

1.96

2.86

ug/l

1.39

Erosion of teeth

316

2.26

8.18

3.8

3.7

4.15

7.97

ug/l

0.77

242

Dipeptidyl peptidase 4 (DPP-4) inhibitors

590

4639

1.31

8.18

4.0

4.3

51.25

22.06

ug/l

0.85

513

3870

ILD, hospital admissions 3, with pneumonia sepsis

396

2949

1.39

8.14

3.0

3.9

12.34

25.50

ug/l

1.17

324

2445

Triptan medication for migraine, min. 3 purchases

1663

15166

0.86

8.13

3.3

3.9

14.04

22.13

ug/l

0.70

1195

11430

Haemolytic anaemias

158

984

1.69

8.10

3.6

4.1

8.07

24.42

ug/l

1.02

135

811

Other abnormalities of plasma proteins

467

2.07

8.09

3.5

4.2

363.79

39.66

ug/l

0.45

397

Carcinoma in situ, bladder

178

1149

1.66

8.09

3.7

4.3

24.73

28.09

ug/l

0.07

148

980

Benign neoplasm: Short bones of upper limb

184

2.63

8.04

4.1

1.5

13.59

4.47

ug/l

0.48

137

Somatoform disorder

685

5474

1.28

8.03

2.8

4.0

5.43

30.86

ug/l

2.89

523

4302

Fracture of femur

1285

9970

1.20

8.02

3.5

3.8

26.08

24.07

ug/l

0.09

1104

8212

Benign neoplasm: Heart

4.96

8.02

2.3

1.5

3.66

2.69

ug/l

0.42

Fibrosis of liver

209

2.73

8.01

3.9

4.1

3.14

28.13

ug/l

0.65

171

Visual disturbances and blindness

2376

21096

1.14

8.00

3.3

4.0

30.50

22.88

ug/l

0.39

1885

17019

Other joint disorders

4361

21179

1.10

8.00

3.6

4.2

20.15

29.09

ug/l

1.19

3438

16824

Parkinson's disease, excluding more controls

486

6117

0.75

7.99

2.7

4.5

11.33

24.49

ug/l

1.18

388

5155

Other disorders of glucose regulation and pancreatic internal secretion

333

2411

1.42

7.98

3.1

4.1

23.59

19.30

ug/l

0.15

283

1963

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1500

12916

1.18

7.97

3.5

3.9

18.63

22.44

ug/l

0.22

1159

10273

Viral and other specified intestinal infections

572

4354

1.30

7.94

3.6

3.9

21.02

23.29

ug/l

0.06

441

3330

Sequelae of other external causes

233

1589

1.53

7.87

4.5

4.1

6.19

20.70

ug/l

1.80

188

1298

Cytomegaloviral disease

108

613

1.88

7.84

3.4

4.5

26.49

31.03

ug/l

0.08

508

Lung diseases due to external agents

627

4981

1.29

7.84

3.1

4.0

8.25

23.07

ug/l

4.16

526

4148

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

3.51

7.81

2.4

1.5

2.40

6.29

ug/l

0.61

Benign neoplasm: Rectum/anal canal icd-9

135

2.94

7.80

3.5

1.3

9.41

5.03

ug/l

0.43

105

Hypothyroidism, other/unspecified

4506

27253

1.10

7.77

3.6

4.0

20.70

24.16

ug/l

0.33

3517

21784

Panic disorder

451

3422

1.34

7.77

3.1

4.0

17.88

29.96

ug/l

0.41

346

2570

Cytomegalovirus infection, IBD co-morbidity

106

601

1.88

7.75

3.3

4.5

27.03

32.09

ug/l

0.09

501

Temporomandibular joint disorders

642

5109

1.28

7.73

3.1

4.1

28.44

26.47

ug/l

0.04

500

3973

Follicular lymphoma, hilmo

222

1514

1.55

7.73

2.9

4.2

25.60

21.39

ug/l

0.13

174

1259

ILD, hospital admissions

714

5780

1.27

7.69

3.2

4.0

14.28

23.82

ug/l

1.17

589

4785

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

866

7031

1.23

7.69

3.6

3.8

21.38

23.55

ug/l

0.09

649

5241

Other nutritional deficiencies

2826

24807

1.12

7.67

3.4

4.1

23.29

23.92

ug/l

0.04

2247

19514

Non-seminoma of testis

3.83

7.65

2.6

5.4

4.91

67.65

ug/l

0.51

Carcinoma in situ of other and unspecified sites

189

1252

1.61

7.64

3.7

4.3

24.88

26.75

ug/l

0.04

157

1065

Disorder of lipoprotein metabolism, unspecified

665

5344

1.28

7.62

3.3

4.2

8.44

24.47

ug/l

4.21

555

4429

Other diseases of hard tissues of teeth

3090

20768

1.12

7.61

3.8

4.1

16.03

27.95

ug/l

2.02

2402

16509

Malignant neoplasm of bladder

344

2533

1.41

7.60

3.2

3.9

52.51

27.29

ug/l

0.32

289

2139

Other and unspecified injuries of head

254

1775

1.48

7.54

3.4

4.2

6.28

20.97

ug/l

2.04

216

1446

Normal-pressure hydrocephalus

112

1862

0.57

7.52

3.6

4.1

5.05

26.21

ug/l

2.96

1559

Benign neoplasm: Spinal cord

191

2.55

7.50

4.2

1.4

3.73

4.30

ug/l

0.10

147

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

3.96

7.45

2.5

1.8

1.94

3.04

ug/l

1.99

Parkinson's disease

486

6217

0.76

7.44

2.7

4.0

11.33

25.87

ug/l

1.39

388

5178

Dental operations, only avohilmo

4027

18818

1.11

7.44

3.8

4.1

20.45

29.53

ug/l

1.10

3234

15288

Congenital malformations, deformations and chromosomal abnormalities

2324

19799

1.13

7.44

3.5

4.0

15.90

24.12

ug/l

0.78

1764

15462

Selective serotonin reuptake inhibitors

5285

25683

1.09

7.37

3.5

4.2

17.88

26.43

ug/l

1.40

4212

20501

Benign neoplasm: Orbit, unspecified

3.64

7.36

3.7

1.5

2.34

2.70

ug/l

0.31

Diseases of the eye and adnexa

3932

17939

1.10

7.31

3.7

4.3

21.99

29.62

ug/l

0.75

3109

14100

Other aneurysm

260

1842

1.47

7.30

4.0

4.2

5.15

23.49

ug/l

2.61

218

1543

Adverse effects, not elsewhere classified

749

6109

1.25

7.29

3.7

3.9

22.43

29.17

ug/l

0.20

581

4767

Benign neoplasm of urinary organs

230

1596

1.51

7.28

3.4

4.1

4.22

19.64

ug/l

2.29

168

1328

Personal history of other diseases and conditions

336

2456

1.39

7.27

3.9

3.7

8.62

31.09

ug/l

0.89

255

1837

Parkinson's disease, strict definition, excluding more controls

450

5670

0.76

7.17

2.7

4.5

11.14

25.13

ug/l

1.14

356

4767

Interstitial lung disease endpoints

720

5881

1.26

7.16

3.2

4.0

14.19

23.59

ug/l

1.16

594

4872

Interstitial lung disease

720

5881

1.26

7.16

3.2

4.0

14.19

23.59

ug/l

1.16

594

4872

COPD-related respiratory insufficiency

555

4404

1.30

7.15

2.8

4.1

24.43

19.78

ug/l

0.20

479

3687

Other interstitial pulmonary diseases

720

5882

1.26

7.15

3.2

4.0

14.19

23.57

ug/l

1.16

594

4877

Other skin changes

785

6466

1.24

7.13

3.4

4.0

6.67

25.34

ug/l

5.04

644

5270

Benign neoplasm: Connective and other soft tissue of head, face and neck

214

2.40

7.12

4.6

1.6

14.77

4.14

ug/l

0.83

165

Other and unspecified glaucoma

348

2600

1.39

7.12

3.8

19.79

23.18

ug/l

0.14

295

2136

Benign neoplasm of mouth and pharynx

503

3944

1.31

7.12

3.5

4.0

11.01

25.57

ug/l

1.80

403

3192

Pregnancy hypertension

1244

13078

0.85

7.10

3.2

3.7

11.14

21.67

ug/l

1.25

907

9732

Impaction of intestines

169

2.71

7.05

4.3

3.6

4.25

47.89

ug/l

0.57

142

Arthropathy in ulcerative colitis

324

2.17

7.05

3.1

4.6

4.58

20.21

ug/l

0.60

261

Abnormal findings on diagnostic imaging of breast

454

2.01

7.04

4.5

3.7

53.93

8.80

ug/l

0.64

362

Alcohol dependence

1175

10030

1.19

7.02

3.1

4.4

36.12

25.99

ug/l

0.38

1008

8212

Urticaria and erythema

1489

12931

1.16

7.02

3.5

4.0

25.89

22.76

ug/l

0.15

1168

10169

Benign neoplasm: Kidney

173

1145

1.60

6.99

3.5

4.0

4.08

22.55

ug/l

1.83

124

944

Other and unspecified effects of external causes

1010

8510

1.20

6.96

3.7

4.0

19.33

26.13

ug/l

0.28

791

6638

Melanocytic naevi of trunk

469

3653

1.31

6.91

3.8

4.0

5.02

24.14

ug/l

4.93

361

2905

Hepatomegaly and splenomegaly, not elsewhere classified

220

2.43

6.91

2.5

4.4

4.17

40.65

ug/l

0.62

182

Disorders resulting from impaired renal tubular function

166

1090

1.60

6.90

2.9

4.3

4.63

25.11

ug/l

1.86

136

906

Hypothyreosis and Thyroxine purchase for inclusion criteria

4660

28377

1.09

6.89

3.5

4.0

22.26

23.58

ug/l

0.10

3627

22665

Later onset COPD

1489

10179

1.17

6.88

3.0

4.0

37.04

22.73

ug/l

0.88

1310

8530

Unspecified/other endometriosis

298

2168

1.40

6.88

2.8

4.0

3.24

43.92

ug/l

1.44

204

1617

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1469

14768

0.86

6.87

3.2

3.8

12.56

21.67

ug/l

1.01

1082

11094

Viral pneumonia (unknown virus, not influenza)

246

1738

1.46

6.86

3.6

4.3

5.01

19.16

ug/l

2.05

194

1413

Malignant melanoma of skin

534

4242

1.29

6.86

3.7

4.0

9.55

21.45

ug/l

2.42

413

3485

Unspecified acute lower respiratory infection

574

4582

1.28

6.85

4.0

4.1

15.43

28.29

ug/l

0.77

480

3728

Disorders of lacrimal system

2014

17897

1.14

6.84

3.3

4.0

15.97

23.67

ug/l

0.61

1588

14411

Pneumonitis due to solids and liquids

348

2609

1.37

6.83

3.2

3.9

5.27

24.85

ug/l

4.21

292

2182

Noninflammatory disorders of female genital tract

1839

8112

1.15

6.81

3.4

4.0

11.53

30.18

ug/l

2.49

1378

6285

Benign neoplasm: Brain, supratentorial

187

2.46

6.80

3.4

1.5

4.59

4.22

ug/l

0.07

140

Concussion

2350

18201

1.13

6.78

3.4

4.4

11.94

29.50

ug/l

3.46

1881

14446

Parkinson's disease, strict definition

450

5733

0.77

6.72

2.7

4.0

11.14

24.32

ug/l

1.11

356

4799

Parkinson's disease, including avohilmo

518

6491

0.78

6.71

2.7

4.0

10.81

25.57

ug/l

1.56

416

5401

Other respiratory diseases principally affecting the interstitium

841

7019

1.22

6.71

3.1

4.0

21.43

26.19

ug/l

0.19

699

5824

Tobacco use

204

1401

1.51

6.69

2.6

4.3

20.82

21.16

ug/l

0.01

188

1134

Respiratory tuberculosis, confirmed

576

1.83

6.69

2.7

4.3

23.29

29.58

ug/l

0.13

495

Non-allergic asthma (mode), excluding more controls

853

7044

1.22

6.69

3.3

4.2

40.99

26.13

ug/l

0.39

694

5608

Other diseases of peritoneum

215

1497

1.50

6.68

3.3

4.2

34.18

16.90

ug/l

0.26

164

1226

Injuries to the knee and lower leg

5943

31689

1.08

6.68

3.6

4.0

18.60

25.92

ug/l

1.05

4722

25253

Other respiratory disorders and diseases

944

7960

1.21

6.66

3.0

3.9

18.05

24.43

ug/l

0.48

790

6608

Other diseases of the respiratory system

944

7960

1.21

6.66

3.0

3.9

18.05

24.43

ug/l

0.48

790

6608

Disorders of oesophagus in diseases classified elsewhere

108

647

1.79

6.64

3.6

4.3

6.48

15.29

ug/l

0.67

531

Anxiety disorders, excluding more controls

3997

24339

1.10

6.60

3.5

4.2

20.03

25.09

ug/l

0.55

3131

19176

Obstructed labour due to malposition and malpresentation of fetus

466

5593

0.78

6.60

3.5

3.6

26.25

22.10

ug/l

0.12

322

3948

Acquired haemolytic anaemia

118

724

1.73

6.59

3.6

4.3

8.85

28.29

ug/l

0.89

103

617

Multiple myeloma and malignant plasma cell neoplasms

233

1656

1.47

6.56

2.8

4.0

5.63

21.07

ug/l

2.18

186

1377

Hydrocephalus

195

2801

0.67

6.53

3.8

4.0

13.27

20.96

ug/l

0.41

161

2312

Phobic anxiety disorders

355

2671

1.35

6.52

3.3

4.1

22.61

30.52

ug/l

0.19

262

1996

Diseases of salivary glands

875

7340

1.21

6.50

3.6

4.0

21.48

22.02

ug/l

0.02

708

5855

Deficiency of other B group vitamins

109

658

1.76

6.47

3.8

4.0

10.15

27.67

ug/l

0.76

550

Other benign neoplasm of uterus: Cervix uteri

3.32

6.43

2.1

1.6

5.12

2.74

ug/l

0.39

Other viral diseases, not elsewhere classified

650

5280

1.25

6.43

4.0

25.11

27.37

ug/l

0.05

508

4136

Other disorders of bone

794

6603

1.22

6.43

3.6

4.2

29.37

29.18

ug/l

0.01

647

5251

Other surgical follow-up care

120

739

1.69

6.40

3.8

4.0

7.65

16.42

ug/l

0.42

587

Diseases of appendix

3438

28677

1.10

6.38

4.0

4.1

17.09

24.93

ug/l

1.38

2724

22770

Other coagulation defects

275

2008

1.41

6.38

3.4

4.0

4.13

37.33

ug/l

1.27

202

1590

Rotator cuff syndrome

3316

22508

1.10

6.37

3.4

4.3

17.77

29.13

ug/l

1.75

2687

18267

Melanocytic naevi of eyelid, including canthus

133

2.73

6.35

3.6

1.4

3.81

4.91

ug/l

0.19

102

Stomatitis and related lesions

332

2497

1.36

6.34

3.8

4.1

9.07

31.90

ug/l

0.99

275

1990

Bronchitis

5286

32246

1.08

6.34

3.8

4.0

17.35

25.76

ug/l

1.57

4223

25674

Other inflammation of eyelid

568

4583

1.27

6.32

3.3

4.0

5.16

25.55

ug/l

3.77

438

3679

Hypothyroidism, strict autoimmune

3741

22734

1.10

6.32

3.5

4.0

19.35

24.14

ug/l

0.46

2924

18117

Pleural plaque

468

3702

1.30

6.29

2.9

4.2

20.74

22.82

ug/l

0.09

404

3144

Benign neoplasm: Skin of other and unspecified parts of face

499

3976

1.29

6.25

3.7

3.9

23.95

22.72

ug/l

0.03

412

3244

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

5.14

6.22

4.6

1.3

2.37

11.75

ug/l

0.52

Malignant neoplasm of bone and articular cartilage

266

2.25

6.22

4.3

4.5

3.91

59.43

ug/l

1.09

218

Enteropathic arthropathies

100

594

1.77

6.21

3.7

4.6

4.15

24.78

ug/l

1.01

489

Non-Hodgkin lymphoma, all

191

1322

1.51

6.20

2.3

3.9

3.98

22.37

ug/l

2.21

147

1125

Respiratory tuberculosis, bacteriologically and histologically confirmed

100

597

1.78

6.18

2.7

4.3

23.02

28.72

ug/l

0.12

512

Foreign body in alimentary tract

221

1567

1.46

6.16

4.0

4.1

23.77

19.75

ug/l

0.09

179

1288

Non-allergic asthma (mode)

853

7110

1.21

6.09

3.3

4.2

40.99

25.33

ug/l

0.42

694

5670

Infection of intervertebral disc (pyogenic)

402

1.98

6.09

4.3

4.6

15.87

36.33

ug/l

0.46

338

Other disorders of veins

1879

16742

1.14

6.08

3.5

3.9

20.41

24.52

ug/l

0.27

1436

13404

Carcinoma in situ of skin of lower limb, including hip

112

698

1.74

6.07

2.8

4.1

11.51

32.47

ug/l

0.89

591

Peripheral artery disease

2308

16740

1.12

6.07

3.0

4.1

29.82

24.70

ug/l

0.35

1984

13926

Acute pharyngitis

412

3177

1.30

6.07

3.9

4.2

5.06

30.51

ug/l

1.62

290

2468

Hydrocele

503

4019

1.28

6.07

4.1

4.4

20.95

27.67

ug/l

0.25

418

3447

Nontraumatic intracranial haemmorrhage

691

8317

0.82

6.04

3.2

4.0

23.90

26.53

ug/l

0.12

585

6846

Respiratory conditions due to other external agents

111

690

1.72

6.01

3.0

3.9

6.65

27.26

ug/l

1.08

577

Disorders of parathyroid gland

1018

8612

1.19

6.01

3.0

3.8

16.72

23.32

ug/l

0.34

817

7016

Crohn disease (strict definition, all UC cases excluded)

174

1183

1.52

5.99

3.5

4.3

6.12

18.21

ug/l

1.42

141

944

Abnormal findings in nipple discharge synovial fluid wound secretions

409

1.94

5.98

4.6

4.2

4.45

33.74

ug/l

0.90

345

Benign neoplasm: Lower jaw bone

3.96

5.97

2.6

1.4

4.36

2.56

ug/l

0.87

Inflammatory disease of uterus

502

4013

1.27

5.96

3.2

3.7

17.34

30.08

ug/l

0.41

354

2995

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

137

2.62

5.96

4.6

1.4

4.66

5.02

ug/l

0.05

100

Asthma, hospital admissions , main diagnosis only

3864

31939

1.09

5.93

3.3

4.0

21.50

24.45

ug/l

0.22

3151

25330

Tubulo-interstitial nephritis, not specified as acute or chronic

300

2252

1.37

5.89

3.7

3.8

27.37

20.23

ug/l

0.20

248

1855

Diseases of the ear and mastoid process

5932

28084

1.07

5.84

3.6

4.1

19.09

27.79

ug/l

1.47

4642

22365

Endometriosis ASRM stages 3,4

989

8466

1.19

5.83

3.2

3.7

20.04

22.61

ug/l

0.11

730

6506

Injuries to the elbow and forearm

3172

26269

1.10

5.83

3.7

4.0

19.44

24.25

ug/l

0.57

2531

20921

ILD, hospital admissions 1, main diag only

622

5123

1.24

5.81

3.1

4.0

15.00

23.13

ug/l

0.79

512

4227

Unspecified dementia

324

3816

0.75

5.81

2.2

3.5

20.07

23.18

ug/l

0.12

272

3198

Benign neoplasm: Oesophagus

402

1.96

5.79

2.8

4.4

7.37

41.18

ug/l

0.99

338

Abnormal findings on diagnostic imaging of central nervous system

169

1153

1.52

5.79

3.3

4.2

5.44

24.16

ug/l

1.67

136

930

Injuries to unspecified part of trunk, limb or body region

389

3036

1.31

5.74

3.5

4.0

22.07

23.57

ug/l

0.04

301

2454

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

134

2.63

5.74

3.0

1.4

3.72

5.04

ug/l

0.23

103

Superficial injury of head

922

7852

1.19

5.74

3.4

4.0

10.77

33.40

ug/l

2.99

737

6293

Other disorders of skin and subcutaneous tissue, not elsewhere classified

645

5332

1.23

5.73

3.1

4.0

9.46

28.70

ug/l

2.14

528

4352

Alcoholic gastritis

430

1.89

5.72

2.7

4.9

13.56

21.08

ug/l

0.23

355

Melanocytic naevi

1196

10396

1.16

5.72

3.6

4.0

9.88

24.44

ug/l

1.84

915

8262

Dermatitis and eczema

5323

32607

1.08

5.69

3.6

4.0

20.25

25.57

ug/l

0.58

4233

25979

Dermatitis due to substances taken internally

222

1599

1.43

5.67

5.0

4.0

18.41

19.88

ug/l

0.07

183

1291

COPD, hospital admissions 1, only main diagnosis

1760

13367

1.14

5.67

2.8

4.1

22.01

24.26

ug/l

0.16

1527

11151

Other and unspecified disorders of skin and subcutaneous tissue

299

2262

1.37

5.67

3.3

4.1

8.21

21.63

ug/l

1.94

241

1848

Diabetic retinopathy, strict definition

518

5597

0.80

5.66

3.2

3.8

21.37

23.49

ug/l

0.06

426

4679

Inguinal hernia, unilateral

130

848

1.61

5.66

3.9

4.1

5.14

17.63

ug/l

1.35

109

706

Femoral hernia, unilateral

130

848

1.61

5.66

3.9

4.1

5.14

17.63

ug/l

1.35

109

706

Inguinal of femoral hernia, unilateral

130

848

1.61

5.66

3.9

4.1

5.14

17.63

ug/l

1.35

109

706

Wet age-related macular degeneration

852

7108

1.20

5.65

3.3

3.7

23.37

22.54

ug/l

0.03

696

5908

AV-block

851

6552

1.20

5.64

3.0

4.3

19.00

27.72

ug/l

0.65

688

5513

Acidosis

599

1.74

5.63

4.4

5.59

33.04

ug/l

1.26

501

Visual disturbances

2150

19398

1.12

5.63

3.4

4.0

29.43

21.93

ug/l

0.37

1703

15626

Coxarthrosis

2832

17532

1.11

5.62

3.8

4.3

22.15

30.99

ug/l

0.75

2349

14375

Abrasion of teeth

1124

7143

1.17

5.60

3.8

3.9

8.75

20.86

ug/l

2.26

865

5583

Pilonidal cyst

249

1824

1.39

5.59

3.6

4.5

14.24

22.64

ug/l

0.53

187

1440

Acute appendicitis

3136

27156

1.10

5.58

4.1

18.20

25.34

ug/l

1.07

2485

21514

Immunodeficiencies

193

1362

1.47

5.58

3.7

4.2

13.45

22.99

ug/l

0.41

149

1097

Hypothyroidism, strict autoimmune, 3 medication purchases required

4210

26639

1.08

5.56

3.5

3.9

20.83

23.42

ug/l

0.23

3286

21227

L02BB Anti-androgens

420

3333

1.30

5.55

3.1

4.1

28.42

26.73

ug/l

0.06

350

2828

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

307

2.09

5.55

2.6

4.4

45.66

45.14

ug/l

0.00

260

L04AA Selective immunosuppressants

896

7644

1.19

5.54

3.1

4.1

35.78

28.17

ug/l

0.23

734

6089

Additional codes for the location of defect, injury or illness

227

1650

1.42

5.53

2.9

4.2

7.10

20.52

ug/l

1.36

170

1350

Subjective visual disturbances

1059

9156

1.17

5.53

3.3

4.0

14.51

25.47

ug/l

0.69

818

7351

Congenital malformations of the urinary system

203

1445

1.44

5.52

2.9

4.3

3.62

20.21

ug/l

2.00

155

1166

Squamous cell neoplasms and carcinomas of the skin

588

4844

1.24

5.50

3.6

3.8

19.13

22.48

ug/l

0.19

482

4043

Opening and dilatation of root channel of tooth

225

1631

1.42

5.50

4.3

4.2

8.61

22.75

ug/l

1.28

175

1303

Other anxiety disorders

1584

12444

1.14

5.49

3.2

4.0

11.37

23.65

ug/l

2.13

1220

9521

Benign neoplasm: Uterine tubes and ligaments

102

2.88

5.48

3.7

1.4

6.08

2.66

ug/l

0.58

Alcohol withdrawal state with delirium

290

2194

1.36

5.47

3.0

4.5

18.30

26.31

ug/l

0.39

250

1833

Acute appendicitis, with complications

865

7367

1.19

5.47

4.3

4.1

18.24

26.48

ug/l

0.59

694

5983

Pain in thoracic spine

649

5389

1.23

5.47

3.4

4.3

6.59

30.78

ug/l

2.70

506

4283

Complications of other internal prosthetic devices, implants and grafts

170

1179

1.50

5.46

3.8

4.0

9.67

20.18

ug/l

0.78

137

968

Benign lipomatous neoplasm of other sites/unspecified

416

3304

1.29

5.46

3.3

3.9

8.18

24.92

ug/l

2.81

339

2705

Dementia in other diseases classified elsewhere

1565

0.61

5.44

3.0

4.0

8.86

25.73

ug/l

1.38

1300

Other benign neoplasm of uterus: Corpus uteri

120

2.69

5.43

5.1

1.3

2.89

2.66

ug/l

0.19

Diseases of middle ear and mastoid

1775

16263

0.89

5.42

3.5

4.0

15.56

22.82

ug/l

0.94

1336

12755

Respiratory insufficiency

352

2731

1.32

5.42

2.6

4.1

24.39

20.91

ug/l

0.09

288

2263

Single delivery by forceps and vacuum extractor

229

1914

0.72

5.41

3.0

3.3

34.06

6.79

ug/l

0.57

148

1258

Open wound of lower leg

585

4815

1.24

5.40

3.0

4.0

12.61

24.75

ug/l

1.13

488

3895

Other problems related to primary support group, including family circumstances

316

2349

1.33

5.40

4.7

3.9

13.68

36.14

ug/l

0.75

238

1756

Carcinoma in situ of skin

386

3049

1.31

5.39

3.7

3.9

28.28

21.65

ug/l

0.19

303

2522

Orchitis and epididymitis

355

2762

1.31

5.37

3.8

4.6

9.77

27.26

ug/l

2.45

297

2365

Malignant neoplasm of eye and adnexa

261

2.16

5.36

2.3

4.1

3.27

31.64

ug/l

0.58

221

Dementia due to Parkinsons disease, excluding more controls

806

0.47

5.35

3.9

4.7

3.19

37.96

ug/l

2.34

689

Urticaria

1149

10009

1.16

5.33

3.5

3.9

29.00

24.50

ug/l

0.17

896

7789

Herpesviral [herpes simplex] infections

461

3707

1.27

5.33

4.3

4.0

90.94

24.11

ug/l

0.46

371

2935

Use of selegiline

107

1652

0.62

5.30

2.9

4.1

42.85

22.31

ug/l

0.30

1389

Alcohol abuse, main dg, excluding more controls

544

4449

1.24

5.30

3.2

4.6

22.00

31.59

ug/l

0.44

469

3600

Hyperparathyroidism

891

7548

1.19

5.30

3.1

3.8

9.54

23.47

ug/l

2.59

710

6146

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1327

8896

0.87

5.28

3.6

3.7

23.36

25.13

ug/l

0.06

952

6546

Ectropion of eyelid

188

1339

1.46

5.27

3.6

3.8

10.69

23.01

ug/l

0.82

165

1129

Disease of hard tissues of teeth, NOS

267

2.09

5.27

5.0

4.3

7.22

7.76

ug/l

0.05

227

Inflammatory disorders of breast

211

1524

1.42

5.27

3.4

3.7

9.01

35.45

ug/l

0.60

164

1147

Other female pelvic inflammatory diseases

724

6102

1.21

5.25

3.2

3.8

12.66

24.01

ug/l

0.86

553

4728

Drug-induced osteoporosis with pathological fracture

529

1.78

5.24

3.2

3.8

4.75

18.26

ug/l

1.02

445

Alzheimer’s disease (Atypical or mixed), excluding more controls

240

2776

0.73

5.23

2.5

4.0

12.50

30.04

ug/l

1.68

189

2358

Intracranial injury

2575

22717

1.10

5.22

3.4

4.0

7.16

27.56

ug/l

13.69

2075

18345

Leukaemia of unspecified cell type

104

2.75

5.22

3.9

1.5

3.71

5.45

ug/l

0.24

Hypoglycaemia, other or unspecified

250

1861

1.38

5.21

3.0

4.1

29.22

20.95

ug/l

0.23

211

1507

Acute lymphadenitis

201

1443

1.43

5.20

3.5

4.1

16.30

23.05

ug/l

0.30

167

1138

Discitis, unspecified

521

1.77

5.18

3.5

4.6

18.01

30.49

ug/l

0.31

432

Beningn neoplasm: Meninges, unspecified

246

2.09

5.17

2.8

1.5

12.51

4.56

ug/l

0.50

194

Fracture of skull and facial bones

817

6955

1.19

5.17

3.5

4.3

11.80

29.57

ug/l

2.35

654

5616

Other acute viral hepatitis

276

2.04

5.14

4.0

4.4

14.68

23.41

ug/l

0.18

226

Varicose veins

3353

23406

1.09

5.13

3.8

3.9

26.20

25.31

ug/l

0.05

2700

18928

Neurotic, stress-related and somatoform disorders

4038

26676

1.08

5.13

3.5

4.1

19.82

23.93

ug/l

0.45

3160

21017

Fibromyalgia

352

2756

1.31

5.11

2.4

4.1

4.20

29.53

ug/l

1.31

262

2086

Nontoxic goitre/thyroid nodule

1493

13294

1.14

5.11

3.5

3.8

16.20

22.94

ug/l

0.49

1196

10663

Postmenopausal atrophic vaginitis

1332

7059

1.15

5.11

3.4

4.1

6.79

28.36

ug/l

5.15

1001

5653

Propionic acid derivatives

1384

6112

1.15

5.09

4.0

4.3

16.52

24.41

ug/l

0.67

1130

4994

Appendicitis, broad definition

3372

28499

1.09

5.09

4.0

4.1

17.36

24.66

ug/l

1.22

2667

22628

Other disorders of white blood cells

230

1703

1.39

5.06

2.9

4.2

41.41

16.85

ug/l

0.42

184

1391

Dementia due to Parkinson's disease

790

0.48

5.05

3.9

3.19

31.57

ug/l

1.97

673

Carcinoma in situ of skin of other and unspecified parts of face

380

3023

1.30

5.03

3.3

3.7

35.21

23.64

ug/l

0.30

293

2522

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

124

2.55

5.03

3.6

1.4

3.35

5.19

ug/l

0.32

Acute myeloid leukaemia, helper endpoint

124

2.55

5.03

3.6

1.4

3.35

5.19

ug/l

0.32

Systemic connective tissue disorders

1667

14943

1.13

5.03

2.9

3.9

9.07

23.25

ug/l

4.04

1313

12045

Nephrotic syndrome

128

853

1.56

5.03

3.5

4.3

3.71

26.54

ug/l

1.64

100

714

Injuries to the hip and thigh

2197

18265

1.11

5.02

3.4

3.9

19.55

23.99

ug/l

0.39

1829

14968

Obesity due to excess calories

1910

17231

1.12

5.02

3.3

4.1

19.90

24.48

ug/l

0.32

1522

13577

Undefined dementia

324

3812

0.77

5.01

2.2

3.4

20.07

22.73

ug/l

0.10

272

3184

Procedures for purposes other than remedying health state

102

646

1.65

5.01

3.4

3.5

7.36

5.58

ug/l

0.14

503

Chondrocostal junction syndrome [Tietze]

152

1050

1.50

5.00

3.1

4.0

35.60

13.63

ug/l

0.30

119

852

Malignant neoplasm of testis

350

1.89

4.98

5.9

5.1

4.51

47.62

ug/l

1.17

299

Visual impairment including blindness (binocular or monocular)

284

2173

1.34

4.98

2.8

3.8

32.97

16.19

ug/l

0.30

227

1788

Coxarthrosis [arthrosis of hip](FG)

3069

20464

1.09

4.97

3.7

4.2

21.02

25.65

ug/l

0.39

2545

16755

Redundant prepuce, phimosis and paraphimosis

667

5573

1.21

4.93

4.2

4.6

11.86

30.85

ug/l

3.56

546

4668

Benign neoplasm: Connective and other soft tissue of pelvis

5.09

4.93

1.5

1.8

2.43

1.81

ug/l

—

therapeutic use

145

1000

1.52

4.93

3.6

4.1

6.55

25.54

ug/l

1.41

116

828

Arterial embolism and thrombosis

259

1960

1.36

4.92

3.4

4.0

43.25

24.43

ug/l

0.29

215

1639

Right bundle-branch block

171

1214

1.47

4.91

4.0

4.5

54.06

32.14

ug/l

0.20

147

1015

Sciatica+with lumbago

2437

21150

1.10

4.89

3.0

4.3

13.28

25.86

ug/l

2.30

1923

16874

Other shoulder lesions

380

3022

1.28

4.88

3.0

4.3

4.79

25.31

ug/l

4.76

290

2403

Injuries to the shoulder and upper arm

4027

31471

1.08

4.87

3.5

4.1

17.40

26.48

ug/l

1.72

3279

25333

Complications of labour and delivery

2363

14456

0.90

4.86

3.7

3.8

16.89

21.66

ug/l

0.36

1787

11016

Osteonecrosis

257

1951

1.36

4.84

5.0

4.2

25.16

15.71

ug/l

0.41

207

1591

Cerebral palsy and other paralytic syndromes

440

3560

1.26

4.84

2.8

4.0

87.60

20.59

ug/l

0.46

332

2875

Carbimazole or st.post thyroidectomy, condition for graves disease

877

7565

1.18

4.79

3.4

3.9

11.41

26.39

ug/l

1.73

670

5948

Other abnormal findings of blood chemistry

178

1278

1.44

4.76

3.2

4.2

31.58

23.53

ug/l

0.15

134

1045

Injury of unspecified body region

293

2265

1.33

4.76

3.6

4.1

28.24

22.53

ug/l

0.13

224

1847

Seminoma of testis

214

2.15

4.75

6.4

5.3

4.14

69.16

ug/l

1.05

181

Marginal zone B-cell lymphoma

288

2.03

4.75

2.0

4.0

2.53

48.24

ug/l

1.04

244

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

134

2.44

4.74

3.8

1.5

3.42

4.76

ug/l

0.23

100

Kidney transplant status

193

1404

1.42

4.73

2.5

4.5

4.86

20.69

ug/l

1.84

159

1145

Complications of internal orthopaedic prosthetic devices, implants and grafts

1067

9353

1.16

4.73

3.2

3.8

10.23

24.21

ug/l

3.29

872

7681

Other symptoms and signs involving the circulatory and respiratory systems

265

2022

1.34

4.73

3.0

4.2

15.97

22.91

ug/l

0.32

221

1631

Leiomyosarcoma

239

2.15

4.72

2.3

4.8

2.63

25.22

ug/l

0.71

201

Immunodeficiency with predominantly antibody defects

105

680

1.61

4.72

3.2

4.1

18.62

25.51

ug/l

0.14

550

Chronic laryngitis and laryngotracheitis

652

5504

1.21

4.72

3.4

4.1

21.89

31.01

ug/l

0.27

528

4476

Gastrojejunal ulcer

367

1.87

4.69

5.3

4.3

18.20

19.75

ug/l

0.03

304

Diseases of external ear

1452

12966

1.13

4.69

3.4

4.1

17.97

25.16

ug/l

0.52

1115

10558

Scabies

146

1012

1.48

4.65

3.9

4.5

24.16

16.90

ug/l

0.26

122

824

Melanoma in situ of scalp and neck

4.56

4.63

5.3

1.4

4.50

2.60

ug/l

0.47

Obesity related asthma

1485

13292

1.13

4.62

3.1

4.1

24.80

25.26

ug/l

0.02

1207

10670

Alzheimer’s disease (Atypical or mixed)

247

3217

0.75

4.62

2.5

3.5

12.19

23.41

ug/l

1.03

195

2719

Melanoma of uvea

334

1.93

4.62

3.7

4.2

9.11

39.57

ug/l

0.70

283

Systemic lupus erythematosus

149

1043

1.48

4.60

3.1

4.0

9.70

14.95

ug/l

0.41

112

825

Endometriosis of pelvic peritoneum

603

4988

1.21

4.60

3.0

4.2

6.39

31.78

ug/l

2.37

442

3810

Ulcer of lower limb, not elsewhere classified

625

5274

1.21

4.58

2.9

4.1

23.86

22.80

ug/l

0.05

527

4377

Failure and rejection of transplanted organs and tissues

310

1.92

4.56

2.7

4.9

2.91

20.85

ug/l

0.71

253

Carcinoma in situ of bronchus and lung

4.33

4.56

7.7

5.4

3.58

95.19

ug/l

0.54

Osteoporosis with pathological fracture (FG)

349

2786

1.29

4.56

2.9

4.0

10.90

23.06

ug/l

1.05

294

2277

Benign neoplasm: Bronchus and lung

432

1.79

4.56

4.5

4.3

51.95

32.16

ug/l

0.17

363

Other congenital malformations

257

1957

1.34

4.55

3.3

4.1

10.36

18.67

ug/l

0.66

178

1517

Unstable angina pectoris

1707

15653

0.89

4.55

3.1

4.2

11.84

28.42

ug/l

5.21

1421

13088

Benign lipomatous neoplasm

1370

12226

1.13

4.54

3.5

4.1

16.79

25.12

ug/l

0.72

1099

9925

Anxiety disorders

4083

27035

1.08

4.53

3.5

4.0

19.65

23.81

ug/l

0.46

3200

21310

Hemiplegia

207

1534

1.39

4.53

2.7

4.0

26.99

18.61

ug/l

0.21

152

1256

Other complications of labour and delivery, not elsewhere classified

107

1556

0.66

4.51

2.6

3.5

6.41

32.81

ug/l

0.50

988

Arterial embolism and thrombosis of lower extremity artery

161

1150

1.45

4.48

3.5

4.0

64.57

23.50

ug/l

0.42

130

977

Ocular pain

296

2310

1.31

4.47

3.3

4.1

16.94

21.49

ug/l

0.18

215

1822

Single spontaneous delivery

1583

9387

0.89

4.47

3.9

3.5

23.04

16.71

ug/l

0.44

1239

7322

Anti-inflammatory and antirheumatic products, non-steroids

1372

6112

1.14

4.47

4.1

4.3

20.12

24.41

ug/l

0.25

1126

4994

Delivery, wide proxy

1305

7818

0.88

4.46

4.0

3.5

16.53

17.47

ug/l

0.07

1030

6092

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

109

721

1.57

4.44

2.5

3.9

5.24

77.28

ug/l

0.84

560

Pediculosis, acariasis and other infestations

199

1469

1.39

4.44

3.8

4.3

22.09

23.89

ug/l

0.06

167

1188

Rash and other nonspecific skin eruption

414

3367

1.26

4.43

3.5

4.0

9.66

20.44

ug/l

1.23

338

2695

Malignant neoplasm of head and neck

360

2890

1.28

4.39

3.3

4.1

10.58

24.69

ug/l

1.60

301

2425

Other general symptoms and signs

166

1178

1.43

4.38

4.1

3.9

8.13

11.95

ug/l

0.48

135

935

Carcinoma in situ of breast, lobular

268

2.04

4.37

4.4

3.9

5.02

11.94

ug/l

1.55

226

Cysts of oral region, not elsewhere classified

182

1332

1.41

4.35

3.4

4.3

12.74

23.70

ug/l

0.84

146

1085

Hypertrophy of breast in women and men

779

6711

1.18

4.35

3.6

3.8

21.54

25.04

ug/l

0.13

600

5211

Femoral hernia

201

1498

1.39

4.34

3.6

4.0

26.52

18.75

ug/l

0.17

164

1242

Other follicular disorders

237

1804

1.34

4.30

3.8

4.2

7.25

21.86

ug/l

1.75

194

1424

Kela-code for severe mental illness

1169

13178

0.88

4.30

3.0

4.1

20.11

24.11

ug/l

0.21

966

10463

Carcinoma in situ of skin of scalp and neck

116

791

1.55

4.29

3.8

4.0

9.21

28.11

ug/l

1.06

666

Vitamin D deficiency

413

1.75

4.28

2.5

4.1

3.80

33.54

ug/l

0.92

345

Other specified/unspecified arthritis

1242

11058

1.14

4.27

3.3

4.3

12.44

28.98

ug/l

2.82

969

8966

Second line medication for Crohn's disease

2522

23241

1.09

4.27

3.3

4.1

20.02

24.83

ug/l

0.37

1963

18555

Disturbances of skin sensation

1057

9313

1.15

4.26

3.3

4.1

11.19

24.60

ug/l

1.82

814

7289

Special screening examination for other diseases and disorders

311

2454

1.29

4.26

3.8

4.2

35.67

40.12

ug/l

0.05

250

1950

Unspecified event, undetermined intent

578

1.62

4.21

3.7

4.3

2.98

31.54

ug/l

1.28

472

Outcome of delivery

437

2204

1.24

4.17

3.2

110.85

9.90

ug/l

0.55

279

1530

Fracture of lower leg, including ankle

2559

23532

1.09

4.16

3.6

4.1

26.78

24.96

ug/l

0.08

2060

18937

Chronic conjunctivitis

125

865

1.50

4.15

2.4

4.1

12.13

27.24

ug/l

0.64

703

Malignant immunoproliferative diseases

316

1.89

4.14

2.8

4.0

9.31

41.99

ug/l

0.70

269

Drug-induced adrenocortical insufficiency

506

1.67

4.10

3.0

4.1

34.85

29.40

ug/l

0.06

418

Cachexia

146

2.36

4.10

3.6

4.3

1034.68

10.55

ug/l

0.50

122

Unspecified urinary incontinence

400

3275

1.25

4.10

3.1

3.8

15.71

20.43

ug/l

0.19

317

2635

Atherosclerosis, excluding cerebral and coronary sclerosis

2144

15714

1.10

4.10

2.9

4.0

31.12

25.41

ug/l

0.37

1838

13084

Spondyloarthritis

712

6119

1.18

4.10

3.3

4.1

76.84

26.75

ug/l

0.85

569

4904

SLE, strict definition

140

992

1.46

4.10

3.2

4.0

10.45

14.52

ug/l

0.28

103

794

SLE, ICD10

140

992

1.46

4.10

3.2

4.0

10.45

14.52

ug/l

0.28

103

794

Other and unspecified urticaria

731

6298

1.17

4.09

3.4

3.9

16.74

28.77

ug/l

0.81

578

4934

Delivery

1604

9396

0.89

4.09

3.8

3.5

22.88

16.70

ug/l

0.43

1250

7325

Polymyalgia rheumatica

632

5403

1.19

4.06

2.9

3.9

10.33

26.61

ug/l

2.99

513

4470

Other and unspecified erythematous conditions

134

945

1.47

4.06

3.5

4.1

16.00

28.31

ug/l

0.36

113

772

Convalescence

206

1554

1.36

4.06

2.8

3.8

6.61

15.82

ug/l

0.88

164

1241

Operations 2 for CAVS

1439

12695

1.12

4.05

3.2

3.9

23.26

22.90

ug/l

0.02

1198

10618

Calcific aortic valvular stenosis, diagnosis (helper)

1439

12695

1.12

4.05

3.2

3.9

23.26

22.90

ug/l

0.02

1198

10618

Congenital iodine-deficiency syndrome/hypothyroidism

137

971

1.47

4.04

3.5

4.0

24.37

22.55

ug/l

0.03

104

799

Unspecified fall

2133

19417

1.10

4.04

3.5

3.9

11.71

23.32

ug/l

3.13

1717

15709

Other and unspecified diseases of spleen

128

2.47

4.03

2.0

4.2

4.50

4.66

ug/l

0.02

108

Calcific aortic valvular stenosis

1440

12709

1.12

4.03

3.2

3.9

23.26

22.87

ug/l

0.02

1198

10630

Calcific aortic valvular stenosis, operated

1440

12709

1.12

4.03

3.2

3.9

23.26

22.87

ug/l

0.02

1198

10630

Inflammatory diseases of prostate (prostatitis)

525

4414

1.21

4.02

3.6

4.6

15.49

28.30

ug/l

0.77

418

3779

Disorders of porphyrin and bilirubin metabolism

279

1.90

4.01

3.1

4.5

3.19

44.38

ug/l

0.84

233

Retinal vascular disorders

568

4817

1.20

4.01

3.5

4.0

16.96

21.03

ug/l

0.27

465

4027

Other arthritis (FG)

1425

12837

1.12

4.01

3.3

4.2

11.89

24.35

ug/l

2.31

1122

10363

Other menopausal disorders

1058

6898

0.87

4.01

3.3

4.2

16.87

33.11

ug/l

0.87

784

5449

Benign neoplasm of breast

545

4604

1.21

4.00

4.0

3.7

9.35

29.19

ug/l

1.48

429

3609

Other congenital malformations of intestine

215

2.04

4.00

4.4

4.3

2.90

7.93

ug/l

2.03

173

Otitis externa

858

7494

1.16

4.00

3.4

4.1

22.52

28.00

ug/l

0.20

671

6027

Nonpyogenic thrombosis of intracranial venous system

222

2.02

4.00

6.0

4.1

6.03

39.69

ug/l

0.52

173

Malnutrition

540

1.63

4.00

3.5

3.7

5.64

30.09

ug/l

0.99

450

Coronary revascularization (ANGIO or CABG)

2164

16419

0.91

3.98

3.4

4.3

18.29

27.81

ug/l

1.12

1803

13752

Inflammatory disease of cervix uteri

291

2310

1.29

3.97

3.1

3.8

7.09

19.63

ug/l

1.22

236

1820

Benign neoplasm: Mediastinum

3.36

3.97

2.8

1.8

2.19

2.87

ug/l

—

Neuroendocrine tumor and carcinoma of stomach

156

2.31

3.96

2.9

4.5

13.77

12.79

ug/l

0.04

126

Exclusions for E4_PCOS_BROAD

608

5174

1.19

3.96

3.3

4.0

36.62

28.12

ug/l

0.20

480

4096

Other headache syndromes

1932

17671

1.10

3.96

3.2

4.1

25.79

23.63

ug/l

0.09

1519

13976

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

930

8161

1.15

3.95

3.1

4.2

15.83

25.92

ug/l

0.81

758

6232

Other and unspecified coagulation defects

171

1259

1.39

3.95

3.4

4.1

4.79

23.68

ug/l

1.72

120

1003

Recurring oral aphthae

181

1347

1.38

3.94

4.2

4.1

12.08

21.26

ug/l

0.51

145

1101

Malignant neoplasm of thymus

104

2.66

3.93

2.3

4.4

1.94

12.47

ug/l

1.49

Generalized skin eruption due to drugs and medicaments

153

1109

1.42

3.93

4.5

4.1

17.41

22.26

ug/l

0.19

123

893

Abnormalities of gait and mobility

519

4376

1.21

3.92

2.7

4.1

11.33

24.20

ug/l

1.49

421

3597

Other ill-defined and unspecified causes of mortality

264

2075

1.31

3.91

3.7

3.8

61.18

22.54

ug/l

0.64

232

1747

Pain and other conditions associated with female genital organs and menstrual cycle

647

5306

1.18

3.91

2.7

4.1

13.39

34.24

ug/l

1.31

456

3986

Calcific aortic valvular stenosis, including rheumatic fever

1442

12739

1.12

3.91

3.2

3.9

23.23

22.85

ug/l

0.02

1200

10654

Hypertrophic disorders of skin

195

1467

1.36

3.89

3.2

4.2

8.78

24.63

ug/l

1.34

140

1151

Intussusception

575

1.60

3.89

4.1

3.9

4.52

24.19

ug/l

0.94

459

Benign neoplasm: Long bones of lower limb

116

801

1.49

3.88

3.6

4.6

38.22

25.01

ug/l

0.15

652

Retinal vascular occlusion

557

4733

1.20

3.87

3.5

4.0

17.24

21.33

ug/l

0.26

455

3954

Hidradenitis suppurativa

112

767

1.50

3.87

2.6

4.3

9.16

22.55

ug/l

0.77

593

Diseases of inner ear

2685

24413

1.09

3.85

3.4

4.0

16.60

24.55

ug/l

1.05

2115

19867

Other and unspecified disorders of white blood cells

170

1260

1.39

3.85

3.0

4.2

17.18

20.08

ug/l

0.07

135

1025

Social phobias

193

1447

1.35

3.84

3.3

4.2

16.94

39.93

ug/l

0.39

142

1078

Other disorders of eyelid

2291

20438

1.09

3.84

3.5

4.0

16.13

24.02

ug/l

1.18

1866

16769

Obesity and other hyperalimentation

2632

24158

1.08

3.84

3.3

4.1

28.02

23.65

ug/l

0.30

2091

18980

Use of levodopa decarbox-comt-inhibitor

1153

0.62

3.82

3.3

4.2

3.20

24.89

ug/l

2.27

969

Seborrhoeic dermatitis

381

3128

1.24

3.78

3.5

4.2

7.62

26.23

ug/l

2.67

306

2560

Assault

349

2831

1.25

3.76

3.4

4.4

37.68

29.72

ug/l

0.11

282

2209

Alcohol abuse, main dg

544

4612

1.19

3.76

3.2

4.4

22.00

33.10

ug/l

0.55

469

3756

Malignant neoplasm of cervix uteri

399

1.71

3.75

3.7

3.6

6.27

8.92

ug/l

0.44

327

Obesity

2615

24039

1.08

3.74

3.3

4.1

28.15

23.74

ug/l

0.30

2078

18884

Subarachnoid haemorrhage

323

3974

0.80

3.73

3.2

4.0

24.66

25.31

ug/l

0.02

276

3234

Primary ovarian failure

398

1.70

3.72

3.2

4.1

7.11

21.16

ug/l

0.57

297

Rheumatism, unspecified

690

5979

1.17

3.72

3.0

4.1

7.52

26.05

ug/l

2.11

551

4724

Preparatory care for dialysis

178

1337

1.38

3.72

2.5

4.4

4.93

22.08

ug/l

1.92

153

1119

Disorders of conjunctiva

3638

28583

1.07

3.71

3.4

4.0

13.10

24.96

ug/l

3.16

2745

22686

Benign neoplasm: Bones of skull and face

123

2.29

3.71

3.2

1.5

191.66

2.62

ug/l

0.69

Other disorders of eye and adnexa

516

4363

1.20

3.71

3.4

3.9

12.37

29.30

ug/l

1.02

380

3438

Bacterial, viral and other infectious agents

279

2215

1.28

3.71

3.9

4.3

23.98

19.81

ug/l

0.13

215

1777

Poisoning by drugs, medicaments and biological substances

790

6894

1.16

3.70

3.3

4.0

13.69

27.75

ug/l

1.21

672

5330

Calculus of lower urinary tract

229

1784

1.32

3.67

4.5

4.2

5.03

23.79

ug/l

2.49

189

1513

Sequelae of poliomyelitis

283

1.89

3.67

5.0

4.2

20.48

45.30

ug/l

0.36

247

Diplopia

542

4612

1.20

3.67

3.3

4.0

48.35

22.64

ug/l

0.48

443

3723

Aneurysms, operations, SAH

568

6629

0.84

3.66

3.4

4.1

19.55

26.80

ug/l

0.45

484

5377

Ovarian dysfunction

171

1271

1.36

3.64

2.8

3.5

8.17

41.78

ug/l

0.60

119

901

Other diseases of arteries and capillaries

387

3199

1.23

3.64

3.9

4.1

7.14

18.66

ug/l

2.37

316

2634

Horner syndrome

366

1.74

3.61

3.4

4.3

3.02

19.39

ug/l

0.80

302

Anomalies of dental arch relationship, including avohilmo

411

4440

0.82

3.61

3.3

4.1

10.43

27.66

ug/l

1.22

300

3413

Idiopathic gout

392

3251

1.23

3.60

3.4

4.2

11.34

22.53

ug/l

1.04

326

2744

Other infective otitis externa

229

1786

1.31

3.60

3.1

4.2

15.54

21.83

ug/l

0.23

183

1453

208

1593

1.32

3.59

3.3

3.4

34.07

32.61

ug/l

0.01

131

1044

Endometriosis diagnosis and infertility diagnosis occurring together

334

2716

1.25

3.59

3.4

3.6

13.27

28.83

ug/l

0.50

242

1979

Excessive attrition of teeth

1531

7525

1.11

3.57

3.7

3.9

19.51

21.69

ug/l

0.12

1176

5845

Viral pneumonia (known virus, not influenza)

100

686

1.52

3.57

4.2

5.30

23.66

ug/l

0.96

584

2098

18226

1.09

3.56

3.3

3.9

17.72

24.62

ug/l

0.55

1674

15200

Other/unspecified reactive arthropathies

243

1912

1.30

3.55

3.5

4.2

15.32

21.41

ug/l

0.24

181

1547

SLE (Finngen)

149

1098

1.40

3.52

3.1

4.2

9.70

22.68

ug/l

0.99

112

857

Disorders of plasma-protein metabolism, not elsewhere classified

190

2.05

3.52

2.8

4.9

4.05

64.34

ug/l

0.81

156

Liposarcoma

242

1.94

3.52

3.6

4.7

3.45

36.55

ug/l

1.02

207

Labour and delivery complicated by fetal stress [distress]

406

3266

0.82

3.51

3.0

3.4

22.71

20.28

ug/l

0.05

247

2151

Benign neoplasm: Short bones of lower limb

133

2.20

3.50

3.7

1.6

7.08

2.77

ug/l

0.55

104

Familial hypercholesterolemia, with ischemic heart disease

483

4100

1.20

3.49

3.1

4.2

10.45

23.43

ug/l

1.36

411

3445

Systemic lupus erythematosus, unspecified

119

846

1.46

3.48

3.3

4.0

11.26

15.05

ug/l

0.22

678

Moderate visual impairment, binocular

127

914

1.44

3.48

2.7

3.5

60.71

18.86

ug/l

0.35

103

766

Prolonged pregnancy

238

2757

0.78

3.47

3.2

3.5

7.18

22.23

ug/l

0.53

164

1836

Disorders of vestibular function (Vertigo)

2279

20990

1.09

3.47

3.4

4.0

16.34

24.09

ug/l

0.87

1789

17085

Use of galantamine

196

2528

0.76

3.47

2.6

3.6

35.37

23.84

ug/l

0.15

164

2126

Sequelae of injuries of lower limb

347

2851

1.24

3.44

3.4

4.2

57.31

19.68

ug/l

0.35

279

2305

Superficial injury of wrist and hand

648

5611

1.17

3.43

3.2

4.1

9.52

28.73

ug/l

2.02

482

4390

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

158

2.19

3.43

5.9

4.9

5.08

36.01

ug/l

0.60

131

Communicating hydrocephalus

685

0.55

3.43

3.2

4.1

4.26

26.55

ug/l

1.25

581

Other specified congenital malformation syndromes affecting multiple systems

247

1.84

3.41

3.2

4.3

4.95

22.29

ug/l

0.48

197

Atrophic disorders of skin

626

5424

1.17

3.40

3.6

4.0

4.82

24.19

ug/l

4.12

477

4337

Thyrotoxicosis with toxic multinodular goitre

276

2224

1.28

3.40

3.0

3.9

4.47

18.07

ug/l

2.77

223

1802

Other disorders of penis

339

2782

1.24

3.40

3.6

4.8

12.14

25.81

ug/l

1.13

263

2376

Meniscus derangement

2988

19124

1.08

3.39

3.9

4.3

13.94

30.50

ug/l

4.22

2415

15511

Other factor of the environment

333

1.74

3.39

3.2

4.6

4.06

40.52

ug/l

0.90

278

Myocardial infarction, strict

2203

17339

0.92

3.39

3.4

4.3

14.84

27.22

ug/l

2.19

1820

14484

Other specified disorders of kidney and ureter

139

1021

1.41

3.39

3.8

4.2

65.16

22.84

ug/l

0.33

113

848

Premature rupture of membranes

427

3746

0.83

3.38

3.4

3.5

4.41

22.45

ug/l

1.05

279

2609

Other erythematous conditions

146

1081

1.40

3.38

3.5

4.1

14.94

26.48

ug/l

0.37

123

881

Shock, not elsewhere classified

266

1.84

3.37

4.3

4.6

54.59

10.31

ug/l

0.40

222

False labour

665

4818

0.86

3.36

3.1

3.5

12.06

22.92

ug/l

0.56

448

3348

Superficial injury of thorax

574

4941

1.18

3.36

3.3

4.1

21.84

30.42

ug/l

0.34

478

4004

Biliary cirrhosis, NAS

113

2.49

3.36

4.0

4.8

2.96

11.02

ug/l

1.35

Other disorders of nervous system

279

2252

1.27

3.35

3.0

4.3

113.64

23.76

ug/l

0.44

238

1849

Bronchitis, not specified as acute or chronic

346

2853

1.23

3.33

3.3

4.2

32.70

19.33

ug/l

0.24

289

2319

Poisoning by medicine

695

6063

1.16

3.32

3.2

4.1

12.03

24.72

ug/l

1.04

590

4687

Palmar fascial fibromatosis [Dupuytren]

751

6604

1.15

3.32

4.0

4.3

23.85

23.43

ug/l

0.02

627

5550

Soft tissue disorders related to use, overuse and pressure

1250

11314

1.12

3.32

3.2

4.3

24.58

26.84

ug/l

0.08

991

9194

Parodontitis, under 40 years

119

845

1.42

3.32

2.8

4.1

7.57

61.40

ug/l

0.56

533

Entropion and trichiasis of eyelid

392

3281

1.22

3.31

3.6

3.9

23.35

23.66

ug/l

0.01

328

2738

Oral leukoplakia and related diseases, including avohilmo

379

3161

1.22

3.31

3.7

4.1

33.50

21.59

ug/l

0.25

313

2571

Pyogenic arthritis

282

2282

1.26

3.29

3.0

4.4

21.23

25.95

ug/l

0.18

237

1913

Long labour

560

5681

0.85

3.28

3.2

3.6

46.66

23.87

ug/l

0.31

393

4070

Other arthrosis

2781

18593

1.08

3.28

3.3

4.4

11.51

30.95

ug/l

5.60

2239

15130

Personality disorders, excluding more controls

839

7417

1.14

3.27

3.0

4.3

11.87

26.69

ug/l

1.67

669

5697

Emergency coronary revascularization (for ACS)

2519

19403

0.93

3.27

3.3

4.1

17.37

27.51

ug/l

1.47

2098

16203

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

174

2.05

3.27

4.5

4.7

22.28

30.88

ug/l

0.11

146

Localized skin eruption due to drugs and medicaments

322

1.74

3.26

6.9

4.0

12.41

41.03

ug/l

0.58

266

Nonorganic sleeping disorders, excluding more controls

610

5282

1.17

3.26

3.1

4.2

6.68

27.13

ug/l

2.21

469

4088

Other peripheral vertigo

406

3414

1.21

3.25

3.0

4.0

11.43

25.92

ug/l

1.34

324

2776

Exclusion endpoint for clefts

311

1.72

3.25

3.5

4.3

4.50

20.14

ug/l

0.57

248

Impacted cerumen

408

3431

1.21

3.25

3.3

4.0

9.62

21.88

ug/l

1.57

286

2827

Other specified/unspecified deforming dorsopathies

494

1.58

3.24

3.1

4.4

14.69

8.61

ug/l

0.29

388

Other disorders of conjunctiva

621

5401

1.17

3.24

3.4

4.0

13.52

25.23

ug/l

1.25

492

4438

Malignant neoplasm of bone and articular cartilage of limbs

106

2.39

3.24

2.2

4.5

2.19

49.14

ug/l

0.59

Parodontitis, under 40 years, or operation codes

119

849

1.41

3.24

2.8

4.1

7.57

60.96

ug/l

0.56

537

Benign neoplasm: Skin of trunk

168

1279

1.35

3.23

3.7

4.1

5.20

25.12

ug/l

1.99

136

1054

Disorders of continuity of bone

350

2900

1.23

3.22

3.8

4.0

10.25

19.81

ug/l

1.04

283

2290

Unknown and unspecified causes of morbidity

270

2178

1.26

3.20

3.6

3.9

9.09

18.77

ug/l

0.93

217

1722

Other diseases of blood and blood-forming organs

272

2201

1.26

3.20

3.3

4.2

3.92

16.73

ug/l

2.78

220

1804

Gonarthrosis [arthrosis of knee](FG)

4220

23514

1.06

3.20

3.6

4.2

22.57

26.85

ug/l

0.44

3388

18996

Other otitis externa (chronic)

248

1986

1.28

3.19

2.9

4.2

53.72

18.74

ug/l

0.53

189

1617

Agoraphobia

485

1.56

3.18

3.1

4.4

17.01

26.32

ug/l

0.24

371

Presbycusis

644

5596

1.16

3.17

3.5

3.7

13.02

28.25

ug/l

2.27

519

4651

Renal cell carcinoma of kidney

160

1216

1.36

3.17

2.6

4.0

7.33

21.71

ug/l

1.26

130

1026

Other blood glucose lowering drugs, excl. Insulins

795

7043

1.14

3.16

3.4

4.1

16.06

24.92

ug/l

0.72

671

5823

Fracture of forearm

2491

21770

1.08

3.15

3.9

19.77

23.65

ug/l

0.35

1989

17419

Other hearing loss

1317

11781

1.11

3.15

3.6

3.9

9.72

25.22

ug/l

5.13

1052

9753

Retinal detachments and breaks

1723

15877

1.10

3.15

3.8

4.1

23.70

22.53

ug/l

0.08

1381

13094

Unspecified mental disorder

1332

14628

0.90

3.15

3.1

4.0

23.46

24.30

ug/l

0.03

1089

11551

Other diseases of upper respiratory tract

5804

28875

1.05

3.14

3.7

4.1

19.68

24.31

ug/l

0.67

4619

23220

ILD-related respiratory insufficiency

142

1063

1.39

3.14

3.6

4.0

17.78

25.71

ug/l

0.24

125

892

Respiratory tuberculosis, confirmed and not-confirmed

243

1947

1.28

3.13

3.2

3.8

58.47

20.95

ug/l

0.54

204

1631

Melanocytic naevi of lower limb, including hip

160

1215

1.35

3.12

3.8

4.3

3.27

22.45

ug/l

2.06

128

989

Respiratory tuberculosis

243

1948

1.28

3.12

3.2

3.8

58.47

20.94

ug/l

0.54

204

1632

Arthropathies in other diseases classified elsewhere

151

1139

1.37

3.12

3.5

4.5

64.03

27.80

ug/l

0.29

118

948

Hypertrophy of breast

661

5785

1.16

3.11

3.5

3.7

20.67

24.52

ug/l

0.13

494

4430

114

826

1.44

3.11

3.2

4.3

4.36

25.51

ug/l

1.46

104

701

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

2.41

3.10

1.6

1.3

4.21

5.82

ug/l

0.17

Other and unspecified visual disturbances

382

3208

1.21

3.09

3.5

4.1

18.05

15.71

ug/l

0.07

306

2583

Use of ropinirole

1298

0.68

3.07

3.1

4.3

4.06

23.30

ug/l

2.15

1073

Medical abortion

2929

14916

1.07

3.07

3.7

14.32

21.16

ug/l

1.02

2297

11422

Perforation of oesophagus

143

2.14

3.07

3.4

5.3

3.80

34.47

ug/l

0.56

125

Symptoms and signs involving emotional state

100

705

1.46

3.07

2.4

4.1

24.18

28.06

ug/l

0.06

569

Acute appendicitis, no complications

2271

21092

1.08

3.06

4.0

4.1

18.18

25.91

ug/l

0.90

1791

16602

Benign neoplasm of other and unspecified sites

137

1023

1.38

3.05

3.7

4.1

61.20

24.51

ug/l

0.28

113

838

Endovascular or surgical operations to intracerebral aneurysms

174

2237

0.76

3.04

3.6

4.1

27.23

19.85

ug/l

0.23

159

1795

Drug-induced hypoglycaemia without coma

430

1.60

3.04

2.6

4.5

8.68

42.77

ug/l

1.06

362

Benign neoplasm: Skin, unspecified

163

1248

1.34

3.04

2.9

4.1

4.00

23.61

ug/l

2.10

129

1019

Other maltreatment syndromes

622

1.48

3.04

3.7

4.9

14.23

22.05

ug/l

0.31

497

Tuberculosis, wide

330

2740

1.23

3.03

3.2

3.8

46.52

21.86

ug/l

0.45

273

2285

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

525

4376

1.17

3.03

3.1

4.1

5.50

23.01

ug/l

4.30

407

3486

Other and unspecified vascular occlusions

429

3651

1.20

3.03

3.5

4.0

20.34

19.53

ug/l

0.04

348

3058

Other systemic involvement of connective tissue

1255

11422

1.11

3.03

2.9

3.9

9.11

24.69

ug/l

3.19

995

9182

Chronic lymphocytic leukaemia

132

984

1.40

3.02

3.4

4.1

8.55

26.48

ug/l

1.14

100

827

Cerebrovascular diseases

3875

26295

1.06

3.01

3.4

4.1

26.50

25.33

ug/l

0.05

3237

21488

Panniculitis affecting regions of neck and back

153

1162

1.35

3.00

2.8

4.5

3.07

22.25

ug/l

1.75

118

939

Phakomatoses, not elsewhere classified

252

1.79

2.99

2.5

4.3

8.88

7.07

ug/l

0.13

204

Intracerebral haemorrhage

410

4820

0.84

2.99

3.2

4.0

21.92

21.37

ug/l

0.02

345

3994

Degenerative macular diseases

577

5030

1.17

2.98

3.5

4.0

27.69

20.94

ug/l

0.18

462

4175

Thyrotoxicosis

1078

9744

1.12

2.98

3.1

3.8

10.59

25.25

ug/l

2.39

842

7706

Acute generalized exanthematous pustulosis

171

1321

1.33

2.97

4.2

4.1

26.44

19.81

ug/l

0.20

137

1068

Otalgia

283

2317

1.24

2.97

3.2

4.0

14.53

20.98

ug/l

0.29

216

1836

Filling of root of tooth

119

872

1.41

2.97

4.4

7.94

15.92

ug/l

0.58

722

Benign neoplasm of bone and articular cartilage

295

2425

1.24

2.97

3.7

4.1

35.16

20.76

ug/l

0.35

232

1938

Tuberculosis, IBD comorbidity

320

2656

1.23

2.96

3.1

3.8

47.99

20.64

ug/l

0.49

264

2219

Acquired absence of organs, not elsewhere classified

363

1.66

2.95

4.4

4.1

48.98

21.22

ug/l

0.28

308

Pneumonia due to Streptococcus pneumoniae

154

1173

1.34

2.95

3.4

4.2

70.86

20.22

ug/l

0.45

127

966

Abnormal findings in peritoneal fluid saliva

118

2.26

2.94

3.6

4.1

5.52

10.08

ug/l

0.69

Reactive arthropathies, FINNGEN

274

2239

1.25

2.94

3.5

4.4

14.27

29.47

ug/l

0.87

204

1813

Fall on and from stairs and steps

1049

9475

1.12

2.94

3.4

4.1

10.17

28.43

ug/l

3.21

832

7655

Diseases of the musculoskeletal system and connective tissue

2587

12121

1.08

2.92

3.7

4.5

16.81

30.54

ug/l

1.78

2028

9578

Generalized anxiety disorder

413

3500

1.19

2.92

3.3

4.0

6.77

30.07

ug/l

1.45

324

2635

Recurring oral aphthae, including avohilmo

521

4510

1.17

2.91

3.6

3.9

27.53

20.93

ug/l

0.16

409

3599

Endocarditis

147

1118

1.35

2.90

3.2

4.5

14.92

28.53

ug/l

0.66

121

938

Benign neoplasm: Parotid gland

326

2720

1.22

2.88

3.9

4.1

31.83

23.04

ug/l

0.16

284

2229

Endometriosis of rectovaginal septum and vagina

328

2736

1.22

2.88

3.3

4.0

21.00

36.93

ug/l

0.43

248

2169

Atypical facial pain

209

1665

1.29

2.87

3.0

4.2

7.34

24.63

ug/l

1.80

150

1320

Circumscribed brain atrophy

685

0.59

2.86

3.0

4.2

17.19

36.10

ug/l

0.58

577

Other hereditary haemolytic anaemias

146

2.05

2.86

4.0

4.5

2.66

7.02

ug/l

1.30

117

Vulvovaginal ulceration/inflammation in other diseases

163

1254

1.32

2.86

2.7

3.8

3.13

36.95

ug/l

0.64

121

924

Type 1 diabetes

905

8104

1.12

2.85

3.6

4.2

28.78

26.85

ug/l

0.05

767

6433

Lack of expected normal physiological development

2.29

2.85

2.8

3.2

2.19

1.77

ug/l

0.49

Benign neoplasm of major salivary glands

416

3551

1.19

2.84

3.8

4.0

28.08

23.74

ug/l

0.10

359

2900

Diseases of tongue

270

2216

1.24

2.83

3.4

4.0

33.64

15.58

ug/l

0.31

232

1788

Algoneurodystrophy

114

836

1.40

2.82

3.1

4.3

10.23

22.15

ug/l

0.61

659

Open wound of forearm

314

2611

1.22

2.82

3.2

4.1

36.05

22.36

ug/l

0.41

262

2121

Single delivery by caesarean section

383

2626

0.84

2.82

3.4

4.96

8.53

ug/l

1.29

262

1803

Postpartum haemorrhage

567

5657

0.87

2.81

3.3

3.6

18.61

21.60

ug/l

0.10

383

4035

Other and unspecified injuries of lower leg

239

1933

1.26

2.81

3.2

4.1

12.26

21.99

ug/l

0.48

187

1534

Erosion of teeth, including avohilmo

648

5505

1.15

2.81

3.6

3.9

6.62

18.04

ug/l

2.04

492

4262

Cushing syndrome

328

1.67

2.81

1.9

4.1

12.96

19.74

ug/l

0.19

274

Lifestyle-related condition

312

1.69

2.81

3.2

4.5

4.03

42.62

ug/l

0.89

260

Acute upper respiratory infections of multiple and unspecified sites

3262

23074

1.06

2.81

3.9

4.0

17.44

25.00

ug/l

1.06

2545

18246

Mood disorders, excluding more controls

4646

26931

1.05

2.79

3.4

4.2

23.19

24.51

ug/l

0.11

3697

21382

Actinic keratosis

1913

16897

1.08

2.79

3.4

3.9

18.74

23.05

ug/l

0.27

1530

14110

Other secondary coxarthrosis

146

1117

1.35

2.79

4.5

4.3

18.20

25.68

ug/l

0.20

121

921

Spontaneous abortion

1623

11964

0.92

2.79

3.8

3.7

28.92

22.10

ug/l

0.21

1239

8974

Tuberculosis

278

2293

1.24

2.77

3.1

3.7

59.51

22.59

ug/l

0.61

237

1919

Parodontitis, under 40 years and operation codes

109

790

1.39

2.77

2.9

4.2

7.93

65.45

ug/l

0.56

499

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

175

1.89

2.76

2.2

1.4

3.67

4.40

ug/l

0.16

135

Maternal care for known or suspected abnormality of pelvic organs

582

4595

0.87

2.76

3.2

3.6

31.45

20.65

ug/l

0.20

391

3257

Adenomyosis (Endometriosis of uterus)

595

5225

1.15

2.75

3.4

4.1

14.42

32.55

ug/l

1.10

461

4168

Parodontitis, operation under 40 years and operation codes

109

791

1.39

2.75

2.9

4.2

7.93

65.32

ug/l

0.56

500

Nontoxic multinodular goitre

985

8915

1.12

2.75

3.6

3.9

8.02

24.40

ug/l

3.02

802

7224

Motor neuron disease (with DMD)

617

0.58

2.74

2.8

4.9

15.76

45.05

ug/l

0.80

518

Skin changes due to chronic exposure to nonionizing radiation

1966

17334

1.08

2.74

3.3

3.9

18.67

22.74

ug/l

0.26

1568

14471

Radiodermatitis

2.60

2.74

4.3

4.9

5.81

6.22

ug/l

0.04

Nonhereditary hypogammaglobulinemia

307

1.69

2.73

3.4

4.1

3.77

6.62

ug/l

0.90

254

L04AX Other immunosuppressants

2432

22809

1.07

2.73

3.3

4.1

20.61

24.64

ug/l

0.28

1898

18226

Temporal arteritis

167

1308

1.32

2.72

2.8

4.1

8.43

21.83

ug/l

1.05

139

1091

Benign neoplasm: Skin of eyelid, including canthus

686

6089

1.14

2.71

3.6

3.9

14.93

23.13

ug/l

0.71

555

4964

Scoliosis

289

2394

1.22

2.71

3.0

4.2

16.37

19.33

ug/l

0.08

219

1868

Dysplasia of cervi uteri

839

5805

1.13

2.70

3.3

4.1

15.83

32.11

ug/l

0.86

632

4417

Gestational [pregnancy-induced] hypertension

665

7494

0.88

2.69

3.3

3.7

4.47

21.61

ug/l

2.41

484

5478

Drug-induced cataract

100

727

1.43

2.69

3.0

4.4

10.77

26.07

ug/l

0.66

609

Maternal care for other known or suspected fetal problems

434

3252

0.85

2.69

3.0

3.4

22.10

20.41

ug/l

0.03

276

2162

All anxiety disorders

2293

17263

1.07

2.69

3.2

4.0

13.36

23.73

ug/l

2.05

1778

13346

Osteomyelitis

241

1966

1.25

2.69

2.8

4.3

9.37

22.97

ug/l

1.42

197

1630

Persistent mood disorders

781

6980

1.13

2.68

2.9

4.1

12.82

26.15

ug/l

1.33

636

5572

Allergic urticaria

268

2208

1.23

2.66

3.6

4.1

12.06

32.80

ug/l

0.71

208

1737

Drug-induced osteoporosis

382

1.61

2.65

3.8

4.1

11.26

35.07

ug/l

0.61

330

Use of disulfiram, acamprosate or naltrexone

290

2410

1.22

2.65

3.1

4.6

12.62

20.77

ug/l

0.77

252

1972

Complications of genitourinary prosthetic devices, implants and grafts

711

1.42

2.65

4.3

4.0

5.27

26.25

ug/l

1.14

576

Achalasia of cardia

519

1.50

2.64

2.9

4.4

3.33

19.32

ug/l

1.26

435

Congenital malformations and deformations of the musculoskeletal system

214

1711

1.26

2.64

3.8

4.1

3.52

23.30

ug/l

2.67

154

1314

Other specified and unspecified personality disorders

287

2382

1.22

2.64

2.6

4.2

10.62

33.76

ug/l

0.91

233

1871

Acute nasopharyngitis (common cold)

371

3131

1.19

2.63

4.1

4.6

5.21

24.91

ug/l

4.23

296

2544

Other neurological diseases

3605

27523

1.06

2.63

3.3

4.0

27.35

25.08

ug/l

0.09

2956

22386

Motor neuron disease

609

0.58

2.63

2.8

4.9

15.76

44.78

ug/l

0.78

512

Benign neoplasm: salivary glands, exclude unknown (D119)

363

3087

1.20

2.62

3.8

4.1

29.55

26.36

ug/l

0.06

315

2510

Other and/or unspecified nontoxic goitre

379

3237

1.19

2.62

3.5

3.8

28.65

18.86

ug/l

0.18

301

2600

Fibroblastic disorders

1130

10317

1.11

2.62

3.7

4.3

28.87

28.64

ug/l

0.01

908

8505

Superficial injury of hip and thigh

575

5052

1.15

2.61

3.1

3.8

11.17

22.11

ug/l

1.30

464

4113

Carcinoma in situ of skin of trunk

135

1035

1.35

2.61

2.8

3.9

12.16

26.98

ug/l

0.78

109

878

Other and unspecified hypertrophic disorders of skin

166

1.93

2.60

2.3

4.5

2.86

5.80

ug/l

1.10

130

Thyrotoxicosis, other and/or unspecified

830

7462

1.12

2.60

3.1

3.9

10.08

26.67

ug/l

2.15

649

5895

Chondropathies

549

4811

1.15

2.59

3.4

4.1

37.99

26.62

ug/l

0.27

444

3813

Perforation of tympanic membrane

379

3236

1.19

2.58

3.5

4.0

29.81

20.73

ug/l

0.30

305

2624

Myocarditis

160

1248

1.30

2.58

4.0

4.4

9.75

20.05

ug/l

0.76

129

1005

Benign neoplasm: Tongue

120

906

1.37

2.56

3.9

4.3

8.17

25.93

ug/l

1.08

102

752

Giant cell arteritis with polymyalgia rheumatica

167

1321

1.30

2.54

2.8

4.0

8.43

21.02

ug/l

0.97

139

1101

Other and unspecified psoriasis

260

2152

1.23

2.54

4.4

4.2

4.69

24.49

ug/l

3.13

219

1752

Recurrent or chronic depression

1695

11354

1.08

2.54

3.3

4.4

13.95

27.45

ug/l

1.83

1305

8817

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

502

1.48

2.54

3.3

4.2

42.88

15.76

ug/l

0.31

394

Fracture of foot, except ankle

862

7770

1.12

2.54

3.4

4.1

24.82

27.93

ug/l

0.10

688

6137

Obsessive-compulsive disorder

135

1029

1.33

2.54

3.0

4.2

13.37

54.19

ug/l

0.61

104

767

Other and unspecified aplastic anaemias

297

1.66

2.53

2.2

4.3

4.30

21.62

ug/l

0.65

247

Disorders of tooth development and eruption

113

817

1.36

2.53

4.5

4.3

37.89

17.16

ug/l

0.30

634

Diabetic retinopathy, excluding more controls

1098

5631

1.11

2.52

3.4

4.0

21.26

28.55

ug/l

0.42

908

4645

Cluster headache, strict

121

913

1.36

2.52

3.3

4.5

9.01

29.92

ug/l

1.07

742

Left side

148

2.02

2.50

4.2

4.6

2.63

38.26

ug/l

0.64

119

Benign leiomyoma with endometriosis

750

6730

1.13

2.50

3.3

3.8

23.89

25.39

ug/l

0.05

580

5338

Vascular dementia

252

2937

0.82

2.50

2.4

3.6

13.53

22.43

ug/l

0.42

207

2470

Other dermatomyositis

162

1.95

2.50

2.2

4.5

3.56

76.89

ug/l

0.86

134

Infections with a predominantly sexual mode of transmission

929

8400

1.11

2.50

3.6

3.9

19.93

22.84

ug/l

0.10

707

6305

Other specified and unspecified retinal disorders

145

1128

1.32

2.49

3.3

4.3

7.90

15.89

ug/l

0.86

115

939

Radiculopathy

771

6926

1.13

2.49

3.2

4.3

12.55

31.01

ug/l

2.13

603

5691

Left bundle-branch block

319

2698

1.21

2.49

3.7

4.3

5.84

23.22

ug/l

3.71

254

2225

Other and unspecified haemorrhagic conditions

460

1.52

2.49

3.4

4.2

29.46

23.19

ug/l

0.12

387

Other systemic involvement of connective tissue (FG)

1227

11197

1.10

2.48

2.9

4.0

9.24

23.71

ug/l

2.89

972

9030

Other mental disorders due to brain damage and dysfunction and to physical disease

370

4309

0.85

2.48

3.0

4.0

5.43

22.46

ug/l

5.99

310

3559

Encephalopathy

308

1.65

2.48

3.0

4.4

22.74

47.19

ug/l

0.38

258

Carrier of infectious disease

584

1.45

2.47

4.4

4.3

4.21

34.03

ug/l

1.36

473

Hypertrophic scar

168

1328

1.29

2.46

3.4

4.3

9.58

24.21

ug/l

1.08

123

1050

Central retinal artery occlusion

714

1.41

2.46

2.8

4.1

5.49

18.25

ug/l

1.18

612

Cluster headache, strict, including avohilmo

150

1170

1.31

2.45

3.3

4.3

7.93

27.21

ug/l

1.26

117

934

Use of rasagiline

930

0.67

2.45

2.7

4.3

2.74

29.01

ug/l

2.17

776

Peripheral arterial reconstruction

764

6870

1.13

2.45

2.9

4.0

29.63

22.29

ug/l

0.29

648

5770

Dislocation, sprain and strain of joints and ligaments of knee

2217

21918

0.94

2.43

3.8

4.2

11.42

26.86

ug/l

4.44

1722

17228

Other autoimmune haemolytic anaemias

407

1.56

2.43

3.9

4.3

3.37

40.07

ug/l

1.15

343

Other abnormal findings in urine

480

1.50

2.42

3.4

4.4

109.23

35.94

ug/l

0.45

406

Deep endometriosis

363

3107

1.19

2.42

3.1

3.7

19.77

30.05

ug/l

0.30

265

2399

Other noninflammatory disorders of vagina

308

2601

1.20

2.42

3.5

4.1

5.35

39.57

ug/l

1.56

235

2040

Monoamine oxidase A inhibitors

521

4583

1.15

2.40

3.6

4.2

38.86

35.52

ug/l

0.06

408

3683

Papillary adenocarcinoma of thyroid gland

204

1659

1.26

2.40

3.5

4.2

9.19

23.75

ug/l

1.02

145

1345

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

114

860

1.35

2.39

2.4

4.3

7.18

26.70

ug/l

1.16

694

Event of undetermined intent

184

1476

1.27

2.39

3.6

4.4

4.88

21.88

ug/l

2.05

154

1195

Allergic rhinitis

808

8869

0.90

2.38

3.3

4.0

31.76

23.24

ug/l

0.21

612

6772

Sequelae of injuries, of poisoning and of other consequences of external causes

896

8127

1.11

2.38

3.4

4.2

34.66

27.95

ug/l

0.13

710

6549

Ill-defined and unknown causes of mortality

281

2361

1.21

2.38

3.7

3.8

64.16

20.81

ug/l

0.80

247

1988

Benign neoplasm of other and unspecified intrathoracic organs

368

1.58

2.38

3.1

4.2

4.20

45.26

ug/l

1.17

311

Hypertrichosis

380

1.54

2.37

2.2

3.9

23.07

19.81

ug/l

0.06

282

Bronchiectasis

362

3111

1.19

2.37

3.2

4.0

17.90

21.26

ug/l

0.13

313

2529

Dislocation of lens

466

1.50

2.36

3.2

3.9

30.62

24.36

ug/l

0.08

399

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1190

10915

1.09

2.35

3.4

4.0

6.74

23.68

ug/l

3.98

887

8429

Peptic ulcer

304

1.63

2.34

3.5

4.2

3.29

21.38

ug/l

0.72

253

Other disorders of the genitourinary system

585

5200

1.14

2.34

3.1

3.9

14.48

25.78

ug/l

0.77

471

4183

Glomerulonephritis

372

3201

1.18

2.34

3.4

4.1

7.76

22.62

ug/l

2.47

299

2621

Benign neoplasm: Other/unspecified site

501

1.48

2.32

3.2

4.0

106.84

29.53

ug/l

0.34

425

Gingival hyperplasia

116

883

1.35

2.32

3.5

4.3

6.72

12.64

ug/l

0.77

724

Examination and encounter for administrative purposes

163

1297

1.28

2.32

3.4

4.6

4.32

16.06

ug/l

3.35

134

1054

Other immunodeficiencies

272

1.65

2.32

4.0

4.1

10.85

48.39

ug/l

0.65

222

Cluster headache, wide

131

1013

1.32

2.32

3.1

4.4

73.36

30.39

ug/l

0.29

105

818

Urethral stricture

235

1947

1.23

2.32

3.4

4.4

22.35

29.67

ug/l

0.16

184

1646

Whooping cough

2.24

2.31

4.5

3.4

5.51

2.86

ug/l

0.66

Herpesviral keratitis and keratoconjunctivitis

169

1353

1.28

2.30

3.5

4.3

5.93

21.29

ug/l

1.52

144

1115

Anxiety (asthma-related co-morbidities)

2288

16972

1.07

2.30

3.2

4.1

13.38

23.64

ug/l

2.01

1775

13040

318

1.57

2.30

3.6

4.3

2.88

23.93

ug/l

0.84

244

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

138

2.01

2.30

4.0

4.7

3.12

10.83

ug/l

1.48

112

Oral leukoplakia and related diseases

236

1960

1.23

2.30

3.8

4.1

47.40

20.54

ug/l

0.41

202

1610

TMD related pain

112

849

1.35

2.29

2.4

3.9

8.59

21.60

ug/l

0.80

660

Oral leukoplakia

596

1.43

2.29

3.1

4.1

99.19

29.21

ug/l

0.37

495

Symptoms and signs involving speech and voice

1473

13687

1.08

2.29

3.4

4.0

10.78

23.41

ug/l

2.59

1156

11009

Lumbar disc prolapse

3077

23220

1.06

2.28

3.2

4.4

20.39

26.27

ug/l

0.50

2445

18575

Abnormal findings on examination of urine, without diagnosis

159

1265

1.28

2.28

3.2

4.2

53.11

21.76

ug/l

0.41

132

1052

Sequelae of infectious and parasitic diseases

278

2340

1.21

2.28

3.9

4.0

31.01

19.42

ug/l

0.33

231

1905

Abdominal aortic aneurysm (AAA)

436

3773

1.16

2.27

3.8

3.9

42.41

20.53

ug/l

0.77

382

3200

Other disorders of gingiva or/and edentulous alveolar ridge

184

1489

1.26

2.27

3.8

4.2

6.03

18.97

ug/l

2.25

145

1210

Major coronary heart disease event excluding revascularizations

3176

23041

0.95

2.26

3.4

4.2

12.85

26.86

ug/l

4.27

2625

19064

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

2.65

2.26

8.9

1.6

5.66

2.63

ug/l

0.55

Postmenopausal osteoporosis with pathological fracture

279

2361

1.21

2.26

2.7

3.6

12.39

18.40

ug/l

0.34

233

1926

Hyperhidrosis

661

1.39

2.25

2.7

4.0

4.37

7.80

ug/l

0.92

515

Aortic aneurysm

1042

9388

1.10

2.25

3.7

4.2

28.18

19.79

ug/l

0.56

861

7918

Pregnancy, childbirth and the puerperium

1169

6655

0.91

2.24

3.7

3.4

15.06

16.93

ug/l

0.21

927

5162

Hyperkinetic disorders, excluding more controls

137

1036

1.29

2.24

2.8

4.1

2.21

47.84

ug/l

0.63

682

Neuroendocrine tumor and carcinoma of rectum

132

2.01

2.23

3.7

4.4

27.52

10.90

ug/l

0.29

104

Listeriosis

131

1.98

2.23

6.0

4.3

23.72

3.96

ug/l

0.73

115

Malignant neoplasm of oral cavity

142

1121

1.30

2.22

3.4

4.3

6.63

23.81

ug/l

1.47

126

952

Other symptoms and signs involving the nervous and musculoskeletal systems

1570

16829

0.93

2.21

3.0

4.0

9.76

23.83

ug/l

4.87

1215

13485

Melanocytic naevi, other sites/unspecified

272

2293

1.20

2.21

3.6

4.1

5.11

22.15

ug/l

3.04

206

1831

Nonorganic sleeping disorders

610

5443

1.13

2.21

3.1

4.0

6.68

27.41

ug/l

2.35

469

4236

Other disorders of prostate

138

1085

1.30

2.20

3.5

4.3

8.31

35.08

ug/l

2.01

112

925

Mental and behavioural disorders due to sedatives or hypnotics

207

1699

1.24

2.20

2.8

4.3

6.33

21.88

ug/l

1.74

176

1360

Adenocarcinoma and Papillary adenocarcinoma of kidney

359

1.56

2.20

3.5

5.0

3.22

28.42

ug/l

1.21

305

Inflammation of lacrimal passages (chronic)

531

0.60

2.19

2.3

4.0

8.40

30.61

ug/l

0.83

444

Carcinoma in situ of breast, other/unspecified

509

1.46

2.19

5.0

3.9

4.30

10.56

ug/l

1.80

417

Lagophthalmos

400

1.52

2.18

3.6

4.4

3.26

35.14

ug/l

0.99

338

Cervicalgia

912

8325

1.11

2.18

2.9

4.3

11.83

27.90

ug/l

2.29

726

6694

Giant cell arteritis

183

1493

1.26

2.17

2.8

4.0

8.02

20.89

ug/l

1.15

149

1236

Glomerular diseases

712

6422

1.12

2.17

3.2

4.2

11.41

23.71

ug/l

1.69

596

5288

Cluster headache, wide,, including avohilmo

160

1280

1.27

2.17

3.2

4.2

62.48

27.69

ug/l

0.27

124

1018

Uterine polyps

414

3616

1.16

2.17

3.3

4.1

24.78

34.29

ug/l

0.27

306

2859

Vasomotor and allergic rhinitis

1223

13037

0.92

2.16

3.4

4.1

24.83

24.70

ug/l

0.00

944

10187

Non-selective monoamine reuptake inhibitors

1912

17423

1.07

2.16

3.0

4.1

21.46

26.74

ug/l

0.35

1544

14048

Intracranial and intraspinal abscess and granuloma

335

1.57

2.15

2.7

4.6

5.30

39.31

ug/l

0.84

285

Systemic atrophies primarily affecting the central nervous system

103

1345

0.75

2.15

3.1

4.2

14.01

22.12

ug/l

0.39

1123

Pre-eclampsia or eclampsia

650

7234

0.89

2.15

3.2

3.7

17.23

22.95

ug/l

0.25

469

5427

Carcinoma in situ of lip, excluding all cancers

5.66

2.15

2.2

2.1

15.58

3.13

ug/l

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

349

1.53

2.15

4.1

3.8

2.61

40.73

ug/l

0.97

279

Neuromuscular dysfunction of bladder

360

3115

1.17

2.15

2.9

4.1

10.12

29.26

ug/l

2.00

289

2539

Congenital malformations of breast

276

1.60

2.15

3.2

3.8

11.53

6.49

ug/l

0.36

204

Findings of drugs and other substances, not normally found in blood

133

1.95

2.14

2.2

4.8

3.11

87.53

ug/l

0.86

116

Inflammatory diseases of the central nervous system

294

2502

1.19

2.14

3.5

4.1

8.11

20.51

ug/l

1.30

223

2024

Melanoma in situ of trunk

461

1.48

2.14

4.2

4.6

4.64

37.32

ug/l

1.18

391

Tic and related disorders

138

1.85

2.13

3.2

4.9

6.51

5.53

ug/l

0.09

109

Carcinoma in situ of skin of ear and external auricular canal

427

1.50

2.13

3.7

4.0

5.10

39.05

ug/l

1.17

365

Melanoma in situ

174

1416

1.26

2.12

3.8

4.1

4.09

22.84

ug/l

2.40

140

1173

Delayed milestone in childhood

2.19

2.12

2.6

2.4

1.92

1.71

ug/l

—

Defect, injury or illness of neck

118

1.98

2.12

4.2

4.6

10.72

43.52

ug/l

0.44

Other and unspecified acquired haemolytic anaemias

280

1.62

2.12

3.1

4.1

3.15

49.41

ug/l

0.98

232

Benign neoplasm of eye and adnexa

415

3634

1.16

2.12

4.4

4.0

12.47

21.13

ug/l

0.79

347

2936

Decubitus ulcer and pressure area

227

1894

1.22

2.11

2.6

3.9

13.55

24.61

ug/l

0.65

188

1581

Artificial joint operation, meniscal resection

4725

30200

1.04

2.11

3.7

4.1

20.16

26.96

ug/l

0.94

3781

24529

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

488

4309

1.14

2.10

3.1

4.1

21.95

26.98

ug/l

0.17

414

3306

Cystic kidney disease

117

907

1.32

2.10

2.4

4.4

3.34

28.54

ug/l

1.95

752

Heart failure and coronary heart disease

1463

11692

0.93

2.09

2.6

4.1

10.84

27.74

ug/l

5.09

1227

9848

Suicide or other Intentional self-harm

836

7610

1.11

2.09

3.1

4.1

16.78

28.04

ug/l

0.86

708

5945

Astigmatism

179

1455

1.25

2.09

3.7

4.2

5.00

21.74

ug/l

1.91

130

1166

Pre-eclampsia

583

6515

0.89

2.09

3.2

3.7

17.51

23.22

ug/l

0.22

421

4859

Injury of muscle and tendon at shoulder and upper arm level

1447

15509

0.93

2.08

3.7

4.3

13.88

26.45

ug/l

1.83

1177

12771

Rare circulating lymphoid malignancy

116

900

1.32

2.07

3.1

4.2

16.57

27.57

ug/l

0.30

755

Hypertensive Renal Disease

144

1148

1.28

2.07

2.5

4.2

7.71

23.88

ug/l

1.41

125

956

Other pulmonary heart/vessel disease

183

1499

1.25

2.07

2.5

3.9

21.65

22.97

ug/l

0.03

139

1255

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

525

4664

1.13

2.07

3.2

3.7

5.85

27.43

ug/l

1.70

416

3495

LSIL lesion of the vulva

108

830

1.33

2.07

3.7

3.50

15.75

ug/l

1.46

649

Female infertility

1083

6147

1.09

2.05

3.4

4.1

9.17

32.61

ug/l

2.46

785

4657

Deep bite

209

2203

0.82

2.05

3.7

4.1

12.71

20.69

ug/l

0.52

161

1712

Late syphilis

405

1.49

2.05

2.8

4.8

21.03

44.13

ug/l

0.51

337

Disorders of vitreous body

2420

22459

1.06

2.04

3.6

4.1

14.10

25.29

ug/l

2.29

1940

18339

Other/unspecified seropositive rheumatoid arthritis

1081

11702

0.92

2.04

3.0

3.9

28.63

24.84

ug/l

0.11

882

9457

Eosinophilic disease (BM)

421

1.48

2.04

3.4

4.0

108.21

37.01

ug/l

0.33

342

Personal history of certain other diseases

232

1.63

2.03

4.6

3.8

3.40

5.49

ug/l

0.80

174

Other inflammation of vagina/vulva

752

1.34

2.02

3.2

4.0

9.39

54.47

ug/l

0.49

574

Lactose intolerance

753

1.34

2.02

3.7

4.1

3.87

26.03

ug/l

1.34

611

Seborrhoeic keratosis

1051

9701

1.09

2.02

3.7

4.0

19.34

23.41

ug/l

0.19

868

7967

Endometriosis ASRM stages 1,2

620

5573

1.12

2.02

3.0

3.7

6.36

24.82

ug/l

1.67

455

4184

Septal defects

169

1342

1.25

2.02

3.0

4.2

4.92

23.53

ug/l

1.99

133

1063

Suggestive for eosinophilic asthma

370

3226

1.16

2.02

3.9

4.1

45.97

25.68

ug/l

0.27

308

2611

Charcot foot

524

1.42

2.01

3.0

5.0

14.76

29.20

ug/l

0.42

439

Sulfasalazine

1225

11364

1.09

2.01

3.5

4.1

41.73

23.22

ug/l

0.54

971

9061

Allergic asthma (mode), excluding more controls

788

7032

1.11

2.01

3.1

4.1

11.53

25.59

ug/l

1.20

618

5367

Other/unspecified soft tissue disorders related to use, overuse and pressure

112

869

1.32

2.01

3.4

4.6

2.62

27.78

ug/l

1.78

700

Hard cardiovascular diseases

4118

25350

1.05

2.01

3.5

4.2

16.88

27.18

ug/l

2.02

3399

20600

D07AA Corticosteroids, weak (group I)

463

4086

1.14

2.00

5.4

3.9

34.72

28.89

ug/l

0.15

374

3180

Lesion of lateral popliteal nerve

185

1522

1.24

2.00

3.2

4.3

10.89

20.27

ug/l

0.58

159

1252

Seropositive rheumatoid arthritis, wide

1094

11826

0.92

2.00

3.0

3.9

28.40

24.64

ug/l

0.11

890

9557

Viral agents as the cause of diseases classified to other chapters

566

1.40

2.00

3.7

4.3

25.21

20.06

ug/l

0.08

469

Special screening examination for infectious and parasitic diseases

692

4664

1.11

1.99

3.5

4.4

7.94

29.73

ug/l

1.73

483

3484

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

210

1.66

1.99

2.1

1.5

3.55

4.18

ug/l

0.16

163

Conjunctivitis

3142

26118

1.05

1.99

3.4

4.0

12.83

24.96

ug/l

2.83

2351

20578

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2328

21592

1.06

1.99

3.6

4.2

15.84

24.92

ug/l

0.94

1824

17379

Nail disorders

285

2437

1.19

1.99

3.7

4.1

7.19

25.29

ug/l

2.09

216

1958

Maternal care for known or suspected malpresentation of fetus

330

2851

0.86

1.99

3.5

3.4

3.19

21.59

ug/l

0.74

210

1891

Other disorders originating in the perinatal period

2.07

1.99

4.6

3.6

2.59

6.83

ug/l

—

Injury of other and unspecified intrathoracic organs

233

1961

1.21

1.98

3.4

4.2

53.09

26.20

ug/l

0.48

200

1622

Chronic thyroiditis

122

1.95

1.98

3.3

4.0

27.07

6.98

ug/l

0.40

Motor- or nonmotor-vehicle accident in traffic area

128

1.88

1.97

2.3

4.5

2.13

8.62

ug/l

2.01

102

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

930

8533

1.10

1.97

3.1

4.0

15.83

26.17

ug/l

0.86

758

6540

Marfan's syndrome

114

1.95

1.96

2.9

5.0

4.93

47.14

ug/l

0.53

Meralgia paraesthetica

132

1050

1.29

1.96

3.2

4.3

12.48

22.43

ug/l

0.39

111

846

Mental and behavioural disorders due to opioids

599

1.37

1.96

3.0

4.9

27.98

28.18

ug/l

0.00

473

Other necrotizing vasculopathies

296

2547

1.18

1.96

2.6

4.1

7.28

20.11

ug/l

1.92

235

2083

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

321

2778

1.17

1.96

3.4

4.1

34.08

23.16

ug/l

0.22

264

2239

Glomerular disorders in diseases classified elsewhere

435

3842

1.15

1.95

3.0

4.2

14.92

22.56

ug/l

0.53

374

3189

Lung transplant status

206

1.69

1.95

2.5

4.7

19.68

42.13

ug/l

0.36

164

Lung transplantation

206

1.69

1.95

2.5

4.7

19.68

42.13

ug/l

0.36

164

Flatulence and related conditions

253

1.60

1.93

3.2

4.2

2.69

11.53

ug/l

2.62

210

Exposure to other specified factors

3125

27980

1.05

1.93

3.7

4.1

13.47

25.95

ug/l

2.54

2474

22217

Type 1 diabetes, wide definition, subgroup 1

672

6073

1.11

1.93

3.5

4.2

25.22

29.58

ug/l

0.11

568

4791

Other necrotizing vasculopathies (FG)

263

2246

1.19

1.93

2.7

4.3

7.68

25.38

ug/l

2.57

211

1853

Viral warts

318

2749

1.17

1.92

2.9

4.1

9.41

21.74

ug/l

1.69

255

2200

Oral lichen ruber planus wide, hypothyreosis or thyroxin

233

1972

1.21

1.92

3.0

4.0

55.95

19.76

ug/l

0.32

175

1592

Secondary right heart disease

165

1350

1.25

1.92

2.4

3.9

23.86

24.81

ug/l

0.02

124

1133

Car occupant injured in noncollision transport accident

107

829

1.31

1.92

3.9

4.4

9.80

24.59

ug/l

0.67

673

Coronary atherosclerosis

3357

22618

0.95

1.91

3.3

4.3

28.24

26.06

ug/l

0.11

2737

18654

Progressive vascular leukoencephalopathy

145

1173

1.27

1.91

2.6

3.9

3.10

29.25

ug/l

2.63

117

989

Effects of foreign body entering through natural orifice

849

7776

1.10

1.91

3.5

4.3

20.13

28.76

ug/l

0.47

676

6345

Other protozoal intestinal diseases

335

1.51

1.90

2.8

4.4

3.30

20.29

ug/l

0.74

275

Allergic asthma (mode)

788

7055

1.10

1.90

3.1

4.1

11.53

25.13

ug/l

1.14

618

5382

Lymphoid leukaemia

220

1852

1.21

1.90

3.2

4.0

6.53

22.63

ug/l

1.97

161

1546

Carcinoma in situ of cervix uteri

229

1928

1.20

1.90

3.6

3.5

11.27

31.94

ug/l

0.54

181

1398

conjunctival haemorrhage

311

2695

1.17

1.89

3.2

4.0

7.81

23.24

ug/l

2.46

247

2220

Use of entacapone

273

0.49

1.89

2.9

4.4

2.91

52.40

ug/l

—

238

Radial styloid tenosynovitis [de Quervain]

202

1686

1.22

1.89

2.7

4.2

3.44

23.27

ug/l

2.67

146

1314

Arthrosis

3821

20138

1.05

1.88

3.6

4.3

19.53

29.89

ug/l

1.42

3082

16244

Seropositive rheumatoid arthritis

1094

11761

0.92

1.88

3.0

4.1

28.40

23.81

ug/l

0.14

890

9534

Carcinoma in situ of skin of upper limb, including shoulder

100

776

1.34

1.88

3.1

4.0

3.54

27.93

ug/l

1.62

656

Sleep disorders

712

6473

1.11

1.88

3.1

4.1

7.10

27.05

ug/l

2.81

548

5084

Cervicocranial syndrome

449

3986

1.14

1.87

3.1

4.2

16.13

25.54

ug/l

0.46

355

3175

Other primary thrombocytopenia

102

2.00

1.87

3.3

4.7

2.75

6.57

ug/l

0.96

Allergic conjunctivitis

2261

21102

1.06

1.87

3.4

3.9

13.18

22.54

ug/l

1.26

1660

16444

Cardiac murmurs and other cardiac sounds

290

2465

1.17

1.87

3.7

4.0

32.67

20.38

ug/l

0.29

227

1928

Dissociative [conversion] disorders

100

770

1.32

1.87

2.9

4.1

39.99

19.04

ug/l

0.43

602

Superficial injury of forearm

292

2514

1.17

1.87

3.4

4.0

7.53

18.72

ug/l

1.45

226

1989

Melanocytic naevi of other and unspecified parts of face

207

1734

1.21

1.87

3.3

4.1

28.91

21.48

ug/l

0.12

156

1383

Vitiligo

288

1.55

1.86

2.9

4.4

3.35

22.32

ug/l

0.69

236

Migraine

1679

15185

0.94

1.86

3.1

4.1

13.55

23.40

ug/l

0.85

1215

11684

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2178

20288

1.06

1.86

3.4

3.9

13.50

23.11

ug/l

1.23

1591

15824

Habitual aborter

286

1.53

1.85

3.7

3.9

26.31

163.83

ug/l

0.51

195

Pneumonia derived septicemia

124

986

1.29

1.85

3.5

4.2

16.25

24.74

ug/l

0.31

103

819

Insomnia

511

4569

1.13

1.85

3.0

4.1

6.45

27.31

ug/l

1.89

382

3577

Monoarthritis, not elsewhere classified

164

1345

1.24

1.85

3.5

4.5

14.84

26.33

ug/l

0.40

142

1093

Disorders of adult personality and behaviour

886

8139

1.09

1.85

3.0

4.1

12.48

27.01

ug/l

1.78

701

6252

Chondrosarcoma

2.06

1.85

2.1

4.6

1.88

124.89

ug/l

0.88

All dysplastic lesions of the cervix uteri

734

6673

1.10

1.84

3.3

3.6

18.08

23.34

ug/l

0.20

546

4799

Otitis externa, unspecified

361

3162

1.15

1.84

3.7

4.2

13.25

23.96

ug/l

0.75

287

2524

Voice disturbances

1147

10665

1.08

1.83

3.4

4.0

8.19

25.67

ug/l

4.02

900

8522

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

193

1607

1.22

1.83

3.3

4.2

7.67

22.46

ug/l

1.39

163

1283

Granuloma annulare

414

1.45

1.83

3.3

3.9

9.03

18.25

ug/l

0.36

341

Other salmonella infections

140

1131

1.26

1.83

4.4

4.2

35.23

23.07

ug/l

0.24

109

928

TMD muscular pain linked with fibromyalgia

233

1.61

1.83

2.2

3.9

2.85

6.81

ug/l

1.23

190

Hypertrophy of tongue papillae

356

1.49

1.83

4.6

4.75

18.24

ug/l

0.61

303

Other nonscarring hair loss

233

1.61

1.82

2.7

3.9

5.14

9.85

ug/l

0.77

186

Nontoxic single thyroid nodule

307

2666

1.17

1.82

3.5

4.0

21.60

19.27

ug/l

0.08

238

2131

Lesion of radial nerve

140

1132

1.26

1.82

3.1

4.3

5.64

22.96

ug/l

1.50

106

926

Gonarthrosis

3541

19463

1.05

1.82

3.5

4.3

25.75

30.32

ug/l

0.38

2842

15784

Disorders of vitreous body and globe

2482

23049

1.06

1.82

3.6

4.1

13.84

24.99

ug/l

2.37

1986

18827

Cervical disc disorders

1765

16653

1.07

1.81

3.1

4.4

9.95

27.32

ug/l

5.82

1450

13486

Cholera

189

1579

1.22

1.81

3.9

4.1

5.07

28.43

ug/l

1.97

144

1292

Ménière disease

414

3670

1.14

1.81

3.4

4.0

12.11

26.79

ug/l

1.16

334

2989

Disorders of muscles

381

3355

1.15

1.81

3.0

4.4

11.53

24.75

ug/l

1.74

295

2705

Endometriosis of intestine

264

1.55

1.81

2.1

4.1

1.84

158.77

ug/l

0.61

195

Bilateral sagittal split ramus osteotomy operation

734

0.70

1.81

3.9

4.4

30.43

20.57

ug/l

0.18

566

Other and unspecified diseases of blood and blood-forming organs

101

788

1.32

1.79

3.1

4.1

3.65

24.51

ug/l

1.28

649

Other disorders of Eustachian tube

106

831

1.31

1.79

4.2

4.4

6.33

26.10

ug/l

1.23

685

Other specified and unspecified disorders of eye and adnexa

143

1161

1.26

1.79

3.2

4.1

18.90

22.04

ug/l

0.07

103

953

Personal history of allergy to drugs, medicaments and biological substances

258

1.57

1.79

4.1

32.61

24.24

ug/l

0.12

214

Pacemaker

1553

14195

1.07

1.79

2.9

4.0

15.75

22.73

ug/l

0.94

1250

11861

Benign neoplasm: Lip

701

1.34

1.79

2.6

4.3

4.37

25.19

ug/l

1.16

590

Other orthopaedic follow-up care

192

1605

1.21

1.78

3.8

45.76

14.01

ug/l

0.44

163

1293

Multiple delivery

230

2699

0.84

1.78

3.6

3.5

22.54

10.45

ug/l

0.45

169

2018

Benign neoplasm of middle ear and respiratory system

311

2707

1.17

1.78

3.7

4.1

44.27

24.57

ug/l

0.32

257

2227

Extrapyramidal and movement disorders

1519

16150

0.93

1.77

3.2

4.0

12.01

23.67

ug/l

2.15

1209

13256

Conjunctivitis (acute, non atopic)

1008

9303

1.09

1.77

3.5

4.1

10.73

25.53

ug/l

2.24

786

7407

Melanoma in situ of upper limb, including shoulder

1.95

1.76

3.3

1.6

2.19

5.62

ug/l

0.61

Viral meningitis

106

831

1.30

1.76

4.2

13.21

18.61

ug/l

0.24

665

Selective deficiency of immunoglobulin G [IgG] subclasses

204

1.65

1.76

3.3

4.1

4.07

28.63

ug/l

0.62

167

HSIL lesion of the cervix uteri

496

4441

1.12

1.76

3.2

3.6

6.14

22.49

ug/l

1.17

366

3177

Open wound of shoulder and upper arm

476

1.40

1.75

3.0

4.7

5.12

33.48

ug/l

1.02

397

Type1 diabetes, definitions combined, early onset

788

0.72

1.75

3.5

4.3

10.64

61.02

ug/l

0.53

547

Protein-energy malnutrition of moderate and mild degree

212

1.63

1.75

3.9

4.2

4.96

38.89

ug/l

0.56

181

Ulcer of vagina/vulva

623

1.35

1.74

3.1

3.7

13.29

10.49

ug/l

0.13

493

Gout due to impairment of renal function

319

1.51

1.74

2.5

4.4

3.87

47.45

ug/l

1.08

268

Idiopathic urticaria

468

1.40

1.74

4.3

3.9

64.63

31.04

ug/l

0.34

377

Other interventions on the root canals of the tooth

426

1.42

1.73

4.8

4.5

4.25

33.41

ug/l

0.90

348

Psychotic depression

211

1783

1.20

1.73

3.1

4.3

13.53

45.27

ug/l

0.91

166

1420

Other bursopathies

569

5148

1.12

1.73

3.2

4.4

12.39

26.17

ug/l

1.27

460

4235

Chronic rhinitis, nasopharyngitis and pharyngitis

1315

12312

1.07

1.72

3.3

4.1

8.17

25.48

ug/l

4.51

1005

9785

Assault by bodily force

180

1498

1.21

1.72

3.0

4.5

7.84

18.18

ug/l

0.99

139

1189

Adalimumab

263

2264

1.17

1.72

3.4

4.3

92.14

17.17

ug/l

0.62

196

1786

Foreign body entering into or through eye or natural orifice

254

2182

1.18

1.71

3.2

4.3

19.82

22.22

ug/l

0.06

200

1772

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

319

1.50

1.71

5.3

3.8

17.61

43.73

ug/l

0.47

260

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1645

13710

0.94

1.71

3.6

3.7

15.57

21.76

ug/l

0.45

1203

10275

Asthma and allergy, excluding more controls

353

3062

1.15

1.71

3.0

3.9

16.21

33.26

ug/l

0.51

271

2261

Demyelinating diseases of the central nervous system

192

2281

0.83

1.71

3.8

4.1

5.09

39.30

ug/l

1.44

148

1759

Other and unspecified degenerative diseases of nervous system

790

0.71

1.71

3.4

4.0

46.08

30.92

ug/l

0.17

677

Car occupant injured in other and unspecified transport accidents

608

5516

1.11

1.70

3.4

4.1

12.48

29.12

ug/l

1.29

479

4323

Major coronary heart disease event

3501

24306

0.96

1.70

3.4

4.2

15.17

26.77

ug/l

2.70

2879

20047

Asthma mixed form (mode), excluding more controls

189

1584

1.21

1.70

3.2

3.8

5.19

44.62

ug/l

1.16

164

1274

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

376

1.44

1.70

3.5

4.3

4.00

18.04

ug/l

0.65

304

All dysplastic lesions of the cervix uteri, vagina or vulva

897

8228

1.09

1.70

3.5

3.6

15.35

21.73

ug/l

0.32

675

5996

Atopic conjunctivitis

132

1068

1.25

1.69

3.6

4.1

19.73

19.40

ug/l

0.01

102

842

Brain glioblastoma and astrocytoma

509

0.65

1.69

2.1

4.4

3.55

33.12

ug/l

1.17

430

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

254

2189

1.18

1.69

3.8

4.2

11.42

20.79

ug/l

0.90

203

1784

Nontoxic diffuse goitre

139

1136

1.25

1.69

3.1

4.0

10.97

15.03

ug/l

0.26

112

917

Asthma and allergy

353

3065

1.14

1.69

3.0

3.9

16.21

32.43

ug/l

0.47

271

2261

Female infertility, cervigal, vaginal, other or unspecified origin

971

6011

1.09

1.68

3.5

4.1

9.18

31.61

ug/l

2.26

703

4563

Other condition

464

4157

1.13

1.67

3.1

4.1

15.97

31.12

ug/l

0.81

388

3344

Other and unspecified follicular disorders

123

990

1.26

1.67

4.8

4.2

7.81

27.10

ug/l

1.32

100

797

L01XX Other antineoplastic agents

237

2036

1.19

1.67

2.7

4.1

24.13

20.94

ug/l

0.10

190

1691

Congenital malformations of cardiac septa

178

1437

1.21

1.67

2.9

4.2

5.71

25.28

ug/l

2.05

141

1139

Mixed and other personality disorders

229

1955

1.18

1.66

3.1

4.3

8.07

17.83

ug/l

1.22

187

1528

MS-disease / Multiple Sclerosis

153

1849

0.82

1.65

3.9

4.1

4.30

34.59

ug/l

0.98

120

1426

Glaucoma suspect

1546

16378

0.94

1.64

4.0

3.9

18.75

24.05

ug/l

0.29

1272

13422

Coxarthrosis, primary

3077

25621

1.05

1.64

3.7

4.0

17.53

26.48

ug/l

1.18

2554

21074

Hirsutism in women

320

1.47

1.64

2.2

3.8

29.29

23.33

ug/l

0.09

231

Injury of intra-abdominal organs

603

1.34

1.64

3.6

4.6

32.94

23.96

ug/l

0.11

508

Fall involving bed

121

978

1.27

1.64

3.0

3.8

17.48

22.13

ug/l

0.11

102

826

Complications associated with artificial fertilization

246

1.53

1.63

3.9

3.5

3.10

184.07

ug/l

0.61

168

Type 1 diabetes, strict definition

1152

0.77

1.63

3.5

4.4

8.44

37.44

ug/l

0.43

811

Malignant neoplasm of renal pelvis

169

1.70

1.63

2.2

4.4

87.49

49.57

ug/l

0.17

142

Cauda equina syndrome

356

1.45

1.63

3.2

4.4

4.02

19.08

ug/l

0.66

288

Other renal tubulo-interstitial diseases

648

1.33

1.63

4.1

3.8

6.68

18.40

ug/l

0.55

528

Contusion of other and unspecified parts of foot

129

1046

1.25

1.62

3.2

4.2

4.87

26.20

ug/l

1.58

102

827

Alcohol abuse counselling and surveillance

415

1.41

1.62

1.9

4.9

4.19

38.71

ug/l

1.07

347

Carcinoma in situ of middle ear and respiratory system

162

1.72

1.62

6.9

4.8

5.37

47.33

ug/l

0.79

137

Benign neoplasm: Skin of upper limb, including shoulder

589

1.34

1.61

3.1

4.4

18.45

32.38

ug/l

0.33

495

Hypoparathyroidism

144

1188

1.24

1.61

3.2

4.0

56.56

21.79

ug/l

0.29

123

963

Speech disturbances, not elsewhere classified

339

2994

1.15

1.60

3.1

3.9

19.19

20.99

ug/l

0.06

267

2453

Artificial joint re-operation

232

2685

0.85

1.59

3.1

4.0

10.00

18.54

ug/l

1.02

186

2204

Pre-eclampsia or poor fetal growth

842

9082

0.92

1.59

3.3

3.7

15.11

20.87

ug/l

0.34

604

6655

Chromophobe cell carcinoma of kidney

163

1.71

1.58

3.2

5.2

5.04

32.67

ug/l

0.56

138

Neurological diseases, wide definition

1250

5861

1.07

1.58

3.6

4.9

11.43

35.40

ug/l

2.40

990

4541

Respiratory tuberculosis, clinically confirmed

401

1.42

1.58

2.9

4.3

9.21

46.64

ug/l

1.08

333

Cardiodefibrillation

1755

16618

1.06

1.57

3.5

4.1

10.41

26.94

ug/l

6.67

1404

13914

Other injuries of upper limb, level unspecified

275

1.51

1.57

2.7

4.3

3.30

23.83

ug/l

0.73

227

Chronic ulcer of skin, not elsewhere classified

269

2344

1.16

1.56

2.7

4.0

10.90

22.46

ug/l

1.26

227

1931

Complications predominantly related to the puerperium

751

8152

0.92

1.56

3.7

43.22

22.09

ug/l

0.52

553

6081

Dislocation, sprain and strain of joints and ligaments of thorax

109

874

1.27

1.56

3.4

4.2

67.41

23.32

ug/l

0.44

720

Statin medication

3391

18270

1.04

1.56

3.5

4.3

26.67

22.37

ug/l

0.26

2730

14379

Meningitis

168

1408

1.21

1.56

3.9

4.2

10.78

19.68

ug/l

0.44

125

1144

Fall on same level involving ice and snow

2510

24008

1.05

1.56

3.7

4.0

30.64

23.32

ug/l

0.37

2003

19281

Carcinoma in situ of prostate

1.94

1.55

5.3

1.4

12.24

6.41

ug/l

0.35

LSIL lesion of the cervix uteri, vagina or vulva

419

3750

1.13

1.55

3.6

25.74

25.17

ug/l

0.01

315

2745

Other/unspecified enthesopathies, not elsewhere classified

365

3246

1.14

1.55

3.1

4.2

36.92

24.78

ug/l

0.16

293

2624

Tooth eruption problems

231

1963

1.17

1.55

3.4

3.9

3.77

39.47

ug/l

1.19

171

1413

Prurigo nodularis

103

824

1.28

1.55

3.0

4.2

4.58

27.85

ug/l

1.61

690

Gonarthrosis,primary

4795

29182

1.04

1.55

3.6

4.1

20.83

26.47

ug/l

0.69

3860

23711

Habit and impulse disorders

308

1.46

1.54

2.8

5.3

4.26

29.87

ug/l

0.94

252

Malignant neoplasm of gum

133

1.78

1.54

3.0

4.6

2.81

37.86

ug/l

0.60

115

Lesion of ulnar nerve

545

4954

1.11

1.54

3.2

4.3

44.89

24.14

ug/l

0.46

453

4023

Bacterial meningitis

122

993

1.25

1.54

4.0

4.5

13.64

23.05

ug/l

0.32

818

Multiple myeloma

105

843

1.28

1.54

2.1

4.0

4.47

30.27

ug/l

1.83

716

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

105

843

1.28

1.54

2.1

4.0

4.47

30.27

ug/l

1.83

716

Neuralgia and neuritis, unspecified

195

1660

1.19

1.54

3.1

4.3

9.68

26.53

ug/l

1.58

161

1334

Thyroiditis, ILD-related definition

414

3709

1.13

1.53

3.2

3.9

52.31

25.96

ug/l

0.49

316

2893

Benign neoplasm: Other parts of oropharynx

269

1.51

1.53

2.5

4.5

4.07

24.62

ug/l

0.70

219

Gonarthrosis, primary, with knee surgery

2767

23555

0.95

1.53

3.4

4.1

21.10

23.99

ug/l

0.21

2220

19392

Bitten or struck by other mammals

327

2887

1.14

1.53

3.8

4.0

30.82

31.15

ug/l

0.01

254

2250

Disturbance of activity and attention

131

1055

1.23

1.53

2.9

4.0

2.21

48.53

ug/l

0.66

700

Asthma mixed form (mode)

189

1603

1.19

1.53

3.2

3.8

5.19

43.66

ug/l

1.14

164

1290

Unspecified contracted kidney

164

1.67

1.52

4.0

4.5

9.51

9.43

ug/l

0.01

135

Asthma and opportunity respiratory infection

197

1683

1.19

1.52

3.0

4.0

4.03

20.18

ug/l

2.51

174

1379

Polyarteritis nodosa and related conditions

378

1.42

1.52

3.1

3.8

11.05

41.39

ug/l

0.75

310

Malignant neoplasm of larynx

517

1.36

1.51

3.1

4.6

7.28

44.73

ug/l

1.52

438

Oral leukoplakia, including avohilmo

108

871

1.27

1.51

3.3

4.3

77.80

25.33

ug/l

0.36

724

Cystic fibrosis with intestinal manifestations

2.72

1.51

3.0

4.3

2.24

9.08

ug/l

—

Gilbert syndrome

188

1.61

1.50

2.6

4.7

2.69

28.62

ug/l

0.61

157

Pedestrian injured in transport accident

238

2061

1.17

1.50

3.1

4.2

12.69

18.79

ug/l

0.30

184

1677

Reactive arthropathies

343

3045

1.14

1.50

3.5

4.4

16.02

26.51

ug/l

0.62

257

2486

Nummular dermatitis

312

2755

1.15

1.50

3.8

4.1

16.09

25.60

ug/l

0.58

256

2253

Other acute skin changes due to ultraviolet radiation

137

1134

1.23

1.49

3.1

4.1

3.54

23.20

ug/l

1.91

112

944

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1075

11476

0.93

1.49

3.0

3.9

17.31

24.44

ug/l

0.57

876

9271

Tongue abnormality

244

2122

1.17

1.49

3.6

4.0

36.36

19.37

ug/l

0.26

212

1729

Other abnormal immunological findings in serum

465

1.36

1.48

4.4

4.0

3.79

36.88

ug/l

1.19

376

Hyperchylomicronaemia

2.20

1.48

4.8

5.0

7.61

6.04

ug/l

—

Mantle cell lymphoma

306

1.48

2.2

4.4

2.30

56.88

ug/l

1.35

259

Dermatopolymyositis, unspecified

166

1.66

1.47

2.6

4.8

2.93

33.58

ug/l

0.66

141

Benign neoplasm: Choroid

236

2050

1.17

1.47

4.7

4.1

19.14

21.12

ug/l

0.07

199

1690

Dental caries 1 and operation codes, only avohilmo

1096

5894

0.93

1.47

3.7

4.0

18.11

18.90

ug/l

0.04

878

4692

Varicose veins of other sites

227

1964

1.17

1.46

4.6

4.3

9.89

22.80

ug/l

1.21

198

1630

Other specified/unspecified hearing loss

324

2875

1.14

1.45

3.6

3.9

6.84

23.74

ug/l

3.21

257

2357

Prolapse and hernia of ovary and fallopian tube

176

1481

1.20

1.45

3.5

3.7

6.41

16.03

ug/l

1.80

140

1230

Other and unspecified myopathies

320

2838

1.14

1.45

3.1

4.0

15.77

22.03

ug/l

0.47

251

2354

Atrial septal defect

104

831

1.26

1.45

2.8

4.2

3.69

17.12

ug/l

1.50

670

Speech and linguistic disorders, excluding more controls

141

1100

1.22

1.44

3.6

4.3

69.50

20.19

ug/l

0.35

101

818

Atopic dermatitis

1825

16371

0.95

1.44

3.3

4.0

31.31

22.50

ug/l

0.32

1397

12577

Delirium, not induced by alcohol and other psychoactive substances

458

4141

1.12

1.44

3.0

3.9

10.25

22.32

ug/l

1.84

382

3453

Other appendicitis

307

2715

1.14

1.44

3.5

4.1

7.46

24.67

ug/l

2.17

240

2171

Crystalline deposits in vitreous body

299

1.47

1.43

2.9

4.7

21.80

46.44

ug/l

0.34

248

Wilms' tumor

183

1.61

1.43

1.6

4.4

3.26

31.77

ug/l

0.68

154

Tic and related disorders

157

1.62

1.43

3.2

4.4

6.51

6.98

ug/l

0.04

124

Postpartum hemorraghe, parous women as controls

567

5434

0.91

1.43

3.3

3.6

18.61

22.43

ug/l

0.13

383

3877

Dentofacial anomalies [including malocclusion]

989

9138

1.08

1.43

3.3

4.0

20.13

21.82

ug/l

0.05

755

7038

Dental caries 3 and operation codes, only avohilmo

1246

6661

0.94

1.43

3.7

4.0

23.79

18.07

ug/l

0.31

993

5254

Open wound of abdomen, lower back and pelvis

714

1.28

1.42

2.5

4.6

33.72

27.05

ug/l

0.12

578

All dysplastic lesions of the vulva

155

1304

1.21

1.42

3.6

3.8

3.64

13.22

ug/l

1.90

121

1020

Infective dermatitis

443

4005

1.12

1.42

3.6

4.1

18.12

24.92

ug/l

0.48

367

3242

Sequelae of other accidents

431

0.66

1.42

2.2

4.2

2.19

36.75

ug/l

1.19

360

Pneumococcal septicemia

116

949

1.25

1.42

3.5

4.2

17.35

27.01

ug/l

0.34

794

Superficial injury of lower leg

897

8357

1.08

1.42

3.3

4.0

10.09

29.33

ug/l

2.48

701

6632

Synovial cyst of popliteal space [Baker]

309

2740

1.14

1.42

3.3

4.2

6.65

22.74

ug/l

2.99

243

2216

Sacroiliitis, not elsewhere classified

125

1028

1.23

1.41

2.8

4.4

4.38

27.49

ug/l

1.59

770

Idiopathic pulmonary fibrosis

311

2761

1.14

1.41

3.0

3.9

19.77

24.27

ug/l

0.22

263

2312

Varicella [chickenpox]

116

948

1.24

1.40

4.0

4.7

18.81

26.31

ug/l

0.26

759

Other disorders of thyroid

402

1.39

1.40

3.1

3.7

55.95

17.38

ug/l

0.32

338

Contusion of toe(s) without damage to nail

495

1.34

1.40

3.7

4.1

3.32

15.48

ug/l

0.76

394

Bruxism

418

1.37

1.39

3.3

4.1

15.25

19.21

ug/l

0.11

326

Macular hole

247

2166

1.16

1.39

3.5

4.1

8.34

21.12

ug/l

1.76

212

1792

LeFortI or BSSRO operation

879

0.76

1.39

3.5

4.3

24.35

21.33

ug/l

0.06

673

Coronary angioplasty

1799

14496

0.95

1.38

3.3

4.3

20.02

29.29

ug/l

0.85

1503

12160

Oligomenorrhoea

101

815

1.26

1.38

2.7

4.0

5.81

56.00

ug/l

0.62

614

Other and unspecified mood [affective] disorders

170

1442

1.19

1.38

2.3

4.3

12.35

42.96

ug/l

0.65

125

1091

Personality disorders

839

7805

1.08

1.37

3.0

4.1

11.87

27.41

ug/l

1.90

669

6025

Other arterial embolism and thrombosis

114

936

1.24

1.37

3.2

4.0

10.16

26.95

ug/l

0.96

789

Blindness, monocular

276

1.47

1.37

3.4

4.1

3.11

9.20

ug/l

2.38

236

Mandibular retrognathia AND surgery (BSSRO)

558

0.71

1.37

3.6

4.3

39.57

25.14

ug/l

0.20

433

Injuries to the wrist and hand

4283

32034

0.97

1.37

3.7

4.1

16.86

25.99

ug/l

1.50

3406

25458

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1005

9421

1.07

1.37

3.2

4.3

17.20

25.97

ug/l

0.40

823

7619

Rheumatoid arthritis, including avohilmo

1621

17047

0.95

1.36

3.2

4.0

24.68

21.79

ug/l

0.13

1311

13775

Retinal haemorrhage

775

1.27

1.36

3.2

4.0

23.51

19.04

ug/l

0.08

661

Hyperkinetic disorders

137

1124

1.21

1.36

2.8

4.1

2.21

49.85

ug/l

0.76

754

Other specified disorders of external ear

145

1220

1.21

1.36

3.7

4.4

17.39

27.85

ug/l

0.31

113

1027

226

1.52

1.36

1.9

4.1

2.60

7.10

ug/l

2.01

184

Inguinal or femoral hernia, bilateral

413

3733

1.12

1.35

4.5

4.3

6.43

26.40

ug/l

4.32

335

3175

Thiamine deficiency

178

1.60

1.35

3.6

5.0

3.93

70.12

ug/l

0.84

145

Gonococcal infection

117

964

1.24

1.35

3.4

4.3

10.66

11.80

ug/l

0.06

783

Endocrine disorders, other/unspecified

561

1.31

1.35

3.8

4.3

6.32

28.40

ug/l

0.90

464

Other abnormal products of conception

834

5976

0.93

1.35

3.4

3.6

11.53

24.84

ug/l

0.94

576

4188

Ovarian hyperstimulation (induction)

233

1.48

1.34

4.1

3.6

3.13

28.00

ug/l

0.56

158

Foreign body in respiratory tract

169

1440

1.19

1.34

2.9

4.1

28.75

22.42

ug/l

0.12

130

1163

Benign neoplasm: other/unspecified salivary gland

113

931

1.24

1.33

3.2

4.1

11.71

28.37

ug/l

0.91

774

Chronic tubulo-interstitial nephritis

148

1249

1.20

1.33

3.9

4.0

3.48

18.98

ug/l

1.73

127

1031

Bursitis of shoulder

100

813

1.26

1.33

3.5

4.4

7.12

24.35

ug/l

1.00

662

Benign neoplasm: Other and unspecified parts of mouth

133

1113

1.22

1.33

3.8

4.3

22.94

23.31

ug/l

0.01

103

924

Unspecified severe protein-energy malnutrition

2.49

1.33

1.9

4.8

3.35

8.33

ug/l

—

Pregnancy with abortive outcome

2986

15024

1.04

1.33

3.6

3.7

20.96

21.04

ug/l

0.00

2332

11512

Other and unspecified mononeuropathies of upper limb

108

885

1.24

1.32

3.4

4.5

13.01

25.36

ug/l

0.55

722

Other and unspecified tonsillitis

898

7107

1.08

1.32

4.3

43.37

26.48

ug/l

0.33

680

5412

Benign neoplasm: Peripheral nerves and autonomic nervous system

476

1.34

1.32

4.1

3.9

3.59

30.96

ug/l

0.97

389

Palindromic rheumatism

329

1.42

1.32

2.0

4.1

3.00

36.79

ug/l

0.93

278

Viral conjunctivitis

483

1.33

1.32

2.7

4.3

2.70

31.70

ug/l

1.02

380

Other/unspecified disorders of vestibular function

152

1289

1.20

1.31

2.7

4.0

70.02

21.06

ug/l

0.38

114

1067

Contracture of joint

363

1.39

1.31

3.7

4.3

18.60

34.42

ug/l

0.35

315

Diseases of the myoneural junction and muscle

454

4131

1.11

1.31

3.1

4.0

15.10

24.08

ug/l

0.86

358

3379

Seropositive rheumatoid arthritis, strict definition

552

6006

0.91

1.31

3.2

4.0

24.22

25.49

ug/l

0.05

452

4815

Crushed, pushed or stepped on by crowd or human stampede

163

1385

1.19

1.31

3.4

4.3

22.31

23.86

ug/l

0.04

126

1092

Diabetic nephropathy, excluding more controls

567

4347

1.10

1.31

3.0

4.0

15.21

32.55

ug/l

1.59

486

3610

Bicipital tendinitis

190

1641

1.18

1.30

3.1

4.6

3.51

28.54

ug/l

3.64

144

1330

Speech and linguistic disorders

142

1143

1.20

1.30

3.6

4.1

68.83

20.93

ug/l

0.34

102

862

Lactose intolerance, other/unspecified

670

1.28

1.30

3.5

4.1

4.02

28.34

ug/l

1.29

544

Sleep disorders (combined)

4825

30706

1.03

1.30

3.3

4.1

20.96

26.00

ug/l

0.51

3801

24608

Campylobacter enteritis

761

1.26

1.29

3.2

4.4

3.47

27.25

ug/l

1.47

631

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

1.94

1.29

4.6

4.2

2.37

93.84

ug/l

0.53

Lichen simplex chronicus and prurigo

241

2118

1.15

1.29

2.8

4.1

4.92

21.14

ug/l

3.14

200

1733

Granulomatous disorders of skin and subcutaneous tissue

707

1.27

1.29

3.1

4.2

7.65

28.92

ug/l

1.04

580

Benign neoplasm: Lower jaw bone

108

1.76

1.29

2.6

4.1

4.36

11.62

ug/l

0.95

Thoracic aortic aneurysm

578

5326

1.10

1.29

3.5

4.5

14.17

19.75

ug/l

0.60

455

4492

Polyarteritis nodosa

196

1.54

1.29

3.8

4.4

14.79

62.08

ug/l

0.60

166

Superficial injury of ankle and foot

327

2924

1.13

1.28

3.1

4.2

14.31

34.83

ug/l

0.79

263

2273

Other and unspecified nail disorders

566

1.30

1.28

3.3

4.3

2.51

28.88

ug/l

1.18

462

Disorders of synovium and tendon

2431

21033

1.04

1.27

3.4

4.2

17.15

27.42

ug/l

0.88

1928

16797

Chronic iridocyclitis

171

1467

1.18

1.27

4.0

4.3

26.16

19.97

ug/l

0.15

134

1194

Injuries to the neck

743

6909

1.08

1.27

3.5

4.1

15.54

26.38

ug/l

0.70

597

5473

Vestibular neuronitis

348

3132

1.12

1.27

3.9

4.1

7.25

25.22

ug/l

3.01

280

2562

LSIL lesion of the cervix uteri

302

2691

1.13

1.27

3.4

3.6

34.87

29.10

ug/l

0.08

223

1957

Eosinophilia

462

1.33

1.26

3.4

4.3

108.21

31.79

ug/l

0.36

384

Other and unspecified immunodeficiencies with predominantly antibody defects

323

1.40

1.26

4.0

4.1

35.99

21.14

ug/l

0.17

267

Embedded teeth, including avohilmo

173

1483

1.17

1.25

3.4

4.1

4.09

46.93

ug/l

1.10

128

1114

Inguinal hernia, bilateral

404

3666

1.11

1.25

4.5

4.3

6.52

26.21

ug/l

4.12

327

3123

Complications of cardiac and vascular prosthetic devices, implants and grafts

649

1.28

1.25

2.8

4.0

24.08

25.68

ug/l

0.02

541

Benign neoplasm of brain and other parts of central nervous system

234

2058

1.15

1.25

3.7

4.2

9.09

19.94

ug/l

1.07

190

1680

Hordeolum and other deep inflammation of eyelid

175

1506

1.18

1.25

3.7

4.3

2.82

22.47

ug/l

2.50

137

1212

Antenatal screening

623

3231

1.09

1.24

3.7

3.4

25.54

16.40

ug/l

0.32

437

2300

Schizophrenia, schizotypal and delusional disorders

998

10612

0.94

1.24

3.1

4.1

22.93

24.34

ug/l

0.05

815

8446

Sequelae of other and unspecified effects of external causes

141

1.64

1.24

3.4

4.3

13.18

36.64

ug/l

0.33

115

Melanocytic naevi of upper limb, including shoulder

613

1.28

1.24

2.9

4.3

26.49

25.31

ug/l

0.02

506

Other specified/unspecified disorders of bone/cartilage

100

820

1.24

3.8

4.2

12.40

15.89

ug/l

0.16

672

Ankylosing spondylitis

313

2802

1.13

1.24

3.3

4.6

124.79

26.02

ug/l

0.82

245

2259

Other assisted single delivery

297

1.41

1.24

3.5

3.7

9.94

6.79

ug/l

0.27

205

Specific personality disorders

715

6646

1.08

1.23

2.9

4.1

14.52

28.18

ug/l

1.24

568

5089

Acute alcohol intoxication, ICD10

661

6129

1.08

1.23

3.2

4.4

30.07

29.91

ug/l

0.00

574

5011

Ovarian dysfunction, other/unspecified

141

1.63

1.23

3.1

4.2

24.62

9.03

ug/l

0.30

111

Haemorrhagic disorder due to circulating anticoagulants

386

1.37

1.23

3.5

4.2

3.29

40.93

ug/l

1.17

326

Disorders of eyelid in diseases classified elsewhere

115

957

1.22

1.23

3.8

4.2

17.68

20.65

ug/l

0.08

774

Ingrowing nail

164

1407

1.18

1.22

4.1

4.2

5.93

20.45

ug/l

1.53

122

1143

Schizophrenia

445

4870

0.91

1.20

2.9

4.3

27.83

30.99

ug/l

0.06

374

3890

Benign neoplasm: Conjunctiva

119

997

1.22

1.20

4.3

3.52

22.94

ug/l

1.61

822

Other cestode infections

110

0.43

1.20

3.2

4.2

2.24

75.75

ug/l

—

Disorders of purine and pyrimidine metabolism

184

1.54

1.19

4.5

4.7

2.95

62.54

ug/l

0.81

158

Ankylosing spondylitis, ICD10

291

2602

1.13

1.19

3.4

4.3

131.58

20.28

ug/l

0.88

229

2097

Superficial injury of abdomen, lower back and pelvis

494

4535

1.10

1.19

3.4

4.0

37.43

30.83

ug/l

0.11

397

3607

Metabolic disorder, other/unspecified

1.95

1.19

2.3

4.5

8.84

74.81

ug/l

—

Carcinoma in situ of breast

168

1.57

1.18

3.0

3.7

1.96

8.94

ug/l

1.80

139

Cardiomyopathy

742

6929

1.08

1.18

3.1

4.5

10.09

25.28

ug/l

4.02

611

5808

Spermatocele

293

2625

1.13

1.18

4.5

4.6

8.88

24.83

ug/l

2.32

246

2252

Toxic effect of corrosive substances

111

0.44

1.17

3.2

4.8

2.08

7.81

ug/l

—

Injury of nerves at wrist and hand level

117

980

1.21

1.17

3.9

4.7

15.57

27.44

ug/l

0.53

801

Other disorders of amniotic fluid and membranes

255

2844

0.88

1.17

3.2

3.5

12.47

22.77

ug/l

0.28

173

1932

Obesity, other/unspecified

1249

11849

1.06

1.16

3.2

4.1

36.44

22.69

ug/l

0.69

981

9286

Nonspecific lymphadenitis

199

1740

1.16

3.2

4.0

4.25

19.60

ug/l

2.05

149

1376

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

517

4766

1.09

1.16

3.6

4.1

12.24

31.61

ug/l

1.53

409

3820

Erythema intertrigo

728

1.25

1.16

3.8

4.2

12.60

34.11

ug/l

0.89

617

Myocardial infarction

2462

18336

0.96

1.15

3.4

4.3

13.56

26.65

ug/l

2.83

2038

15294

Insulin, fast-acting (human)

362

3992

0.90

1.15

3.2

4.0

10.47

27.27

ug/l

1.17

305

3154

Ptosis of eyelid

460

4224

1.10

1.15

3.3

4.0

28.59

21.33

ug/l

0.21

374

3458

Iridocyclitis

890

8368

1.07

1.15

3.5

4.1

70.14

25.78

ug/l

0.96

708

6759

Hallux rigidus

594

6397

0.92

1.15

3.2

4.3

13.19

26.12

ug/l

1.29

469

5296

Other and unspecified acute skin changes due to ultraviolet radiation

107

893

1.22

1.15

3.1

4.1

3.49

27.81

ug/l

1.86

750

Behavioural syndromes associated with physiological disturbances and physical factors

977

9200

1.07

1.14

3.1

4.0

9.25

25.11

ug/l

2.21

748

7105

Use of amantadine

502

0.72

1.14

3.7

3.9

3.35

30.62

ug/l

1.05

414

Juvenile rheumatoid arthirtis

447

0.71

1.14

3.8

4.2

16.22

17.77

ug/l

0.04

354

Cerebral cysts

167

1444

1.17

1.14

2.7

4.2

10.28

24.18

ug/l

1.00

134

1159

Trochanteric bursitis

608

5648

1.09

1.14

3.0

4.1

5.41

29.19

ug/l

2.96

470

4503

Benign neoplasm: Tonsil

365

1.36

1.13

3.5

4.4

12.95

19.23

ug/l

0.21

307

Other and unspecified nerve root and plexus disorders, also in other diseases

724

6766

1.08

1.13

3.2

4.3

16.91

28.68

ug/l

0.58

567

5451

Intentional self-harm by unspecified means

176

1.51

1.13

2.4

4.1

3.18

7.78

ug/l

1.21

131

Pyoderma

523

1.29

1.13

3.5

4.4

8.25

36.56

ug/l

1.02

431

Dermatopolymyositis

453

1.31

1.12

2.5

4.0

2.97

31.78

ug/l

1.00

377

Crystal arthropathies, rheuma endpoint

651

1.26

1.12

2.3

4.2

27.42

35.63

ug/l

0.12

560

Other crystal arthropathies

651

1.26

1.12

2.3

4.2

27.42

29.20

ug/l

0.02

557

Erythema nodosum

105

876

1.22

1.12

3.5

3.9

17.61

21.73

ug/l

0.09

713

Congenital malformations of the circulatory system

423

3747

1.10

1.12

3.3

4.2

6.96

23.05

ug/l

3.02

326

2976

Psoas tendinitis

121

1.65

1.12

3.7

4.6

2.11

42.57

ug/l

0.57

Episodal and paroxysmal disorders

5509

27522

1.03

1.11

3.4

4.2

18.94

26.97

ug/l

1.12

4316

21953

Abnormal blood-pressure reading, without diagnosis

161

1393

1.17

1.11

3.8

4.4

9.51

22.90

ug/l

0.94

114

1110

Cerebral amyloid angiopathy

130

1.64

1.11

2.1

4.7

7.46

87.65

ug/l

0.74

110

Pathological resorption of teeth

803

1.23

1.11

3.8

4.3

3.23

12.78

ug/l

2.00

656

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

139

1191

1.19

1.10

3.4

4.2

5.59

20.90

ug/l

1.34

114

977

conjunctival degenerations and deposits

733

1.24

1.10

3.3

4.2

12.47

27.22

ug/l

0.57

611

Schizophrenia or delusion

996

10542

0.94

1.10

3.1

4.1

22.92

24.38

ug/l

0.06

812

8386

Calcific tendinitis of shoulder

232

2061

1.14

1.10

3.2

4.4

43.96

22.43

ug/l

0.27

192

1643

Benign neoplasm of other and unspecified female genital organs

172

1499

1.17

1.10

3.4

3.8

6.43

13.22

ug/l

1.24

132

1195

Infectious mononucleosis

150

1288

1.17

1.10

3.7

4.2

5.97

45.32

ug/l

0.78

109

932

Sequelae of cerebrovascular disease

1531

14054

0.95

1.09

3.0

4.0

22.42

23.57

ug/l

0.06

1258

11647

Other and specified injuries of hip and thigh

652

1.25

1.09

2.9

4.1

11.10

30.85

ug/l

0.76

552

Open wound of wrist and hand

1611

15260

1.05

1.08

3.8

4.3

11.68

27.62

ug/l

3.74

1304

12258

Sacrococcygeal disorders, not elsewhere classified

103

861

1.21

1.08

3.2

4.3

6.64

21.33

ug/l

0.80

669

Other and unspecified nonscarring hair loss

171

1.51

1.07

3.2

4.0

3.04

5.23

ug/l

0.88

136

Other bursitis of hip

663

1.25

1.07

3.5

4.5

4.91

33.69

ug/l

1.52

536

Striae atrophicae

255

1.41

1.07

4.5

4.0

3.53

24.79

ug/l

0.67

206

Impetigo

103

860

1.21

1.07

3.7

4.3

24.70

25.56

ug/l

0.02

673

Spirochaetal infections, other/unspecified

318

2882

1.12

1.07

3.8

4.1

32.90

26.23

ug/l

0.09

254

2340

Erosion and ectropion of cervix uteri

120

1020

1.20

1.06

3.3

4.1

20.50

42.64

ug/l

0.45

824

Benign neoplasm: Spinal meninges

361

1.35

1.06

3.4

3.9

2.46

21.43

ug/l

0.99

304

Shoulder region

413

1.32

1.06

2.0

4.1

2.31

33.74

ug/l

0.97

339

Exposure to other and unspecified animate mechanical forces

571

1.26

1.06

4.5

4.3

19.46

27.17

ug/l

0.14

453

Drug-induced systemic lupus erythematosus

214

1.46

1.06

1.7

3.9

20.45

9.61

ug/l

0.26

171

Congenital lactase deficiency

2.01

1.06

4.9

3.4

2.57

6.53

ug/l

—

Emotionally unstable personality disorder

292

2630

1.12

1.05

2.9

3.9

12.45

28.11

ug/l

0.56

232

1939

Physical medicine devices associated with adverse incidents

0.00

1.05

0.0

4.9

—

2.67

—

Vascular dementia (subcortical)

972

0.81

1.05

2.5

3.6

3.41

24.39

ug/l

1.97

836

Orthopaedic devices associated with adverse incidents

639

1.26

1.05

2.6

4.2

4.00

32.99

ug/l

1.54

535

Dermatopolymyositis (FG)

458

1.30

1.05

2.5

4.3

2.97

41.79

ug/l

1.46

385

Acute alcohol intoxication

952

8998

1.06

1.05

3.2

4.3

28.24

28.09

ug/l

0.01

823

7323

Residual foreign body in soft tissue

162

1409

1.16

1.05

4.3

4.6

9.93

24.49

ug/l

1.25

127

1135

Syphilis

718

1.23

1.05

2.8

4.8

14.53

27.62

ug/l

0.50

604

Erectile dysfunction

327

2972

1.11

1.05

4.9

4.4

7.86

26.87

ug/l

2.90

268

2537

Other specified/unspecified systemic involvement of connective tissue

211

1870

1.14

1.05

3.0

4.1

3.07

23.61

ug/l

3.46

160

1492

Benign paroxysmal vertigo

1285

12252

1.05

3.4

4.0

15.52

25.15

ug/l

1.11

994

9965

Benign neoplasm: Heart

124

1.63

1.05

2.3

4.2

3.66

40.41

ug/l

0.58

107

Spinal instabilities

104

874

1.21

1.04

3.0

4.4

7.37

21.70

ug/l

1.20

692

Melanocytic naevi of ear and external auricular canal

156

1.54

1.04

3.4

4.7

3.11

36.16

ug/l

0.66

130

Hereditary deficiency of other clotting factors

214

1.44

1.04

3.3

4.1

2.40

8.48

ug/l

1.72

168

Intercostal neuropathy

249

1.42

1.04

3.0

4.3

3.13

52.61

ug/l

0.90

205

Malignant neoplasm of tongue

639

1.25

1.04

3.7

4.5

5.01

31.09

ug/l

1.33

543

Cardiomyopathy, other and unspecified

311

2820

1.11

1.04

2.8

4.5

7.67

24.05

ug/l

2.39

253

2326

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

459

1.30

1.03

2.7

4.5

2.79

38.85

ug/l

1.25

368

Abnormal spermatozoa

486

4499

1.09

1.03

4.2

4.4

10.02

27.24

ug/l

3.05

403

3842

Pure hyperglyceridaemia

638

1.25

1.03

3.5

4.5

5.73

32.44

ug/l

1.32

533

Sulfonylureas

1796

13765

1.05

1.03

3.4

4.0

35.41

23.88

ug/l

0.62

1523

11459

Other specified/unspecified spondylopathies

106

895

1.21

1.03

2.8

4.3

3.09

24.25

ug/l

1.55

732

Hypotension due to drugs

433

1.31

1.03

4.0

4.1

3.59

42.17

ug/l

1.33

363

Etanercept

145

1674

0.86

1.03

2.8

4.2

54.67

18.03

ug/l

0.53

108

1318

Other specific arthropathies, wide

684

1.24

1.03

2.8

4.5

2.85

29.39

ug/l

1.50

565

Congenital malformations of trachea and bronchus

284

1.38

1.03

3.1

4.1

5.43

23.91

ug/l

0.66

236

Injury of muscle and tendon at hip and thigh level

274

3037

0.89

1.02

4.6

4.2

17.34

25.93

ug/l

0.34

216

2447

Other congenital malformations of tongue, mouth and pharynx

130

1.55

1.02

3.9

2.61

4.85

ug/l

0.71

Spinal osteochondrosis

275

1.38

1.01

2.4

5.3

4.47

24.54

ug/l

0.69

222

Oral lichen ruber planus, hypothyreosis or thyroxin

533

1.27

1.01

2.9

4.0

3.03

8.77

ug/l

3.04

432

Meningitis, viral

1.70

1.01

5.4

3.7

2.23

76.75

ug/l

—

Benign neoplasm of thyroid gland

126

1081

1.18

1.01

4.4

3.9

14.01

19.42

ug/l

0.24

878

Benign neoplasm: Nasopharynx

285

1.38

1.01

3.5

4.3

3.23

47.73

ug/l

0.96

237

Depression

4352

29189

1.03

1.00

3.4

4.1

23.77

24.62

ug/l

0.06

3446

23078

Oral lichen ruber planus

797

1.22

1.00

3.1

4.2

3.67

15.28

ug/l

1.39

646

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

573

4001

0.93

1.00

3.4

3.3

14.41

18.17

ug/l

0.10

351

2624

Sequelae of malnutrition and other nutritional deficiencies

1.90

1.00

2.1

4.7

10.55

75.95

ug/l

—

Ankylosing spondylitis, strict definition

119

1015

1.18

1.00

3.1

4.6

209.85

19.96

ug/l

0.68

808

Chronic Coagulation defects

577

1.25

0.99

2.8

4.2

3.00

39.16

ug/l

1.51

466

Idiopathic thrombocytopenic purpura

100

842

1.21

0.99

4.0

4.3

20.85

26.13

ug/l

0.14

699

Arthropathies

4277

21192

1.03

0.99

3.6

4.2

13.97

29.08

ug/l

3.51

3338

16830

Specific development disorders of scholastic skills

357

1.31

0.99

2.4

4.1

235.86

4.90

ug/l

0.49

243

Dermatophytosis

489

4536

1.09

0.98

3.4

4.2

19.81

19.55

ug/l

0.01

396

3738

Papilloedema, unspecified

533

1.26

0.98

4.6

4.4

148.56

36.23

ug/l

0.37

436

Suppurative and unspecified otitis media

908

8510

0.94

0.98

3.5

4.0

11.83

24.06

ug/l

1.42

660

6505

Other neurotic disorders

182

1607

1.15

0.98

2.9

4.2

17.40

19.86

ug/l

0.07

147

1327

Mixed hyperlipidaemia

148

1289

1.16

0.98

3.5

4.2

123.85

31.10

ug/l

0.57

121

1078

Hallux valgus (acquired)

1755

12207

1.04

0.97

3.5

4.1

13.99

29.36

ug/l

2.48

1376

9808

Autoimmune thyroiditis

453

1.28

0.97

3.6

4.0

44.86

17.98

ug/l

0.38

368

Other and unspecified primary disorders of muscles

192

1.45

0.97

1.7

4.4

31.58

28.73

ug/l

0.03

151

Other specified/unspecified dorsopathies

130

1122

1.17

0.97

2.7

4.4

4.22

28.36

ug/l

2.03

101

899

Other epidermal thickening

153

1337

1.16

0.96

3.5

4.2

8.96

19.95

ug/l

0.89

124

1096

Anogenital herpesviral [herpes simplex] infection

141

1222

1.16

0.96

3.8

4.2

5.61

47.16

ug/l

0.81

109

913

Pedestrian injured in collision with car, pick-up truck or van

680

1.23

0.96

3.1

4.2

26.63

27.51

ug/l

0.01

572

Other disorders of peripheral nervous system

219

1.43

0.96

4.4

4.5

30.95

27.46

ug/l

0.04

178

Sexual assault by bodily force

1.96

0.96

3.3

4.7

23.77

8.77

ug/l

—

Other superficial mycoses

490

1.27

0.96

3.2

4.4

2.80

21.11

ug/l

1.13

403

Burn and corrosion of shoulder and upper limb, except wrist and hand

521

0.76

0.96

3.2

4.6

2.53

36.37

ug/l

1.39

426

Perineal laceration during delivery

279

2748

0.90

0.95

3.1

3.5

9.21

27.43

ug/l

0.64

189

1860

Benign neoplasm: Skin of lip

429

1.29

0.95

3.3

4.0

3.62

37.68

ug/l

1.14

356

Sudden idiopathic hearing loss

404

3727

1.09

0.95

3.7

4.1

6.21

23.12

ug/l

4.39

324

3047

Loose body in joint

709

0.79

0.95

4.0

4.6

8.53

26.34

ug/l

0.94

605

Other/unspecified enthesopathies of lower limb, excluding foot

247

2225

1.12

0.95

3.5

4.4

36.53

18.53

ug/l

0.25

197

1765

Acquired coagulation factor deficiency

1.95

0.95

8.6

5.1

3.81

11.79

ug/l

—

Other and unspecified injuries of wrist and hand

107

910

1.19

0.94

3.8

4.4

3.40

23.57

ug/l

1.46

731

Disorder of thyroid, unspecified

412

1.30

0.94

3.2

3.8

58.49

19.15

ug/l

0.31

343

Dislocation, sprain and strain of joints and ligaments at neck level

431

3983

1.09

0.94

3.5

4.1

5.70

29.66

ug/l

1.94

334

3103

Deforming dorsopathies

1182

11281

1.05

0.94

3.0

4.3

9.83

26.91

ug/l

2.97

940

9050

Deviated nasal septum

1303

13608

0.95

0.94

3.4

4.4

15.85

27.14

ug/l

1.30

1031

11138

Anterior Iridocyclitis

777

7335

1.06

0.94

3.6

4.1

79.09

26.55

ug/l

1.01

620

5909

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

357

1.31

0.94

3.9

4.0

2.78

109.25

ug/l

0.54

258

Artrosis, including avohilmo

4351

23279

1.03

0.93

3.6

4.2

17.94

28.46

ug/l

1.76

3475

18708

Maltreatment syndromes

105

891

1.19

0.93

3.7

4.5

8.97

22.36

ug/l

0.91

676

Brain meningioma

159

1804

0.87

0.93

3.5

4.1

27.26

21.27

ug/l

0.10

129

1485

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

103

1.64

0.93

2.4

5.2

29.83

48.62

ug/l

—

Infective bursitis

106

904

1.19

0.93

3.2

4.6

5.90

27.89

ug/l

1.53

749

Puerperal sepsis

454

4890

0.92

0.93

3.8

65.02

26.13

ug/l

0.65

350

3808

Transient ischemic attack

2644

21247

1.03

0.92

3.4

4.0

22.07

25.02

ug/l

0.20

2168

17522

Mental disorders, not otherwise specified

226

2028

1.12

0.92

3.3

4.1

38.68

34.72

ug/l

0.04

173

1566

Arthropathy in Crohn disease

263

1.37

0.92

3.8

4.5

3.37

25.30

ug/l

0.72

210

Panniculitis, unspecified

325

1.33

0.91

4.1

4.2

3.27

42.70

ug/l

0.95

266

Other congenital malformations of kidney

1.65

0.91

2.3

4.7

4.53

5.65

ug/l

—

Autoimmune hyperthyroidism

222

1994

1.12

0.91

3.3

4.0

10.37

22.42

ug/l

1.11

170

1565

Maternal care for known or suspected fetal abnormality and damage

352

2871

1.09

0.91

3.6

3.5

8.02

21.48

ug/l

0.49

209

1935

Other bacterial agents as the cause of diseases classified to other chapters

299

1.34

0.91

3.4

3.8

68.58

42.77

ug/l

0.15

251

Other osteochondrodysplasias

186

1.43

0.90

4.0

4.8

5.21

6.63

ug/l

0.18

149

Secondary polycythaemia

695

1.22

0.90

4.0

4.5

4.69

26.66

ug/l

1.18

586

Chronic nephritic syndrome

140

1223

1.16

0.90

3.0

4.3

11.65

21.25

ug/l

0.47

113

1006

Other and unspecified disorders of vitreous body

1987

19095

1.04

0.90

3.6

4.1

14.91

24.24

ug/l

1.47

1576

15568

Postpartum care and examination

236

1675

0.90

3.2

3.1

7.41

10.18

ug/l

0.33

170

1125

Supervision of high-risk pregnancy

549

3094

1.08

0.90

3.8

3.4

17.27

14.66

ug/l

0.09

386

2196

Torticollis

351

1.30

0.90

3.4

5.1

2.52

19.08

ug/l

0.72

278

Autonomic disorders

659

1.22

0.90

3.1

4.4

2.92

25.30

ug/l

1.18

545

Female infertility, tubal origin

156

1372

1.15

0.90

3.4

4.1

3.55

46.98

ug/l

0.96

112

1025

Right side

214

1.42

0.89

2.7

4.8

27.82

26.77

ug/l

0.01

185

Benign neoplasm: Orbit, unspecified

179

1.45

0.89

3.7

3.9

2.34

44.07

ug/l

0.58

150

Occupational exposure to risk-factors

118

1020

1.17

0.89

3.3

4.4

50.25

26.12

ug/l

0.35

101

844

Xerosis cutis

470

1.26

0.88

3.8

4.2

5.50

32.91

ug/l

1.01

404

Benign neoplasm of meninges

418

3878

1.09

0.88

3.6

3.9

14.99

22.05

ug/l

0.34

333

3131

Use of teriflunomide

192

0.61

0.88

2.8

4.0

1.90

5.61

ug/l

1.64

143

Vitreous haemorrhage

378

3492

1.09

0.88

3.5

4.1

11.62

22.67

ug/l

1.48

317

2858

Acute and subacute iridocyclitis

731

6906

1.06

0.88

3.6

4.2

81.66

27.33

ug/l

0.98

584

5564

Melanocytic naevi of scalp and neck

587

1.23

0.87

4.1

4.3

2.93

20.84

ug/l

1.42

482

Other noninflammatory disorders of cervix uteri

214

1927

1.12

0.87

3.5

4.1

16.87

27.77

ug/l

0.39

160

1553

Dyshidrosis [pompholyx]

380

1.29

0.87

3.0

4.4

3.75

33.21

ug/l

0.90

313

Congenital malformations of the respiratory system

443

1.27

0.87

2.9

4.2

11.81

17.80

ug/l

0.21

367

Benign neoplasm: Connective and other soft tissue of pelvis

1.79

0.87

1.5

4.6

2.43

12.29

ug/l

—

Psoriatic and enteropathic arthropathies

453

4216

1.08

0.87

3.3

4.4

11.26

21.49

ug/l

1.21

362

3404

Placenta praevia

105

899

1.18

0.86

3.6

3.7

28.92

48.64

ug/l

0.18

640

Iron deficiency

335

1.30

0.86

3.3

4.0

3.98

30.66

ug/l

0.61

244

Other and unspecified disorders of pigmentation

197

1.41

0.86

5.0

4.2

30.40

43.74

ug/l

0.13

161

Congenital malformations of uterus and cervix

344

1.30

0.86

2.0

3.7

3.57

21.92

ug/l

0.68

249

Cholesteatoma of middle ear

160

1804

0.88

0.86

3.9

4.1

5.75

20.66

ug/l

2.28

133

1510

Pedestrian injured in other and unspecified transport accidents

346

1.30

0.86

3.2

4.2

3.07

39.76

ug/l

0.96

289

HSIL lesion of the cervix uteri, vagina or vulva

556

5210

1.07

0.86

3.3

3.6

5.91

26.26

ug/l

1.73

412

3774

Irregular menses

1724

13478

1.04

0.85

3.2

3.8

21.14

21.49

ug/l

0.01

1280

10068

Other and unspecified injuries of ankle and foot

109

938

1.17

0.85

3.7

4.3

5.84

25.61

ug/l

1.36

757

Dermatitis due to ingested food

287

0.70

0.85

3.2

3.6

3.79

4.91

ug/l

0.29

193

Other noninflammatory disorders of vulva and perineum

309

2833

1.10

0.85

3.5

4.1

5.92

37.03

ug/l

1.51

224

2209

Pollen allergy

363

3891

0.92

0.85

3.2

4.0

4.81

28.07

ug/l

1.68

258

2884

Exposure to other and unspecified inanimate mechanical forces

195

1747

1.13

0.84

4.4

4.2

24.65

21.84

ug/l

0.06

155

1410

Traumatic amputation of forearm

0.00

0.84

0.0

4.4

—

14.65

—

Bullous disorders

211

1902

1.12

0.84

3.6

4.1

5.28

22.26

ug/l

2.37

168

1572

Benign neoplasm: Central nervous system, other parts/unspecified

1.79

0.84

2.8

1.5

2.27

8.09

ug/l

—

Acute poliomyelitis

428

1.27

0.84

4.8

4.2

27.90

23.84

ug/l

0.07

360

Use of cabergoline

295

0.70

0.84

3.2

4.8

2.01

30.24

ug/l

1.04

246

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

143

1256

1.15

0.84

2.3

4.6

7.89

24.12

ug/l

1.10

120

976

Maternal care for other conditions predominantly related to pregnancy

494

5215

0.93

0.84

4.1

3.6

6.18

21.61

ug/l

1.29

338

3669

Corns and callosities

259

2360

1.11

0.84

2.8

4.2

5.39

20.31

ug/l

2.83

215

1932

Bus occupant injured in other and unspecified transport accidents

190

1.41

0.83

2.5

4.3

2.64

8.93

ug/l

1.76

151

Other forms of systemic lupus erythematosus

233

1.37

0.83

3.5

4.0

6.38

6.82

ug/l

0.05

191

Preterm labour and delivery

867

9113

0.95

0.83

3.7

3.8

11.14

23.67

ug/l

1.38

651

6893

Malignant neoplasm of eye, brain and central nervous system

141

1241

1.15

0.83

2.5

4.3

3.05

24.06

ug/l

2.37

102

1025

Pemphigus erythematosus

0.00

0.83

0.0

4.8

—

16.68

—

Vasculitis limited to skin, not elsewhere classified

823

1.19

0.82

3.8

4.2

86.31

28.93

ug/l

0.51

679

Methotrexate

527

5617

0.93

0.82

2.9

4.1

23.99

29.46

ug/l

0.20

421

4447

Other benign neoplasm of uterus: Cervix uteri

182

1.42

0.82

2.1

4.0

5.12

7.69

ug/l

0.30

148

Contact with blunt object, undetermined intent

148

0.59

0.82

2.9

4.2

3.32

39.19

ug/l

—

120

Hyperaldosteronism

105

907

1.18

0.82

3.5

4.3

11.17

29.12

ug/l

1.02

763

Acne

161

1426

1.13

0.82

3.8

4.1

6.16

41.87

ug/l

0.76

125

1013

Chloasma

140

1.49

0.82

2.8

3.9

3.13

10.29

ug/l

1.29

109

Other and unspecified disease of Bartholin gland

107

926

1.17

0.81

3.0

4.0

3.19

11.72

ug/l

3.67

737

Anorexia

339

1.29

0.81

3.7

3.9

31.05

21.88

ug/l

0.19

271

Postpartum hemorraghe, all women as controls

567

6006

0.94

0.81

3.3

3.5

18.61

20.50

ug/l

0.06

383

4245

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

153

1722

0.88

0.81

4.0

3.9

12.02

29.81

ug/l

0.65

122

1356

Ischemic heart diseases

4094

25051

1.03

0.81

3.5

4.3

22.85

27.70

ug/l

0.37

3328

20454

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

740

1.19

0.81

2.9

4.5

40.56

29.85

ug/l

0.14

612

Extreme obesity with alveolar hypoventilation

148

1311

1.14

0.81

2.8

4.2

38.22

22.30

ug/l

0.26

119

1074

Injury of eye and orbit

439

4092

1.08

0.81

4.0

4.4

12.14

36.72

ug/l

1.66

350

3291

Post-traumatic stress disorder

163

1448

1.13

0.81

3.0

4.0

69.06

37.86

ug/l

0.20

113

1045

Use of interferon beta-1a

463

0.77

0.81

2.9

4.3

4.65

17.69

ug/l

0.68

358

Need for immunization against other single viral diseases

539

1.23

0.80

4.7

4.6

4.38

19.09

ug/l

0.95

446

Defects in the complement system

174

1.42

0.80

2.8

3.6

18.27

8.25

ug/l

0.27

138

Other congenital malformations of skin

111

963

1.16

0.80

3.6

4.3

13.47

13.41

ug/l

0.00

780

Congenital musculoskeletal deformities of head, face, spine and chest

199

1.38

0.80

4.9

4.7

3.01

63.63

ug/l

0.83

157

Contact with heat and hot substances

117

1340

0.87

0.80

4.5

4.2

4.23

23.49

ug/l

2.21

103

1088

Retinal breaks without detachment

675

6390

1.06

0.80

3.7

4.2

20.53

22.29

ug/l

0.07

527

5233

Other disorders involving the immune mechanism, not elsewhere classified

806

1.18

0.80

3.1

4.5

37.77

27.94

ug/l

0.14

669

Brain glioblastoma

415

0.75

0.80

2.2

4.3

3.67

38.87

ug/l

1.11

349

Transient global amnesia

355

3826

0.92

0.80

3.9

4.1

9.83

28.10

ug/l

2.56

294

3137

Calcification and ossification of muscle

1.69

0.79

1.2

4.9

1.92

102.72

ug/l

—

Benign neoplasm: Rectum/anal canal icd-9

288

1.32

0.79

3.5

4.0

9.41

35.85

ug/l

0.57

246

Other retinal disorders in diseases classified elsewhere

1.80

0.79

2.3

3.9

3.14

79.84

ug/l

—

Failed attempted abortion

165

1.41

0.79

2.4

3.4

1.98

3.80

ug/l

1.01

116

Other, unspecified and serous retinal detachments

113

985

1.16

0.79

4.2

4.1

15.25

15.95

ug/l

0.03

816

Melanocytic naevi of lip

262

1.33

0.79

3.4

3.9

2.21

50.42

ug/l

0.93

214

Adhesive capsulitis of shoulder

752

7142

1.06

0.79

3.2

4.3

16.81

24.05

ug/l

0.28

616

5777

Injury of blood vessels at abdomen, lower back and pelvis level

116

1.53

0.78

2.4

4.6

143.58

65.57

ug/l

0.25

100

Thyroiditis

247

2254

1.11

0.78

3.2

4.0

15.04

24.82

ug/l

0.48

190

1780

Type 1 diabetes, strict definition, subgroup 1

985

0.85

0.78

3.7

4.3

8.62

43.31

ug/l

0.45

691

Medical treatment for female infertility

487

4549

1.07

0.78

3.2

3.5

4.45

22.67

ug/l

1.35

321

3125

Malignant neoplasm of oropharynx

533

1.23

0.78

3.3

4.5

32.97

38.06

ug/l

0.06

442

Autism spe, excluding more controls

165

1.40

0.78

2.3

4.9

2.92

5.68

ug/l

0.56

123

Necrotizing fasciitis

133

1.49

0.78

4.1

4.8

64.19

61.41

ug/l

0.01

109

Cardiomyopathy, Hypertrophic obstructive

613

0.80

0.78

3.1

4.7

4.04

27.09

ug/l

1.25

513

Systemic sclerosis,strict definition

289

0.71

0.78

2.1

4.1

3.44

7.64

ug/l

1.39

239

Vascular dementia (undefined)

100

1144

0.86

0.78

2.2

3.3

28.68

28.59

ug/l

0.00

980

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

297

1.30

0.78

3.1

4.4

2.62

21.83

ug/l

0.71

237

Polyarthrosis

988

9061

1.05

0.77

3.2

4.2

6.12

26.58

ug/l

7.78

816

7420

Otitis media, unspecified

198

2020

0.90

0.77

3.2

4.1

13.33

36.95

ug/l

0.68

140

1564

Combined immunodeficiencies

334

1.29

0.77

4.3

3.8

3.49

40.08

ug/l

0.95

287

Ankylosis of teeth

2.19

0.77

2.6

4.1

3.38

2.17

ug/l

—

Other disorders of male genital organs

102

883

1.17

0.77

5.1

4.8

3.99

27.77

ug/l

2.01

751

Other obstetric conditions, not elsewhere classified

608

4189

0.94

0.76

3.4

3.3

13.56

18.42

ug/l

0.14

379

2776

Other osteochondropathies

217

1970

1.11

0.76

3.9

4.3

42.53

17.55

ug/l

0.37

181

1585

Benign neoplasm: Cerebral meninges

378

3520

1.08

0.76

3.6

3.9

15.14

23.41

ug/l

0.37

303

2838

Other specified/unspecified soft tissue disorders

192

1734

1.12

0.76

2.9

4.1

4.64

20.48

ug/l

2.32

160

1395

Malignant neoplasm of tonsil

480

1.24

0.76

3.4

4.6

35.36

27.81

ug/l

0.10

398

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

467

0.77

0.76

3.6

4.4

3.13

36.82

ug/l

1.30

404

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

261

2388

1.10

0.76

3.4

4.0

7.32

23.51

ug/l

2.22

220

1980

Emotional disorders starting during childhood or adolescence

345

0.74

0.76

3.8

2.97

5.09

ug/l

0.61

229

Evidence of alcohol involvement determined by blood alcohol level

352

1.27

0.76

2.1

5.2

3.50

44.24

ug/l

1.10

298

Other conjunctival vascular disorders and cysts

784

1.18

0.76

3.9

4.1

9.84

32.51

ug/l

1.18

647

Acute sinusitis

2021

18263

1.03

0.76

3.6

4.0

27.75

23.40

ug/l

0.19

1553

14304

Amyloidosis, other/unspecified

544

1.22

0.75

2.5

4.3

3.14

37.74

ug/l

1.56

457

Other congenital malformations of respiratory system

1.90

0.75

2.9

3.6

50.07

14.48

ug/l

—

Tic disorders

141

1.44

0.75

3.7

4.4

7.40

6.06

ug/l

0.09

110

Glaucoma secondary to other eye disorders

146

1299

1.14

0.75

3.0

4.0

25.15

23.30

ug/l

0.05

115

1081

Acne vulgaris

116

1013

1.15

0.75

3.7

4.2

7.20

51.34

ug/l

0.63

716

Disorders of iron metabolism

398

1.26

0.75

2.6

4.8

3.14

33.54

ug/l

0.88

327

Behçet disease

1.65

0.75

1.4

4.4

2.40

7.77

ug/l

—

Bell's palsy

438

4100

1.07

0.75

3.4

4.1

11.70

24.78

ug/l

1.28

364

3299

Certain zoonotic bacterial diseases

544

1.22

0.75

3.3

4.4

10.65

33.93

ug/l

0.79

463

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

2.13

0.75

1.4

6.5

1.92

10.71

ug/l

—

Myeloproliferative diseases

331

3069

1.09

0.75

3.0

4.0

13.89

22.59

ug/l

0.49

253

2522

Assault by blunt object

272

1.31

0.75

4.5

5.0

5.27

31.10

ug/l

0.80

225

Benign neoplasm: Skin of lower limb, including hip

859

1.17

0.75

4.3

3.9

14.01

25.09

ug/l

0.41

708

Injuries involving multiple body regions

106

923

1.16

0.74

2.6

4.3

3.68

21.65

ug/l

1.30

758

Other chondrocalcinosis

418

1.25

0.74

2.2

4.3

4.07

35.10

ug/l

1.03

359

Other degenerative diseases of the basal ganglia

564

0.80

0.74

2.7

4.6

2.68

35.67

ug/l

1.62

485

Exophthalmic conditions

336

1.28

0.74

5.0

3.8

282.44

39.09

ug/l

0.42

283

Other hypertrichosis

1.68

0.74

1.7

4.0

1.82

6.68

ug/l

—

Unspecified chronic bronchitis

136

1206

1.14

0.74

3.7

4.0

6.45

23.01

ug/l

1.45

110

987

Antepartum haemorrhage, not elsewhere classified

164

1829

0.89

0.74

2.6

3.4

7.85

27.57

ug/l

0.46

108

1261

Polyglandular dysfunction, other/unspecified

2.07

0.74

2.0

5.0

2.86

9.11

ug/l

—

Disturbances of smell and taste

159

1425

1.13

0.74

3.8

4.3

11.91

22.74

ug/l

0.64

136

1178

Cholesteatoma of external ear

239

1.34

0.74

3.9

4.6

3.73

61.77

ug/l

1.06

204

Complications following myocardial infarction

263

0.70

0.73

2.1

4.6

9.73

61.71

ug/l

0.98

219

Congenital deformities of hip

290

1.29

0.73

5.6

3.8

2.72

7.01

ug/l

1.59

225

Seronegative rheumatoid arthritis

460

4897

0.93

0.73

3.2

4.1

13.78

26.81

ug/l

1.52

377

3985

Cerebral aneurysm, nonruptured

288

3118

0.92

0.73

3.5

4.0

18.05

24.99

ug/l

0.35

247

2489

Pedal cyclist injured in noncollision transport accidents

346

3214

1.08

0.73

3.7

4.2

4.23

18.32

ug/l

4.05

281

2576

Malignant neoplasm of vulva

329

1.28

0.72

3.8

3.6

6.03

6.05

ug/l

0.00

276

Mood disorders

4783

30794

1.02

0.72

3.4

4.1

22.77

24.07

ug/l

0.11

3797

24458

Benign neoplasm: Parathyroid gland

365

1.27

0.72

3.7

4.3

6.37

18.73

ug/l

0.54

304

Retinal detachment with retinal break

531

5012

1.07

0.72

4.0

4.2

39.12

20.91

ug/l

0.75

420

4149

Mental retardation, excluding more controls

744

1.17

0.72

2.4

4.7

111.17

17.42

ug/l

0.51

581

Acquired absence of limb

284

1.30

0.72

3.3

4.6

31.28

33.88

ug/l

0.03

238

Other disorders of optic [2nd] nerve and visual pathways

199

1808

1.11

0.71

3.9

4.2

53.34

19.34

ug/l

0.32

152

1466

Sleep disorders, other/unspecified

675

1.18

0.71

2.7

4.2

3.88

24.60

ug/l

0.98

520

Mood [affective] disorders

4768

30749

1.02

0.71

3.4

4.1

22.81

24.10

ug/l

0.11

3786

24416

Iliotibial band syndrome

320

1.28

0.71

3.4

4.6

2.83

9.01

ug/l

2.39

251

Dental pulpitis 3, only avohilmo

463

1.19

0.71

2.4

3.2

1.78

2.22

ug/l

0.76

236

Acute upper respiratory infections

5087

31265

1.02

0.71

3.8

4.0

23.41

23.72

ug/l

0.02

3969

25022

Amyloidosis

650

1.19

0.70

2.8

4.2

3.24

32.91

ug/l

1.62

546

Other and unspecified nonorganic psychotic disorders

475

5049

0.94

0.70

3.1

4.2

23.96

24.14

ug/l

0.00

372

3911

Other prurigo

348

1.26

0.70

3.3

4.2

8.72

47.63

ug/l

0.98

294

Dental pulpitis 3

517

1.17

0.70

2.4

3.3

1.75

2.74

ug/l

1.47

277

Effects of heat and light

179

1.37

0.70

3.9

4.4

9.53

68.42

ug/l

0.73

150

Abnormal findings on antenatal screening of mother

105

1199

0.87

0.70

2.8

3.4

4.03

41.70

ug/l

0.57

761

Superficial injuries involving multiple body regions

631

1.19

0.69

2.4

4.3

3.98

28.06

ug/l

1.17

528

Rapidly progressive nephritic syndrome

1.66

0.69

6.9

4.4

3.39

7.30

ug/l

0.79

Other and unspecified vasculitis limited to skin

744

1.17

0.69

3.9

4.2

92.29

30.57

ug/l

0.51

619

Problems related to social environment

705

1.18

0.69

2.4

3.9

5.87

29.83

ug/l

1.29

582

Burn and corrosion of ankle and foot

362

0.76

0.69

3.2

4.8

17.62

25.97

ug/l

0.20

303

Iridocyclitis in diseases classified elsewhere

503

1.21

0.69

3.8

4.4

4.29

36.70

ug/l

1.27

416

Mild mental retardation

502

1.21

0.69

2.4

4.5

160.87

22.21

ug/l

0.51

403

Mature T/NK-cell lymphomas, hilmo

440

1.23

0.69

2.1

4.4

3.75

35.71

ug/l

1.13

376

Dronedarone medication

127

1131

1.14

0.68

3.8

4.5

10.63

29.77

ug/l

1.12

104

945

Benign lipomatous neoplasm of spermatic cord

1.69

0.68

2.4

4.7

3.43

7.86

ug/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

444

4172

1.07

0.68

3.9

12.53

26.71

ug/l

0.79

333

3090

Thromboangiitis obliterans

129

1.46

0.67

2.1

4.9

3.01

44.05

ug/l

0.71

111

Amenorrhoea

146

1307

1.12

0.67

2.8

3.9

4.76

48.16

ug/l

0.86

105

948

Hypertension, Pulmonary Arterial

260

1.30

0.67

2.1

4.2

38.27

43.02

ug/l

0.05

214

Iliac crest spur

1.88

0.67

3.2

5.0

2.48

7.90

ug/l

—

Other benign neoplasms of connective and other soft tissue

359

3355

1.08

0.67

3.9

4.0

38.78

23.20

ug/l

0.27

290

2701

Postdysenteric arthropathy

242

1.31

0.67

3.7

4.2

79.81

25.23

ug/l

0.30

201

Other corneal oedema

261

1.30

0.67

2.8

4.0

3.15

49.12

ug/l

0.92

223

Abnormality of red blood cells

155

1.40

0.66

2.5

4.3

3.22

38.84

ug/l

0.71

128

Dependence on enabling machines and devices, not elsewhere classified

291

0.74

0.66

2.0

4.5

126.95

31.94

ug/l

0.35

247

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2237

18744

0.97

0.66

3.7

3.9

13.70

23.19

ug/l

1.27

1689

14553

Distal bite

469

0.80

0.66

2.4

3.9

4.01

16.56

ug/l

0.65

341

Personality and behavioural disorders due to brain disease, damage and dysfunction

458

0.79

0.66

3.2

4.4

3.45

40.91

ug/l

1.37

382

Congenital malformations of heart and great arteries

361

3266

1.07

0.66

3.3

4.2

53.01

22.02

ug/l

0.48

283

2596

Asymptomatic human immunodeficiency virus [HIV] infection status

129

0.61

0.66

5.6

6.2

2.10

39.96

ug/l

—

109

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

297

1.28

0.66

3.7

4.3

36.03

43.51

ug/l

0.07

248

Sicca syndrome [Sjögren]

345

3224

1.08

0.66

2.8

4.0

11.40

23.29

ug/l

0.80

273

2562

Striking against or struck by other objects

1039

9985

1.04

0.66

3.6

4.2

7.57

27.54

ug/l

4.57

808

7986

Reiter disease

164

1.38

0.65

3.0

5.0

7.15

32.60

ug/l

0.49

136

Microscopic polyangiitis

200

1.35

0.65

1.9

4.8

2.19

27.37

ug/l

0.64

168

Viral infections of the central nervous system

223

2048

1.10

0.65

3.8

4.1

12.54

21.30

ug/l

0.67

171

1651

Ectopic pregnancy

636

6053

1.06

0.65

3.6

3.8

19.85

21.12

ug/l

0.04

471

4530

Symptoms and signs involving the nervous and musculoskeletal systems

2423

24827

0.97

0.65

2.9

4.0

9.78

24.13

ug/l

7.26

1904

20022

Rheumatic valve diseases

729

0.84

0.65

3.6

4.0

9.14

28.99

ug/l

0.97

626

Family history of other conditions

225

1.31

0.65

3.8

4.2

2.97

25.26

ug/l

0.58

175

Other early complications of trauma

0.00

0.64

0.0

6.6

—

6.33

—

Sequelae of tuberculosis

609

1.18

0.64

3.2

3.7

78.68

28.11

ug/l

0.45

521

Pedestrian injured in collision with pedal cycle

103

908

1.15

0.64

2.8

4.2

6.24

23.84

ug/l

1.18

753

Onycholysis

191

1.35

0.64

2.8

4.3

23.25

43.08

ug/l

0.20

156

Tinnitus

986

9485

1.04

0.64

3.5

4.2

10.68

25.35

ug/l

3.13

764

7709

Juvenile osteochondrosis

636

1.17

0.64

2.8

4.2

4.68

14.94

ug/l

0.82

504

Disorders of olfactory nerve

1.77

0.64

5.2

3.4

35.22

158.25

ug/l

—

Coalworker pneumoconiosis

0.00

0.63

0.0

5.2

—

12.60

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

1.75

0.63

5.6

3.5

1.50

2.83

ug/l

—

Contact with other hot fluids

685

0.84

0.63

5.3

4.5

4.57

27.10

ug/l

1.14

557

Other disorders of patella

649

6185

1.05

0.63

3.8

4.3

13.09

35.08

ug/l

1.62

505

4862

Burns and corrosions of multiple and unspecified body regions

554

0.82

0.62

3.9

4.5

20.63

24.86

ug/l

0.09

457

Ehlers-Danlos syndrome

156

1.37

0.62

3.8

4.3

2.46

8.29

ug/l

1.20

119

Galactorrhea

200

1.32

0.62

3.8

4.0

18.85

7.44

ug/l

0.32

153

Blood alcohol or alcohol intoxication level

536

1.19

0.62

2.5

5.0

7.30

34.45

ug/l

1.03

441

Lyme disease

1051

10130

1.04

0.62

3.7

4.1

16.07

25.31

ug/l

0.44

806

8196

Allergic colitis

199

1.31

0.62

4.3

3.7

3.55

8.35

ug/l

0.95

143

Cyst of Bartholin Gland

116

1033

1.13

0.62

3.3

3.9

9.29

12.24

ug/l

0.24

792

Contact with machinery

372

3493

1.07

0.62

4.3

4.6

33.24

25.79

ug/l

0.14

309

2941

Profound mental retardation

0.00

0.62

0.0

3.9

—

11.21

—

Fracture of neck

201

1844

1.10

0.62

3.3

4.1

40.30

23.42

ug/l

0.35

176

1529

Anisometropia and aniseikonia

100

883

1.14

0.62

3.6

4.1

96.53

25.16

ug/l

0.38

729

Chorioretinal inflammation

827

1.15

0.61

3.2

4.3

54.57

21.67

ug/l

0.64

673

Chondromalacia

827

1.15

0.61

3.1

4.5

58.50

16.91

ug/l

0.49

669

Other spirochaetal diseases

1060

10222

1.04

0.61

3.7

4.1

16.03

25.88

ug/l

0.49

813

8274

Congenital malformations of anterior segment of eye

210

1.31

0.61

4.7

4.5

2.44

27.36

ug/l

0.68

176

Lesion of plantar nerve

222

2403

0.92

0.61

3.4

4.1

31.24

21.05

ug/l

0.16

183

1915

Tularaemia

373

1.23

0.61

2.8

4.6

4.03

42.89

ug/l

1.12

318

Other benign neoplasms of uterus

236

2186

1.09

0.60

3.2

3.7

4.67

12.59

ug/l

4.41

185

1785

Tooth agenesis EXCLUDE clefts and syndromes

426

1.20

0.60

3.9

4.1

7.48

19.33

ug/l

0.47

309

Fitting and adjustment of external prosthetic device

1.55

0.60

3.6

3.9

7.58

4.26

ug/l

—

Other peripheral vascular diseases

284

2646

1.08

0.60

3.1

4.1

7.49

18.55

ug/l

1.95

239

2130

Embolic stroke

153

1682

0.90

0.60

3.2

4.0

16.31

28.86

ug/l

0.59

126

1407

Disorders of psychological development

178

1503

1.10

0.60

3.3

4.1

56.16

20.68

ug/l

0.31

126

1107

Focal epilepsy

758

7259

1.05

0.60

3.9

4.1

13.78

28.14

ug/l

1.47

617

5864

Miliary tuberculosis

1.55

0.60

1.5

3.4

2.40

6.25

ug/l

—

Alopecia areata

669

1.16

0.60

3.0

4.2

4.16

16.35

ug/l

1.12

530

Viral infections of central nervous system, not elsewhere classified/unspecified

309

0.76

0.60

4.7

4.6

3.71

30.79

ug/l

0.65

253

Ototoxic hearing loss

1.55

0.60

2.3

4.4

8.24

14.74

ug/l

—

Haemophilus septicemia

1.55

0.60

2.4

4.5

3.18

24.33

ug/l

—

Glaucoma, exfoliation

479

4542

1.06

0.59

3.7

34.08

26.84

ug/l

0.13

408

3740

Neovascular glaucoma

142

1285

1.12

0.59

3.0

4.1

25.51

22.35

ug/l

0.08

113

1077

Injury of nerves and spinal cord at thorax level

150

1.37

0.59

2.4

5.6

3.10

34.43

ug/l

—

124

Traumatic amputation of part of head

1.74

0.59

4.0

3.4

7.12

146.74

ug/l

—

Toxic effect of carbon monoxide

485

1.19

0.58

2.5

4.5

13.91

35.45

ug/l

0.58

407

Mental and behavioural disorders due to cannabinoids

343

0.78

0.58

2.2

5.2

3.03

10.08

ug/l

0.87

263

Other infections specific to the perinatal period

0.00

0.58

0.0

3.3

—

6.09

—

Disorders of synovium and tendon in diseases classified elsewhere

653

1.16

0.58

2.8

4.7

8.80

34.49

ug/l

1.14

528

Other lesions of median nerve

108

964

1.13

0.58

2.7

4.2

21.53

26.84

ug/l

0.11

795

Non-allergic asthma

279

2989

0.93

0.58

3.3

4.0

93.72

22.12

ug/l

0.82

233

2425

Exposure to smoke, fire and flames

646

0.84

0.58

3.5

4.4

21.10

30.27

ug/l

0.22

538

Endometriosis of fallopian tube

185

1.32

0.58

3.0

3.9

4.49

5.95

ug/l

0.33

146

Vasomotor rhinitis (mode)

223

2409

0.92

0.58

3.5

4.1

6.97

20.02

ug/l

1.88

172

1939

Benign neoplasm: Skin of ear and external auricular canal

141

1278

1.11

0.57

3.1

3.9

4.68

18.96

ug/l

1.53

119

1057

Paraplegia, diplegia of upper limbs

663

1.16

0.57

2.3

4.3

408.40

26.45

ug/l

0.47

550

Open wound of ankle and foot

311

2912

1.07

0.57

3.8

4.2

15.61

25.37

ug/l

0.54

254

2357

Disorders of sclera, cornea, iris and ciliary body

2282

22286

1.03

0.57

3.6

4.0

34.55

23.70

ug/l

0.49

1819

17860

Episcleritis

136

1502

0.90

0.57

3.6

4.1

8.67

22.42

ug/l

1.05

107

1201

Corneal degeneration

492

0.82

0.57

3.9

4.2

4.16

35.86

ug/l

1.22

413

Primary angle-closure glaucoma

178

1634

1.10

0.57

3.3

4.0

12.61

19.62

ug/l

0.40

145

1347

Angina pectoris

3070

21152

0.98

0.57

3.3

4.3

16.79

25.61

ug/l

1.28

2528

17504

Benign neoplasm: Mediastinum

108

1.45

0.56

2.8

4.8

2.19

10.65

ug/l

—

Guillain-Barre syndrome

481

0.82

0.56

2.4

4.4

84.00

30.27

ug/l

0.35

409

Other symptoms and signs involving cognitive functions and awareness

2050

18760

1.03

0.56

3.1

4.1

11.57

26.22

ug/l

4.75

1644

15480

Amputation of toe

259

2415

1.08

0.56

3.0

4.0

4.90

26.43

ug/l

3.95

220

2018

Dysplastic lesion of the vagina of unknown severity

1.64

0.56

2.0

4.1

3.83

5.76

ug/l

—

Recurrent dislocation of patella

107

955

1.13

0.56

3.2

4.1

3.72

49.62

ug/l

0.66

704

Caught, crushed, jammed or pinched in or between objects

130

1175

1.11

0.55

4.0

4.4

3.49

23.12

ug/l

1.95

970

Schizotypal disorder

503

0.83

0.55

3.6

4.6

68.62

20.98

ug/l

0.42

402

Eccrine sweat disorders

1.58

0.55

4.2

4.5

2.72

67.21

ug/l

—

Phantom limb syndrome with pain

1.50

0.55

3.9

4.2

2.53

184.67

ug/l

—

Sub-endpoint used in defining T1D endpoints

978

9963

0.96

0.55

3.5

4.0

27.33

23.70

ug/l

0.12

830

8023

Focal epilepsy, strict definition

707

6781

1.05

0.55

3.9

4.1

12.80

28.39

ug/l

1.55

576

5499

Mixed conductive and sensorineural hearing loss

505

4810

1.06

0.55

3.5

4.0

22.81

25.78

ug/l

0.11

402

3944

Golimumab

731

1.14

0.54

3.1

4.3

198.36

19.26

ug/l

0.44

574

Fracture at wrist and hand level

1209

11707

1.03

0.54

3.9

4.2

26.27

27.72

ug/l

0.05

982

9427

Maternal care for known or suspected disproportion

982

0.88

0.54

3.7

3.6

2.70

44.70

ug/l

0.58

688

Unspecified hairloss

1.58

0.54

4.8

4.0

3.20

117.17

ug/l

—

Macular cyst

102

914

1.13

0.54

3.7

4.2

3.71

15.30

ug/l

1.70

758

Allergic bronchopulmonary aspergillosis (ABPA)

109

1.43

0.54

4.7

4.9

3.08

54.36

ug/l

0.71

Benign neoplasm: Vagina

416

1.20

0.54

2.6

4.1

14.56

9.55

ug/l

0.22

351

Open bite

770

0.87

0.53

2.7

4.1

21.73

23.82

ug/l

0.04

564

Phantom limb syndrome

1.53

0.53

5.5

5.2

2.39

61.06

ug/l

0.54

Cerebral palsy

260

0.76

0.53

1.8

4.5

10.20

9.06

ug/l

—

205

Persistent delusional disorders

228

2450

0.92

0.53

3.2

4.1

56.71

17.66

ug/l

0.57

190

1991

Olecranon bursitis

222

2063

1.08

0.53

3.5

4.8

17.39

33.59

ug/l

0.72

184

1742

Other enthesopathies

1302

12640

1.03

0.53

3.1

4.3

21.78

27.47

ug/l

0.23

1032

10084

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

734

1.14

0.53

3.7

4.3

35.73

28.55

ug/l

0.09

614

Amiodarone users

402

3811

1.06

0.53

3.1

4.2

17.11

22.09

ug/l

0.19

320

3184

Focal epilepsy, mode (most common among epilepsy diagnosis)

667

6396

1.05

0.53

3.9

4.1

13.77

28.78

ug/l

1.34

547

5179

Somnolence, stupor and coma

140

1275

1.11

0.53

3.2

4.3

17.35

23.60

ug/l

0.20

112

1075

Hypersensitivity angiitis

171

1.33

0.53

2.3

4.7

3.90

68.05

ug/l

0.83

149

Superficial injury of shoulder and upper arm

328

3481

0.94

0.53

2.9

4.1

22.60

20.98

ug/l

0.04

259

2801

Anoxic brain damage

401

0.81

0.52

2.8

4.5

5.12

38.85

ug/l

1.03

335

Thyrotoxicosis with diffuse goitre

518

4942

1.05

0.52

3.2

3.9

14.61

27.11

ug/l

0.75

397

3874

Lumbosacral root disorders, not elsewhere classified

408

1.20

0.52

2.7

4.7

4.58

18.98

ug/l

0.75

336

Complications following abortion and ectopic and molar pregnancy

134

1220

1.11

0.52

3.9

3.8

7.33

13.66

ug/l

1.07

107

957

Myeloid leukaemia

830

1.13

0.52

3.5

4.0

15.43

26.32

ug/l

0.32

697

Other or ill-defined heart diseases

165

1515

1.10

0.52

3.9

4.5

8.38

22.95

ug/l

1.49

133

1256

Mental retardation, wide definition

875

1.13

0.52

2.8

4.3

98.97

15.88

ug/l

0.51

704

Other contact dermatitis

274

2568

1.07

0.52

3.6

4.0

89.34

19.19

ug/l

0.53

224

2040

Other and unspecified hydrocephalus

562

0.84

0.51

4.0

3.8

4.60

30.44

ug/l

1.15

472

Mental retardation

781

1.13

0.51

2.4

4.4

111.17

16.77

ug/l

0.51

619

Carcinoma in situ of skin, other sites/unspecified

428

1.19

0.51

2.5

3.8

3.09

36.89

ug/l

1.16

362

Childhood asthma (age<16), excluding more controls

173

1260

1.09

0.51

3.3

3.9

4.04

37.13

ug/l

0.55

106

843

Acute drug-induced interstitial lung disorder

244

1.26

0.51

2.6

4.2

12.06

58.96

ug/l

0.81

209

Other specified/unspecified diseases of inner ear

163

1.33

0.51

3.0

4.1

1.94

50.40

ug/l

0.61

135

Primary coxarthrosis, bilateral

1282

13188

0.97

0.50

3.3

4.0

27.40

22.07

ug/l

0.23

1055

10928

Lichenoid drug reaction

111

1.42

0.50

2.8

4.4

7.43

13.18

ug/l

—

Exclusion endpoint for supernumerary teeth

180

1.29

0.50

3.0

4.3

124.16

34.83

ug/l

0.32

140

Contracture of muscle

128

1.37

0.50

1.9

5.3

2.49

28.79

ug/l

—

104

Intermittent heterotropia

123

1115

1.11

0.50

3.0

4.2

7.24

25.03

ug/l

1.25

867

Other encephalitis

718

1.14

0.50

3.3

4.3

4.13

29.85

ug/l

1.48

587

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

236

2203

1.08

0.50

4.2

3.7

59.63

34.70

ug/l

0.24

179

1636

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

236

2203

1.08

0.50

4.2

3.7

59.63

33.58

ug/l

0.25

179

1626

Desensitization to allergens

871

0.88

0.50

4.8

4.2

3.45

18.60

ug/l

1.27

647

Peripheral retinal degeneration

108

975

1.12

0.50

2.8

4.0

39.97

16.55

ug/l

0.28

800

Cerebral atherosclerosis

386

0.81

0.50

2.6

3.9

2.53

39.52

ug/l

1.18

335

Stroke, excluding SAH

3014

21976

1.02

0.50

3.4

4.1

30.92

24.03

ug/l

0.30

2526

18157

Other melanin hyperpigmentation

761

0.87

0.49

3.4

4.0

4.58

26.57

ug/l

1.40

636

Wegener granulomatosis

484

0.84

0.49

3.1

4.2

9.23

37.32

ug/l

0.89

410

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

290

1.22

0.49

3.0

4.0

14.37

8.25

ug/l

0.33

228

Amputation of foot

835

0.88

0.49

2.4

4.3

4.88

29.11

ug/l

1.65

706

Eustachian salpingitis and obstruction

175

1616

1.09

0.49

3.9

4.2

8.22

43.01

ug/l

0.91

118

1228

Post-traumatic wound infection, not elsewhere classified

701

1.14

0.49

2.6

4.4

3.72

28.59

ug/l

1.41

588

Other/unspecified synovitis and tenosynovitis

445

4241

1.05

0.49

3.5

4.3

38.04

35.19

ug/l

0.04

349

3396

Trichomoniasis

310

1.22

0.49

2.8

4.0

4.52

7.90

ug/l

1.05

263

Benign neoplasm: Vulva

683

1.14

0.49

3.7

3.8

3.00

10.30

ug/l

3.52

549

Thyroiditis, unspecified

448

1.18

0.49

2.2

3.9

2.59

18.72

ug/l

0.99

357

Respiratory tuberculosis, not confirmed

158

1456

1.09

0.48

3.4

3.9

74.74

21.89

ug/l

0.50

135

1210

Short stature, not elsewhere classified

1.39

0.48

3.4

1.49

3.13

ug/l

—

Other retinal artery occlusion

769

1.13

0.48

3.7

4.2

12.26

18.30

ug/l

0.30

656

Benign neoplasm: Cranial nerves

104

940

1.12

0.48

3.9

4.2

15.04

24.85

ug/l

0.35

784

Secondary parkinsonism

897

0.88

0.48

2.4

4.1

3.88

28.54

ug/l

1.90

759

Pulmonary eosinophilia, not elsewhere classified

412

1.19

0.48

2.1

4.2

145.80

44.79

ug/l

0.31

347

Peroneal tendinitis

440

0.83

0.48

2.7

4.6

2.97

17.82

ug/l

0.83

342

Macular pucker

661

6363

1.04

0.48

3.9

4.1

11.36

24.84

ug/l

2.05

543

5285

Polycystic ovarian syndrome

757

1.13

0.48

2.4

3.5

5.81

65.44

ug/l

0.62

515

Dystonia

187

1736

1.08

0.48

3.4

4.1

10.66

19.39

ug/l

0.74

146

1397

Effects of other external causes

560

1.15

0.48

3.3

4.7

19.25

22.57

ug/l

0.08

451

Monoplegia

449

1.18

0.48

3.1

4.4

4.62

30.79

ug/l

0.88

383

Enthesopathies of lower limb, excluding foot

883

8540

1.04

0.48

3.3

4.3

14.35

28.07

ug/l

0.76

693

6781

Infections of breast associated with childbirth

692

1.13

0.47

3.9

6.13

15.66

ug/l

0.65

499

Mandibular retrognathia

125

1366

0.91

0.47

4.1

15.39

16.84

ug/l

0.05

1028

Respiratory disorders in diseases classified elsewhere

431

1.18

0.47

2.3

4.2

9.24

16.92

ug/l

0.31

365

Specific development disorders of speech and language

857

1.12

0.47

4.1

5.52

24.97

ug/l

1.17

672

Emotional disorders starting during childhood or adolecense, excluding more controls

315

0.81

0.47

3.8

3.7

2.97

4.72

ug/l

0.46

195

Melanoma in situ of other and unspecified parts of face

404

1.19

0.47

3.7

4.0

4.67

36.66

ug/l

1.01

343

Tarsal tunnel syndrome

348

1.20

0.47

3.7

3.9

2.55

29.53

ug/l

0.77

286

Abscess of Bartholin gland

618

1.14

0.47

3.3

4.1

3.42

10.11

ug/l

2.71

476

Impingement syndrome of shoulder

1127

10950

1.03

0.47

3.4

4.5

20.68

29.01

ug/l

0.56

926

8900

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

864

1.12

0.47

3.2

4.4

7.44

14.01

ug/l

0.48

660

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1078

10464

1.03

0.47

3.4

4.2

13.10

28.28

ug/l

2.06

852

8485

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

145

1333

1.09

0.47

3.1

4.5

7.93

27.89

ug/l

1.57

115

1054

Sequelae of injuries of upper limb

318

3008

1.06

0.47

3.8

4.3

16.15

20.58

ug/l

0.23

253

2431

Cleft lip, lip and palate or palate

265

0.79

0.46

2.8

4.4

141.99

23.81

ug/l

0.38

210

Parapsoriasis

544

1.15

0.46

2.4

4.3

112.19

28.31

ug/l

0.42

456

Biological medicines for asthma

319

0.80

0.46

2.6

4.4

2.94

6.95

ug/l

1.65

258

Disorders of optic nerve and visual pathways

292

2756

1.06

0.46

3.7

4.1

36.42

18.66

ug/l

0.25

234

2192

Other and unspecified injuries of neck

174

1.28

0.46

1.6

4.5

3.04

8.05

ug/l

1.46

142

Secondary parkinsonism+Parkinsonism in other disease

925

0.89

0.46

2.6

4.1

3.90

27.52

ug/l

1.85

779

Spondylopathies (FG)

473

4523

1.05

0.46

3.3

4.4

109.39

30.22

ug/l

0.88

367

3596

Tuberculosis of other organs, strict

829

1.12

0.46

3.2

3.8

49.77

28.10

ug/l

0.22

688

Benign neoplasm: Larynx

111

1010

1.11

0.46

3.4

4.3

10.54

26.45

ug/l

0.86

847

Venous complications and haemorrhoids in the puerperium

318

0.80

0.45

4.7

3.8

3.45

9.27

ug/l

1.81

250

Purulent endophthalmitis

166

1.30

0.45

4.7

4.2

3.58

35.13

ug/l

0.63

132

Melanoma in situ of scalp and neck

1.45

0.45

5.3

5.2

4.50

60.24

ug/l

0.57

Hyperfunction of pituitary gland

127

1162

1.10

0.45

3.7

4.0

77.58

26.30

ug/l

0.37

104

910

Traumatic subarachnoid haemorrhage

131

1202

1.10

0.45

4.2

4.6

5.66

28.56

ug/l

2.14

102

999

Postprocedural musculoskeletal disorders, not elsewhere classified

265

2498

1.07

0.45

2.8

4.1

48.18

18.24

ug/l

0.43

223

2044

Assault by unspecified means

376

1.18

0.45

3.5

4.8

5.04

19.49

ug/l

0.67

302

Childhood asthma (age<16)

173

1270

1.08

0.45

3.3

3.9

4.04

36.67

ug/l

0.55

106

854

Other dialysis

858

1.12

0.45

1.9

4.5

4.62

29.15

ug/l

1.72

715

Hereditary corneal dystrophies

122

1117

1.10

0.45

3.8

4.4

3.86

23.38

ug/l

1.92

923

Toxic effect of contact with venomous animals

100

1103

0.90

0.45

4.6

4.3

4.22

23.16

ug/l

1.74

901

Malignant neoplasm of other and unspecified parts of tongue

471

1.17

0.45

3.5

4.5

5.11

35.63

ug/l

1.10

400

Malignant neoplasm of brain

914

0.89

0.45

2.4

4.3

3.00

27.24

ug/l

1.88

765

Other facial nerve disorders

840

0.88

0.45

4.4

4.3

3.71

26.27

ug/l

1.51

679

Crossbite

102

1043

0.90

0.44

3.2

4.2

4.52

14.34

ug/l

1.18

796

Ankle and foot

239

1.24

0.44

2.9

3.9

2.85

24.05

ug/l

0.62

193

Convergent concomitant strabismus

140

1288

1.09

0.44

3.4

4.2

5.12

18.49

ug/l

1.66

113

1001

Papulosquamous disorders

1678

16403

1.03

0.44

3.5

4.1

30.63

24.74

ug/l

0.26

1347

13276

Schizophrenia or delusion, excluding more controls

996

10181

0.97

0.44

3.1

4.2

22.92

25.05

ug/l

0.08

812

8027

Complications of the puerperium, not elsewhere classified

767

0.88

0.44

3.4

3.8

7.99

63.16

ug/l

0.59

541

Pemphigoid

898

1.11

0.44

3.5

3.8

3.89

26.35

ug/l

1.76

759

Injury of urinary and pelvic organs

546

1.15

0.44

5.2

4.7

40.94

33.37

ug/l

0.07

452

Epilepsy

1260

12237

1.03

0.44

3.7

4.2

15.28

25.60

ug/l

1.43

1033

9957

Other nonthrombocytopenic purpura

267

1.22

0.44

3.2

4.5

3.46

47.69

ug/l

0.86

222

Nocardiosis

1.60

0.43

1.4

5.5

2.18

5.61

ug/l

—

Vertigo of central origin

520

1.15

0.43

2.9

4.1

3.42

34.31

ug/l

1.29

439

Juvenile arthritis (FINNGEN)

860

0.89

0.43

3.8

4.4

7.60

31.69

ug/l

1.24

647

Systemic sclerosis, icd10

766

1.12

0.43

2.4

3.9

4.40

25.71

ug/l

1.28

611

Guttate psoriasis

360

1.18

0.43

4.1

4.3

3.22

19.03

ug/l

0.73

294

Congenital malformations of the musculoskeletal system, not elsewhere classified

267

1.21

0.43

3.1

4.2

2.68

7.40

ug/l

1.67

212

Melanoma in situ of upper limb, including shoulder

227

0.77

0.42

3.3

4.5

2.19

27.77

ug/l

0.78

190

Schizoid personality disorder

466

0.85

0.42

2.7

4.9

19.72

28.64

ug/l

0.19

377

Inflammatory disorders of male genital organs, not elsewhere classified

342

1.18

0.42

3.6

5.0

22.87

40.53

ug/l

0.29

297

Bicuspidal aortic valve syndrome

931

0.90

0.42

3.6

4.6

3.15

23.15

ug/l

1.56

773

Gluteal tendinitis

129

1188

1.09

0.42

3.5

4.5

6.06

19.70

ug/l

1.47

103

936

Symptoms and signs involving appearance and behaviour

213

1.24

0.42

3.2

4.7

3.42

9.53

ug/l

1.77

174

Chalazion

386

3684

1.05

0.42

4.1

9.33

20.75

ug/l

1.17

306

2959

Other acquired deformities of ankle and foot

260

0.79

0.42

3.7

4.5

4.24

35.49

ug/l

0.66

221

TMD related operations

498

5187

0.96

0.42

3.2

4.1

10.42

31.78

ug/l

1.84

385

4074

Autism

185

1.25

0.42

2.3

4.7

2.92

5.25

ug/l

0.72

136

Wide developmental disorders, excluding more controls

219

1.22

0.42

2.2

4.9

2.66

38.82

ug/l

0.54

165

Carcinoma in situ of other and unspecified genital organs

540

1.14

0.42

3.3

3.6

3.23

9.12

ug/l

3.11

432

Preparation and fitting of bite rail to mouth

395

4134

0.95

0.42

3.3

4.1

12.36

28.57

ug/l

1.02

305

3241

Male infertility

728

1.12

0.41

5.8

5.3

50.62

14.54

ug/l

0.35

599

Benign neoplasm: Bladder

306

1.20

0.41

3.1

4.4

3.87

47.17

ug/l

1.03

261

Family history of other specific disorders

250

1.21

0.41

5.3

3.8

1.70

23.59

ug/l

0.69

203

Disorders of speech understanding and production

696

1.12

0.41

4.2

3.8

6.22

28.73

ug/l

1.11

561

Other disorders of bone density and structure

663

1.13

0.41

2.9

4.4

8.19

15.98

ug/l

0.54

535

Dialysis

120

1103

1.10

0.41

2.0

4.3

5.04

21.84

ug/l

1.49

101

919

Biological medication for rheuma

450

4314

1.05

0.41

3.1

4.2

86.27

28.43

ug/l

0.73

341

3363

Left ventricular outflow tract obstruction (LVOTO), broad definition

309

2937

1.06

0.40

3.7

4.5

37.00

19.98

ug/l

0.28

241

2404

Overexertion and strenuous or repetitive movements

306

2908

1.06

0.40

3.5

4.3

7.14

19.70

ug/l

2.33

232

2349

Other disorders of electrolyte and fluid balance, not elsewhere classified

270

1.21

0.40

2.7

4.1

130.32

51.72

ug/l

0.26

228

Disorders of globe

801

0.89

0.40

3.4

3.9

2.72

31.51

ug/l

1.96

660

Congenital malformations of the nervous system

357

0.83

0.40

2.5

4.2

3.36

20.78

ug/l

0.77

277

Acute inflammation of orbit

151

1.28

0.40

2.0

4.8

2.63

37.94

ug/l

0.68

125

Dermatographic urticaria

192

1800

1.07

0.40

3.3

4.0

86.88

38.86

ug/l

0.38

145

1402

Carpal tunnel syndrome

2804

25717

0.98

0.40

3.4

4.1

15.75

24.42

ug/l

1.31

2280

20506

Fall on and from ladder

270

2561

1.06

0.39

4.2

4.3

12.17

25.77

ug/l

1.35

218

2132

Metatarsalgia

358

3420

1.05

0.39

2.9

4.3

26.22

25.40

ug/l

0.02

267

2710

Hypersomnia

366

0.84

0.39

3.5

4.3

5.87

37.63

ug/l

0.79

294

Malignant neoplasm of floor of mouth

161

1.28

0.39

2.2

5.5

6.28

35.54

ug/l

0.61

139

Contact with sharp glass

780

0.89

0.39

4.2

4.5

38.87

30.70

ug/l

0.09

622

Autism spe

187

1.24

0.39

2.3

4.7

2.92

5.24

ug/l

0.72

137

Torsion of testis

233

1.21

0.39

5.4

5.8

3.04

34.91

ug/l

0.56

193

Acute epiglottitis

419

0.85

0.39

4.7

4.9

4.53

31.96

ug/l

0.82

347

Hydatidiform mole

317

1.18

0.39

2.9

4.0

3.58

11.46

ug/l

1.39

242

Amputation of thigh

903

0.90

0.39

1.7

3.8

14.44

24.79

ug/l

0.32

768

Transport accidents

1862

16184

1.02

0.38

3.5

4.2

11.16

29.18

ug/l

4.16

1474

12831

Other demyelinating diseases of the central nervous system

810

0.90

0.38

3.3

4.4

6.11

18.62

ug/l

0.88

624

Congenital malformations of eye, ear, face and neck

146

1357

1.08

0.38

2.8

4.1

11.08

19.81

ug/l

0.49

111

1069

Rheumatic fever incl heart disease

997

0.91

0.38

3.3

4.1

7.38

27.88

ug/l

1.49

843

Sleep apnoea, including avohilmo

4620

30347

0.99

0.38

3.3

4.2

19.71

26.37

ug/l

0.79

3635

24402

Neurofibromatosis, type 1

152

1.27

0.38

1.4

3.9

2.54

9.62

ug/l

1.50

118

Glaucoma

2769

23925

1.02

0.38

3.8

3.9

17.24

25.78

ug/l

1.05

2291

19628

Fibrosarcoma

235

1.22

0.38

5.0

4.3

4.91

28.38

ug/l

0.68

189

Graves disease, strict definition

309

2944

1.05

0.38

3.0

3.9

14.19

34.20

ug/l

0.81

231

2278

Urethritis and urethral syndrome

639

1.12

0.38

3.4

4.2

3.09

27.84

ug/l

1.25

512

Other articular cartilage disorders

802

1.11

0.38

3.7

4.7

65.73

26.26

ug/l

0.28

666

L04AC Interleukin inhibitors

129

1195

1.09

0.38

3.1

4.4

105.37

14.05

ug/l

0.66

102

958

Vertical strabismus

102

936

1.10

0.37

3.0

4.3

5.26

23.63

ug/l

1.29

768

Other and unspecified injuries of shoulder and upper arm

821

1.10

0.37

2.5

4.4

16.83

31.10

ug/l

0.50

683

Toxoplasmosis

171

1.25

0.37

1.5

4.2

2.20

33.48

ug/l

0.71

146

Otorrhoea

0.63

0.37

8.4

4.2

2.44

12.25

ug/l

—

Hypermobility syndrome

122

1128

1.09

0.37

3.1

3.7

3.04

13.10

ug/l

1.54

825

Anomalies of pupillary function

488

1.14

0.37

4.1

10.88

16.85

ug/l

0.21

396

Other disorders of binocular movement

469

1.14

0.37

3.7

4.2

7.71

32.36

ug/l

0.75

376

Tuberculosis of other organs

727

1.11

0.37

2.9

3.8

12.11

29.98

ug/l

0.64

607

Sequelae of other and unspecified infectious and parasitic diseases

158

1477

1.07

0.37

3.9

4.3

9.84

23.26

ug/l

1.05

127

1182

Glaucoma secondary to eye inflammation

266

0.81

0.37

2.5

4.4

2.56

8.98

ug/l

2.52

221

Sequelae of injuries of head

153

1429

1.08

0.37

2.7

4.4

7.75

22.44

ug/l

1.39

117

1162

Chronic myeloproliferative disease

458

0.86

0.36

3.7

4.2

3.10

42.14

ug/l

1.47

386

Sequelae of injuries of neck and trunk

832

1.10

0.36

2.6

4.5

49.07

27.66

ug/l

0.19

692

Degenerative and vascular disorders of ear

1.44

0.36

2.3

4.7

12.85

7.43

ug/l

—

Other congenital malformations of face and neck

631

1.12

0.36

2.6

4.4

5.28

27.35

ug/l

0.99

503

Kyphosis

395

1.15

0.36

3.8

4.2

12.34

39.28

ug/l

0.63

317

Migraine without aura

521

5400

0.96

0.36

2.9

3.9

7.40

27.05

ug/l

1.81

370

4015

Multifocal fibrosclerosis

218

1.22

0.36

1.9

4.1

3.81

38.80

ug/l

0.60

185

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

147

1371

1.08

0.36

4.6

3.5

35.47

38.73

ug/l

0.03

107

964

IgA nephropathy (IgA glomerulonephritis)

651

1.12

0.36

2.8

4.6

19.03

28.64

ug/l

0.21

538

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

1.42

0.36

5.7

5.5

4.57

107.03

ug/l

—

Hypothyroidism due to medicaments and other exogenous substances

339

1.17

0.36

4.0

4.1

2.90

10.00

ug/l

2.89

280

Tumor necrosis factor alpha inhibitors

399

3830

1.04

0.36

3.2

4.2

61.84

26.71

ug/l

0.38

299

2975

Mouth breathing

1574

16041

0.98

0.36

3.6

4.2

17.26

26.51

ug/l

1.06

1226

13006

Abnormal involuntary movements

443

4600

0.96

0.35

2.9

4.0

6.18

26.01

ug/l

4.62

363

3718

Restless leg syndrome

451

4345

1.04

0.35

3.4

4.0

7.38

25.04

ug/l

3.38

361

3499

Contact with nonpowered hand tool

109

1179

0.92

0.35

3.7

4.5

5.65

23.42

ug/l

1.62

980

Other obstetric trauma

110

1016

1.09

0.35

3.9

3.8

14.06

43.07

ug/l

0.36

712

Injury of nerves and spinal cord at neck level

672

1.11

0.35

4.3

4.6

3.09

31.22

ug/l

1.59

563

Airway disease due to specific organic dust

0.68

0.35

8.0

4.5

2.87

91.77

ug/l

—

Other and unspecified mononeuropathies, also in other diseases

104

960

1.09

0.35

3.8

4.3

14.71

27.65

ug/l

0.57

785

Other disorders of cornea

330

3160

1.05

0.35

4.1

5.31

19.30

ug/l

3.25

254

2550

Psoriasis vulgaris

694

6738

1.03

0.35

3.7

4.2

38.87

23.95

ug/l

0.47

575

5494

Myositis

816

1.10

0.34

2.7

4.3

30.48

28.92

ug/l

0.03

663

Other diseases of spinal cord

876

0.91

0.34

2.6

4.4

3.78

26.70

ug/l

1.68

724

Other disorders of pigmentation

154

1444

1.07

0.34

3.8

4.3

9.37

22.08

ug/l

1.16

127

1187

Graves ophthalmopathy

719

0.90

0.34

2.8

4.1

11.37

15.39

ug/l

0.22

579

Lateral epicondylitis

483

5003

0.96

0.34

3.3

4.5

10.50

34.27

ug/l

2.05

398

3978

Allergic contact dermatitis

467

4505

1.04

0.34

3.2

3.9

18.80

27.88

ug/l

0.38

358

3491

Hereditary retinal dystrophy

392

0.86

0.34

2.4

4.2

12.25

18.24

ug/l

0.17

325

Keratitis

1355

13273

1.02

0.34

3.6

4.1

11.62

23.52

ug/l

2.22

1089

10658

Other/unspecified rheumatoid arthritis

484

5010

0.96

0.34

3.1

3.8

49.55

25.91

ug/l

0.42

396

4079

Left ventricular outflow tract obstruction, narrow definition

126

1173

1.08

0.34

3.1

4.4

68.70

21.73

ug/l

0.34

100

960

Other disorders of choroid

426

1.14

0.34

3.6

4.0

34.02

17.59

ug/l

0.21

363

Unspecified visual impairment (binocular)

426

1.14

0.33

2.6

4.1

5.19

23.81

ug/l

0.98

360

Manic episode

740

1.10

0.33

3.0

4.6

17.28

27.96

ug/l

0.25

596

Crushing injury of wrist and hand

445

1.14

0.33

3.9

4.9

24.26

45.12

ug/l

0.41

377

Myeloproliferative diseases (CML excluded)

292

2792

1.05

0.33

2.9

4.0

11.78

19.05

ug/l

0.39

217

2303

Acute and transient psychotic disorders

335

3494

0.96

0.33

3.1

4.1

5.62

22.07

ug/l

3.09

267

2771

Obstructed labour due to maternal pelvic abnormality

573

5912

0.97

0.33

4.0

3.8

7.70

26.69

ug/l

1.86

447

4569

Injury of muscle and tendon at ankle and foot level

655

1.11

0.33

2.8

4.4

13.85

28.38

ug/l

0.45

535

Diabetic retinopathy

1400

8660

1.02

0.33

3.4

3.8

26.52

25.59

ug/l

0.04

1154

7241

Melanocytic naevi of eyelid, including canthus

295

1.17

0.33

3.6

3.9

3.81

21.62

ug/l

0.65

241

Other symptoms and signs involving general sensations and perceptions

118

1098

1.08

0.33

3.3

4.0

6.39

24.68

ug/l

1.63

921

Benign neoplasm: Uterine tubes and ligaments

230

1.20

0.33

3.7

3.9

6.08

8.23

ug/l

0.25

190

211

1.20

0.33

2.5

4.2

5.99

60.28

ug/l

0.85

180

Other and unspecified acne

229

1.19

0.33

5.6

4.3

4.60

4.91

ug/l

0.08

177

Rubella [German measles]

857

1.09

0.32

5.1

4.9

29.20

13.26

ug/l

0.28

714

Spinal enthesopathy

102

942

1.09

0.32

3.0

3.7

21.84

20.82

ug/l

0.03

786

Myocardial infarction, with ST-elevation

690

7095

0.97

0.32

3.4

4.1

13.62

22.04

ug/l

0.90

580

5959

Hereditary motor and sensory neuropathy

262

0.83

0.32

3.2

4.5

9.76

23.90

ug/l

0.39

219

Molar incisor enamel hypoplasia

206

1.19

0.32

2.9

3.1

2.01

5.91

ug/l

0.88

134

Postprocedural disorders of nervous system

160

1700

0.94

0.32

3.1

4.2

7.19

38.34

ug/l

0.84

115

1291

HSIL lesion of the vulva

494

1.13

0.32

3.5

3.7

3.94

9.54

ug/l

2.37

394

Psoriasis

1124

10997

1.02

0.32

3.5

4.1

28.90

24.65

ug/l

0.17

921

8900

Other disorders starting during childhood or adolecense, excluding more controls

356

1.14

0.32

2.6

4.3

2.63

6.64

ug/l

1.64

240

Disorders of ocular muscles, binocular movement, accommodation and refraction

1645

16607

0.98

0.32

3.5

4.0

14.78

22.86

ug/l

0.66

1259

13094

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

251

2175

1.05

0.32

2.7

3.9

6.01

29.91

ug/l

0.72

171

1475

Nezelof syndrome

138

1.26

0.32

6.1

4.2

3.17

58.79

ug/l

0.58

114

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

100

0.68

0.32

4.9

5.0

2.84

50.96

ug/l

—

Hyperosmolality and hypernatraemia

390

1.14

0.32

2.9

4.0

19.76

37.33

ug/l

0.32

330

Eating disorder

116

1245

0.93

0.32

2.5

3.6

28.51

45.44

ug/l

0.17

853

Causalgia

474

0.88

0.32

3.9

4.4

2.89

23.77

ug/l

1.24

376

Separation of retinal layers (serosa)

132

1236

1.07

0.32

3.8

4.3

6.71

17.51

ug/l

1.37

104

1003

Measles

230

1.19

0.31

3.8

4.4

5.56

13.52

ug/l

0.54

176

Carcinoma in situ of prostate

196

0.80

0.31

5.3

4.8

12.24

28.35

ug/l

0.32

162

Other sleep disorders

396

3817

1.04

0.31

3.3

4.4

30.71

22.89

ug/l

0.15

328

3134

Trigger finger

578

5609

1.03

0.31

3.2

4.4

24.05

30.65

ug/l

0.16

478

4488

Other bursitis of knee

419

1.13

0.31

2.9

4.9

9.14

41.96

ug/l

0.94

342

Mixed connective tissue disease

218

2074

1.06

0.31

3.0

4.1

3.14

21.54

ug/l

3.44

171

1660

Other and unspecified epidermal thickening

773

1.09

0.31

3.4

4.3

12.13

28.87

ug/l

0.74

638

Systemic sclerosis

783

1.09

0.31

2.4

4.0

4.40

29.84

ug/l

1.58

617

Migraine without aura and triptan purchases

383

3976

0.96

0.31

3.1

3.8

8.88

27.78

ug/l

1.20

262

2926

Epiphora

716

1.10

0.31

3.4

4.2

6.52

24.97

ug/l

0.97

592

Polyhydramnios

859

1.09

0.31

3.7

3.5

57.72

51.01

ug/l

0.03

605

Exfoliative dermatitis

325

1.15

0.31

2.5

4.9

4.90

52.50

ug/l

1.20

275

Acute nephritic syndrome

620

1.11

0.31

3.9

4.6

24.37

25.69

ug/l

0.02

524

Other and unspecified injuries of thorax

467

1.12

0.31

3.0

4.5

9.83

17.14

ug/l

0.27

384

Dislocation, sprain and strain of joint and ligaments of hip

123

1151

1.08

0.31

3.4

4.1

4.17

23.59

ug/l

1.99

105

953

Muscular dystrophy

222

1.19

0.30

2.2

4.2

30.06

27.40

ug/l

0.03

182

Pregnancy examination and test

302

1968

0.96

0.30

3.5

3.2

17.07

10.13

ug/l

0.43

189

1343

Benign neoplasm: Skin of scalp and neck

755

1.09

0.30

3.2

4.4

7.65

28.46

ug/l

1.13

629

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

851

1.09

0.30

3.7

4.2

2.96

23.05

ug/l

1.40

683

Primary gonarthrosis, bilateral

2520

22347

0.98

0.30

3.4

4.1

23.15

24.02

ug/l

0.05

2008

18366

Congenital deformities of feet

486

1.12

0.30

2.7

4.3

3.64

16.18

ug/l

0.78

390

Other bullous disorders

842

1.09

0.30

3.5

4.3

6.90

25.62

ug/l

1.05

694

Contact with other specified venomous animals

185

1.21

0.30

4.0

3.26

32.41

ug/l

0.68

152

Exposure to uncontrolled fire, not in building or structure

1.27

0.30

5.9

4.8

43.69

10.18

ug/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

108

0.72

0.30

2.8

4.0

2.28

51.32

ug/l

—

Other fall from one level to another

712

6931

1.03

0.30

3.6

4.2

20.25

27.22

ug/l

0.29

591

5628

Livedoid vasculitis

121

1.27

0.30

5.1

4.2

2.54

46.71

ug/l

—

100

Contraceptive management

1377

9496

1.02

0.30

3.6

4.0

23.71

23.91

ug/l

0.01

1029

7377

Fourth [trochlear] nerve palsy

708

1.10

0.30

3.7

4.4

6.99

29.15

ug/l

1.18

605

Optic neuritis

112

1045

1.08

0.30

3.2

4.1

5.12

28.04

ug/l

1.73

818

Asymmetry of jaw

292

0.85

0.30

3.4

4.3

3.31

22.31

ug/l

0.68

232

Stenosis and insufficiency of lacrimal passages

329

3418

0.96

0.30

3.5

3.9

13.07

23.16

ug/l

0.77

271

2743

Eating disorders

183

1928

0.95

0.29

2.7

3.7

21.48

35.11

ug/l

0.23

132

1404

Convergence insufficiency and excess

249

0.84

0.29

4.1

4.3

2.43

23.64

ug/l

0.64

199

Congenital malformations of great arteries

329

1.14

0.29

3.7

4.4

13.57

20.85

ug/l

0.17

258

Other abnormal auditory perceptions

298

1.15

0.29

3.5

4.2

9.01

21.54

ug/l

0.37

245

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

573

1.10

0.29

3.8

4.3

13.82

15.24

ug/l

0.04

438

Chromosomal abnormalities, not elsewhere classified

259

1.16

0.29

3.3

4.6

2.31

23.59

ug/l

0.64

198

Other puerperal infections

121

1292

0.93

0.29

3.2

3.4

6.04

42.03

ug/l

0.65

889

Disorders of lacrimal system and orbit in diseases classified elsewhere

711

0.91

0.29

2.8

4.2

11.37

16.42

ug/l

0.28

565

Other congenital malformations of circulatory system

728

1.09

0.29

4.1

4.5

9.68

26.79

ug/l

0.78

607

Arthropod-borne viral fevers and viral haemorrhagic fevers

326

3138

1.04

0.29

3.8

4.3

10.85

24.82

ug/l

1.83

263

2571

Migraine with aura and triptan purchases

397

3834

1.04

0.29

3.3

3.8

5.06

27.17

ug/l

1.55

297

2830

Embedded and impacted teeth

427

3755

0.97

0.29

3.7

3.9

3.94

26.02

ug/l

1.52

313

2692

Disorders in reading

130

1.24

0.29

3.3

4.1

2.61

7.79

ug/l

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

345

1.14

0.29

1.8

5.1

19.62

11.17

ug/l

0.21

265

Mandibular prognathia

291

0.85

0.29

3.0

4.0

2.79

32.84

ug/l

1.00

225

Aspergillosis

252

1.17

0.28

4.6

4.4

3.83

53.37

ug/l

0.94

210

Nonsuppurative otitis media

514

4578

0.97

0.28

3.4

3.9

12.73

31.08

ug/l

1.28

383

3521

Failed induction of labour

825

0.92

0.28

3.5

2.05

54.06

ug/l

0.57

552

Use of biperiden

154

1627

0.94

0.28

2.4

4.3

10.67

20.44

ug/l

0.81

128

1338

Postzoster neuralgia

490

1.11

0.28

2.5

4.0

4.97

38.00

ug/l

1.27

415

Amputation of ankle bones

688

0.91

0.28

2.2

4.5

4.40

35.13

ug/l

1.75

577

Polycystic ovarian syndrome, broad definition

175

1844

0.95

0.28

2.9

3.4

7.81

32.10

ug/l

0.58

121

1223

Other and unspecified injuries of abdomen, lower back and pelvis

375

1.13

0.28

1.3

4.3

4.17

43.13

ug/l

1.08

309

!Aliquae complicationes praecoces traumatis

123

1156

1.07

0.28

3.0

4.3

3.77

23.80

ug/l

1.98

102

958

Early complications of trauma

123

1156

1.07

0.28

3.0

4.3

3.77

23.80

ug/l

1.98

102

958

Pustular psoriasis

159

1507

1.06

0.28

3.0

4.2

51.25

20.61

ug/l

0.42

128

1230

Other benign neoplasm of uterus: Other parts/unspecified

183

1743

1.06

0.27

3.0

3.5

4.90

13.19

ug/l

3.50

142

1414

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

711

1.09

0.27

2.5

4.5

3.59

26.94

ug/l

1.28

580

Other acquired deformities of musculoskeletal system and connective tissue

150

1420

1.06

0.27

3.6

4.1

58.75

22.67

ug/l

0.29

120

1167

Oral lichen ruber planus, including avohilmo

198

2074

0.95

0.27

3.0

4.1

4.02

24.17

ug/l

2.35

153

1678

Other enthesopathy of foot (+metatarsalgia)

379

3666

1.04

0.27

2.8

4.2

25.19

24.16

ug/l

0.02

282

2904

Nail dystrophy

197

1.19

0.27

3.6

4.3

15.92

27.46

ug/l

0.19

166

Pneumoconiosis due to asbestos and other mineral fibres

707

0.91

0.27

2.3

4.0

19.24

36.46

ug/l

0.53

587

Encephalitis

770

1.08

0.27

3.2

4.2

4.12

27.92

ug/l

1.47

633

Chronic sinusitis

1768

17936

0.98

0.27

3.3

4.1

40.03

24.83

ug/l

0.59

1339

14314

676

0.91

0.27

2.6

4.4

7.90

18.45

ug/l

0.63

536

Stroke, including SAH

3172

23209

1.01

0.27

3.4

4.1

30.72

25.39

ug/l

0.23

2665

19102

Other extrapyramidal and movement disorders in other diseases

921

9022

1.02

0.27

3.3

4.1

15.39

28.60

ug/l

1.18

736

7356

Spondylolisthesis/Spondylolysis

737

7542

0.97

0.26

3.0

4.3

7.10

29.31

ug/l

3.78

605

6084

Atopic dermatitis, strict definition

763

7306

1.02

0.26

3.4

3.9

53.72

21.39

ug/l

0.60

591

5446

Recurrent dislocation and subluxation of joint

190

1811

1.05

0.26

3.0

4.4

16.36

46.34

ug/l

0.76

148

1425

Hypoplasia of dental enamel , including avohilmo

194

1.17

0.26

3.1

3.2

2.14

6.19

ug/l

0.84

125

Sixth [abducent] nerve palsy

113

1062

1.07

0.26

3.8

4.2

4.12

25.37

ug/l

1.94

892

Secondary parkinsonism, excluding more controls

861

0.92

0.26

2.3

4.9

3.88

34.80

ug/l

2.09

721

Urticaria due to cold and heat

192

0.82

0.26

4.1

4.3

6.32

30.42

ug/l

—

151

Systemic sclerosis (FG)

791

1.08

0.26

2.4

4.5

4.40

30.07

ug/l

1.70

642

Dislocation, sprain and strain of joints and ligaments of head

101

945

1.07

0.26

3.6

4.4

11.95

26.44

ug/l

0.68

739

Schizoaffective disorder

195

2042

0.95

0.26

2.6

4.2

9.95

19.77

ug/l

0.95

168

1607

Short Achilles tendon (acquired)

830

0.92

0.26

4.1

4.3

2.64

28.51

ug/l

1.79

659

Injury of muscle and tendon at wrist and hand level

425

4381

0.97

0.26

4.1

4.4

29.05

28.16

ug/l

0.01

342

3587

Explosion of other materials

1.23

0.26

5.7

4.4

1.94

14.26

ug/l

—

Ganglion

780

7974

0.98

0.26

3.5

4.3

9.39

28.03

ug/l

2.39

613

6262

Scleritis

330

1.13

0.26

4.4

4.2

2.40

21.71

ug/l

0.85

267

Excessive vomiting in pregnancy

215

2058

1.05

0.26

3.1

3.7

15.77

33.33

ug/l

0.39

137

1523

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

188

1.18

0.26

6.2

3.5

5.36

6.19

ug/l

0.09

136

All dysplastic lesions of the vagina

714

1.09

0.26

3.9

3.8

3.28

9.33

ug/l

3.02

565

Androgenic alopecia

245

1.16

0.26

2.8

3.9

3.06

6.71

ug/l

1.11

195

Toxic effect of ethanol

917

1.07

0.25

3.4

4.6

15.58

25.46

ug/l

0.40

742

Female genital prolapse

1335

7576

1.02

0.25

3.3

4.1

6.71

31.39

ug/l

4.10

1019

5994

Labour and delivery complicated by umbilical cord complications

121

1282

0.94

0.25

3.9

7.27

47.92

ug/l

0.80

966

Other localized connective tissue disorders

609

1.09

0.25

2.8

3.9

47.64

27.12

ug/l

0.18

499

Blepharochalasis

1384

13624

1.02

0.25

3.5

4.0

18.73

21.00

ug/l

0.16

1102

11169

Embolic stroke with flimmer

817

0.92

0.25

2.6

4.1

19.39

35.09

ug/l

0.37

696

Nystagmus and other irregular eye movements

318

0.87

0.25

4.2

3.9

2.69

21.08

ug/l

0.75

257

Intentional self-harm by sharp object

359

1.12

0.25

2.5

4.3

8.01

19.54

ug/l

0.41

274

Other and unspecified paralytic syndromes

398

1.12

0.25

2.5

4.3

11.34

39.60

ug/l

0.74

328

Coxarthrosis, primary, with hip surgery

2305

21585

1.01

0.24

3.8

4.0

19.26

24.87

ug/l

0.46

1916

17838

Paralytic strabismus

247

2377

1.04

0.24

3.5

4.1

6.27

19.17

ug/l

2.50

207

1972

Anankastic personality disorder

879

0.93

0.24

2.5

4.3

4.94

21.17

ug/l

1.34

686

Malignant neoplasm of parotid gland

256

1.15

0.24

3.8

4.3

6.09

50.36

ug/l

0.82

215

Wide developmental disorders

236

1.15

0.24

2.2

4.5

2.66

6.29

ug/l

1.04

173

Osteitis due to dental implant

209

1.17

0.24

4.3

4.5

7.50

28.20

ug/l

0.49

172

Primary open-angle glaucoma, strict

1177

11940

0.98

0.24

3.6

3.8

12.77

22.88

ug/l

1.80

981

9854

Injury of nerves at lower leg level

275

1.14

0.24

2.7

4.9

4.47

31.87

ug/l

0.89

228

Achilles tendinitis

374

3853

0.97

0.23

3.3

4.5

6.88

29.87

ug/l

3.07

296

3132

Other and unspecified iridocyclitis

128

1214

1.06

0.23

3.4

4.3

7.20

21.40

ug/l

1.03

992

Contusion of toe(s) with damage to nail

247

1.14

0.23

5.0

4.5

3.08

53.58

ug/l

0.87

196

Patellar tendinitis

327

0.88

0.23

2.6

5.2

2.19

41.22

ug/l

0.92

263

Use of pramipexole

929

9123

1.02

0.23

3.1

4.0

9.46

24.91

ug/l

2.91

736

7458

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

257

1.14

0.23

3.9

4.8

20.86

24.54

ug/l

0.06

211

Syndactyly

1.27

0.23

1.2

4.1

1.92

12.02

ug/l

—

Testicular dysfunction

796

1.07

0.23

4.6

5.1

18.09

24.55

ug/l

0.18

669

Nasal polyp

751

7663

0.98

0.23

3.8

4.3

42.43

25.03

ug/l

0.40

610

6335

Traumatic subdural haemorrhage

557

5349

1.03

0.23

3.5

4.3

8.44

25.21

ug/l

5.34

467

4521

Other operation for atrial fibrillation

182

1.18

0.22

4.1

4.8

10.31

79.73

ug/l

0.92

157

Female infertility, associated with anovulation

130

1234

1.06

0.22

3.0

3.7

7.34

45.15

ug/l

0.63

833

Scleritis and episcleritis

170

1776

0.95

0.22

3.7

4.1

7.45

23.78

ug/l

1.66

131

1410

Viral haemorrhagic fevers, not elsewhere classified/unspecified

258

2491

1.04

0.22

3.8

4.3

13.07

23.08

ug/l

0.91

207

2044

Felty syndrome

201

1.16

0.22

4.2

3.7

6.74

10.44

ug/l

0.45

171

Mosquito-borne viral encephalitis

0.00

0.22

0.0

5.7

—

3.27

—

Epileptic seizures related to alcohol

182

1.17

0.22

3.0

5.3

18.73

78.17

ug/l

0.69

156

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

154

1.19

0.22

4.6

4.7

3.21

73.20

ug/l

0.79

132

Disorders of optic nerve, not elsewhere classified

672

1.08

0.22

3.1

4.2

4.37

29.89

ug/l

1.41

573

Polyp of middle ear

1.21

0.22

4.0

4.4

19.06

11.91

ug/l

—

Other meningitis

401

1.10

0.22

3.6

4.0

2.56

17.69

ug/l

0.79

325

Drug-induced tremor

192

1.16

0.21

1.5

4.2

3.14

29.41

ug/l

0.59

150

Other disorders of optic disc

325

1.12

0.21

4.4

4.2

2.54

39.67

ug/l

0.88

269

Conductive hearing loss, unspecified

280

2710

1.04

0.21

3.8

4.1

8.22

29.31

ug/l

2.52

222

2187

Other disorders of the musculoskeletal system and connective tissue

554

5416

1.03

0.21

3.0

4.0

40.87

25.06

ug/l

0.32

456

4391

Dermatitis herpetiformis

566

1.09

0.21

3.6

4.2

2.76

32.47

ug/l

1.37

481

Focal brain injury

220

2282

0.96

0.21

3.1

4.7

7.53

22.62

ug/l

2.53

175

1904

Bulimia nervosa (incl. atypical)

430

1.10

0.21

2.1

3.8

2.03

19.20

ug/l

0.77

291

Graves ophthalmopathy, strict

636

0.92

0.21

2.9

4.2

11.80

15.17

ug/l

0.16

514

Spontaneous rupture of synovium and tendon

314

3046

1.03

0.21

3.8

4.3

4.30

27.23

ug/l

4.75

250

2463

Other strabismus

661

6729

0.98

0.21

3.3

4.0

6.01

27.78

ug/l

3.09

505

5277

Ischaemic heart disease, wide definition

4005

24852

1.01

0.21

3.4

4.3

20.74

26.44

ug/l

0.48

3264

20307

Burn and corrosion of wrist and hand

857

1.07

0.21

4.0

4.5

8.09

24.06

ug/l

0.88

702

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

173

1804

0.96

0.21

2.9

3.7

5.80

32.43

ug/l

0.71

126

1284

Chronic mastoiditis

858

1.07

0.21

3.1

4.2

13.78

26.56

ug/l

0.50

721

Bipolar affective disorders

548

5357

1.02

0.21

3.0

4.2

7.62

27.91

ug/l

2.10

438

4118

Other juvenile arthritis

667

0.93

0.21

3.9

4.4

8.71

29.42

ug/l

0.82

514

Chondrolysis

0.00

0.21

0.0

4.1

—

2.01

—

Benign neoplasm: Short bones of upper limb

422

1.10

0.21

4.1

4.4

13.59

19.04

ug/l

0.16

348

Operations for atrial fibrillation

531

0.91

0.21

3.5

4.7

5.75

36.98

ug/l

1.31

453

Recurrent and persistent haematuria

221

1.14

0.21

2.8

4.1

3.43

9.90

ug/l

1.78

181

Other benign neoplasm of uterus: Corpus uteri

269

1.13

0.21

5.1

3.7

2.89

7.61

ug/l

1.77

227

Tibial collateral bursitis [Pellegrini-Stieda]

355

1.11

0.21

3.0

4.7

3.54

20.19

ug/l

0.77

291

Premature separation of placenta [abruptio placentae]

499

1.09

0.21

3.4

3.9

3.30

79.65

ug/l

0.55

366

Hereditary ataxia

386

0.90

0.21

4.3

4.6

4.51

39.81

ug/l

1.08

331

Injury of nerves at shoulder and upper arm level

307

1.12

0.21

2.6

5.0

19.19

50.58

ug/l

0.56

260

Migraine with aura, drug-induced

292

0.88

0.20

2.7

3.9

3.82

23.48

ug/l

0.73

236

Other and unspecified pemphigoid

298

1.12

0.20

4.1

4.2

5.09

44.51

ug/l

0.89

255

Other vitreous opacities

136

1299

1.05

0.20

3.2

4.2

7.86

23.95

ug/l

1.30

106

1062

Follicular adenocarcinoma of thyroid gland

193

1.16

0.20

3.7

4.4

2.68

31.03

ug/l

0.67

153

Emotional disorders and disorders of social functioning with onset specific to childhood

361

0.90

0.20

2.6

3.9

3.44

6.33

ug/l

0.89

229

Sleep apnoea

4399

30057

0.99

0.20

3.4

4.2

20.28

26.23

ug/l

0.64

3483

24188

Motorcycle rider injured in other and unspecified transport accidents

107

1128

0.95

0.20

3.8

4.7

36.40

26.25

ug/l

0.12

909

Other and unspecified mental retardation

240

1.13

0.20

2.7

4.4

7.18

7.40

ug/l

0.02

180

Cardiovascular disorders originating in the perinatal period

0.00

0.20

0.0

2.2

—

2.96

—

Other (seronegative) rheumatoid arthritis, wide

767

7809

0.98

0.20

3.2

3.9

37.25

28.81

ug/l

0.20

624

6310

Type 1 diabetes, wide definition

690

6760

1.02

0.20

3.5

4.2

24.85

28.35

ug/l

0.09

582

5336

Polyarthritis, unspecified

125

1192

1.05

0.20

3.4

4.4

11.07

23.82

ug/l

0.64

102

994

Dependent personality disorder

617

1.08

0.20

3.5

4.2

22.28

14.92

ug/l

0.21

492

Allergic purpura

743

1.07

0.20

4.5

4.3

7.09

22.77

ug/l

0.81

608

Glucosamine medication

2600

20551

1.01

0.20

3.5

3.9

24.46

21.90

ug/l

0.18

2095

16912

Cytomegaloviral pneumonitis

1.17

0.20

3.7

5.2

2.67

8.25

ug/l

—

Other and unspecified atrophic disorders of skin

156

1.17

0.19

2.2

3.7

2.40

9.06

ug/l

1.51

127

Temporomandibular joint disorders, including avohilmo

1394

13738

1.01

0.19

3.1

3.9

16.33

22.48

ug/l

0.29

1038

10494

Cervical root disorders

232

1.13

0.19

2.2

4.5

2.60

61.24

ug/l

0.95

179

Hyperprolactinaemia

763

1.07

0.19

3.7

4.2

4.42

32.74

ug/l

1.47

588

Embolism and thrombosis of abdominal aorta

1.25

0.19

3.4

4.2

9.31

133.66

ug/l

—

Psoriatic arthropathies

364

3734

0.97

0.19

3.2

4.5

12.73

32.29

ug/l

1.60

299

3051

Contact with and exposure to communicable diseases

733

7433

0.98

0.19

4.0

3.9

19.76

21.59

ug/l

0.06

553

5513

Deformity of finger(s)

206

0.86

0.19

2.2

4.6

4.33

23.46

ug/l

0.93

185

Other congenital malformations of ear

137

1.17

0.19

1.1

4.3

55.26

4.66

ug/l

0.44

Atypical virus infections of central nervous system

290

1.11

0.19

5.3

4.4

15.64

20.77

ug/l

0.11

245

Disorders of orbit

139

1332

1.05

0.19

3.3

4.3

105.61

23.72

ug/l

0.49

110

1081

Villonodular synovitis (pigmented)

223

1.13

0.18

4.8

4.5

2.68

8.44

ug/l

1.76

195

Diabetic neuropathy

406

3943

1.03

0.18

3.3

3.8

32.55

21.89

ug/l

0.22

339

3309

Lichen simplex chronicus

114

1088

1.05

0.18

2.9

4.1

4.39

26.14

ug/l

1.99

901

Correction of physiology of bite - demanding therapy visit

182

1887

0.96

0.18

3.1

4.0

16.76

28.02

ug/l

0.51

144

1484

Lesion of sciatic nerve

164

1703

0.96

0.18

4.1

37.05

25.14

ug/l

0.15

145

1411

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

310

0.90

0.18

4.4

2.60

22.61

ug/l

0.85

258

Other specified/unspecified inflammatory spondylopathies

129

1235

1.05

0.18

3.6

4.5

95.88

20.83

ug/l

0.38

957

Maternal care for cervical incompetence

112

1173

0.95

0.18

3.4

4.1

88.27

10.95

ug/l

0.46

930

Deaf mutism, not elsewhere classified

163

0.85

0.18

1.9

4.6

3.05

48.28

ug/l

—

142

Heart failure and hypertrophic cardiomyopathy

578

0.93

0.18

2.1

4.2

21.68

32.70

ug/l

0.23

492

Exposure to sunlight

1.14

0.18

5.1

4.5

5.30

9.55

ug/l

—

Kissing spine

0.70

0.17

4.0

4.9

1.62

65.69

ug/l

—

Retained placenta and membranes, without haemorrhage

426

4167

1.02

0.17

4.3

3.8

16.01

28.44

ug/l

0.57

342

3199

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.74

0.17

1.6

4.0

1.60

75.42

ug/l

—

Acute bronchiolitis

627

1.06

0.17

2.6

3.7

3.48

25.79

ug/l

0.96

473

Erythema in diseases classified elsewhere

1.22

0.17

1.4

4.1

2.42

7.26

ug/l

—

Bullous pemphigoid

709

1.06

0.17

3.3

3.9

3.96

26.14

ug/l

1.32

607

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

895

9084

0.98

0.17

3.5

4.2

11.14

26.14

ug/l

1.70

693

7149

Dysplastic lesion of unknown severity of the cervix uteri

205

1.13

0.17

3.3

4.2

22.36

7.73

ug/l

0.50

163

Burn and corrosion of head and neck

516

0.93

0.17

5.7

4.8

101.74

13.39

ug/l

0.48

422

Postpartum haemorrhage due to retained placenta

278

2704

1.03

0.17

3.4

3.5

11.79

34.73

ug/l

0.86

186

1909

Noise effects on inner ear

127

1218

1.05

0.17

3.3

4.6

7.13

24.09

ug/l

1.52

1024

Drug-induced obesity

234

1.12

0.17

4.5

4.0

3.60

27.41

ug/l

0.72

193

Nonischemic cardiomyopathy

184

1903

0.96

0.17

3.7

4.5

10.61

27.72

ug/l

1.48

155

1572

Lichen sclerosus et atrophicus

375

3836

0.98

0.17

3.5

3.9

5.69

25.36

ug/l

2.61

290

3075

Mental and behavioural disorders due to hallucinogens

0.71

0.17

3.2

5.8

2.52

61.88

ug/l

—

Fasciculation

298

0.90

0.17

2.4

4.5

1.93

8.37

ug/l

3.03

245

Exposure to unspecified smoke, fire and flames

244

1.12

0.17

2.8

5.0

24.76

26.11

ug/l

0.02

205

Von Willebrand disease

321

1.10

0.17

2.4

4.1

3.64

22.10

ug/l

0.74

254

Early lumbar disc prolapse operation

208

2146

0.97

0.16

3.5

4.3

9.69

27.85

ug/l

0.55

159

1596

Maxillary retrognathism

298

0.90

0.16

3.0

4.4

7.56

22.36

ug/l

0.48

233

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

102

1067

0.95

0.16

3.7

4.0

110.98

27.39

ug/l

0.51

894

Other and unspecified rosacea

288

2807

1.03

0.16

3.3

4.0

5.89

18.83

ug/l

2.54

216

2248

Other specified disorders of muscle

877

1.05

0.16

3.7

4.5

10.14

30.57

ug/l

1.12

714

Amputation

362

3538

1.02

0.16

2.8

4.1

7.17

21.00

ug/l

2.71

308

2960

Other specified and unspecified disorders of conjunctiva

293

1.10

0.16

2.2

4.1

21.74

22.15

ug/l

0.01

246

Acute suppurative otitis media

554

5078

1.02

0.16

3.5

3.9

12.33

22.09

ug/l

0.58

387

3766

Congenital malformations of ear causing impairment of hearing

0.76

0.16

1.0

4.5

1.82

13.19

ug/l

—

Psoriasis (vulgaris), strict definition

848

1.05

0.16

3.4

4.5

59.84

16.82

ug/l

0.37

691

LSIL lesion of the vagina

390

0.92

0.16

4.0

3.9

3.38

8.54

ug/l

1.86

317

Pustulosis palmaris et plantaris

141

1359

1.04

0.16

2.6

4.2

58.05

22.12

ug/l

0.43

112

1107

Crowding of teeth, including avohilmo

115

909

1.04

0.16

2.6

3.9

9.11

11.40

ug/l

0.11

654

Type 1 diabetes, strict (exclude DM2)

180

1854

0.97

0.15

4.0

4.2

17.10

34.11

ug/l

0.37

146

1391

Carcinoma in situ of lip, oral cavity and pharynx

1.11

0.15

3.3

4.5

5.47

137.73

ug/l

—

Other sexually transmitted chlamydial diseases

790

0.95

0.15

3.9

4.2

14.80

65.70

ug/l

0.52

544

Glaucoma-related operations

204

2099

0.97

0.15

3.8

3.9

16.85

19.51

ug/l

0.11

168

1734

Disorder of external ear, unspecified

948

1.05

0.15

3.3

4.4

6.01

27.79

ug/l

1.58

792

Rheumatoid arthritis

1497

13743

0.99

0.15

3.1

4.2

26.19

28.47

ug/l

0.09

1217

11141

Benign neoplasm: Spinal cord

430

1.08

0.15

4.2

3.73

32.65

ug/l

0.95

363

Arthropathic psoriasis

387

3792

1.02

0.15

3.2

4.2

30.52

23.69

ug/l

0.14

318

3065

Acute laryngitis and tracheitis

234

2241

1.03

0.15

3.0

4.1

10.34

34.43

ug/l

0.84

171

1686

Corneal ulcer

589

5985

0.98

0.14

3.6

4.2

11.36

24.77

ug/l

1.21

483

4776

Overjet

264

1.10

0.14

3.2

3.8

22.40

6.66

ug/l

0.36

193

Muscle strain

861

1.05

0.14

3.1

4.7

6.48

29.43

ug/l

1.40

699

Burns and corrosions

376

3836

0.98

0.14

4.2

18.98

21.97

ug/l

0.09

307

3083

Plantar fascial fibromatosis

369

3617

1.02

0.14

3.3

4.2

38.25

36.98

ug/l

0.01

274

2864

Suppurative otitis media, unspecified

603

0.94

0.14

2.6

4.1

24.18

33.26

ug/l

0.14

494

Retinoschisis and retinal cysts

827

0.95

0.14

4.1

4.2

14.04

20.77

ug/l

0.33

691

Benign neoplasm: Brain, supratentorial

412

1.07

0.14

3.4

4.4

4.59

35.54

ug/l

0.93

334

Viral encephalitis, not elsewhere classified/unspecified

578

1.06

0.14

3.4

4.4

4.14

30.50

ug/l

1.19

489

Anxious personality disorder

334

1.08

0.14

2.2

4.5

6.34

19.44

ug/l

0.48

265

Disorders of myoneural junction and muscle in diseases classified elsewhere

257

1.10

0.14

2.6

4.2

3.19

24.19

ug/l

0.70

215

Allergic contact dermatitis due to drugs in contact with skin

676

1.06

0.14

3.4

4.1

5.74

15.30

ug/l

0.84

553

Memory loss

367

3600

1.02

0.14

3.1

4.0

4.47

21.84

ug/l

5.57

276

2989

Anorexia (incl.atypical)

111

1152

0.96

0.13

2.8

3.9

7.53

23.29

ug/l

0.94

856

Brachial plexus disorders

270

2762

0.98

0.13

3.3

4.1

6.88

31.25

ug/l

1.19

212

2130

Other infiltrative disorders of skin and subcutaneous tissue

161

1.13

0.13

3.7

4.6

3.29

12.60

ug/l

2.03

132

Venous complications and haemorrhoids in pregnancy

286

1.09

0.13

3.6

3.8

2.79

133.19

ug/l

0.52

205

Acute otitis externa, noninfective

489

0.94

0.13

3.0

4.2

3.68

22.15

ug/l

1.16

407

Major anomalies of jaw size

663

0.95

0.13

4.3

4.4

3.69

17.98

ug/l

1.16

528

Cardiomyopathies, Primary/intrinsic

479

4712

1.02

0.13

3.1

4.6

9.83

24.86

ug/l

3.18

391

3982

Caries in Clefts patients

159

0.88

0.13

2.9

4.5

228.43

33.87

ug/l

—

124

Use of glatiramer acetate

304

0.92

0.13

2.0

4.2

2.47

7.30

ug/l

2.11

229

Other hammer toe(s) (acquired)

832

7893

0.99

0.13

3.3

4.1

12.74

25.41

ug/l

1.24

665

6499

Use of antiglaucoma preparations and miotics

307

3133

0.98

0.13

3.5

3.7

22.48

23.87

ug/l

0.04

251

2592

Haemorrhage in early pregnancy

950

9165

1.01

0.13

3.2

3.7

12.95

21.02

ug/l

0.69

674

6827

Personal history of risk-factors, not elsewhere classified

252

0.91

0.13

2.2

4.5

11.12

22.72

ug/l

0.26

202

Perichondritis of external ear

580

1.06

0.13

3.7

4.1

12.41

32.46

ug/l

0.69

495

Donors of organs and tissues

258

1.09

0.12

2.6

4.4

139.52

5.33

ug/l

0.48

206

Foreign body on external eye

427

4199

1.02

0.12

3.4

4.6

15.88

25.66

ug/l

0.46

343

3469

Vascular dementia (mixed)

467

0.94

0.12

2.6

3.8

5.33

33.99

ug/l

1.05

403

Infections of genitourinary tract in pregnancy

282

2762

1.02

0.12

3.0

3.7

5.28

38.72

ug/l

1.53

217

2093

Hypermetropia

175

1797

0.97

0.12

3.9

4.1

2.84

18.81

ug/l

2.63

134

1440

Myasthenia gravis

538

0.94

0.12

3.5

4.1

26.03

34.56

ug/l

0.13

452

CR(E)ST syndrome

493

1.06

0.12

2.3

3.8

5.05

8.79

ug/l

1.19

401

Use of rotigotine

374

0.93

0.12

2.9

4.1

2.33

42.70

ug/l

1.19

318

Toxic effects of substances chiefly nonmedicinal as to source

317

3110

1.02

0.12

3.7

4.2

8.03

20.71

ug/l

2.19

262

2490

Disorders of refraction and accommodation

821

8085

1.01

0.12

3.7

4.1

23.66

26.84

ug/l

0.09

603

6338

Struck by thrown, projected or falling objec

115

1189

0.97

0.12

4.2

4.5

3.81

24.30

ug/l

2.07

977

Foreign body in ear

456

0.94

0.12

4.3

4.5

5.84

16.73

ug/l

0.59

376

Calcaneal spur

425

1.07

0.12

2.5

4.4

26.77

18.90

ug/l

0.12

341

Dissection of aorta

102

1056

0.96

0.12

3.9

4.2

5.87

24.99

ug/l

1.62

889

Primary open-angle glaucoma

1475

14486

0.99

0.11

3.7

3.8

19.48

22.24

ug/l

0.14

1233

11988

Migraine, unspecified, drug-induced

209

0.90

0.11

2.4

3.8

2.26

8.68

ug/l

1.88

170

Osteomalacia

240

1.09

0.11

3.7

4.4

77.40

25.67

ug/l

0.30

192

Peritonsillar abscess

656

6479

1.01

0.11

4.5

4.2

20.87

28.85

ug/l

0.24

544

5077

Intrahepatic Cholestasis of Pregnancy (ICP)

147

1429

1.03

0.11

4.6

3.6

35.47

37.55

ug/l

0.02

107

1005

Other and unspecified mononeuropathies of lower limb

927

1.04

0.11

2.9

4.4

8.24

24.25

ug/l

0.99

753

Family history of certain disabilities and chronic diseases leading to disablement

887

1.04

0.11

3.5

4.0

17.51

20.81

ug/l

0.10

684

Ulcer of oesophagus, drug-induced

163

1.12

0.11

3.3

4.6

4.21

74.33

ug/l

0.85

139

Juvenile Open Angle Glaucoma

136

0.88

0.11

1.5

4.5

2.03

37.99

ug/l

—

113

Foreign body or object entering through skin

167

1628

1.03

0.11

3.8

4.4

67.94

22.74

ug/l

0.48

137

1332

Lichen planus

508

5012

1.02

0.11

3.4

3.9

34.29

23.55

ug/l

0.19

393

4071

Injury of muscle and tendon at lower leg level

520

5131

1.01

0.11

4.1

4.4

14.58

23.32

ug/l

0.77

403

4222

Ischaemic Stroke, excluding all haemorrhages

2790

20972

1.01

0.11

3.4

4.1

31.97

24.66

ug/l

0.29

2331

17352

Strabismus

870

8771

0.99

0.10

3.3

4.0

6.18

26.95

ug/l

4.28

681

6954

Unspecified abortion

155

1590

0.97

0.10

3.9

3.8

5.10

17.32

ug/l

0.90

107

1207

Perioral dermatitis

505

1.05

0.10

1.9

3.9

40.38

7.76

ug/l

0.44

394

Pedal cyclist injured in other and unspecified transport accidents

335

3295

1.02

0.10

3.6

4.1

8.96

23.83

ug/l

1.85

271

2655

Other congenital malformations of peripheral vascular system

280

1.08

0.10

2.3

4.1

3.12

25.18

ug/l

0.81

227

Cervicobrachial syndrome

872

8805

0.99

0.10

3.3

4.3

5.16

28.47

ug/l

5.22

717

6993

Injuries to the ankle and foot

2599

23538

1.01

0.10

3.5

4.0

14.97

24.91

ug/l

1.51

2015

18450

Pedal cyclist injured in transport accident

720

7123

1.01

0.10

3.5

4.2

7.03

30.28

ug/l

3.52

576

5681

Carcinoma in situ of oral cavity and pharynx

1.18

0.10

3.6

4.7

2.00

13.43

ug/l

—

Pigmented purpuric dermatosis

310

1.07

0.10

3.8

4.4

7.03

9.81

ug/l

0.35

259

Lichen ruber planus, wide definition including periferal and oral lichen planus

849

8571

0.99

0.10

3.3

4.0

25.26

21.93

ug/l

0.09

663

6944

Benign neoplasm of male genital organs

636

0.96

0.10

4.2

4.4

4.47

35.48

ug/l

1.58

536

Lower leg

164

1.11

0.10

2.7

4.0

4.52

7.93

ug/l

0.48

128

Visual field defects

291

2959

0.98

0.10

3.6

4.1

48.32

21.52

ug/l

0.38

240

2429

Other keratitis

326

3312

0.98

0.10

3.4

4.1

13.04

29.65

ug/l

0.78

258

2654

Congenital malformations of aortic and mitral valves

1001

0.97

0.10

3.4

4.4

3.09

21.87

ug/l

1.56

824

Ankyloglossia

1.14

0.10

3.5

3.6

1.72

2.93

ug/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

132

1286

1.03

0.10

3.6

4.3

67.23

22.96

ug/l

0.33

106

1060

Routine general health check-up of defined subpopulation

473

0.95

0.10

3.4

4.1

20.97

7.82

ug/l

0.41

352

Disorders of pituitary gland, other and/or unspecified

174

1.10

0.10

4.6

4.1

232.09

8.06

ug/l

0.46

142

Superficial injury of neck

369

1.06

0.09

3.7

4.6

3.69

20.15

ug/l

0.78

296

Internal derangement of knee

1614

16204

0.99

0.09

3.9

4.3

20.68

31.20

ug/l

0.90

1276

13076

Exposure to other and unspecified man-made environmental factors

381

0.94

0.09

3.2

4.4

2.52

36.79

ug/l

0.98

313

Cerebral oedema

1.07

0.09

5.2

4.6

10.02

10.69

ug/l

—

Leukaemia of unspecified cell type

252

1.08

0.09

3.9

4.3

3.71

64.15

ug/l

1.14

206

Burns and corrosions of external body surface, specified by site

288

2928

0.98

0.09

4.2

21.28

21.47

ug/l

0.00

236

2350

Early lumbar disc prolapse, operated

206

2101

0.98

0.09

3.5

4.6

9.79

31.84

ug/l

0.69

157

1572

Keratoconus

586

1.04

0.09

3.9

4.8

7.14

30.60

ug/l

0.96

483

Rickettsioses

1.10

0.09

1.5

4.7

1.88

132.58

ug/l

—

Dacryoadenitis

243

1.08

0.09

2.8

4.4

13.09

24.94

ug/l

0.28

206

Medial epicondylitis

124

1209

1.03

0.09

3.5

4.5

15.92

26.76

ug/l

0.32

102

956

Acute alcohol intoxication ICD-9

115

1120

1.03

0.09

3.7

4.4

25.59

23.18

ug/l

0.07

100

923

Ankylosing hyperostosis [Forestier]

459

1.05

0.09

4.0

4.8

5.73

33.70

ug/l

0.98

387

Burn and corrosion of trunk

806

0.97

0.09

4.6

4.5

7.76

30.05

ug/l

1.25

675

Contact with sharp object, undetermined intent

459

1.05

0.08

3.9

4.8

9.12

36.51

ug/l

0.81

374

Other disorders of central nervous system

308

0.94

0.08

2.9

4.5

10.10

44.92

ug/l

0.70

249

Impacted maxillary molar

573

0.96

0.08

2.9

3.9

2.17

13.43

ug/l

0.69

394

Somnolence

308

0.94

0.08

2.8

3.8

3.06

46.87

ug/l

0.98

245

Simple and mucopurulent chronic bronchitis

142

1388

1.02

0.08

3.5

3.9

6.86

25.25

ug/l

1.75

122

1164

Other psoriatic arthropathies

334

3386

0.99

0.08

3.1

4.2

13.58

24.47

ug/l

0.80

274

2725

Localized scleroderma [morphea]

440

0.95

0.08

2.7

3.8

71.05

19.21

ug/l

0.34

360

Background retinopathy and retinal vascular changes

637

1.04

0.08

3.0

4.3

144.86

18.40

ug/l

0.43

542

Generalized epilepsy, mode (most common among epilepsy diagnosis)

696

1.04

0.08

4.5

4.3

19.97

29.85

ug/l

0.28

562

Cramp and spasm

123

1260

0.97

0.08

3.6

4.2

5.75

20.11

ug/l

1.27

102

1016

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

297

3013

0.98

0.08

3.2

3.8

16.74

37.06

ug/l

0.55

223

2323

Injury of blood vessels at shoulder and upper arm level

0.84

0.08

1.5

5.7

4.07

71.36

ug/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

531

1.04

0.08

2.8

4.0

2.70

5.91

ug/l

2.12

366

Exposure to other specified electric current

205

1.08

0.08

2.5

5.2

17.76

29.33

ug/l

0.18

165

Contact with other sharp object(s)

145

1420

1.02

0.08

3.5

4.4

10.89

19.61

ug/l

0.56

116

1137

Injury of nerves at forearm level

323

1.06

0.07

4.0

5.1

8.94

29.00

ug/l

0.65

261

Motorcycle rider injured in noncollision transport accidents

591

0.96

0.07

3.4

4.8

3.41

18.30

ug/l

1.06

473

Type 1 diabetes, definitions combined

183

1858

0.98

0.07

4.0

4.2

16.81

34.09

ug/l

0.38

149

1392

Benign neoplasm: Bones of skull and face

286

0.94

0.07

3.2

4.1

191.66

44.07

ug/l

0.49

240

Lichen planus, including avohilmo

725

7308

0.99

0.07

3.3

4.0

28.74

23.58

ug/l

0.12

567

5949

Atopic dermatitis, strict definition with reimbursement

817

7860

1.01

0.07

3.4

4.0

50.77

23.47

ug/l

0.52

632

5916

Scissor bite

273

1.06

0.07

4.7

4.0

4.60

24.95

ug/l

0.61

201

Flat foot [pes planus] (acquired)

368

3638

1.01

0.07

3.6

4.3

6.40

29.76

ug/l

2.91

282

2937

Burns and corrosions confined to eye and internal organs

639

1.04

0.07

3.1

4.7

5.12

22.69

ug/l

0.86

518

Localized adiposity

157

1.09

0.07

5.1

4.4

7.29

7.14

ug/l

0.01

123

Other bursal cyst

529

0.96

0.07

2.7

4.7

59.58

34.67

ug/l

0.18

432

Other specified and unspecified disorders of eyelid

452

1.04

0.07

3.8

4.5

3.69

34.81

ug/l

1.12

380

Certain conditions originating in the perinatal period

102

882

1.03

0.07

3.4

3.8

3.29

13.10

ug/l

1.08

632

Amblyopia ex anopsia

897

1.03

0.07

3.4

4.3

2.65

17.46

ug/l

1.89

728

Burn and corrosion of hip and lower limb, except ankle and foot

559

0.96

0.07

2.9

4.5

3.80

33.27

ug/l

1.29

468

Erythema multiforme

660

1.03

0.07

3.3

4.1

13.66

31.50

ug/l

0.53

544

Subacute thyroiditis

110

1124

0.98

0.06

3.3

4.2

8.49

24.65

ug/l

1.15

902

Obstructive hydrocephalus

437

0.96

0.06

4.3

4.0

6.73

32.11

ug/l

0.80

370

Open wound of hip and thigh

779

1.03

0.06

3.2

4.7

4.22

31.75

ug/l

1.70

637

Open wounds involving multiple body regions

104

0.86

0.06

1.4

4.5

2.26

6.77

ug/l

—

Divergent concomitant strabismus

218

2211

0.98

0.06

2.9

4.1

8.78

19.95

ug/l

1.33

156

1755

Hypothermia

552

1.04

0.06

3.2

4.4

11.28

30.45

ug/l

0.66

464

Tetraplegia

197

1.07

0.06

3.7

4.5

7.40

30.61

ug/l

0.53

158

Generalized epilepsy, strict definition

453

1.04

0.06

4.6

4.3

3.54

41.32

ug/l

1.34

374

Other intracranial haemorrhages

108

1058

1.02

0.06

4.2

4.0

54.46

33.12

ug/l

0.25

896

Optic atrophy

507

0.96

0.06

4.1

4.5

191.09

34.00

ug/l

0.40

421

Pedal cyclist injured in collision with motor vehicle

810

0.97

0.06

3.1

4.3

13.08

27.17

ug/l

0.51

666

Other and unspecified intracranial injuries

830

1.03

0.06

3.2

4.2

5.76

28.36

ug/l

1.53

694

Postpartum haemorrhage due to anatomy

159

1616

0.98

0.06

3.2

3.4

41.60

35.22

ug/l

0.06

104

1066

Other drug-induced secondary parkinsonism

296

1.05

0.06

2.5

4.5

2.88

30.62

ug/l

1.05

252

Other disorders starting during childhood or adolescence

401

1.04

0.06

2.6

3.7

2.63

6.29

ug/l

1.63

259

Status epilepticus

111

1089

1.02

0.05

2.9

4.4

10.78

23.92

ug/l

0.74

900

Hyperkinetic disorders (excl. ADHD)

150

0.92

0.05

1.1

4.6

1.92

6.01

ug/l

—

110

Diabetes insipidus

263

0.95

0.05

3.2

4.0

3.68

48.35

ug/l

0.86

219

167

1640

1.02

0.05

2.8

3.6

6.43

23.64

ug/l

2.06

141

1372

Other overlap syndromes

524

1.03

0.05

2.7

3.9

2.96

18.08

ug/l

1.16

429

Abscess of external ear

354

0.96

0.05

2.7

4.3

4.56

42.74

ug/l

1.01

291

Sexual dysfunction

354

0.96

0.05

3.7

5.3

2.93

45.64

ug/l

1.14

292

Otosclerosis

288

2851

1.01

0.05

3.8

4.1

21.24

22.59

ug/l

0.04

244

2314

Toxic effect of alcohol

576

0.97

0.05

4.0

4.7

4.72

33.05

ug/l

1.25

479

Dislocation, sprain and strain of joints and ligaments of elbow

160

1577

1.02

0.05

3.4

4.2

16.04

17.72

ug/l

0.08

121

1246

Beningn neoplasm: Meninges, unspecified

505

0.97

0.05

2.8

4.0

12.51

16.41

ug/l

0.14

427

Pulmonary oedema

535

0.97

0.05

4.0

4.1

4.58

31.24

ug/l

1.14

455

Isolated proteinuria with specified morphological lesion

333

0.96

0.05

3.4

4.0

3.48

45.19

ug/l

1.07

278

KRA_PSY_EATING, excluding more controls

116

1176

0.98

0.05

2.5

3.7

28.51

44.23

ug/l

0.15

788

Benign neoplasm: Pituitary gland, craniopharyngeal duct

147

1449

1.02

0.05

3.8

4.2

100.21

25.51

ug/l

0.59

111

1177

Neurological diseases

4262

21409

1.00

0.05

3.6

4.4

18.89

27.55

ug/l

1.11

3380

16992

Biomechanical lesions, not elsewhere classified

157

1549

1.01

0.05

2.9

4.2

6.99

21.38

ug/l

1.62

129

1274

ILD medications: nintedanib

199

1.06

0.05

1.6

5.5

14.06

42.92

ug/l

0.56

169

Valvular operations

571

5675

1.01

0.05

3.1

4.5

32.15

25.70

ug/l

0.16

460

4809

Myocardial infarction, without ST-elevation

1839

16911

1.00

0.04

3.3

4.0

8.73

28.68

ug/l

10.10

1526

14121

Migraine with aura

742

7458

0.99

0.04

3.1

4.0

6.22

24.15

ug/l

2.63

544

5672

Childhood allergy (age < 16)

784

1.02

0.04

2.7

3.5

3.96

4.36

ug/l

0.07

436

Other and unspecified bullous disorders

298

1.04

0.04

3.5

4.1

15.98

35.95

ug/l

0.34

251

Other secondary gonarthrosis

184

1819

1.01

0.04

3.4

4.3

22.79

21.80

ug/l

0.03

152

1518

Chronic suppurative otitis media

202

1998

1.01

0.04

3.7

4.2

15.99

17.45

ug/l

0.06

153

1632

Third [oculomotor] nerve palsy

584

0.97

0.04

3.4

4.2

10.33

33.42

ug/l

0.87

492

Poisoning by medicine, drug-induced

338

1.04

0.04

3.8

4.2

2.42

19.61

ug/l

0.73

269

Supervision of normal pregnancy

541

3111

0.99

0.04

3.5

3.4

33.44

15.19

ug/l

0.60

358

2209

Mesial bite

160

1.07

0.04

2.4

4.5

4.29

36.13

ug/l

—

124

Other and unspecified trigeminal disorders

483

0.97

0.04

2.3

4.3

2.81

17.31

ug/l

0.97

394

FESS (DNB20)

404

4067

0.99

0.04

3.1

4.2

5.67

31.81

ug/l

2.34

324

3254

Disorders of brain, other and unspecified

279

1.04

0.04

2.8

4.3

40.01

53.75

ug/l

0.11

233

Other eating disorders

646

1.02

0.04

2.4

3.6

46.88

23.85

ug/l

0.21

447

Hyphaema and other vascular disorders of iris and ciliary body

563

0.97

0.04

3.5

4.2

5.18

33.31

ug/l

1.26

480

Myopia

306

3083

0.99

0.04

3.4

4.1

48.98

27.74

ug/l

0.26

208

2387

severe traumatic brain injury, does not include concussion

842

8385

1.00

0.03

3.5

4.0

7.87

22.46

ug/l

5.96

683

6973

Myotonic disorders

220

0.95

0.03

3.0

4.4

8.79

59.05

ug/l

0.75

179

Certolizumab pegol

321

0.96

0.03

3.6

4.0

3.07

8.25

ug/l

1.88

257

Psoriatic arthropathies, ICD10

348

3503

0.99

0.03

3.2

4.2

13.20

24.49

ug/l

0.89

286

2823

Heterophoria

210

2081

1.01

0.03

3.6

4.1

4.10

20.99

ug/l

2.91

157

1635

Other congenital malformations, not elsewhere classified

139

0.93

0.03

4.0

4.1

3.17

11.21

ug/l

—

107

Correction of physiology of bite - very demanding therapy visit

683

0.98

0.03

2.2

4.1

10.21

29.03

ug/l

0.69

539

Contusion of ankle

874

0.98

0.03

2.6

4.2

39.95

22.98

ug/l

0.28

705

Inflammation of lacrimal passages (acute and unspecified)

532

0.98

0.03

4.2

4.0

13.39

28.35

ug/l

0.41

438

Frostbite

250

0.96

0.03

2.0

4.6

2.78

28.41

ug/l

0.87

205

Impacted teeth

258

2382

1.01

0.03

3.9

3.95

33.20

ug/l

1.12

186

1659

Other specified and unspecified strabismus

270

1.04

0.03

4.1

4.4

5.38

6.91

ug/l

0.18

231

171

1.06

0.03

2.6

4.6

7.41

34.53

ug/l

0.57

143

Renal tubulo-interstitial disorders in diseases classified elsewhere

300

1.04

0.03

2.3

4.5

3.35

41.73

ug/l

0.87

258

Increased muscle tone

181

1.05

0.03

1.9

4.5

2.55

42.08

ug/l

0.56

155

Hypersensitivity pneumonitis due to organic dust

529

1.02

0.03

3.0

4.3

20.75

34.63

ug/l

0.31

447

Hypopituitarism

167

1654

1.01

0.03

3.2

4.5

43.16

20.71

ug/l

0.35

125

1351

Burn and corrosion confined to eye and adnexa

539

1.02

0.03

3.3

4.8

5.80

19.46

ug/l

0.79

438

Diffuse brain injury

109

1077

1.01

0.03

3.5

4.8

5.43

31.98

ug/l

2.18

883

Multiple gestation

221

2194

1.01

0.02

3.1

3.5

21.85

27.36

ug/l

0.10

154

1537

Exposure to other and unspecified forces of nature

138

0.94

0.02

3.2

4.3

3.14

93.96

ug/l

0.88

110

Other deformities of toe(s)

126

1273

0.99

0.02

3.2

4.3

15.46

31.84

ug/l

0.75

1047

Vascular syndromes of brain in cerebrovascular disorders

166

1646

1.01

0.02

3.3

4.1

8.99

24.87

ug/l

1.36

145

1382

Other endophthalmitis

148

0.94

0.02

2.9

4.1

2.53

8.99

ug/l

—

119

Twin gestation

211

2095

1.01

0.02

3.2

3.5

22.77

27.97

ug/l

0.09

147

1475

Prepatellar bursitis

142

1433

0.99

0.02

3.2

4.7

65.76

34.48

ug/l

0.27

113

1195

Abnormalities of forces of labour

286

2876

0.99

0.02

3.6

3.7

24.62

29.33

ug/l

0.08

203

2100

Cardiac arrest

229

1985

0.99

0.02

3.0

4.5

3.85

19.88

ug/l

2.98

196

1654

Diabetic nephropathy

573

5637

1.00

0.02

3.0

3.8

15.13

23.47

ug/l

0.79

489

4725

Other disorders of breast and lactation associated with childbirth

228

0.96

0.02

2.6

3.9

2.20

9.37

ug/l

1.77

164

Ethmoidectomy

425

4234

1.00

0.02

3.2

4.2

5.79

31.17

ug/l

2.38

343

3389

Polypectomy (DHB20)

224

2227

1.01

0.02

3.7

4.3

49.48

24.83

ug/l

0.48

176

1845

Helminthiases

489

0.98

0.02

4.0

4.1

3.19

32.81

ug/l

1.14

409

Migraine without aura, drug-induced

268

0.97

0.02

2.7

3.7

4.68

7.64

ug/l

0.52

214

Trigeminal neuralgia

195

1962

0.99

0.02

3.1

4.1

20.31

22.29

ug/l

0.05

152

1572

Xanthelasma of eyelid

312

1.03

0.02

1.9

4.2

2.46

21.21

ug/l

0.79

262

Calcific tendinitis

328

0.97

0.02

2.1

5.2

7.17

49.10

ug/l

0.98

270

Adult respiratory distress syndrome

392

1.02

0.01

2.7

4.3

5.42

40.58

ug/l

1.04

324

Hypertrophic cardiomyopathy

128

1290

0.99

0.01

3.1

4.2

15.70

23.04

ug/l

0.34

112

1073

Aortic valve malfunction, age under 60 years

281

2798

1.00

0.01

3.9

4.5

38.82

18.84

ug/l

0.31

221

2301

Paranoid personality disorder

462

1.02

0.01

2.3

4.3

25.86

36.76

ug/l

0.15

379

Lesion of femoral nerve

267

0.97

0.01

2.5

4.3

4.24

7.23

ug/l

0.66

218

Other disorders of iris and ciliary body

758

0.99

0.01

3.2

4.2

5.71

27.13

ug/l

1.25

633

327

0.98

0.01

2.7

4.5

5.78

41.41

ug/l

0.84

272

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

347

0.98

0.01

4.2

5.1

5.80

25.40

ug/l

0.74

283

HSIL lesion of the vagina

393

1.02

0.01

3.9

3.8

2.87

9.84

ug/l

2.72

317

Other specified/unspecified necrotizing vasculopathies

437

0.98

0.01

2.1

4.2

3.87

35.30

ug/l

1.08

370

Lupus erythematosus

783

1.01

0.01

3.8

4.0

8.41

27.88

ug/l

1.00

637

Mixed specific developmental disorders

106

1.05

0.01

3.1

3.4

1.87

2.10

ug/l

—

Acquired clawhand, clubhand, clawfoot and clubfoot

134

1.05

0.00

4.8

4.5

2.46

11.00

ug/l

—

118

Cleft palate

156

0.96

0.00

2.7

4.1

204.42

9.62

ug/l

—

120

Pityriasis rosea

176

0.96

0.00

2.1

4.0

3.22

6.67

ug/l

1.08

135

Normotensive glaucoma

346

3467

1.00

0.00

3.7

3.8

7.34

24.28

ug/l

3.21

283

2845

Isolated proteinuria

804

1.01

0.00

3.1

4.5

5.13

28.50

ug/l

1.44

665

Rosacea

383

3824

1.00

0.00

3.1

3.9

10.18

28.08

ug/l

1.01

292

3025

Cardiomyopathy (excluding other)

488

4874

1.00

0.00

3.2

4.6

9.67

23.58

ug/l

2.95

400

4112

Generalized epilepsy

981

1.00

0.00

4.3

15.50

23.16

ug/l

0.30

782

Other obstructed labour

229

2295

1.00

0.00

3.4

3.9

53.91

32.24

ug/l

0.19

171

1747

Poor fetal growth

228

2285

1.00

0.00

3.5

3.4

7.54

27.40

ug/l

0.60

158

1531

Universal erythroderma, KELA reimbursement

425

1.01

0.00

3.5

4.7

10.22

40.07

ug/l

0.84

353

Other lack of coordination

515

0.99

0.00

2.8

4.2

15.76

36.02

ug/l

0.51

431

Injury of muscle and tendon at forearm level

486

1.01

0.00

3.2

4.8

42.65

22.19

ug/l

0.37

397

Benign neoplasm: Connective and other soft tissue of head, face and neck

494

0.99

0.00

4.6

4.2

14.77

37.94

ug/l

0.67

410

Contact with lifting and transmission devices, not elsewhere classified

483

0.99

0.00

4.6

4.8

5.69

43.13

ug/l

1.38

404

Pityriasis lichenoides chronica

116

1.04

0.00

2.3

4.6

704.10

63.63

ug/l

—

101

Degeneration of the brain due to alcohol

737

1.00

0.00

2.4

4.4

10.81

32.05

ug/l

0.93

618

Adhesive middle ear disease

418

1.01

0.00

3.2

4.5

25.04

40.98

ug/l

0.29

349

Malignant neoplasm of lip

242

0.99

0.00

2.7

4.2

3.14

60.05

ug/l

1.11

208

Pyogenic granuloma

462

1.00

0.00

3.0

4.1

8.38

35.23

ug/l

0.88

386

Contact with other and unspecified heat and hot substances

151

0.99

0.00

4.4

4.8

3.11

9.28

ug/l

—

123

Acute myeloid leukaemia and myelodysplastic syndromes

558

1.00

0.00

2.9

4.0

3.53

34.48

ug/l

1.43

476

Testicular hypofunction

708

1.00

0.00

4.7

5.1

20.97

24.05

ug/l

0.07

594

Unspecified nephritic syndrome

678

1.00

0.00

3.8

4.3

4.64

25.47

ug/l

1.09

566

Degeneration of nervous system due to alcohol

738

1.00

0.00

2.4

4.4

10.81

32.08

ug/l

0.93

618

Mumps

742

1.00

0.00

3.6

4.3

24.52

29.25

ug/l

0.08

597

Myelodysplastic syndrome

261

1.00

0.00

2.2

4.2

3.75

40.08

ug/l

0.79

222

Disorder of the sleep-wake schedule

351

1.00

0.00

2.7

4.5

3.46

19.29

ug/l

0.71

287

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

225

2248

1.00

0.00

3.0

4.4

14.48

44.31

ug/l

1.00

174

1761

Adult-onset Still disease

1.03

0.00

2.6

3.9

1.22

10.04

ug/l

—

Presbyopia

197

1967

1.00

0.00

3.7

4.2

65.18

20.75

ug/l

0.46

152

1578

Other and unspecified corneal deformities and disorders

937

1.00

0.00

4.7

4.3

6.84

27.52

ug/l

1.37

758

Mastocytosis

163

0.98

0.00

2.3

4.8

2.98

9.29

ug/l

1.29

130

Corneal scars and opacities

825

1.01

0.00

4.3

27.51

28.73

ug/l

0.02

695

Other papulosquamous disorders

313

0.99

0.00

3.7

4.3

18.61

22.16

ug/l

0.08

259

Peripheral artery operations in Hilmo

485

4848

1.00

0.00

2.9

4.1

8.30

17.71

ug/l

2.78

415

4039

Traumatic amputation of wrist and hand

133

1325

1.00

0.00

4.5

12.72

32.81

ug/l

1.09

112

1101

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

139

1385

1.00

0.00

3.5

4.2

63.13

19.56

ug/l

0.33

118

1130

Cutis laxa senilis

275

1.02

0.00

2.2

3.8

29.33

6.14

ug/l

0.66

230

Chronic suppurative otitis media, including avohilmo

233

2327

1.00

0.00

3.6

4.1

31.98

17.35

ug/l

0.35

179

1894

Acute myeloid leukaemia

305

0.98

0.00

3.6

4.0

3.35

49.40

ug/l

1.12

259

Aphakia

424

0.99

0.00

2.9

4.1

5.87

21.65

ug/l

0.74

361

Thyrotoxicosis with toxic single thyroid nodule

266

1.02

0.00

1.7

4.0

2.72

49.19

ug/l

0.90

218

Benign neoplasm: Short bones of lower limb

284

0.98

0.00

3.7

4.3

7.08

46.29

ug/l

0.77

233

Abscess of tendon sheath

185

1.03

0.00

3.2

4.6

1.86

7.89

ug/l

1.78

153

Thrombotic microangiopathy

165

1.03

0.00

1.8

4.3

2.48

78.60

ug/l

0.92

135

Ankylosis of joint

168

1.01

0.00

3.4

4.5

4.15

68.22

ug/l

0.97

154

Other and unspecified localized connective tissue disorders

105

1.05

0.00

2.8

4.0

5.57

8.10

ug/l

—

Megavitamin-B6 syndrome

0.00

0.0

5.6

—

3.04

—

Carcinoma in situ of larynx

0.93

0.00

3.0

4.8

12.28

68.16

ug/l

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

0.0

5.6

—

2.28

—

Epileptic seizures related to drugs

0.92

0.00

1.4

3.9

2.66

6.94

ug/l

—

Cytomegaloviral hepatitis

0.90

0.00

2.5

4.4

5.05

58.75

ug/l

—

Lipoprotein deficiency

0.93

0.00

4.2

2.68

6.09

ug/l

—

Atrioventricular septal defect

0.93

0.00

2.7

4.6

2.24

10.80

ug/l

—

Paracoccidioidomycosis

0.00

0.0

5.1

—

21.69

—

Bullous disorders in diseases classified elsewhere

0.00

0.0

4.0

—

24.06

—

Folliculitis decalvans

0.92

0.00

2.8

3.5

2.20

13.17

ug/l

—

Pterygium

102

1020

1.00

0.00

3.2

4.2

37.38

27.74

ug/l

0.14

858

Arenaviral haemorrhagic fever

0.00

0.0

4.2

—

2.62

—

Carcinoma in situ of penis

0.85

0.00

2.4

5.3

3.08

81.55

ug/l

—

Hereditary angioödema type 2

0.00

0.0

7.1

—

2.21

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS